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Abstract 
Objectives: To evaluate comprehensively the psychometric properties of 
the Functional Independence Measure (FIM) and the Functional 
Independence Measure + Functional Assessment Measure (FIM+FAM), and 
to compare their performance in stroke and multiple sclerosis (MS) patients 
and with the Barthel Index. To evaluate the conceptual models of both 
instruments using item analysis, and determine the feasibility of developing 
a short-form measure. To compare five methods of evaluating 
responsiveness. 
Design: Psychometric study. 
Subjects: 209 inpatients with a variety of neurological disorders recruited 
from three neurorehabilitation units in Southeast England. 
Method: Standard methods were used to evaluate the acceptability, 
reliability, validity, and responsiveness of the FIM and FIM+FAM. Detailed 
item analyses were performed including internal consistency, 
intercorrelations between scales and subscales, item convergent and 
discriminant validity, and principal components analysis. Item reduction 
techniques were used to develop a short-form FIM. Five methods were 
used to evaluate responsiveness: t - statistics, relative efficiency, effect 
size, standardised response mean, and the responsiveness index. 
Results: The FIM and FIM+FAM are acceptable, reliable, valid, and 
6 
responsive measures of disability in neurorehabilitation. However, they 
demonstrate no psychometric advantage over the Barthel Index, show item 
redundancy, limited item discriminant validity, and inadequate support for 
hypothesised subscales. An 8-item short-form FIM is developed that shows 
similar psychometric performance to the 18-item FIM and 30-item FIM+FAM. 
Five methods of evaluating responsiveness rank order scales similarly, but 
generate numerical estimates of different magnitude. 
Conclusions: Results demonstrate the need for a more systematic 
and rigorous approach to the development and psychometric evaluation of 
instruments before their introduction into practice to ensure the accurate 
measurement of patient-oriented outcomes in health care. This approach 
includes the development of appropriate conceptual and measurement 
models, the application of standard item analysis and item reduction 
techniques during questionnaire development, and comprehensive 
evaluation of the recommended full range of psychometric properties. 
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Chapter 1 
I ntrod uction 
1.1 The public health impact of neurological disease 
The public health impact of neurological disease is considerable. It is the 
single most important group of severely disabling disorders and accounts for 
over 90% of residents in NHS young disabled units (1, 2). In a health district 
with a population of 250,000 it has been estimated that between 4,000 and 
5,000 people will have a disabling neurological disease (3). Of these, 
approximately 1,500 people will be so disabled that they require daily help to 
remain out of institutional care. 
The incidence of disabling neurological disorders varies across conditions. 
At least 130, 000 people in the UK have a stroke each year; of the 80% who 
survive, many remain permanently disabled (4). Whilst the incidence of 
other neurological disorders is low, the prevalence is much higher (Table 
1.1). This is because many neurological diseases begin in young age and 
are incurable and progressive over many decades, but have little effect on 
longevity. They can be complex disorders with diverse effects, an 
unpredictable course, and variable manifestations, thus posing unique 
problems to patients and their families. 
25 
Neurological disorders are associated with high health service costs. In the 
UK, multiple sclerosis (MS) alone is estimated to cost £1.2 billion per year 
(5), whilst in Sweden (population 9 million), MS is reported to account for 
140,000 days absent from work due to sickness per year and 5,048 lost 
working years due to premature retirement (6). It is notable that the costs 
associated with chronic disorders increase as disability progresses (7,8). 
At present, stroke care accounts for about five per cent of all NHS 
resources, but this estimate is certain to rise given the increasing incidence 
of stroke and population ageing (9). As neurological diseases are a major 
financial concern to the NHS in the UK, rigorous evaluation of the outcomes 
of therapeutic interventions such as rehabilitation is essential. 
1.2 Measuring health outcomes in neurology 
Measurement is defined as the assignment of numbers to objects or events 
according to rules (10, 11). It is an essential component of research in the 
natural, social, or health sciences (12,13), and is considered a sine qua 
non of any science (14). In fact, Helmholtz said that "all science is 
measurement" (cited in 15, page 6). 
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Measurement in medicine combines laboratory and clinical science. It is 
aimed largely at determining whether a disease is present (making a 
diagnosis), and evaluating and quantifying the results (outcomes) of 
disease and therapeutic interventions. In the laboratory sciences, 
measurement is based on the development of appropriate instrumentation. 
Subjective judgement plays a minor role and measurement difficulties are 
largely amenable to technological solutions. In contrast, clinical 
measurement relies on human judgement with all its inherent subjectivity 
(13). 
Traditionally, health outcomes have been measured using 
pathophysiological parameters of disease such as blood tests and radiology, 
and simple clinical endpoints such as mortality rates and duration of survival 
(16). Measurement of these indicators requires little subjective judgement. 
As Streiner and Norman (13, page 1) observe: "'objective' criteria, based 
on laboratory or tissue diagnosis where possible, can be used to decide 
whether a patient has the disease, and warrants inclusion in the study. The 
investigator then waits an appropriate period of time and counts those who 
did or did not survive". 
Recently, the measurement of health outcomes has become more complex. 
There is an increasing interest in the measurement of broader, more 
27 
abstract, and more subjective aspects of health such as disability, 
handicap, emotional well-being, health-related quality of life, and patient 
satisfaction. The interest in measuring broader health outcomes indicates 
an evolving conceptualisation of health that can be attributed to several 
factors including: the World Health Organisation (WHO) definition of health 
as a "state of complete physical, mental and social well-being and not 
merely the absence of disease or infirmity" (17); developments in health 
care and changing social conditions that have altered disease epidemiology 
and led to an increase in the prevalence of chronic illnesses (18); the 
development of new interventions with marginal differences in effectiveness 
(19); increased demand from commissioners and providers of health care 
for rigorous evidence of treatment effectiveness (20); and finally, but most 
importantly, the requirement to incorporate the patient's perspective into 
health care evaluation (21). The scientific discipline of health measurement 
has developed in response to the need to supplement clinical judgement 
about patient outcomes with reliable and valid quantitative measures of 
aspects of health that were previously thought to be unmeasurable. 
A simple but useful classification (see Table 1.2) considers health outcomes 
in neurology to be either physician or patient-oriented (22). Each of these 
categories has two subcategories. This classification is not exhaustive but 
provides a framework for considering health outcomes. Pathophysiological 
parameters of disease and clinical end-points are termed physician-oriented 
outcomes because they are defined and measured by clinicians to whom the 
results are of most interest. The data generated by these measures of 
outcome provide information on the presence, natural history, severity, 
and activity of disease. This information is essential for an improved 
understanding of disease process and for the evaluation of interventions, 
and has been the traditional focus of healthcare evaluation. 
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Physician-oriented outcomes are, however, of limited use when evaluating 
treatment effectiveness. They do not provide a complete picture of disease 
impact because they offer limited information about the diverse clinical 
consequences of disease, and fail to address the effects of illness upon 
subjectively assessed functioning and well-being (23). There is some 
evidence that physician-oriented outcomes are not always related to patient-
oriented outcomes. Pertinent examples in neurology include the weak 
relationship between: lesion load quantified by Magnetic Resonance 
Imaging (MRI) of the brain and disability in MS (24), seizure frequency and 
aspects of well-being in epilepsy (25), and tremor severity and physical and 
mental health in Parkinson's disease (26). It is not surprising, therefore, 
that treatments with demonstrated effectiveness in terms of physiological 
parameters and clinical endpoints are not always associated with a positive 
impact on health status. For example, although there is incontrovertible 
evidence that the use of interferon beta in MS reduces abnormalities 
detected by MRI and relapse rate (27-29), the effect on disability is unclear 
and is associated with considerable controversy (30-33). 
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The limitations of physician-oriented outcomes can be addressed by 
supplementing these with measures of patient-oriented outcomes. Patient-
oriented outcomes are the consequences of disease and treatment that are 
considered important to patients. Although there is no consensus as to how 
patient-oriented outcomes should be classified, Gill (34) defines two 
categories: measures of health status and health-related quality of life. 
Whilst these two terms have been used interchangeably (35), it is 
preferable to try and distinguish between them because patient-oriented 
outcomes are diverse in terms of their methods of administration, the health 
constructs they measure, and the method by which they are development. 
In the classification shown in Table 1.2 the term health-related quality of life 
refers specifically to instruments that are self-report, disease-specific, 
multidimensional, and incorporate patients in their development. 
Consequently, it can be misleading for clinicians if all measures that define 
health beyond traditional indicators of biological function are referred to as 
measures of health-related quality of life. 
Patient-oriented outcomes can be administered using a variety of methods 
including self-report (also termed patient-based outcomes; 36) and rating by 
observation (e.g. health professionals or significant others) or interview. 
Whilst a number of self-report measures exist in neurology, for example the 
Parkinson's Disease Questionnaire (PDQ-39; 26) and the Subjective 
Handicap of Epilepsy Scale (SHE; 37), studies have more commonly used 
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clinician-report measures. For example, studies in MS have mostly used 
the Kurtzke Expanded Disability Status Scale (EDSS; 38), studies in stroke 
have used the Rankin Scale (39), and studies in Parkinson's disease have 
often used the Unified Parkinson's Disease Rating Scale (UPDRS; 40). 
Different methods of administering instruments offer unique perspectives 
and can give conflicting information. This has been demonstrated in a 
variety of neurological disorders including MS (41, 42), Parkinson's disease 
(43, 44), epilepsy (45), and stroke (46). As expected, agreement is 
generally better for directly observable dimensions of health such as 
physical function than for more subjective dimensions such as pain and 
emotional well-being (41,47). Whilst information about outcomes that is 
obtained from clinician-report is extremely valuable in clinical studies, it 
does not provide a complete picture of the impact of the disease and 
treatment on patients as it fails to address subjectively assessed function 
and well-being (23). As it is only patients themselves who can truly 
understand the impact of their illness, it is important to incorporate their 
self-evaluations into any formal assessment of outcomes. Indeed, ignoring 
the patients' view limits our understanding of the consequences of disease 
and treatment and limits the ability to help them (48). Consequently, 
patients' views have been termed the optimum outcome measure (49) and 
persuasive arguments have been made that all treatment evaluations should 
include direct reports from patients (50). 
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Health-related quality of life has been defined in several ways (see 51, page 
6, box 2). Whilst there is no agreed definition and considerable controversy 
as to what the term means (52-55), there is consensus that health-related 
quality of life is a multidimensional and self-perceived concept. 
Furthermore, as Fitzpatrick et al. (51) observe, the dimensions of a health-
related quality of life measure will be disease-specific. For example, 
patients with Parkinson's disease highlighted the importance of stigma and 
embarrassment associated with the illness (26). This dimension is not 
included in generic health measures such as the Medical Outcomes Study 
36-ltem Short Form Health Survey (SF-36; 56), Nottingham Health Profile 
(NHP; 57), and EuroQol (58). If these arguments are followed it seems 
appropriate to reserve the term health-related quality of life specifically for 
measures that are not only self-report and multidimensional but also 
disease-specific where the domains are derived from patients with the 
disorder. Patient-oriented outcomes that do not fulfil these criteria are 
considered measures of aspects of health status. 
In neurOlogy, it is particularly pertinent to measure patient-oriented 
outcomes as a substantial proportion of neurological disorders are 
associated with disablement, and many are chronic, progressive, and 
associated with little prospect of cure. Moreover, advances in basic 
neuroscience have resulted in the development of therapeutic interventions 
that either modify disease progression (e.g. interferon beta for MS (59), 
antiglutamates for motor neurone disease (60), acetylcholinesterase 
inhibitors for Alzheimer's disease) or reduce the extent of tissue damage 
(e.g. thrombolysis in cerebral infarction) rather than arresting the disease 
process. 
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In keeping with these developments in neuroscience, neurologists have 
recognised the importance of measuring patient-oriented outcomes when 
evaluating therapeutic effectiveness (48, 61). However, there is still strong 
evidence that physician-oriented outcomes are considered to be more 
important. In MS, for example, the effectiveness of interferons has been 
evaluated primarily by measuring disease activity in terms of brain MRI and 
relapse rate (27, 28). In stroke, the effectiveness of stroke units has been 
measured largely in terms of reduction in mortality rates (62), whilst the 
effectiveness of aspirin has been measured in terms of the prevention of 
recurrent stroke (63). For epilepsy, seizure frequency has been a 
prominent outcome in the evaluation of treatment outcomes (25), and in 
motor neurone disease (MND), the primary outcome in studies evaluating 
the effectiveness of the antiglutamate riluzole™ was duration of survival (60). 
Whilst many of these studies have used patient-oriented measures as 
secondary outcomes, it is notable that few have used patient-report 
questionnaires and several have concentrated on physical function rather 
than other domains of health. 
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The discussion above suggests that neurologists have only recently become 
interested in patient-oriented outcomes. However, there is considerable 
evidence to the contrary. For example, in the 1950's Kurtzke (64) 
developed two disability scales for MS, Rankin (39) developed a disability 
scale for stroke, and Mahoney and Barthel (65) developed a measure of 
self-care for patients with neuromuscular and musculoskeletal disorders 
undergoing rehabilitation. Similarly in the 1960's, Ashworth (66) developed 
a measure of spasticity for MS, and Hoehn and Yahr (67) developed a 
severity grading scale for the clinical manifestations of Parkinsonism. The 
fact that all of these scales are still used widely indicates their clinical 
usefulness. However, the heavy criticism of such measures (68) indicates 
that the measurement of patient-oriented outcomes in neurology has 
progressed slowly over the last 45 years. 
Three factors have contributed to this slow progress. First, there have been 
dramatic advances in basic neuroscience, particularly in neuroimaging, 
that have maintained the focus on physician-oriented outcomes. For 
example, the development of computed tomography (CT) scanning in 1972, 
and soon afterwards MRI, revolutionised the investigation of brain 
pathology. These techniques, particularly MRI, enable neurologists to 
quantify the amount of tissue destroyed or disrupted by the disease process. 
Not surprisingly, research interest has focused on MRI as an objective 
measure of treatment effectiveness (69) rather than on patient-oriented 
measures. This situation has been compounded by the absence of gold 
34 
standard measures of patient-oriented outcomes (70) and concerns that 
such data are too soft (71). However, the demonstration of only moderate 
relationships between pathology and disablement (72), and the 
demonstration that MRI changes are not accompanied by similar changes in 
disability, has resulted in a renewed appreciation of the importance of 
patient-oriented outcomes. 
A second reason for the slow development of patient-oriented outcome 
measures in neurology is that scientific attention has typically focused on 
the rigour of study design rather than measurement. For example, the MS 
literature has been more concerned with issues of blinding (73), 
randomisation (74), placebo-controls (75), sample size (76), ethics (77), 
and data analysis (78,79), rather than on the development and evaluation 
of outcome measures. This bias indicates a failure to appreciate that study 
design is directly dependent on the properties of the instruments used (80), 
and that the quality of data is dependent on the quality of the measures 
used to collect the data (81). 
The third and perhaps most important reason for the slow progression of 
patient-oriented outcome measurement in neurology is due to a general lack 
of awareness of the science of measurement. Although there is an 
enormous social sciences literature on methods for rigorously measuring 
complex constructs, it is not surprising that neurologists are generally 
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unfamiliar with the fundamental principals of the science of measurement as 
this literature is outside their domain of expertise. They have, however, 
appreciated the fundamental importance of rigorous measurement. For 
example, Kurtzke recognised that disability scales for MS should be user-
friendly (64), applicable to all patients (82, 83), and reproducible (64). He 
stated that the sum total of any patient's disabilities should be able to be 
categorised on a scale (64), and that any change in disability should be 
reflected in a change of status on that scale (64). In short, Kurtzke 
appreciated that scales should be clinically useful (capable of being 
incorporated into routine clinical practice) and scientifically sound 
(acceptable, reliable, valid, and responsive). Unfortunately, techniques 
for evaluating these properties were largely unavailable to clinicians at this 
time, which is why early scales such as Kurtzke's were not evaluated using 
standard methods. 
1.3 The science of measuring health outcomes 
If complex, abstract, and inherently subjective constructs are to be 
evaluated, then patient-oriented outcomes must be measured. As 
measurement of such outcomes will influence decisions that affect patient 
welfare, policy development, and the expenditure of public funds, it is 
essential that rigorous measurement instruments are used in health care 
evaluation (84). Because the field of health measurement provides the 
scientific basis for evaluating health outcomes, this section provides an 
overview of this discipline to measuring outcomes in neurology. 
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Although health measurement as a distinct discipline emerged in the 1980's 
(97, 111, 113), it is derived from well-established theories and methods of 
measurement in the field of social sciences whose origins can be traced to 
the mid 1800's. The basic scientific principles of measurement were 
established by mathematical psychologists interested in the human being as 
a measuring instrument. By studying how people make subjective 
judgements about measurable physical stimuli (e.g. length, weight, 
loudness), they developed the science of psychophysics: the precise and 
quantitative study of how human judgements are made (85). The 
investigation of overt responses to physical stimuli requires precise 
methods, referred to as psychophysical methods, for presenting the stimuli 
and for measuring responses (86). 
The work of psychophysicists seems far removed from health measurement. 
In fact, it established the fundamental principles of subjective measurement 
which are as equally relevant to judgements about health as to judgements 
about physical stimuli. The psychophysicists demonstrated three important 
findings about human judgement: that subjective judgement is a valid 
approach to measurement; that humans make judgements about abstract 
comparisons in an internally consistent manner; and, that accurate 
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judgements can be made on ratio rather than simple ordinal scales. It is 
notable that psychophysical methods are still used in neurology; thermal 
threshold testing is based on the principle of the just noticeable differences 
in temperature detection, and audiometry on a person's response to 
different sound frequencies. 
Whilst the psychophysicists were measuring subjective judgements about 
physical stimuli that could be independently and objectively measured and 
verified, experimental psychologists were attempting to measure human 
attributes for which there were no independent physical scales of 
measurement (e.g. intelligence, personality, attitudes) (86). Darwin's 
empirical demonstration of evolution in the Origin of Species in 1859 was 
the impetus behind the study of individual differences in psychology (87). It 
was reasoned that if animals inherit ancestral characteristics, and if 
individual differences influence their ability to adapt and survive, so 
individual differences in humans would have functional significance and 
could be inherited. Galton, who followed Darwin and believed that the 
human race could be bettered through controlled mating (eugenics), 
realised that human characteristics must be measured in a standardised 
manner before their inheritance could be studied. He coined the term 
"mental test" for any measure of a human attribute, and set about the large-
scale testing of sensory discrimination and motor function in the belief that 
people with the most acute senses would be the most gifted and most 
knowledgeable (87). However, when Galton's colleague Pearson 
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developed and applied the correlation coefficient, it became clear that 
results from these simple sensory and motor tests bore almost no 
relationship to measures of intellectual achievement, such as school grades 
(88). This finding prompted the development of the mental test movement, 
i.e. the widespread interest in the development and application of mental 
testing, and the measurement of individual differences. 
A major advance in mental testing (12) was made when Thurstone 
demonstrated that psychophysical scaling methods could be used to 
accurately measure psychological attributes (89, 90). This finding prompted 
the development of psychological (or psychometric) scaling methods, which 
are defined as procedures for constructing scales for the measurement of 
psychological attributes (85). Spurred on by the practical need to measure 
diverse outcomes, the mental test movement flourished between 1930 and 
1950 with the spread of standardised testing for assessing educational 
achievement, measuring attitudes and personality, and selecting and 
screening personnel. In addition, scientific interest in methods of testing 
led to the development of psychometrics as a prominent discipline within 
psychology and established the cornerstones of the scientific evaluation of 
measuring instruments based on reliability and validity testing (85, 91). 
The growth and development of psychometrics required standards for the 
development and evaluation of measurement instruments. The first of these 
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was introduced in 1954 by a committee of the American Psychological 
Association (APA; 92). The following year similar guidelines were prepared 
by a committee representing the American Educational Research 
Association (AERA) and the National Council on Measurement used in 
Education (NCME; 93). Subsequently, standards have been published by 
the Committee to Develop Standards for Educational and Psychological 
Testing which represents the APA, AERA, and NCME (94-96) along with a . 
commitment to the continual review of measurement standards in 
psychology and education (96). 
Thus, when health care evaluation needed methods for measuring patient-
oriented outcomes, the technology already existed. Since the 1970's, the 
focus of health care evaluation has moved to the measurement of function 
(the ability of patients to perform the daily activities of their lives), how 
patients feel, and their own personal evaluation of their health in general 
(36). The primary source of this information is standardised surveys (97), 
for which psychometric techniques of scale construction are highly 
appropriate (36). 
Two studies in the US confirmed the value of psychometric methods in 
assessing health outcomes. The Health Insurance Experiment (98), a 
randomised experiment conducted by The RAND Corporation between 1974 
and 1981, demonstrated that psychometric methods can be used to 
40 
generate reliable and valid measures for assessing changes in health status 
for both adults and children in the general population. Following on from 
this, the Medical Outcomes Study (36, 99) demonstrated that psychometric 
methods of scale construction and data collection were successful for 
measuring health status in samples of sick and elderly people. This study 
also demonstrated that psychometrically equivalent short-form measures 
could be constructed from the original longer-forms (100), thereby reducing 
respondent and administrative burden and improving measurement 
efficiency. These two pivotal studies confirmed that psychometric methods, 
borrowed from the social sciences, generated scientifically sound and 
clinically useful health measures. 
Unfortunately, psychometric methods have been slow to transfer to clinical 
practice. Spitzer (101, page 469-70) argues that this is because "many 
clinical investigators have not taken the trouble to learn from several 
decades of conceptual and methodological developments of the social 
scientist in instrument development". Certainly, many clinicians do not have 
the time to learn about instrument development and evaluation. In addition, 
the literature is not easily accessible to clinical investigators. It is directed 
primarily towards educationalists and psychologists, focuses on issues and 
topiCS of little relevance, and is incomprehensible to most readers (13). 
However, the problem may be more fundamental as many developers and 
users of health measures are not aware of the field of psychometrics or its 
relevance to health. 
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Regardless of the reasons why psychometric methods have been slow to 
transfer to clinical research, the consequence is that many instruments 
have not been adequately evaluated from a scientific point of view. Spitzer 
comments that attempts at validation (when they are present) are often 
"cursory, .... shoddilyexecuted, .... unsatisfactory, .... unconventional and 
even bizarre" (101, page 469-470). In his keynote address to the 1986 
Portuguese Conference on Quality of Life Research, Spitzer commented: 
"it is almost amusing to note the plaintive bleat with which authors bemoan 
the lack of the gold standard. They then go on smugly to do sloppy 
calibration work which tends to perpetuate the state of affairs" (101, page 
470). Spitzer, highlighting the absence of standards for health 
measurement instruments, called for published minimum criteria of validity 
agreed by a prestigious panel of inter-disciplinary methodologists, and 
introduced the notion of a reference library or a bureau of standards to serve 
all. Such criteria, he says, "should be met in order for people to be credible 
when declaring a measure valid ... we would then end up with a situation 
where some scientists could advance calibration and others application in a 
complimentary and synergistic fashion" (101, page 470-471). 
These strong words concerning the limited scientific evaluation of many 
health measurement instruments were important in alerting the clinical 
community to a crucial yet under-appreciated science. However, Spitzer's 
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views were perhaps somewhat over-stated as there were already several 
previous attempts to define frameworks for instrument evaluation and to 
tackle specific methodological issues (102-108). Subsequently, the mid 
1980's saw a rapid expansion of the health measurement literature (13, 51, 
109-127). But, as many of these writings are in disparate sources and 
much of the work represents the opinions of individuals or groups rather 
than expert consensus, the literature has come under some criticism (128). 
In 1994, the Medical Outcomes Trust (MOT) formed an independent 
Scientific Advisory Committee (SAC) to establish standards for assessing 
the scientific properties of health measurement instruments (129). This 
answered the need for consensus standards in health measurement 
produced by a prestigious inter-disciplinary panel of methodologists, and 
the development of a bureau of standards. As most users will not have the 
experience to independently evaluate the measurement qualities of 
instruments the MOT saw the need to establish the SAC with the aim of 
facilitating the universal adoption of outcome measures in health care 
through the use of high quality measurement instruments with user 
guidelines. The SAC published instrument review criteria (130) in the form 
of a concise (4 pages), pithy, unreferenced document that provides explicit 
guidelines for the methods and standards to be used to evaluate the 
success of instruments according to eight criteria: conceptual and 
measurement model; reliability; validity; responsiveness; interpretability; 
burden; alternative forms; and, cultural and language adaptations. These 
criteria are now applied to all new measures submitted to the MOT for 
inclusion in their library. 
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Since then, two complementary documents (51, 127) have been published 
in the UK. McDowell and Jenkinson (127) address aspects of instrument 
design, testing and technical guides, and publication of the completed 
instrument. They discuss key issues not covered by the MOT instrument 
review criteria (e.g. item writing, scaling methods, post development 
marketing), expand on some areas (e.g. conceptual basis for 
measurement, reliability and validity testing, interpretation of scores), and 
highlight some important methodological issues. 
Fitzpatrick et al. (51) were commissioned by the NHS Health Technology 
Assessment Programme to describe the diversity and reasons for the 
diversity of available patient-based outcome measures, and to clarify 
criteria for selecting patient-based outcome measures for use in clinical 
trials. Fitzpatrick et al. 's report is similar to the MOT's instrument review 
criteria since it discusses eight instrument selection criteria: 
appropriateness, reliability, validity, responsiveness, precision, 
interpretation, acceptability, and feasibility. Although it appears that only 
four criteria are addressed in both documents, more overlap is present. 
For example, Fitzpatrick et a/. consider the respondent and administrative 
burden of health measures under the heading of feasibility, and translation 
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and cultural applicability under the heading of acceptability. Although 
Fitzpatrick et al. do not provide explicit guidelines for the evaluation of 
health measures, their document addresses broader issues (e.g. what are 
patient-based outcomes?), is longer (74 pages), more explanatory, and 
well referenced. Despite referring to "methods of assessing health, illness, 
and benefits of health care interventions from the patient's perspective" (51, 
page iii), Fitzpatrick et al. 's criteria are equally pertinent to health outcome 
measures that, while patient-oriented, are not patient-report (e.g. observer-
rated disability measures). 
It should be noted that although the principles and standards developed in 
psychology and education are highly applicable to health, they may not be 
wholly appropriate as measurement of health differs from measurement of 
psychological and educational constructs (127). McDowell and Jenkinson 
argue that "as health is based on biological processes it includes a factual 
element and a consistent internal logical structure that is absent in ratings of 
political opinions or economic preferences" (127, page 238). 
One measurement property that is specifically pertinent to health 
measurement is responsiveness: the ability of an instrument to detect 
change in the outcome of interest (110). As one of the major goals of health 
care is to change health status, an assessment of the ability of an 
instrument to detect changes in health is an important prerequisite for the 
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use of such measures in research and clinical practice (107). However, 
unlike reliability and validity testing, there is no clear consensus as to how 
responsiveness should be measured and multiple methods have been 
proposed in the health measurement literature (110,116,131-137). 
Arguments concern the conditions under which it is appropriate to measure 
change and the most appropriate approach to the statistical analysis of 
change (138). It is important (and reassuring) to note that the same 
arguments took place in the psychology literature many years ago (139, 
140) and have not been resolved. 
1.4 Measuring health outcomes in neurorehabilitation 
Inpatient neurorehabilitation is a therapeutic intervention that provides a co-
ordinated multidisciplinary approach to managing the everyday problems of 
people with disablement associated with neurological diseases. It is 
recognised as an integral part of health care in neurology and advocated as 
an important and effective intervention (141-143). 
As there is no consensus as to how inpatient rehabilitation should be 
delivered, there are considerable variations in clinical practice (144-146). 
However, there is a common conceptual and practical framework to 
rehabilitation practice that is based on a model of comprehensive care 
(147). This model emphasises that rehabilitation extends beyond 
46 
symptomatic treatment and aims to achieve the optimal quality of life for 
people within the limits of their diseases (148). Although rehabilitation 
practice is based on clinical judgement, and its scientific basis is considered 
to be weak (149), scientific evidence is accumulating that rehabilitation is 
indeed an effective therapeutic intervention (4, 150). 
Despite variations in practice, there is consensus regarding the aims of 
rehabilitation (144-146, 151). These are: a comprehensive assessment of 
physical, psychological, and social needs; promotion of physical, 
psychological, and social adaptation to disability and handicap; facilitation 
of independence in daily activities; maximisation of patient and carer 
satisfaction; empowerment; self management; and the prevention of 
complications. The key elements of the rehabilitation process include a 
multidisciplinary team approach, individually-tailored programmes, and 
patient-centred function-based goal setting (143, 152-154). 
The WHO's International Classification of Impairments, Disabilities, and 
Handicaps (ICIDH; 155) is considered to be the cornerstone for evaluating 
the outcomes of rehabilitation (156). The ICIDH provides a theory of 
disablement and the rehabilitation process which has proved to be relevant, 
easily operationalised, and reasonably comprehensive with respect to the 
aims of rehabilitation. Each of the three concepts can be defined, modified 
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by treatment, and measured. Furthermore, as the terminology of the ICIOH 
is well established, data are universally understood (156). 
The ICIDH was developed to provide a framework for conceptualising 
disablement, the consequences of disease (157). In the 1970's, the WHO 
attempted to investigate how different countries addressed the problems 
associated with disablement. Data could not be collated as investigators 
were using neither common terminology nor an agreed set of concepts 
(158). Recognising the need for a conceptual and operational framework for 
describing and measuring the consequences of disease, the WHO 
developed the ICIDH. The conceptual basis of the ICIOH is that the 
consequences of disease can be defined in relation to different points in its 
progression from the cause (aetiology), to the active state (pathology) and 
the long-term consequences on the function of bodily organs (impairment) in 
terms of functional change (disability) and socioeconomic limitations 
(handicap) (156). 
The ICIDH classifies disablement into three conceptually distinct categories; 
impairments, disabilities, and handicaps (157). Impairment refer to any 
loss or abnormality of psychological, physiological, or anatomical structure 
or function. It represents disturbance at the organ level and indicates that a 
pathological state is exteriorised (157), that is, "become visible" (159). 
Disability refers to any restriction or lack of ability to perform an activity in 
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the manner or within the range considered normal for a human being. It 
represents the consequences of impairment on functional performance and 
activity, and indicates that the illness experience is objectified, that is, 
"externalised" (159). Handicap refers to the disadvantage to an individual 
that limits or prevents the fulfilment of a role that is normal (depending on 
age, sex, social, and cultural factors) for that individual. It represents the 
consequences of impairment and disability on an individual, and indicates 
the socialisation of an illness experience (155). Since 1993 the WHO have 
been developing the ICIDH-2: the International Classification of 
Impairments, Activities, and Participation (160). The revised version 
avoids the negative connotations associated with the terms disability and 
handicap. The neutral terms activities and participation are used and the 
negative circumstances of these dimensions are activity limitations and 
participation restrictions (159). It is intended that the ICIDH-2 will be 
completed, approved, and released during 2000 (160). 
The conceptual distinction in the ICIDH between impairment, disability and 
handicap is crucial for two reasons. First, there are clear discordances in 
severity across the three dimensions. For example, the concert pianist with 
a broken finger is mildly disabled but greatly handicapped. Second, 
impairment, disability, and handicap correspond to the obligations of 
different components of health care (157). Impairment is the primary 
concern of medical services, disability of rehabilitation services, and 
handicap of social services (157). Not surprisingly, disability has been the 
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main health outcome in the evaluation of rehabilitation. Furthermore, 
physical functioning is fundamental to health care as the degree of disability 
is a major determinant of the ability to live and work independently and the 
need for specific kinds of assistance and support (84, 161, 162). Finally, 
the effect of neurological diseases on neuromuscular function inevitably 
causes physical disability and, therefore, functional improvement is an 
important focus for evaluating the impact of neurorehabilitation (149, 163-
166). 
There are numerous instruments for measuring disability (68,84, 114, 122, 
125, 167, 168). However, it is generally agreed that the field of disability 
measurement is poorly developed and in its scientific infancy (169, 170). 
Potential users are faced with a wide choice of scales without adequate 
criteria for choosing amongst them, and with no consensus as to how 
disability should be measured (111, 164, 167). The situation is further 
complicated by conceptual problems in defining disability, the changing 
emphasis over time of health care for disabled and chronically sick 
individuals, and a general lack of psychometric expertise in instrument 
development and evaluation. 
At a conceptual level, problems with disability measurement arise from a 
lack of consensus about definitions, the range of activities to be evaluated, 
and the operational criteria used. Whilst many definitions of disability have 
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been proposed (171-173) and there is agreement that disability refers to 
disease-related restrictions in activity (174), there is no agreement 
concerning the situations in which these restrictions occur. Some authors 
(175) define disability as ability without reference to situational requirements 
(e.g. basic abilities such as reaching, bending, and dexterity). Some 
authors (176) use the term "functional limitations" to describe such 
restrictions, and define disability as restrictions in relation to specific 
domains of a person's own environment e.g. personal care and domestic 
activities. Some authors (177, 178) extend the definition of disability to 
include limitations in performance of socially defined roles and tasks within a 
sociocultural and physical environment. 
These disagreements concerning the basic definition of disability have led to 
an overlap with other health constructs. Although the WHO attempted to 
separate disability from impairment and handicap (155,157,179,180), 
these efforts have only been partially successful (181, 182). Some authors 
argue that assessing limitations in simple activities measures both 
impairment and disability (183), whilst assessing limitations in complex 
activities measures both disability and handicap (84, 98). 
The activities to be evaluated by disability measures is also an area of 
controversy. There are an unlimited number of activities and a wide variety 
of domains that can be included in disability measures. However, there is 
no agreement about either (68, 164). 
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Historically, the development of disability measures since their advent in the 
1930's (184) has accompanied changes in the emphasis of health care for 
disabled individuals rather than developments in the conceptual 
understanding of disability (84). Early disability scales, such as the Barthel 
Index (65) and the Katz Index of ADL (185), reflected information 
requirements for the institutional care of severely disabled individuals by 
measuring personal activities of daily living (ADL) such as feeding, 
dressing, and bathing. As the emphasis in health care moved towards care 
in the community and ultimately social reintegration, measurement of 
personal ADL was inadequate and wider indicators of applied functional 
ability were needed. In response to this changing need, disability scales 
were developed that included instrumental activities of daily living (IADL) 
such as outdoor mobility, cooking and shopping. Thus, disability scales 
came to encompass instruments from those limited to personal ADL to more 
complex measures of social functioning. 
The operational definitions that have been used to measure the degree of 
restriction for activities is another problem in disability measurement. For 
example, there is a difference between the potential to perform an activity 
and actual performance. Some authors (186) believe that capacity-oriented 
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questions are more meaningful in practical terms. Others (84) suggest that 
performance-oriented questions provide a more realistic assessment of 
actual disability. Some authors (187) argue for both types of measure as 
capacity-oriented questions establish the limits but are poor predictors of 
performance. 
Further problems for disability measurement are due to the fact that 
clinicians are largely unfamiliar with the rigorous scientific methods used to 
design and evaluate health measurement tools. In order to ensure rigorous 
measurement of any health outcome, it is essential that the instruments 
used are scientifically sound (97). As discussed earlier, the theoretical 
foundations and methodological concepts of measurement were developed 
in the social sciences, particularly psychology, but have been slow to 
transfer to medicine. As these techniques remain largely unavailable to 
clinicians, most disability measures have not been adequately evaluated in 
terms of their scientific properties. Scale development has been ad hoc with 
little standardisation amongst users and frequent local modifications without 
a formal evaluation of the scientific properties of the modified instrument. 
The Rankin Scale (39) provides an example of local modification of a scale 
without scientific evaluation. It was developed as a clinician-rated measure 
of functional recovery after stroke (39). The original publication documents 
a single-item measure with five response options: no significant disability, 
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slight disability, moderate disability, moderately severe disability, severe 
disability. Van Swieten et al. (188) modified the Rankin Scale by adding 
another grade (no symptoms at all), named it the Modified Rankin Handicap 
Scale, and demonstrated good inter-rater reproducibility (weighted Kappa = 
.91). Bamford et al. (189) also modified the original version of the Rankin 
scale and called it the Oxford Handicap Scale. They added a new grade (no 
symptoms), changed the names of the other grades from "disability" to 
"handicap" (e.g. "moderate disability" to "moderate handicap") and altered 
the descriptors for each grade so that they were less ambiguous and more 
focused on handicap. For example, "grade 1, no significant disability: able 
to carry out usual activities" was changed to "grade 1 minor symptoms that 
do not interfere with lifestyle". Inter-rater reliability of the Oxford Handicap 
Scale was reported (weighted Kappa = .72). Neither modification was based 
on empirically data, and none of the three measures was subjected to 
adequate psychometric evaluation. 
Amongst the many available disability measures, two are becoming 
increasingly popular among commissioners and providers of health care 
who have advocated their widespread use for the evaluation of rehabilitation 
(190). These instruments are the Functional Independence Measure (FIM; 
163) and the Functional Independence Measure + Functional Assessment 
Measure (FIM+FAM; 191). The FIM is popular because it was developed 
specifically to bring standardisation to disability measurement in medical 
rehabilitation, was marketed successfully, and was designed to be superior 
to alternatives. The FIM+FAM, an extension of the FIM, is popular 
because it provides a more thorough assessment of cognitive disabilities 
and is, therefore, most appropriate for disability measurement in patients 
with neurological diseases. As the widespread use of the FIM and 
FIM+FAM has important implications for clinical practice, research, and 
health policy, it is essential that they meet rigorous criteria for both 
scientifically sound and clinically useful measurement. 
1.5 The Functional Independence Measure (FIM) and Functional 
Independence Measure + Functional Assessment Measure 
(FIM+FAM) 
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In 1983 the US Federal Government attempted to introduce mandatory 
prospective payments for medical services (Social Security Amendments 
Public Law 98-21 cited in 165). However, the absence of uniform and 
reliable methods of measuring the outcomes of chronic care contributed to 
the exemption of medical rehabilitation facilities from this system (192, 193). 
Recognising the inability to evaluate and compare different clinical practices 
in rehabilitation, a Task Force was formed to develop a Uniform National 
Data System for Medical Rehabilitation (UDS). The purpose of the UDS was 
to improve the effectiveness and efficiency of rehabilitation services in the 
United States. The FIM (Table 1.3) was developed as the disability 
measurement instrument of the UDS (163, 194). In attempting to 
standardise rehabilitation practices, the FIM has succeeded in becoming 
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widely used throughout the world, not only as part of the UDS, but also as 
a stand alone measure of disability. By 1993, FIM data on 150,000 patients 
had been entered into the UDS database (195). 
In developing the FIM, the Task Force reviewed 36 published functional 
assessment instruments and other unpublished instruments that would be 
helpful in identifying items that measure function. From this process, the 
Task Force selected the most common and useful functional assessment 
items (163). Initially 16 items and a four-point response scale were chosen. 
This instrument was piloted for face validity and ease of administration 
(163). Following this process one item was discarded, two items were 
added, one of the response options was divided into three intermediate 
levels, another response option was added, and minor (unexplained) 
revisions were made (163). This version of the FIM was then used in the 
trial phase to evaluate inter-rater reliability, validity, precision, and time 
and cost to administer. Subsequently, another item has been added. 
The FIM+FAM (Table 1.4) is an extension of the FIM. Clinicians using the 
FIM in brain injured patients felt that the five items of the FIM cognitive scale 
provided only a modest assessment of communication, cognitive, and 
psychosocial disabilities (191). In order to provide a more thorough 
evaluation of these domains of disability, a group at the Santa Clara Valley 
Medical Centre developed a 12-item adjunct, the Functional Assessment 
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Measure (FAM) (191). The FAM items (nine to assess cognitive disabilities 
and three to assess motor disabilities) were designed to be added to the 
FIM in order to produce the FIM+FAM, a more comprehensive and sensitive 
instrument (191). They were not intended to be a stand alone measure. 
Like the FIM, the FIM+FAM has been received enthusiastically, reflecting 
the need for a measure of cognitive disabilities. Although it was originally 
intended as a measure for neurological disabled patients with brain injury, 
the developers of the FIM+FAM now recommend its use for all patients 
undergoing rehabilitation (Karyl Hall personal communication July 1997). 
1.5.1 Description 
The FIM (Table 1.3) is an 18-item instrument that measures disability in 
terms of burden of care. The items comprise two scales, a motor scale 
containing 13 items and a cognitive scale containing five items. Each of the 
two FIM scales has two or more subscales. The motor scale has four 
subscales: self-care (six items), sphincter care (two items), transfer (three 
items), and locomotion (two items). The cognitive scale has two subscales: 
communication (two items) and social cognition (three items). Each item 
has a seven-point response scale (Table 1.5: 1 = maximum disability, 7 = 
minimum disability) and is rated by consensus opinion of the rehabilitation 
team treating the patient on the basis of observing patient behaviour for up 
to 72 hours. Items are added to generate summary scores for the six 
subscales, motor and cognitive scales, and a total score. The FIM is 
designed to be discipline-free and, therefore, can be used by any trained 
rehabilitation professional (163, 165, 166). 
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Guidelines for rating FIM items are contained in the manual (196). For each 
item there are two aids for rating: a written text and a flow diagram (decision 
tree). Appendix 1 provides the guidelines for rating the grooming item and 
illustrates how they are individually tailored. 
The FIM+FAM (Table 1.4) is a 30-item instrument with the same conceptual 
basis and 7-point response scale as the FIM. The items comprise two 
scales, a motor scale containing 16 items and a cognitive scale containing 
14 items. Each of these two FIM+FAM scales has three or more subscales. 
The motor scale has four subscales: self-care (seven items), sphincter care 
(two items), transfer (four items), and locomotion (three items). The 
cognitive scale has three subscales: communication (five items), 
psychosocial adjustment (four items), and cognitive function (four items). 
Ratings are made by team consensus from behavioural observation for up to 
10 days and items are added to generate summary scores for the seven 
subscales, motor and cognitive scales, and a total score. Like the FIM, 
the FIM+FAM is designed to be discipline-free so that any trained 
rehabilitation professional can administer the scale (Karyl Hall, personal 
communication 1993). As for the FIM, the common 7-point response scale 
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is individually tailored for each item. A manual is available to guide rating of 
the 12 FAM items. 
1.5.2 Clinical usefulness 
By 1993 the clinical acceptance of the FIM was not in doubt. In the US, it 
was being used in approximately 600/0 of rehabilitation facilities and already 
the Uniform Data System had collected FIM data for nearly 150, 000 
patients (195). In addition, two studies have indicated that the FIM can be 
administered by team consensus (197) or by an individual rater (163) in less 
that 15 minutes. Less data were available for the use of the FIM+FAM in the 
US, or the FIM and FIM+FAM in the UK. However, the first FIM and 
FIM+FAM workshop in the UK in December 1994, organised by the British 
Society of Rehabilitation Medicine (190), was attended by over 400 
delegates. A UK FIM+FAM Users Group was formed in 1995 to develop 
guidelines for use of both instruments and provide regular training 
workshops. This Group continues to expand (personal communication 
1999: FIM+FAM co-ordinator, Regional Neurorehabilitation Unit, Northwick 
Park Hospital, Harrow, Middlesex). 
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1.5.3 Scientific rigour 
In the 15 years since the FIM was developed and 10 years since the 
FIM+FAM was developed, the field of health measurement has advanced 
considerably. It is understandable, therefore, that the examinations of the 
measurement properties of the two instruments reported in the original 
publications (163, 191) now appear somewhat limited. Even though data 
have been reported subsequently, when these are compared with 
recommended standards both instruments remain poorly evaluated from the 
scientific perspective. 
The original publications about the FIM and FIM+FAM reported little 
information about their scientific properties. In fact, for the FIM, no 
empirical data were reported but future psychometric analysis plans were 
outlined (163, 165, 166). For the FIM+FAM, evidence for reliability was 
reported in terms of percent agreement for item scores generated by 20 
observers from three patient narratives (191). Results demonstrated 
considerably worse agreement for the FAM items than for the FIM items. 
Even though this statistical method does not correct for chance agreement 
(198, 199), it raised concerns that the inter-rater reliability of the FIM+FAM 
might be less than acceptable. Evidence for the validity of the FIM+FAM is 
also found in Hall et al. 's study (191). Although not stated explicitly by the 
authors, correlations between the FIM+FAM and other measures provide 
evidence of convergent and discriminant construct validity. 
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Subsequent to their use in clinical practice, data supporting the scientific 
properties of the FIM and FIM+FAM have accumulated. For the FIM, 
evidence supports its reliability (194, 195, 200-207), validity (191, 197, 201, 
207-212) and, latterly, its responsiveness (207,213). For the FIM+FAM, 
although studies have addressed the reliability of the items (214, 215) and 
validity of the total score (216), little is known about its psychometric 
properties. The results of these studies are discussed in more detail later. 
Despite the accumulation of evidence for the psychometric properties of the 
FIM and FIM+FAM, the evaluation of both instruments is limited when these 
studies are compared with the standards recommended by the Medical 
Outcomes Trust (130), McDowell and Jenkinson (127), and Fitzpatrick et 
al. (51). Although it is widely known that measurement properties are largely 
independent of each other (107, 217), but dependent on the sample in 
which they are examined (51,127,130), only one recent study of the FIM 
has examined some aspects of its reliability, validity, and responsiveness 
in the same sample (207). In fact, there have been no comprehensive 
psychometric evaluations of either the FIM or FIM+FAM. Similarly, despite 
multiple reliability studies of the FIM, no study has comprehensively 
evaluated all types of reliability that are appropriate for multi-item observer-
rated measures. Likewise, there are no comprehensive validity studies for 
either measure. Those reported have concentrated on convergent validity 
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rather than proposed a validation strategy based on explicit logic (127), and 
examined the extent to which empirical data supported hypotheses 
concerning the behaviour of the measure and its components. There are 
few responsiveness data. 
Further studies of the FIM and FIM+FAM are required. For example, none 
have compared the performance of the FIM or FIM+FAM in different disease 
groups. Although designed to be generic measures, and theoretically 
usable with any disorder in many different settings (218), this assumption 
has not been tested for either the FIM or FIM+FAM. This is particularly 
important as both instruments cover a limited range of the disability 
spectrum. Similarly, no studies have examined whether the FIM is superior 
to the Barthel Index developed more than 30 years previously, or whether 
the FIM+FAM is superior to the FIM in neurologica"y disabled patients. To 
justify their introduction into clinical practice, new instruments need to 
demonstrate superior measurement properties to existing measures. Also, 
no studies have examined the extent to which empirical evidence supports 
the conceptual models of disability defined by the FIM and FIM+FAM. 
Examination of the scale and subscale structure of a measure, and the 
procedures followed to create scale and subscale scores, is necessary to 
justify the selection and grouping of items and the reporting of summary 
scores (130). This is important given concerns raised by others about the 
conceptualisation of disability (111, 164). Fina"y, the feasibility of 
developing short-form versions of the FIM or FIM+FAM has not been 
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examined. As patients are sick or disabled, and staff resources are limited 
it is necessary to maximise the measurement efficiency of an instrument: 
maximum information from the minimum number of items (219). 
1.6 Summary and study objectives 
, 
Disability due to neurological disease has a considerable public health 
impact which justifies the importance of measuring disability as an outcome 
of neurorehabilitation. Rigorous disability measurement can be achieved 
using psychometric methods of scale construction. The FIM and FIM+FAM 
have an important role in the future of disability measurement and the 
evaluation of rehabilitation. However, their psychometric properties have 
not been extensively studied. Responsiveness is an important property of 
health measures. Unlike reliability and validity, there is no consensus as to 
how it should be measured. 
The first objective of this study is to evaluate comprehensively the 
psychometric properties of the FIM and FIM+FAM. This includes a 
comparison of the performance of both instruments in stroke and MS 
patients and with the 8arthellndex. The second objective of this study is to 
evaluate conceptual models of disability through detailed item analyses of 
both measures. This includes an examination of the feasibility of developing 
a short-form measure. The third objective of this study is to compare 




2.1 Study sites 
Patients were recruited to the study at three clinical sites: the 
Neurorehabilitation Unit (NRU), National Hospital for Neurology and 
Neurosurgery; the Regional Neurorehabilitation Unit (RNRU), Homerton 
Hospital; and the Rehabilitation Research Unit (RRU), Southampton 
General Hospital. 
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These three neurorehabilitation units treat different patient populations. The 
NRU treats predominantly patients with multiple sclerosis (40% of 
admissions in 1993) whereas the RNRU treats predominantly patients with 
head injury, and the RRU treats predominantly patients with complex stroke. 
At the NRU and RNRU the second most common diagnostic group is 
complicated stroke; at the RRU this is head injury. All three units provide 
inpatient rehabilitation for any neurological disorder in all age groups and all 
are allied to regional neurosurgical units. Collaboration of these three units 
aimed to ensure that this study encompassed a wide spectrum of 
neurological disease, addressed high incidence pathologies and common 
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causes of severe and progressive disability in predominantly young people, 
maximised patient numbers, and included a broad range of rehabilitation 
programmes. 
2.2 Recruitment 
The recruitment strategy differed at each unit due to the varying rates of 
patient turnover. Methods of recruitment were pre-determined to limit 
selection bias. At the NRU, a maximum of two patients was entered into the 
study every Monday over a period of 18 months. The first two patients who 
arrived on that day were selected. At the RNRU, a maximum of one patient 
each week was entered into the study until the target number of 60 subjects 
was attained. Of the planned admissions each week, the person whose 
surname was nearest to the beginning of the alphabet was selected. At the 
RRU, all patients admitted over a one-year period were invited to 
participate in the study. 
Ethical approval was obtained from the ethical committees of each study site 
and informed consent was obtained before any patient was enrolled. In 
circumstances where patients were not able to give informed consent (e.g. 
due to cognitive impairment or aphasia), written consent was obtained from 
the next of kin. Any patient over 16 years of age, with any neurological 
disorder, who consented to participate was eligible for entry into the study. 
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Patients were excluded if they declined to participate, were admitted for 
respite care rather than rehabilitation, or had an expected duration of stay 
of less than two weeks. Appendix 2 contains the ethical approval, consent 
form, and patient information leaflet for each of the three clinical sites. 
2.3 Rehabilitation intervention 
Each of the three units provides intensive, multidisciplinary, goal-oriented, 
inpatient rehabilitation. Whilst standard techniques and methods are used, 
the nature of the rehabilitation process is tailored to individual patients 
according to diagnosis, disabilities, handicaps, needs, and goals. 
Rehabilitation might include any combination of the following professional 
disciplines: medicine, physiotherapy, occupational therapy, 
neuropsychology, speech and language therapy, nursing, and social work. 
On admission to the rehabilitation unit, each patient is assigned to a 
treating team consisting of a member from each professional discipline 
required for the rehabilitation treatment plan. A typical team consists of a 
nurse, physiotherapist and occupational therapist. Neuropsychologists, 
speech and language therapists, and social workers are part of the treating 
team when appropriate. Treating teams range in size from three to six 
persons and are responsible for consensus rating of the FIM, FIM+FAM, 
and 8arthellndex. 
2.4 Health outcome measures 
Table 2.1 provides details about the outcome assessment in this study, 
including the method of administration, assessment point, and site of 
administration for all health outcome measures. 
2.4.1 FIM and FIM+FAM 
The FIM (163) and the FIM+FAM (191) measure disability in terms of 
independence in functional tasks. Both measures are fully described in 
Chapter 1. 
2.4.2 Barthel Index 
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The Barthel Index (65, 220) measures disability as independence in 10 
personal activities of daily living such as feeding, dressing, and bathing 
(Appendix 3). Items are rated on a 2-point (two items), 3-point (six items), 
or 4-point scale (two items) and summed to give a total score ranging from 0 
(maximum disability) to 20 (minimum disability). Rating is from observation 
by any health professional. In this study the Barthel Index is rated by team 
consensus opinion of the treating multidisciplinary team of each patient. 
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The Barthel Index is widely used as a measure of disability, has been 
described as "the best activities of daily living measurement scale" (221), 
and is recommended as a benchmark against which other instruments 
should be evaluated (149). Multiple versions of the original instrument exist 
(222-225). Wade's version (226) is used in this study as this is the one 
advocated by the Royal College of Physicians of London (227) and the 
version on which most psychometric data are available. 
A number of studies have addressed the reliability (221,223,224,228-232), 
validity (220,225,233-235), and responsiveness (236) of the Barthel Index. 
Although the Barthel Index is widely regarded as a reliable and valid 
measure of disability, a closer analysis of the data shows that the 
psychometric properties have not been comprehensively evaluated and 
different studies apply to different versions of the instrument. Notable 
deficiencies are in the assessment of construct validity and responsiveness 
which have received little attention. However, the available data are very 
encouragmg. 
2.4.3 Modified Barthel Index 
The Modified Barthel Index (237), shown in Appendix 4, is an alternative 
form of the Barthel Index. This was used at one site (RNRU) where it was 
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developed to meet the needs of their patient population and is in routine 
clinical practice. The only modification involves changes in the guidelines 
for scoring; the 10 items and rating scale of the Barthel Index remain 
unchanged. Preliminary psychometric data suggest that the modified 
Barthel Index retains validity and inter-rater reliability (237). Modified 
Barthel Index ratings were made at the same time and in the same manner 
(consensus opinion of the treating team) as FIM and FIM+FAM ratings. 
2.4.4 Kurtzke Expanded Disability Status Scale (EDSS) 
The EDSS (38) is an MS-specific, neurologist rated instrument grading 
disability on a continuum of 0 (normal neurological examination) to 10 (death 
due to MS) in 20 steps (Appendix 5). It is scored on the basis of the 
neurological history and examination and was developed specifically to 
enable comparisons of disability within and between patients. The EDSS is 
the most widely used measure of outcome in clinical trials of MS (27, 28, 
238). Kurtzke also developed the Functional Systems (FS, 82) which 
consists of eight scales representing different functions of the central 
nervous system: pyramidal, cerebellar, brainstem, bladder I bowels, 
sensory, mental, visual, and other. The FS and EDSS are intimately 
related. The FS delineates the type and severity of eight neurological 
impairments and the EDSS represents the sum of a person's neurological 
dysfunction (82). Hence, comments about FS scores appear in the 
guidelines for rating the EDSS. 
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Studies evaluating the psychometric properties of the EDSS report variable 
reliability (207,239,240), support convergent validity (207), and 
demonstrate limited responsiveness (70, 207). However, a close 
examination of the literature indicates that no comprehensive evaluations of 
the EDSS have been undertaken. 
In this study, EDSS and FS data were collected only at the NRU as this was 
the only unit regularly treating patients with MS. All ratings were undertaken 
by a single neurologist (JH) on the basis of clinical examination and patient 
interview. Only EDSS data are reported. 
2.4.5 Office of Population Censuses and Surveys Disability 
Scales (OPCS) 
The OPCS (175) measure disability in 13 dimensions: locomotion, reaching 
and stretching, dexterity, personal care, continence, seeing, hearing, 
communication, behaviour, eating I drinking I digestion, disfigurement, 
intellectual functioning, and consciousness (Appendix 6). Disability in each 
dimension is graded on an individually weighted scale and is rated from 
patient interview. OPCS scores can be reported in three ways: 13 scores 
for the individual dimensions of disability, an overall weighted disability 
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severity score, and an overall disability severity category. In all 
circumstances high scores indicate high disability. The weighted overall 
disability severity score ranges from 0.5 to 21.4 and is computed from the 
three highest ratings on the 10 core dimensions (eating I drinking I 
digestion, disfigurement, and consciousness dimensions are excluded). 
This severity score then translates to a disability severity category between 
1 and 10 in single point increments. 
OPCS scales were developed for use in a national UK survey to investigate 
the prevalence and severity of all forms of disability in the adult population 
(175). The scales are based on the conceptual framework of the WHO 
International Classification of Impairments, Disabilities, and Handicaps 
which categorises (155). 
A limited psychometric evaluation of the OPCS scales has been undertaken 
(234). Inter-rater reliability between two independent raters was high (r = 
0.96; n = 120). The type of correlation coefficient used is not reported. 
Evidence for convergent construct validity was provided by demonstrating a 
high correlation with the Barthel Index (rho = 0.82; n = 265). Evidence for 
comparable responsiveness of the OPCS and Barthel Index was provided by 
demonstrating significant improvements in mean scores for two groups of 
patients whose level of disability was expected to change, but not in a third 
group whose level of disability was not anticipated to change. 
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In this study opes disability data were collected on a subsample of patients 
involved in the study at two units, NRU and RRU. Ratings were based on 
patient interview with the study co-ordinator at the relevant unit. Overall 
weighted disability severity scores are reported. 
2.4.6 London Handicap Scale (LHS) 
The LHS (241) is a self-report generic measure evaluating handicap as 
degree of disadvantage on six items: mobility, physical independence, 
occupation, social integration, orientation and economic self-sufficiency 
(Appendix 7). Each item is rated on a 6-point scale (1 = minimum handicap, 
6 = maximum handicap) and raw scores are weighted using part utilities. 
Item scores can be reported as a profile of disadvantages or summed to 
generate an overall handicap severity score. 
The LHS shows adequate internal consistency (alpha coefficients: .67 to 
.88) and test-retest reproducibility (Intraclass correlation coefficients: .72 to 
.91) for group comparison studies. Evidence supports content validity, 
construct validity (internal consistency, factor analysis, group differences, 
convergent and discriminant validity). Responsiveness was determined by 
examining pre and post intervention scores in nine studies, effect sizes 
ranged from 0.07 to 0.85 (241). 
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The manual provides extensive information on the development and 
evaluation of the instrument as well as comprehensive guidelines for its use 
and the interpretation of data (241). The LHS has been approved by the 
Medical Outcome Trust (242). 
2.4.7 Medical Outcomes Study 36-ltem Short-Form Health 
Survey (SF-36) 
The SF-36 (56) is a self-report, generic measure of health status in eight 
dimensions (Appendix 8). Two summary measures, the Mental and 
Physical Component Summary Scales, can also be generated (243). The 
reliability and validity of the eight dimensions and two summary measures 
have been extensively evaluated with favourable results and are 
summarised elsewhere (56,243-247). 
Scores for the eight SF-36 scales range from 0 (poorest health) to 100 (best 
health) (56). The two summary measures are scored to have a mean of 50 
and standard deviation of 10 in the general US population (248). SF-36 
data were only collected at the NRU and RRU. In this study summary 
scores are reported used. 
2.4.8 General Health Questionnaire (GHQ) 
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The GHQ (249) is a self-report measure of psychological distress (Appendix 
9). The 28-item version used in this study has four subscales each 
containing seven items: somatic symptoms, anxiety and insomnia, social 
dysfunction, and severe depression. Items are rated on a dichotomous 
rating scale and summed to generate subscale and total scores (250). High 
scores indicate greater psychological distress. Evidence supports the 
reliability, convergent and discriminant validity of the GHQ-28. Several 
other studies address the validity of the various versions of the GHQ (84, 
114,249,250). No responsiveness data are available. 
2.4.9 Measures of neuropsychological functioning 
Measures of neuropsychological functioning included two measures of 
global cognitive decline, three measures of reasoning ability, and two 
memory measures. The two measures of global cognitive decline were: 
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2.4.9.1 Mini-Mental State Examination (MMSE) 
The MMSE (251) measures cognitive state on the basis of 11 items in five 
domains: orientation (2 items), registration (1 item), attention and 
calculation (1 item), recall (1 item), and language (6 items) (Appendix 10). 
The MMSE, designed as a simplified form of the cognitive mental status 
examination, concentrates only on the cognitive aspects of mental functions 
and is in widespread clinical use. The MMSE is rated by interview, with the 
points scored for correct responses summed to generate a total score 
ranging form 0 (maximum cognitive impairment) to 30 (no cognitive 
impairment registered on the scale). Values less than 24 are considered 
indicative of cognitive impairment. 
Limited psychometric data are available for reliability and validity. High 
levels of test-retest reliability (r = .89 to .99) and inter-rater reliability (r =.83) 
have been reported (251). High correlations between the MMSE and the 
verbal 10 (r =.78) and performance 10 (r =.67) of the Wechsler Adult 
Intelligence Scale provides evidence for convergent construct validity. 
Evidence supports group differences construct validity of the MMSE. 
Responsiveness has been evaluated by examining change scores pre and 
post treatment. For patients with uncorrectable brain disease (dementia), 
there was no significant change between pre and post treatment results. A 
small but significant difference is shown in patients with depression, and a 
large and significant difference is shown in patients with depression 
associated with severe cognitive impairment (251). 
2.4.9.1 Wechsler Adult Intelligence Scale-Revised 
Version (WAIS-R) 
The WAIS-R (252) is a measure of general intellectual level. It comprises 
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11 subsets divided into verbal (six subsets) and performance (five subsets) 
subscales. Scores are derived for verbal, performance, and full scale IQ. 
The WAIS-R gives a good indication of the current level of intellectual 
function (253), with high scores indicating high intellectual performance. 
Only the verbal subscale (information, comprehension, vocabulary, 
similarities of pairs of words, arithmetic, and digit span) was used as 
neurological disability can affects patients on the performance subtest (253). 
There is good support for the reliability and validity of the WAIS-R (252). 
The three measures of reasoning ability were: 
2.4.9.3 Halstead Book Category Test (HBCT) 
The HBCT (254) is a measure of abstracting ability (reasoning) and consists 
of 208 visually presented items in seven subsets. For six of the subsets, 
items are organised on the basis of different principles. The subject's task is 
to figure out the principle presented in each set and signal the answer. The 
77 
seventh subset is made up of previously shown items and tests the subject's 
recall. The score is the number of errors. Therefore, high scores indicate 
poor reasoning ability. A number of studies demonstrate the reliability and 
validity of the HBCT (254). 
2.4.9.4 Wisconsin Card Sorting Test (WCST) 
The WCST (255) is a measure of reasoning, specifically abstract behaviour 
and set-shifting ability. Subjects are given a pack of 64 cards on which are 
printed one to four symbols (triangle, star, cross, circle) in one of four 
colours (red, green, yellow, blue). No two cards are identical. The 
subject's task is to place the cards, one by one, under four stimulus cards 
(one red triangle, two green circles, three yellow squares, and four blue 
stars) according to the principle that the subject must deduce from the 
examiner's responses. The test begins with colour, then shifts to form, 
then to number. High scores indicate good reasoning ability. The reliability 
and validity of the WCST have been demonstrated in a number of studies 
(255). 
2.4.9.5 Verbal and Spatial Reasoning Test (VESPAR) 
The VESPAR (256) is a test of reasoning specifically designed for patients 
with neurological disability. Three types of inductive reasoning are 
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examined: categorisation, analogy, and series completion (253). Each of 
these three problems is arranged in matched sets of 25 verbal and spatial 
items. The matched design allows clear conclusions to be drawn if either 
verbal or spatial stimuli lead to poor performance. This is because the 
difference is unlikely to be due to different test procedures or task demands 
and most likely to be due to a specific deficit in either verbal or spatial 
reasoning (253). The stimuli were selected for their appropriateness for 
neurological patients. The verbal items use words less vulnerable to 
acquired language deficits and the spatial items do not depend on fine 
visual acuity or shape discrimination. No manual dexterity is required and 
there are no penalties for slow performance (256). High scores indicate 
good reasoning ability. Evidence supports the reliability and validity of the 
VESPAR (256). 
The two measures of memory were: 
2.4.9.6 California Verbal Learning Test (CVL T) 
The CVL T (257) is a measure of interaction between verbal memory and 
conceptual ability. It provides information about a subject's use and 
effectiveness of learning strategies and the capacity for concept formation 
(258). Subjects are presented with lists of 16 items and the number of items 
recalled is counted. High scores indicate good memory function. Several 
studies have demonstrated the reliability and validity of the CVLT (257, 
258). 
2.4.9.7 Recognition Memory Test (RMT) 
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The RMT (259) measures two aspects of memory: verbal (recognition 
memory for words) and non-verbal (recognition memory for male faces) 
memory. Each test contains 50 stimulus items and 50 distractors. Only the 
recognition memory test for words was used in this study as neurological 
disorders often result in visual disabilities. First, subjects are presented 
with the 50 one-syllable high frequency stimulus words (one every three 
seconds) and required to say whether they like each word as a method of 
ensuring their attention. Then, 50 pairs of words are shown which include 
one of the original words. They are required to identify the word seen 
previously. Recognition Memory Tests are a relatively pure test of memory 
function as they place few demands on other cognitive functions (253). High 
scores indicate good memory function. Reliability and validity have been 
demonstrated for the RMT in a number of studies (258,259). 
All measures of neuropsychological functioning, except for the MMSE, 
were administered only at the NRU as this was the only clinical site with a 
full-time neuropsychologist. One neuropsychologist administered all these 
measures. The MMSE was administered by the study co-ordinator at two 
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sites (NRU and RRU) on admission and discharge. MMSE scores of less 
than 18 were used as a cut-off to evaluate whether a patient would be able 
to adequately complete self-report questionnaires. 
2.4.10 Staff-report transition question of change in disability 
Staff perceptions of change in disability due to rehabilitation were measured 
using a transition (131, 260; Appendix 11). On discharge from each 
neurorehabilitation unit, the treating multidisciplinary team for each patient 
was asked to indicate on a 7 -point scale (1 = marked deterioration, 4 = no 
change, 7 = marked improvement) the extent of their change in disability 
due to rehabilitation. 
2.5 Training of FIM and FIM+FAM raters 
In the few days before the study commenced, FIM and FIM+FAM raters at 
the three study sites underwent a structured training programme that was 
developed locally at the NRU. All three clinical sites were already using the 
FIM routinely. The formal training programme lasted one day. First, there 
was lecturer on the importance of measuring outcomes, the development of 
the FIM and FIM+FAM, and the need for this study. Next, there were four 
training sessions: basic scoring principals, scoring cognitive items, scoring 
communication items, and scoring physical and self-care items. Each of 
these interactive sessions consisted of vignettes (simple, short, written 
scenarios of patient performance) based on actual clinical examples and 
video footage of patients whose consent had been obtained in advance. 
Ongoing training of new staff was undertaken by the study co-ordinator at 
each clinical site. Appendix 12 reports the results of a small study, 
undertaken during training, to determine the effect of the training 
programme on rater proficiency. 
2.6 Data collection 
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Recruitment at NRU took place between June 1994 and February 1996 (21 
months); at RNRU between June 1994 and October 1995 (17 months); and 
at RRU between July 1995 and May 1996 (11 months). At each study site 
data were collected on admission and discharge. Collection and storage of 
data were the responsibility of each study co-ordinator. Details about the 
outcome measures used are provided in Table 2.1. 
Within 48 hours of admission to the neurorehabilitation unit, consenting 
patients were interviewed by the study co-ordinator to obtain 
sociodemographic and diagnostic data. Where necessary (e.g. diagnosis), 
these data were substantiated by review of the medical notes. At this 
interview, instruments rated by the study co-ordinator (e.g. MMSE, EDSS) 
were administered and self-report questionnaires (e.g. SF-36) were 
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distributed. Instruments rated by consensus opinion of the treating 
multidisciplinary team (e.g. FIM and Barthel Index) were rated 
independently from other admission data at a team meeting. The timing of 
the team meeting to decide consensus rating differed for each unit. Team 
ratings were made three or four days after admission at the NRU, two days 
after admission at the RNRU, and seven to ten days after admission at the 
RRU. These differences reflected the usual clinical practice of each unit. 
Within 72 hours of discharge, the study co-ordinator at each unit distributed 
self-report questionnaires and administered co-ordinator rated measures. 
Measures rated by team consensus opinion were collected independently at 
a discharge meeting along with the transition question. Raters did not have 
access to admission scores. As the SF-36 concerns health status "in the 
past four weeks" discharge SF-36 ratings were collected by postal survey 
four weeks after the date of discharge. 
All ratings made by team consensus opinion did not include the study co-
ordinator. All information was collected on separate sheets of paper, 
gathered and stored by the unit co-ordinator. Admission data were not 
available for review at discharge. Where guidelines are available, all 




Psychometric Evaluation of the FIM and FIM+FAM: 
Method and Results 
This chapter reports the method and results for the psychometric evaluation 
of the FIM and FIM+FAM. This chapter includes: a comprehensive 
evaluation of the acceptability, reliability, validity, and responsiveness of 
the FIM and FIM+FAM; a comparison of the performance of the FIM and 
FIM+FAM in patients with stroke and with MS; and a comparison of the 
psychometric properties of the FIM, FIM+FAM, and Barthel Index. 
3a Method 
3a.1 Psychometric evaluation of the FIM and FIM+FAM 
Standard psychometric methods are used to determine the acceptability, 
reliability, validity, and responsiveness of the FIM and FIM+FAM. Identical 
analyses are used for both instruments and all analyses are performed 
separately for total, motor, and cognitive scales. 
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3a.1.1 Acceptability 
An instrument is considered acceptable when it can be successfully 
incorporated into clinical practice and when score distributions adequately 
represent the true distribution of health status in the sample (261). An 
empirical indicator of whether an instrument can be incorporated into clinical 
practice is proportion of missing data which is calculated as the percentage 
of possible responses that are missing (262). To the extent that the criteria 
defined below concerning score distributions are satisfied, items and scales 
are considered acceptable. 
Score distributions are reported for FIM and FIM+FAM item and scale 
ratings at admission. Item score distributions are considered acceptable 
when four criteria are met: all response categories are endorsed (ideally 
with equal numbers of patients endorsing each response option for 
maximum discrimination (85); maximum endorsement frequencies, 
calculated as the percentage of responses for the most frequently endorsed 
response category, do not exceed the generally recommended criterion of 
800/0 (13); and item floor and ceiling effects, calculated as the percentage 
of responses for the lowest and highest scores, respectively, are minimal. 
Widely accepted criteria for maximum item floor and ceiling effects do not 
exist. Two published recommendations are 75% (263), and 90% (264). 
However, the choice of neither is substantiated. As maximum endorsement 
frequency and item floor and ceiling effects are logically related, the 
criterion of 800/0 was chosen for this study. 
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Scale score distributions are considered acceptable when: scores span the 
full scale range (97); mean scores are situated near the scale mid-point 
(265); scale floor and ceiling effects, calculated as the percentage of 
responses for the minimum and maximum scores, respectively, are 
minimal; and score distributions are not excessively skewed (246). There 
are no widely accepted criteria for maximum floor and ceiling effects and 
extent of skewness for scales. Authors have recommended that scale floor 
and ceiling effects should not exceed 150/0 (266) or 20% (267). In this study 
the more stringent criterion of 150/0 is chosen. Holmes et al. 's 
recommendation that skewness statistics should be within the -1 to +1 range 
(263) is adopted. 
3a.1.2 Reliability 
In classical test theory it is assumed that the scores generated by a 
measurement instrument, observed scores, include two components: a 
true score and random error (217). The relationship between observed 
scores (0), true scores (t), and random error (e) is expressed as: 
0= t+ e 
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The reliability of an instrument is defined as the extent to which it is free 
from random error (85). As reliability increases (or decreases), scores are 
more (or less) consistent and, therefore, measured variance reflects true 
variance in the construct (or random error) (47). In keeping with this 
definition, reliability coefficients estimate the proportion of total score 
variance that is due to true score variance (85). 
In this study two types of reliability are examined: internal consistency and 
reproducibility. These are the most appropriate methods for estimating the 
reliability of multi-item observer-rated instruments like the FIM and 
FIM+FAM (268). In addition, standard errors of measurement are 
calculated from reliability coefficients to determine confidence intervals 
around individual patient scores. 
3a. 1.2. 1 Internal consistency 
Internal consistency is the extent to which items are interrelated (217). If the 
items in a scale are assumed to measure the same underlying construct, 
the intercorrelations among the items represent the reciprocal of error (269). 
Three measures of internal consistency are examined: corrected item-total 
correlations, Cronbach's alpha coefficients, and homogeneity coefficients. 
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Corrected item-total correlations are Pearson's product-moment correlations 
between item and scale scores after the item of interest has been removed 
to prevent spurious estimates (85, 270). These analyses indicate the 
strength of relationship between item and scale scores. The higher the 
correlation, the higher the shared variance and the higher the reliability of 
the item. A range of recommended minimum values for item-total 
correlations has been suggested: .20 (113); .30 (271); .40 (246). In this 
study .30 is used as the minimum criterion for item-total correlations. 
Cronbach's alpha coefficients estimate the internal consistency of a group of 
items from their average intercorrelation (272). Alpha coefficients indicate 
the proportion of the variance of the sum of the items which is comprised of 
the sum of the covariances of each pair of items (273). Alpha coefficients 
exceeding .70 are considered acceptable for scales used to make group 
comparisons, whereas the more stringent criterion of .90 to .95 is required 
for scales used to make individual comparisons (130, 217). In this study 
alpha coefficients are reported with single sided (lower limit) confidence 
intervals (273, 274) to determine the likelihood that obtained values are 
significantly greater than the recommended criteria (273). Alpha coefficients 
are also reported for scales with items omitted one by one to assess the 
influence of individual items on internal consistency. 
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As alpha coefficients are related to scale length (275-277) Ware et a/. (97) 
recommend that homogeneity coefficients are also reported as indices of 
internal consistency. Homogeneity coefficients are the average item-
intercorrelations for scales; it is recommended that values exceed .30 (265). 
They are of particular value when comparing the internal consistency of 
instruments with differing numbers of items. 
3a.1.2.2 Reproducibility 
Reproducibility is the agreement between two or more ratings of the same 
patient (130, 271). Two types of reproducibility are examined: intra-rater 
and inter-rater. 
Intra-rater reproducibility is the agreement between two or more ratings 
made by the same observer of the same patient. It provides an estimate of 
the stability of scores and within-rater variability over time. For the FIM and 
FIM+FAM, intra-rater reproducibility is estimated by determining the 
agreement between ratings made by the same multidisciplinary team for the 
same patients on two different occasions. The interval between the two 
ratings is three to five days. This interval was chosen specifically to 
minimise rater memory bias and the likelihood of change in disability 
between the two ratings. These influences tend to over- and underestimate 
instrument reproducibility, respectively (278). 
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Inter-rater reproducibility is the agreement between ratings on the same 
patients made by different observers at approximately the same point in 
time. It provides an estimate of between-rater variability in scoring. As the 
FIM and FIM+FAM are rated by team consensus, inter-rater reliability 
should be estimated by examining the agreement between ratings generated 
by different teams. As it was not possible to introduce this methodology into 
the routine clinical practice of each study unit, an alternative approach was 
used. The team consensus rating is compared with a rating made by the 
study co-ordinator at each unit. Study co-ordinators' ratings are based on 
information obtained from independent interviews with each member of the 
team before the team consensus rating was made. 
Intra-rater and inter-rater reproducibility analyses are undertaken on 
subsamples of patients. Patients were allocated to either intra-rater or inter-
rater reproducibility samples prior to entry into the study. All reproducibility 
analyses are reported as intraclass correlation coefficients, i.e., the 
percentage of total variance that results from true variance among patients 
(273, 279-282). Estimates of variance are obtained from repeated measures 
analysis of variance under random effects models (80). Lower limit 
confidence intervals are calculated according Fleiss' formula (80). Minimum 
recommended standards for reproducibility are. 70 for group comparisons 
and .90 to .95 for individual comparisons (130, 271). 
3a.1.2.3 Standard error of measurement (SEM) 
Standard errors of measurement are reported because of the difficulty in 
interpreting reliability coefficients for individual patient scores (13). 
Measurement error introduces uncertainty about individual scores, the 
magnitude of which is indicated by the SEM (85). 
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Standard errors of measurement are estimates of the standard deviation of 
scores obtained with repeated administrations of an instrument to the same 
individual (217). Therefore, they are direct indicators of the probable extent 
of random error associated with scores and can be used to calculate 
confidence intervals around individual patient scores (85). Standard errors 
of measurement and 950/0 confidence intervals (950/0CI) around true scores 
are calculated as follows: 
SEM = SO x y' (1 - reliability) 
95%CI = true score +/- 1.96 SEM 
where: SO = standard deviation of admission scores; 
reliability = a reliability coefficient (discussed further below). 
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It should be noted that confidence intervals are symmetrical around the true 
score for an individual but asymmetrical around their observed score. This 
is because scores tend to be biased, high scores tending to be biased 
upward and low scores downward. Estimates of unbiased (true) scores are 
the average scores that would be obtained if the instrument was 
administered on multiple occasions (217). 
In this study 95% confidence intervals around individual scores are 
calculated using alphas and intra-rater reproducibility coefficients as the 
estimates for reliability. These reliability coefficients are used as each has a 
different interpretation. When confidence intervals are calculated from 
alpha coefficients they estimate cross-sectional measurement error at a 
single point in time and reflect instrument accuracy for individual patient 
assessment and clinical decision making (128). When confidence intervals 
are calculated from intra-rater reproducibility coefficients they estimate 
longitudinal measurement error and gauge the likelihood that an individual 
patient's change in score is attributable to random error rather than true 
change (266). 
3a.1.3 Validity 
An instrument is valid if it measures the construct it purports to measure 
(93). Whilst valid measurement of a physical parameter such as length is 
easy to verify, valid measurement of health constructs like disability is not 
an all-or-none property. Under these circumstances evidence must be 
gathered to determine the degree to which an instrument measures the 
construct it purports to measure. 
There are three types of validity: content, criterion, and construct (93). 
Construct validity is the principal method used in this study. Content 
validity, the adequacy of item sampling, is not assessed as this is usually 
an aspect of instrument development. It is supported by appropriate 
methods of item generation and selection (271). Criterion-related validity, 
the degree to which a measure correlates with a gold standard (the 
criterion), is not assessed as gold standard measures of disability in 
patients with neurological disease do not exist (164). 
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Construct validity is the process used to establish the validity of a 
measurement instrument when no criterion or universe of content is 
accepted as entirely adequate to define the attribute being measured (283). 
Construct validity involves the generation of hypotheses concerning the 
construct the instrument is purported to measure and examination of the 
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extent to which empirical data support these hypotheses (283). Although 
there are several methods for determining construct validity, two categories 
have been distinguished by Bohrnstedt (14). He termed them internal and 
external construct validity. Internal construct validity involves statistical 
analyses of scale scores to determine if hypotheses concerning the 
theoretical structure of the instrument are supported. In contrast, external 
construct validity examines the relationships between scores on the 
instrument and other variables or measures to determine if hypotheses 
concerning the interpretation of scores are supported by empirical data. In 
this study evidence for both types of construct validity is examined. Other 
authors have categorised construct validity in a similar manner to Bohrnstedt 
and termed them psychometric and clinical test of validity (245), and logical 
and empirical analyses of validity (284). 
3a. 1.3. 1 Internal construct validity 
Two types of analyses are undertaken to examine the internal construct 
validity of FIM and FIM+FAM scales: internal consistency and 
intercorrelations between scales. 
Evidence for the internal consistency of FIM and FIM+FAM scales also 
provides evidence for internal construct validity as it indicates the extent to 
which items are interrelated. In order to combine items to generate a score, 
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items should be homogeneous, that is, measure different aspects of the 
same attribute. Internal consistency is a necessary but not sufficient 
condition for homogeneity (unidimensionality) (285, 286). Construct validity 
is supported when minimum requirements for internal consistency, outlined 
above in the section on reliability, are satisfied. 
Intercorrelations between scales of the FIM and FIM+FAM, as evaluated by 
Pearson's product-moment correlations, indicate the strength of 
relationships between the total, motor, and cognitive scales for each 
instrument. Construct validity is supported when the scales of an instrument 
are shown to be measuring related but different dimensions, and when the 
magnitude and pattern of the intercorrelations between scales conform to 
hypotheses based on theoretical considerations. Four specific predictions 
are tested concerning the intercorrelations between FIM and FIM+FAM 
scales. First, all intercorrelations between scales should be substantial (> 
.50) as all these scales measure different aspects of the same construct. 
Second, correlations between motor and cognitive scales of both 
instruments are expected to be in the .50 to .70 range, as these scales are 
purported to measure distinct subconstructs of disability. Third, because 
the total scales contain the motor and cognitive scales, correlations 
between the motor and cognitive scales of both instruments are predicted to 
be lower than correlations between each of these two scales and the total 
scales. Fourth, the correlation between the motor and total scales of the 
FIM is predicted to be higher than the correlation between the cognitive and 
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total scales. This is because of greater item overlap between the motor and 
total scales (13 items) than between the cognitive and total scales (5 items). 
For the FIM+FAM, the motor and cognitive scales are predicted to have 
similar correlations with the total scale as the degree of item overlap is 
similar (16 and 14 items respectively). 
3b.1.3.2 External construct validity 
Two types of analyses are undertaken to determine the external construct 
validity of FIM and FIM+FAM scales: correlations with other variables and 
known group discrimination. 
Examining Pearson's product-moment correlations between FIM and 
FIM+FAM scales and other variables aims to provide evidence for 
convergent and discriminant validity. High correlations with measures of 
similar constructs indicates that an instrument measures the construct it is 
purported to measure and provides evidence of convergent validity. Low 
correlations with measures of dissimilar constructs indicates that an 
instrument does not measure a construct other than the one it is devised to 
measure and provides evidence of discriminant validity (283). Correlations 
are examined between FIM and FIM+FAM scales and other measures 
including: four measures of disability; measures of handicap, health status 
and psychological distress; seven measures of neuropsychological 
96 
functioning; and age. To the extent that observed associations agree with 
predicted relationships based on theoretical considerations, external 
construct validity is supported. 
The expected direction, strength, and patterns of correlations between 
each FIM and FIM+FAM scale and other measures are presented in Table 
3.1. In general, predictions are that greater disability will be associated with 
more handicap and poorer health status and psychological well-being. 
Similarly, greater cognitive disability will be associated with greater 
impairment as measured by neuropsychological tests. 
As shown in Table 3.1, predictions concerning the strength and pattern of 
relationships between FIM and FIM+FAM scales and other measures are 
based on the conceptual similarity of the health constructs measured. They 
are defined approximately as strong (r> .70), moderate to substantial (.30 
< r < .70), or weak (r < .30) (245). For example, the FIM total score is 
predicted to be highly correlated with other measures of disability, 
moderately correlated with measures of handicap and physical health status, 
and poorly correlated with measures of mental health status and 
psychological well-being. In addition, predictions are made concerning the 
order of magnitude of correlations between each validating instrument and 
the total, motor, and cognitive scales of the FIM and FIM+FAM (see right 
hand column of Table 3.1). For example, correlations with measures of 
physical disability are predicted to be highest for the motor scales and 
lowest for the cognitive scales. 
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For each FIM and FIM+FAM scale, two types of evidence are examined to 
evaluate convergent validity. First, correlations for each FIM or FIM+FAM 
scale with measures of the same disability subconstruct should exceed 
correlations with all other measures. For example, the highest correlations 
for the FIM motor scale should be with other measures of physical disability. 
Second, the magnitude of correlations should conform to predictions as 
specified above. For example, correlations between the FIM motor scale 
and other measures of physical disability should exceed .70 
Three types of evidence are examined to evaluate the discriminant validity 
of each FIM and FIM+FAM scale. First, each scale is expected to 
discriminate disability from other health constructs. That is, for all FIM and 
FIM+FAM scales correlations with measures of other related but different 
constructs such as handicap, health status, and psychological distress 
should be low to moderate. Furthermore, the pattern of these correlations 
should be consistent with predictions. For example, correlations with 
measures of handicap should exceed correlations with measures of 
psychological distress as disability is conceptually more similar to handicap. 
Second, FIM and FIM+FAM scores should be uncorrelated with age. Third, 
correlations among the FIM and FIM+FAM scales should exceed 
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correlations between these scales and measures of other health constructs 
(Le. handicap, psychological distress and health status). This is because 
all FIM+FAM scales are measuring aspects of disability. Correlations 
between the cognitive scales of the FIM and FIM+FAM and measures of 
neuropsychological functioning are predicted to be substantial but not very 
high (>.80). This is because the cognitive scales of the FIM and FIM+FAM 
measure disability whereas measures of neuropsychological functioning 
measure individual cognitive impairments such as memory and reasoning. 
Group differences (or known-groups) construct validity is supported when an 
instrument demonstrates the ability to detect differences in groups known or 
hypothesised to differ in the construct being measured (283). This is usually 
undertaken by the statistical comparison of mean scores for the groups of 
interest (287). In this study, the ability of FIM and FIM+FAM scores to 
discriminate between groups defined on the basis of staff-rated improvement 
and diagnostic category is tested. 
The first hypothesis is that change scores for all FIM and FIM+FAM scales 
will be higher for groups defined as having undergone greater improvement 
in disability during neurorehabilitation. To test the hypothesis, FIM and 
FIM+FAM change scores are compared for patients whose level of 
improvement is rated by staff on a 4-point scale (1 = no change, 4 = marked 
improvement). External construct validity is supported when a stepwise 
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increase in the magnitude of FIM and FIM+FAM change scores parallels 
staff-rated improvement. The evidence for construct validity is stronger 
when these differences are statistically significant. Mean change scores for 
the different groups are compared using one-way analysis of variance with 
Duncan's multiple range tests for post hoc comparisons. Results are 
reported in terms of the magnitude and statistical significance of change 
scores as clinical and statistical significance are not necessarily equivalent 
(288,289). 
The second hypothesis is that stroke patients will demonstrate greater 
improvement after rehabilitation than MS patients as measured by all three 
FIM and FIM+FAM scales. This is because the overwhelming majority of MS 
patients studied have progressive disease, whereas stroke is an acute 
neurological event from which some recovery typically occurs. To test this 
hypothesis FIM and FIM+FAM change scores are compared for stroke and 
MS patients using independent sample t -tests. 
3a.1.4 Responsiveness 
Responsiveness is defined as the ability of an instrument to detect clinically 
significant change in the construct being measured (110). There is a debate 
as to whether responsiveness should be considered an aspect of validity 
(290,291) or a separate psychometric property (112). Several methods 
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have been proposed for evaluating responsiveness, but there is no clear 
consensus as to which is the optimal method (292). Most methods examine 
scores at two points in time, usually before and after an intervention known 
to influence the construct being measured. Responsiveness is assessed on 
the basis of the magnitude of the standardised change score. 
In this study FIM and FIM+FAM admission and discharge scores are 
compared. Responsiveness is determined by calculating an effect size 
statistic, of which there are several types (134, 291, 293). In this study, 
effect size is defined as the mean change score (admission minus discharge 
scores) divided by the standard deviation of the admission scores (132). 
Larger effect sizes indicate greater responsiveness. Values are interpreted 
using Cohen's criteria (small = .2, medium = .5, large = .8; 132, 293). In 
addition, the responsiveness of the FIM and FIM+FAM is compared with the 
Barthel Index, Modified Barthel Index, EDSS, and OPCS by comparing 
effect sizes. 
3a.2 Comparison of the psychometric properties of the FIM and 
FIM+FAM in stroke and MS patients 
The aim of these analyses is to compare the acceptability, reliability, 
validity, and responsiveness of FIM and FIM+FAM scales in patients with 
stroke and MS. 
3a.2.1 Acceptability 
Acceptability of FIM and FIM+FAM scales in stroke and MS patients is 
compared by examining score distributions. Criteria for acceptability are 
outlined above. 
3a.2.2 Reliability 
Reliability of FIM and FIM+FAM scales in stroke and MS patients is 
compared in terms of internal consistency, intra-rater and inter-rater 




Validity of FIM and FIM+FAM scales in stroke and MS patients is compared 
by examining the internal construct validity (internal consistency and 
intercorrelations between scales) and external construct validity 




Responsiveness of FIM and FIM+FAM scales in stroke and MS patients is 
compared by examining effect sizes. 
3a.3 Comparison of the psychometric properties of the FIM, 
FIM+FAM and Barthel Index 
The aim of these analyses is to compare the acceptability, reliability, 
validity, and responsiveness of the FIM, FIM+FAM, and Barthel Index in 
order to determine the incremental validity (294) of each scale relative to the 
others. Although all three instruments are disability measures, they 
measure distinct aspects of disability. Consequently, measures of the same 
aspect of disability are compared: FIM and FIM+FAM total scales are 
compared as measures of global disability; FIM and FIM+FAM motor scales 
and the Barthel Index are compared as measures of motor disability; and 
FIM and FIM+FAM cognitive scales are compared as measures of cognitive 
disability. 
3a.3.1 Acceptability 
Acceptability is compared in terms of the percentage of missing data and 
descriptive statistics for scale scores for all three measures. 
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3a.3.2 Reliability 
Reliability is compared in terms of internal consistency and reproducibility 
for all three measures. Reproducibility data are not available for the Barthel 
Index as this was not part of the original study protocol. 
3a.3.3 Validity 
Validity is compared in terms of internal and external construct validity for all 
three measures. 
3a.3.3.1 Internal construct validity 
Internal construct validity is compared by examining internal consistency. 
Internal consistency is compared on the basis of corrected item-total 
correlations, Cronbach's alphas, and homogeneity coefficients. 
Homogeneity coefficients are particularly useful for comparing the internal 
consistency of these three measures as alpha coefficients are influenced by 
their differing scale lengths. 
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3a.3.3.2 External construct validity 
External construct validity is compared by examining concurrent validity, 
convergent and discriminant validity, and group differences validity. 
Concurrent validity is the extent to which the measure of a construct predicts 
(or is correlated with) another measure of the same construct evaluated at 
the same point in time (217). The extent to which scales measuring the 
same aspect of disability (e.g. FIM and FIM+FAM motor scales and the 
Barthel Index) predict each other is determined by the magnitude of the 
Pearson's product-moment correlation. Convergent and discriminant validity 
are compared by examining correlations between scales purporting to 
measure the same aspect of disability and other measures of disability, 
handicap, health status, psychological well-being, and neuropsychological 
functioning administered at the same time. Correlations with age are also 
compared. The extent of the similarity between the magnitude and pattern 
of these correlations for measures of the same aspect of disability indicate 
how similar they are with respect to their convergent and discriminant 
validity. 
Group differences validity is compared by examining the relative 
measurement precision of comparable scales for all three measures. 
Measurement precision is the extent to which an instrument can detect small 
differences in the construct being measured (36). Using the group 
differences method of examining validity, the measurement precision of an 
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instrument is defined as the degree to which it separates the groups relative 
to within-groups variance (100). The F -statistic, derived from a one-way 
analysis of variance, takes both of these attributes into account as it defines 
the ratio of between-groups (systematic) variance to within-group (error) 
variance. Therefore, the higher the F -statistic the greater the 
measurement precision (245). By comparing different instruments in the 
same sample, relative measurement precision can be estimated by the ratio 
of pairwise F -statistics (F for one measure divided by F for another). 
Consequently, relative measurement precision estimates, in proportional 
terms, how much more (or less) precise one measure is compared to 
another in detecting group differences (100). 
The importance of measurement precision lies in the trade-off between 
sample size and statistical power. This fact has implications for clinical trials 
as better measurement precision in detecting group differences means 
higher power for a fixed sample size or fewer patients to achieve a fixed 
level of statistical power (133). That is, for a given sample size the greater 
the measurement precision of an instrument the more likely it is to 
demonstrate statistically Significant results. Alternatively, using instruments 
with better measurement precision in detecting group differences means that 
smaller samples can be used to detect statistically significant results (133). 
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The relative measurement precision of the FIM, FIM+FAM, and Barthel 
Index is evaluated by comparing their ability to discriminate between 
patients on the basis of different levels of staff-rated improvement in 
disability. Improvement in disability from admission to discharge for each 
patient is rated by staff as minimal, moderate, or marked. For each of 
these three groups (minimal, moderate or marked improvement) mean 
change scores are calculated for the FIM, FIM+FAM, and the Barthel 
Index. Mean change scores for each scale are compared using one-way 
analysis of variance to generate an F -statistic. From each group of scales 
being compared (total, motor, or cognitive scales), one measure is chosen 
arbitrarily as the standard and the others are compared using pairwise F-
statistics: i.e. F -statistic for the scale of interest divided by F -statistic for 
the arbitrary standard. The relevant FIM scale in each group of scales being 
compared is used as the arbitrary standard and, therefore, will be assigned 
a relative measurement precision of 1. For other scales, values> 1 (or < 1) 
indicate in percentage terms greater (or lesser) measurement precision than 
the comparable FIM scale. 
3a.3.4 Responsiveness 
Responsiveness is compared on the basis of effect sizes. For measures of 
the same aspect of disability, the instrument with the largest effect size is 
considered the most responsive. 
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3b Results 
Results are presented in five sections followed by a summary. The first 
section describes the patient samples. The next two sections present 
results of analyses of the psychometric properties of the FIM and FIM+FAM, 
respectively. The fourth section presents results of analyses comparing the 
psychometric properties of the FIM and FIM+FAM in stroke and MS patients. 
The final section presents results of analyses comparing the psychometric 
properties of comparable scales of the FIM, FIM+FAM, and Barthel Index. 
3b.1 Patient samples 
3b.1.1 Descriptive characteristics of patient samples 
A total of 214 neurologically disabled inpatients from three sites were invited 
to participate in the study. Two patients declined to participate: both were 
from the RRU and no specific reasons were given. Three of the 212 
patients who agreed to participate in the study were discharged within one 
week of admission and were, therefore, withdrawn for failing to meet 
inclusion criteria. One patient self-discharged, and two patients were 
transferred due to clinical deterioration; all three patients were from NRU. 
The final study sample consisted of the remaining 209 patients. 
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Table 3.2 presents characteristics of patients in the total sample and at the 
three clinical sites compared to the 1994 local population treated between 
1st April 1994 and 31 st March 1995. Men and women are evenly represented 
and patients across a wide range of ages are included. Stroke, MS, and 
head injury patients are the three largest diagnostic groups, constituting 
80.4% of the sample. The remaining 19.60/0 of the total sample represents a 
mix of neurological disorders. 
The mean length of stay for patients in the total sample was approximately 
nine weeks (range 11 days to 14 months). Length of stay calculations only 
include patients who completed their planned in-patient rehabilitation 
programme (n = 194; 92.8% of sample). Of the 15 patients who did not 
complete their planned rehabilitation, seven were still in-patients at the end 
of data collection, six were transferred for acute hospitalisation, one self-
discharged, and one was transferred to another rehabilitation unit for 
ongoing rehabilitation. 
The three clinical sites differ in terms of numbers of patients enrolled, 
proportion of men, casemix, and length of stay. The NRU has the largest 
sample, a large proportion of MS patients, and the shortest length of stay. 
These findings reflect the longer duration of recruitment at the NRU and its 
expertise in short stay rehabilitation of MS patients. The RNRU has the 
109 
highest proportion of head injury patients and of men and the longest length 
of stay. The RRU has the highest proportion of stroke patients and of 
women and a medium length of stay. 
Samples from the three clinical sites are largely representative of their 
respective 1994 populations. The NRU sample has more MS patients and 
fewer patients with other diagnoses than the local population. The RNRU 
sample is similar to the 1994 local population as almost all patients were 
enrolled into the study. The RRU has fewer males and head injury patients, 
more stroke patients, and fewer patients in the other three diagnostic 
categories compared with the 1994 local population. The small size of the 
RRU sample and the fact that most patients with head injuries are male are 
likely to have contributed to these differences. 
3b.1.2 Characteristics of patients with stroke and MS 
Table 3.3 presents characteristics of patients with stroke and MS which form 
the two largest diagnostic groups in the study sample. Differences between 
the two groups are compared qualitatively rather than statistically as they 
are expected to differ considerably. Consistent with clinical expectation, the 
two diagnostic groups differ in gender, age, and length of stay, and are not 
distributed equally among the three clinical sites. Multiple sclerosis 
predominantly affects young women, whereas stroke tends to affect men 
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and women more equally, especially in the younger age group. Length of 
stay for MS patients in this study is short as most of these patients have 
progressive disabilities and rehabilitation is highly focused towards specific 
aims. In addition, all MS patients are at the NRU where short stay 
rehabilitation is a feature. In contrast, stroke patients in this study have 
longer stays reflecting the impact of acute disability and the potential for 
gradual recovery. 
In the stroke subgroup, 720/0 have unilateral hemispheric lesions, 200/0 
have subarachnoid haemorrhage, 6 % have brainstem stroke, and 2% 
have bilateral hemisphere stroke. Of the hemispheric strokes, 730/0 are 
infarcts and 590/0 involve the dominant hemisphere. In the MS subgroup, 
the disease type is secondary progressive in 810/0, primary progressive in 
110/0, and relapsing remitting disease in 8%. These figures are similar to 
population statistics for stroke (295) but not for MS reflecting the greater 
disability that is associated with the progressive form of MS. 
3b.1.3 Characteristics of patients in the intra- and inter-rater 
reproducibility subsamples 
Table 3.4 presents a comparison of FIM and FIM+FAM admission scores for 
patients in the intra- and inter-rater reproducibility subsamples with patients 
in the total sample. There are no statistically significant differences between 
either subsample and the total sample. These results indicate that the 
samples used to assess intra and inter-rater reproducibility are 
representative of the total sample. 
3b.2 Psychometric evaluation of the FIM 
3b.2.1 Acceptability 
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The fact that there are no missing FIM data indicate that the instrument has 
been successfully incorporated into clinical practice at the three study sites. 
Table 3.5 presents descriptive statistics and floor and ceiling effects for FIM 
items at admission. Responses are well distributed across response 
categories. Only one response category for one item (feeding - response 3) 
is not endorsed by any patient. Maximum endorsement frequencies range 
from 19.1 % for problem solving to 56.0% for stairs (mean 36.0%). Item 
floor effects range from 7.2%for comprehension to 56.00/0 for stairs (mean 
19.4%). Item ceiling effects range from 1.9% for shower/tub transfer to 
47.4% for comprehension (mean 26.2%). Maximum endorsement 
frequencies, floor effects, and ceiling effects do not exceed the maximum 
criterion of 80% used in this study. These results indicate a relatively even 
distribution of disabilities, as defined by FIM items, in the study sample. 
112 
Table 3.6 presents descriptive statistics, floor and ceiling effects, and 
skewness statistics for FIM scale scores at admission. Scores span almost 
the entire range with mean scores near to and consistently higher than the 
scale mid-point. Floor and ceiling effects are generally small and none 
exceed the maximum recommended criterion of 150/0. All skewness 
statistics are within the recommended range of -1 to +1. These results 
indicate that FIM scales adequately represent the range of severity of 
disabilities in patients in this sample, and demonstrate good variability in 
the constructs they measure. 
3b.2.2 Reliability 
3b. 2. 2. 1 Internal consistency 
Table 3.7 presents reliability estimates for FIM scales. High internal 
consistency is demonstrated for all three FIM scales. Item-total correlations 
exceed the required minimum standard of .30, indicating that all items are 
substantially linearly related to scale scores. Alpha coefficients exceed .90 
for all scales, indicating that each scale satisfies minimum internal 
consistency criteria for both group and individual comparisons. When items 
are deleted, alpha coefficients do not increase substantially (results not 
shown), indicating that no individual items compromise the internal 
consistency of FIM scales. Homogeneity coefficients exceed .30 and, 
therefore, satisfy minimum requirements. 
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3b.2.2.2 Reproducibility 
High reproducibility is also demonstrated for all three FIM scales. Intraclass 
correlation coefficients for both intra- and inter-rater reproducibility exceed 
.90, indicating a high degree of stability of FIM scores over time and 
agreement between raters. Minimum standards for individual and group 
comparisons are satisfied. 
Despite the high internal consistency and reproducibility reported above, 
the estimated 950/0 confidence intervals for individual scores are large. For 
example, the cross-sectional 95% confidence interval for an individual 
patient's FIM total score is +/- 11.5 points. This confidence interval of 23 
points on the FIM comprises 21.3% of the possible score range and 
indicates that individual scores must be interpreted with caution. Similarly, 
the longitudinal confidence intervals indicate that FIM total scores for an 
individual patient will have to change by at least 8.1 points for the change to 
be considered statistically significant. In other words, there is a high 




3b.2.3.1 Internal construct validity 
Evidence for the internal consistency of FIM scales (see Table 3.7) also 
supports their construct validity as high internal consistency supports scale 
homogeneity. As predicted, item-total correlations and homogeneity 
coefficients are higher for motor and cognitive scales than for the total scale. 
These results provide evidence to support two distinct subconstructs, motor 
and cognitive disability, within the overall construct of disability. 
Table 3.8 presents intercorrelations between the three FIM scales. 
Intercorrelations are moderate to high, indicating that the three scales are 
measuring related constructs and thus providing evidence for convergent 
validity. As predicted, the correlation between the motor and cognitive 
scales is in the range .50 to .70 and is lower than the correlations between 
each of these two scales and the total scale. These results indicate that the 
motor and cognitive scales measure related but separate constructs and 
provide evidence for discriminant validity. As predicted the correlation 
between the motor and total scale exceeds the correlation between the 
cognitive and total scale. The correlation between the motor and total scales 
is very high. This raises a concern about whether the motor and total scales 
indeed measure distinct constructs. However, the correlations between the 
motor and total scales with the cognitive scale are quite different, indicating 
that the motor and total scales are measuring related but different 
constructs. 
3b.2.3.2 External construct validity 
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Table 3.9 presents correlations between FIM scales and measures of 
disability, handicap, health status, psychological distress, and age. Table 
3.11 presents correlations between FIM scales and neuropsychological 
measures. 
The FIM total scale is highly correlated with the four disability measures and 
moderately correlated with neuropsychological measures and measures of 
handicap and physical health status. Correlations with mental health status 
and psychological distress are low. The direction, magnitude, and pattern 
of these correlations are consistent with predictions and provide evidence 
for the convergent and discriminant validity of the FIM total scale as a 
measure of global disability. 
The FIM motor scale is also highly correlated with all four measures of 
disability, and is moderately correlated with neuropsychological measures 
and measures of handicap and physical health status. Correlations with 
mental health status and psychological distress are low. Correlations 
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between the FIM motor scale and neuropsychological measures are lower 
than correlations between the FIM total scale and neuropsychological 
measures. Correlations with measures of disability, handicap, and physical 
health status are marginally but consistently higher for the FIM motor than 
total scale. These findings provide evidence for the convergent and 
discriminant validity of the FIM motor scale as a measure of motor disability. 
Correlations between the FIM cognitive scale and other disability measures 
are generally moderate and lower than those found for the FIM total and 
motor scales. Correlations between the FIM cognitive scale and 
neuropsychological measures are moderate or high, and generally higher 
than those for either the total or motor scale. Correlations with handicap, 
physical and mental health status and psychological distress are low. 
Unlike the FIM total and motor scales, the cognitive scale has low 
correlations with handicap and physical health status. These findings 
provide evidence for the convergent and discriminant validity of the FIM 
cognitive scale as a measure of cognitive disability. 
Finally, all three FIM scales are uncorrelated with age. This finding 
provides further evidence of discriminant validity for the FIM. 
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Tables 3.11 and 3.12 provide evidence for group differences validity of FIM 
scales. Table 3.11 presents mean FIM change scores associated with 
different levels of staff-rated improvement in disability. Staff ratings of 
change in disability are available for 181 patients: data for 13 patients are 
missing and two persons whose disability worsened were excluded. Results 
are presented for the remaining 179 patients. Negative change scores 
indicate improvement in disability at discharge. As hypothesised, a 
stepwise pattern of improvement in disability as measured by all three FIM 
scales is associated with statistically significant improvement in disability as 
assessed by staff ratings. 
Post hoc comparisons reveal that for all FIM scales, change scores for 
patients rated as markedly improved are significantly higher (p < .05) than 
for patients rated as moderately improved. In addition, change scores for 
patients rated as moderately improved are significantly higher (p < .05) than 
for patients rated as minimally improved. However, there are no significant 
differences (p > .05) in FIM change scores between patients rated as 
minimally improved and those rated as showing no improvement. These 
results provide evidence that FIM scores are able to detect differences 
between groups distinguished by staff-rated improvements in disability. 
Table 3.12 presents FIM change scores for stroke and MS patients. Change 
scores for FIM total and motor scales are Significantly higher for stroke than 
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for MS patients, but do not differ for cognitive scale scores, indicating 
greater improvement in stroke patients. These results provide evidence that 
FIM scores are able to detect differences between groups distinguished on 
the basis of diagnosis. 
3b.2.4 Responsiveness 
Table 3.13 presents FIM admission, discharge, and change scores with 
responsiveness reported as effect sizes. All change scores are statistically 
significant (p < 0.001). Effect sizes indicate that the responsiveness of the 
FIM motor and total scales is medium, whilst the responsiveness of the 
cognitive scale is small. 
Table 3.14 shows the relative responsiveness of the FIM compared with 
other disability measures. Effect size calculations show that the FIM motor 
and total scales, FIM+FAM motor and total scales, Modified Barthel Index, 
and Barthel Index have similar medium responsiveness. The 
responsiveness of the opes is small to medium. The responsiveness of the 
cognitive scales of the FIM and FIM+FAM is similar and small. The 
responsiveness of the EDSS is very small. 
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3b.3 Psychometric evaluation of the FIM+FAM 
3b.3.1 Acceptability 
There are no missing FIM+FAM data indicating that the instrument has been 
successfully incorporated into clinical practice at all three study sites. Table 
3.15 presents descriptive statistics and floor and ceiling effects for FIM+FAM 
items at admission. Responses are well distributed across response 
categories. Only one response category for one item (feeding - response 3) 
is not endorsed by any patient. Maximum endorsement frequencies range 
from 18.7% for adjustment to limitations to 70.8% for swallowing (mean 
37.2%). Item floor effects range from 3.3% for swallowing to 56.00/0 for stairs 
(mean 17.7%). Item ceiling effects range from 1.9% for showerltub transfer 
to 70.8% for swallowing (mean 28.40/0). Maximum endorsement frequencies 
and floor and ceiling effects do not exceed the maximum criterion of 80% 
used in this study. These results indicate a relatively distribution of 
disabilities, as defined by the FIM+FAM items, in the study sample. 
Table 3.16 presents descriptive statistics, floor and ceiling effects, and 
skewness statistics for FIM+FAM scales at admission. Scores span almost 
the entire possible ranges, with mean scores near to and but consistently 
higher than the scale mid-point. Floor and ceiling effects are small, ranging 
from 00/0 to 1.90/0. Skewness statistics are within the recommended range of 
-1 to +1. These results indicate that FIM+FAM scales adequately represent 
the range of severity of disabilities in the study sample and demonstrate 
good variability in the constructs they measure. 
3b.3.2 Reliability 
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Table 3.17 presents reliability estimates for FIM+FAM scales. High internal 
consistency and reproducibility are demonstrated for all three scales. Item-
total correlations and homogeneity coefficients exceed minimum 
requirements. Alpha coefficients and intraclass correlation coefficients for 
intra- and inter-rater reproducibility are very high (all approach 1.00), 
exceeding minimum requirements for individual and group comparison 
studies. Confidence intervals for individual scores are large. For example, 
the cross-sectional 950/0 confidence band for FIM+FAM total scores is 31 
points, 17.20/0 of the score range, indicating that individual patient scores 
should be interpreted cautiously. Similarly, longitudinal 950/0 confidence 
intervals indicate that a FIM+FAM total score for an individual should 
change by more than 12.6 points to be considered statistically significant. 
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3b.3.3 Validity 
3b.3.3.1 Internal construct validity 
Evidence for the internal consistency of FIM+FAM scales (see Table 3.17) 
supports their internal construct validity as high internal consistency 
supports scale homogeneity. Item-total correlations and homogeneity 
coefficients are higher for the motor and cognitive scales than for the total 
scale. These findings provide evidence to support the existence of motor 
and cognitive disability subconstructs within an overall construct of disability. 
Table 3.18 presents intercorrelations between FIM+FAM scales. All 
correlations are high, indicating that FIM+FAM scales are measuring 
related constructs. These findings provide evidence for convergent validity. 
The correlation between motor and cognitive scales is lower than 
correlations between each of these scales and the total scale, indicating 
that these scales are measuring related but separate constructs and 
providing evidence of discriminant validity. Very high correlations between 
motor and total scales (.93) and between cognitive and total scales (.91) 
suggests that these three scales are measuring the same construct. 
However, different correlations between motor and total with cognitive 
scales (.69 and .91), and cognitive and total with motor scales (.69 and .93) 
indicate that the scales are measuring related but different constructs. 
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3b.3.3.2 External construct validity 
Table 3.19 presents correlations between FIM+FAM scales and measures of 
disability, handicap, health status, psychological distress, and age. Table 
3.20 presents correlations between FIM+FAM scales and 
neuropsychological measures. 
The FIM+FAM total scale is highly correlated with all four disability 
measures, and moderately correlated with neuropsychological measures 
and measures of handicap and physical health status. Correlations with 
mental health status and psychological distress are low. The direction, 
magnitude and pattern of these correlations are consistent with predictions 
and provide evidence for the convergent and discriminant validity of the 
FIM+FAM total scale as a measure of global disability. 
The FIM+FAM motor scale is also highly correlated with all four measures of 
disability, and is moderately correlated with neuropsychological measures 
and measures of handicap and physical health status. Correlations with 
mental health status and psychological distress are low. Correlations 
between the FIM+FAM motor scale and neuropsychological measures are 
lower than correlations between the FIM+FAM total scale and 
neuropsychological measures. Correlations with measures of disability, 
handicap, and physical health status are higher for the FIM+FAM motor 
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than total scale. These findings provide evidence for the convergent and 
discriminant validity of the FIM motor scale as a measure of motor disability. 
Correlations between the FIM+FAM cognitive scale and the four disability 
measures are generally moderate and lower than those found for the 
FIM+FAM total and motor scales. Correlations between the FIM+FAM 
cognitive scale and neuropsychological measures are moderate or high, 
and generally higher than those for either the total or motor scale. 
Correlations with handicap, physical and mental health status, and 
psychological distress are low. Unlike the FIM+FAM total and motor scales, 
the FIM+FAM cognitive scale shows a low correlation with handicap and 
physical health status. These findings provide evidence for the convergent 
and discriminant validity of the FIM+FAM cognitive scale as a measure of 
cognitive disability. 
Finally, all three FIM+FAM scales are uncorrelated with age, providing 
further evidence of discriminant validity. 
Tables 3.21 and 3.22 provide evidence for group differences validity of 
FIM+FAM scales. As for the FIM, staff ratings of change in disability are 
presented for 179 patients. Table 3.21 presents mean FIM+FAM change 
scores associated with different levels of staff-rated improvement in 
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disability. As hypothesised, a stepwise pattern of improvement in disability 
as measured by all three FIM+FAM scales is significantly associated with a 
similar pattern of improvement in disability as assessed by staff ratings. 
Post hoc comparisons of mean scores reveal that for all FIM+FAM scales, 
change scores for patients rated as markedly improved are significantly 
higher (p < .05) than for patients rated as moderately improved. Also, 
change scores for patients rated as moderately improved are significantly 
higher than for patients rated as minimally improved. There are no 
significant differences (p> .05) in FIM+FAM change scores between 
patients rated as minimally improved and those rated as showing no 
improvement. 
Table 3.22 presents FIM+FAM change scores for stroke and MS patients. 
Change scores for FIM+FAM total and motor scales are significantly higher 
for stroke than MS patients, but do not differ for cognitive scale scores, 
indicating greater improvement in stroke patients. These findings provide 
evidence that the FIM+FAM is able to detect differences between groups 
distinguished on the basis of diagnosis. 
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3b.3.4 Responsiveness 
Table 3.23 presents FIM+FAM admission, discharge, and change scores 
with responsiveness reported as effect sizes. Change scores for all three 
scales indicate statistically significant improvements in disability from 
admission to discharge (p < 0.001). Effect sizes indicate medium 
responsiveness for the FIM+FAM motor and total scales and small 
responsiveness for the cognitive scale. 
Table 3.14 shows the relative responsiveness of FIM+FAM scales compared 
to seven other measures. Effect size calculations show that the FIM+FAM 
motor and total scales, FIM motor and total scales, Modified Barthel Index, 
and Barthel Index have similar medium responsiveness. The 
responsiveness of the OPCS is small to medium. The responsiveness of the 
cognitive scales of the FIM+FAM and FIM is similar and small. The 
responsiveness of the EDSS is very small. 
3b.4 Comparison of the psychometric properties of the FIM and 
FIM+FAM in stroke and MS patients 
3b.4.1 FIM 
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Tables 3.24 and 3.25 present results comparing the psychometric properties 
of each of the three FIM scales in stroke and MS patients. Table 3.24 
presents results for acceptability, reliability, and internal construct validity 
(internal consistency and intercorrelations between FIM scales). Table 3.25 
presents results for external construct validity and responsiveness. 
Table 3.24 shows that the acceptability, reliability, and internal construct 
validity of FIM scales are similar in stroke and MS patients. Some small 
differences in acceptability and internal consistency are demonstrated for 
the FIM cognitive scale. Unlike scores for stroke patients, scores for MS 
patients do not span the lower (more disabled) end of the scale and show a 
ceiling effect at the recommended upper limit of 15%. These findings 
indicate that the FIM cognitive scale is marginally more acceptable in stroke 
than MS patients. 
Intercorrelations between scales are almost identical for stroke and MS 
patients, indicating that the strength of relationships between the three FIM 
scales is similar in the two patient groups. This finding, along with the 
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demonstration of similar internal consistency in Table 3.24, indicate similar 
internal construct validity for all FIM scales in stroke and MS patients. 
Table 3.25 shows that correlations between FIM scales and the Barthel 
Index, SF-36 PCS and MCS, and age are comparable for stroke and MS 
patients, indicating similar convergent and discriminant construct validity. 
However, correlations between the FIM scales and the London Handicap 
Scale are higher for MS than for stroke patients. These results indicate that 
the FIM is less able to discriminate between disability and handicap in MS 
than in stroke patients. 
Table 3.25 also demonstrates that all three FIM scales have larger effect 
sizes for stroke than for MS patients indicating that all FIM scales are more 
responsive in stroke than in MS patients. In both disease groups the 
cognitive scales are less responsive than the motor and total scales. 
3b.4.2 FIM+FAM 
Tables 3.26 and 3.27 present results comparing the psychometric properties 
of the three FIM+FAM scales in stroke and MS patients. Table 3.26 
presents results for acceptability, reliability, and internal construct validity. 
Table 3.27 presents results for external construct validity and 
responsiveness. 
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Table 3.26 shows similar acceptability, reliability, and internal construct 
validity for all three scales in both patient groups. One small difference in 
acceptability between the two diseases is that FIM+FAM cognitive scores for 
MS patients do not span the lower (more disabled) end of the scale range. 
However, this is not associated with a notable ceiling effect. 
Intercorrelations between scales are almost identical for the two patient 
groups. These findings, together with the demonstration of similar internal 
consistency in Table 3.26, indicate similar internal construct validity of 
FIM+FAM scales in stroke and MS patients. 
Table 3.27 shows that for all three FIM+FAM scales, correlations between 
FIM+FAM scales and the Barthel Index, SF-36 PCS and MCS, and age are 
comparable in stroke and MS patients, indicating similar convergent and 
discriminant validity. However, correlations between FIM+FAM scales and 
the London Handicap Scale are higher for MS than stroke patients indicating 
that the FIM+FAM is less able to discriminate between disability and 
handicap in MS than in stroke patients. Table 3.27 also shows that all three 
FIM+FAM scales have larger effect sizes for stroke than for MS patients, 
indicating greater responsiveness in stroke than in MS patients. 
3b.S Comparison of the psychometric properties of the FIM, 
FIM+FAM, and Barthel Index 
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The Barthel Index was administered at two study sites, the NRU and RRU. 
Therefore, FIM, FIM+FAM, and Barthel Index scores are available for 149 
patients. Tables 3.28 to 3.34 inclusive present results comparing the 
psychometric properties of the three instruments. Each table is arranged 
such that scales measuring the same aspects of disability are group 
together: FIM and FIM+FAM total scales as measures of global disability; 
FIM and FIM+FAM motor scales and the Barthel Index as measures of motor 
disability; FIM and FIM+FAM cognitive scales as measures of cognitive 
disability. 
3b.S.1 Acceptability 
There are no missing data for any of the three measures. Table 3.28 
presents score ranges, means and standard deviations, floor and ceiling 
effects, and skewness statistics for the FIM, FIM+FAM, and Barthel Index. 
Descriptive statistics are similar for both global disability measures and all 
criteria of acceptability are satisfied. These findings indicate no advantage 
in acceptability for either FIM or FIM+FAM total scales. Similar findings of 
comparable acceptability are demonstrated for the three measures of motor 
disability. Ceiling effects and skewness for the FIM cognitive scale exceed 
recommended criteria only slightly. These results suggest small advantages 
in terms of acceptability for the FIM+FAM cognitive scale over the FIM 
cognitive scale as a measure of cognitive disability. 
3b.S.2 Reliability 
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Table 3.29 compares reliability estimates for the FIM, FIM+FAM, and 
Barthel Index. For all three aspects of disability measurement, the three 
instruments have nearly identical internal consistency and reproducibility. 
These results indicate that none of the three instruments has better 
reliability despite differences in the number of items in each scale. All 
scales satisfy minimum recommended reliability criteria for individual and 
group comparisons. 
3b.3 Validity 
3b.S.3.1 Internal construct validity 
Internal consistency estimates for measures of global, motor, and cognitive 
disability are presented in Table 3.29. They are discussed above and 
provide evidence of similar internal construct validity for the different 
instruments. 
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3b.S.3.2 External construct validity 
Tables 3.30 to 3.33 inclusive compare the external construct validity of 
scales of the FIM, FIM+FAM, and Barthel scales measuring global, motor, 
and cognitive disability. Table 3.30 presents intercorrelations between FIM 
and FIM+FAM scales and the Barthel Index. This table demonstrates two 
findings. First, correlations between measures of the same aspect of 
disability (in bold type) are very high. For example, intercorrelations 
between the FIM motor scale, FIM+FAM motor scale, and the Barthel Index 
which all measure motor disability range from .97 to .996. These results 
provide strong evidence for the concurrent validity of the two scales of 
global disability, for the three scales of motor disability, and for the two 
scales of cognitive disability. Second, scales measuring the same aspect 
of disability have very similar correlations with scales measuring other 
aspects of disability. For example, the FIM and FIM+FAM total scales have 
similar correlations with measures of motor disability and with measures of 
cognitive disability. These results provide evidence for similar convergent 
and discriminant validity of scales measuring the same aspects of disability. 
Tables 3.31 and 3.32 provide further evidence that scales of the FIM, 
FIM+FAM and Barthel Index which measure the same aspects of disability 
have similar convergent and discriminant validity. Table 3.31 demonstrates 
near identical correlations between measures of global, motor, and 
cognitive disability and other measures of disability, handicap, health 
status, psychological distress, and age. Table 3.32 demonstrates near 
identical correlations between measures of global, motor, and cognitive 
disability and measures of neuropsychological functioning. 
Table 3.33 presents relative precision estimates for the FIM, FIM+FAM, 
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and 8arthellndex. All scales demonstrate a stepwise increase in change 
scores associated with increasing staff-rated improvement in disability. 
Whilst these results are statistically significant, there are notable 
differences in relative measurement precision. The FIM+FAM total scale is 
81 % as precise as the FIM total score. These results indicate that the FIM 
total scale is superior to the FIM+FAM total scale in discriminating between 
clinical groups differing in staff-rated improvement in disability. The FIM and 
FIM+FAM motor scales show almost identical measurement precision. 
However, the 8arthellndex is only 61% as precise as the FIM motor scale, 
indicating that the FIM and FIM+FAM motor scales are superior for detecting 
group differences in motor disability. For the measurement of cognitive 
disability, the FIM and FIM+FAM cognitive scales have almost identical 
measurement precision in detecting group differences. 
3b.S.4 Responsiveness 
Table 3.34 presents admission, discharge, and change scores and effect 
sizes for scales of the FIM, FIM+FAM and Barthel Index measuring global, 
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motor, and cognitive disability. Data are available for 136 patients. Seven 
patients were still inpatients when data collection stopped, five patients 
acutely deteriorated during the rehabilitation period and were transferred 
elsewhere, and one patient was transferred to another unit for ongoing 
rehabilitation. Effect sizes indicate comparable responsiveness for scales 
measuring the same aspects of disability. These results suggest no 
advantage in responsiveness among the three measures. 
3b.6 Summary of results 
The FIM and FIM+FAM are acceptable, reliable, valid, and responsive 
measures of disability in the sample studied. The FIM and FIM+FAM are 
rigorous disability measures in stroke and MS patients. There are three 
psychometric differences between the two patient groups. The FIM 
cognitive scale may be less acceptable in MS than in stroke patients. All 
scales are more responsive in stroke than in MS suggesting that 
responsiveness may be disease-dependent. Correlations with handicap are 
higher for MS than for stroke. 
The FIM, FIM+FAM, and Barthel Index have very similar measurement 
properties in patients undergoing inpatient neurorehabilitation. Comparable 
scales of the FIM and FIM+FAM have virtually identical psychometric 
properties. The Barthel Index has virtually identical psychometric properties 
to the motor scales of the FIM and FIM+FAM, except for measurement 
precision. The total and motor scales of the FIM and FIM+FAM and the 




Evaluating Conceptual Models Using Item Analysis: 
Method and Results 
Chapter 3 provides evidence that the FIM and FIM+FAM are reliable, valid, 
and responsive measures of disability. However, when the FIM and 
FIM+FAM are compared with each other and with the Barthel Index, 
comparable scales of the three instruments are shown to have almost 
identical measurement properties. These findings indicate that the 
purported conceptual advantages of the FIM over the Barthel Index and the 
FIM+FAM over the FIM are not supported by empirical data. In addition, 
the finding of identical measurement properties of scales which differ in 
length suggests item redundancy in the FIM and FIM+FAM. The fact that 
the development of the FIM and FIM+FAM did not include an item reduction 
stage or a test of their underlying conceptual models raises two questions: 
to what extent are the conceptual models of the FIM and FIM+FAM 
supported by empirical data and, if there is item redundancy, can a short-
form measure be developed? 
This chapter addresses these two questions. A detailed item analysiS is 
performed to determine the extent of empirical support for the conceptual 
models of the FIM and FIM+FAM. Item reduction is then performed to 
determine whether a reliable and valid short-from measure can be 
developed. 
4a Item analysis of the FIM and FIM+FAM 
4a.1 Conceptual and measurement models of the FIM and 
FIM+FAM 
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The conceptual model of disability on which the FIM is based hypothesises 
that disability consists of two distinct domains, motor and cognitive 
disability, and that each domain consists of two or more subconstructs. For 
the motor domain, the subconstructs are self-care, sphincter care, transfer, 
and mobility. For the cognitive domain, the subconstructs are 
communication and social cognition. 
The measurement model of an instrument refers to the scale and subscale 
structure and the procedures followed to create scale and subscale scores 
(130). Table 4.1 shows the measurement model for the FIM. The 18 items 
comprise two scales, a motor scale containing 13 items and a cognitive 
scale containing 5 items. Each of the two FIM scales consists of two or 
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more subscales. The motor scale has four subscales: self-care (6 items), 
sphincter care (2 items), transfer (3 items), and locomotion (2 items). The 
cognitive scale has two subscales: communication (2 items) and social 
cognition (3 items). 
The conceptual model of disability on which the FIM+FAM is based is an 
extension of the conceptual model of the FIM. There are still motor and 
cognitive domains, but each domain consists of three or more 
subconstructs. For the motor domain, the subconstructs are self-care, 
sphincter care, transfer, and mobility. For the cognitive domain, the 
subconstructs are communication psychosocial adjustment, and cognitive 
function. 
Table 4.2 shows the measurement model for the FIM+FAM. The 30 items 
comprise two scales, a motor scale containing 16 items and a cognitive 
scale containing 14 items. Each of the two FIM+FAM scales consists of 
three or more subscales. The motor scale has four subscales: self-care (7 
items), sphincter care (2 items), transfer (4 items), and locomotion (3 
items). The cognitive scale has three subscales: communication (5 items), 
psychosocial adjustment (4 items), and cognitive function (5 items). 
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Each FIM and FIM+FAM scale and subscale contains multiple items which 
are summed in accordance with Likert's method of summated ratings, 
without weighting, to generate total scores (296). The grouping of items 
into subscales and scales and the calculation of summated scores is based 
on four scaling assumptions. First, items within each scale or subscale 
measure the same construct. Second, items can be summed, without 
weighting, to generate scale and subscale scores. Third, scales and 
subscales measure distinct constructs. Fourth, the subscales and scales 
defined by the developers are the most appropriate method of grouping the 
items. 
The following section evaluates each of these four scaling assumptions for 
the FIM and FIM+FAM. The method and results for each assumption are 
presented together. 
4a.2 Do the items of each scale and subscale measure the same 
construct? 
4a.2.1 Method 
Items measuring different aspects of the same underlying construct are 
inter-related (internally consistent). The extent to which items are internally 
consistent is determined by examining the results of three analyses: 
correlations between all possible pairs of items (item intercorrelations); 
correlations between each item and the total scale or subscale score 
corrected for item overlap (corrected item-total correlation); and alpha 
coefficients for each scale and subscale. 
Item intercorrelations indicate the extent to which items are related. It is 
recommended that the mean item-intercorrelation for a scale or subscale 
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also called the homogeneity coefficient (265), should exceed .30 (261,275, 
276). However, items that are highly correlated indicate that one item may 
be redundant. Although there is no widely accepted criterion for item 
redundancy, Juniper et al. (297) recommend that item-intercorrelations 
exceeding .70 indicate that an item can be removed. 
Item-total correlations indicate the strength of relationship between 
individual items and the construct being measured. It is recommended that 
item-total correlations corrected for overlap should exceed .30 (217). 
Alpha coefficients indicate the extent to which items in a scale are 
interrelated by comparing the variance of the total score to the sum of the 
variances of the individual items. As correlations between items increase, 
the variance for the total score increases and alpha coefficients approximate 
unity (269). It is recommended that alpha coefficients should exceed .70 
(217). However, alpha coefficients exceeding .90 to .95 (286, 298), 




Tables 4.3 and 4.4 present internal consistency estimates for scales and 
subscales of the FIM and FIM+FAM. Recommended criteria are satisfied for 
item-intercorrelations, item-total correlations, and alpha coefficients. 
These findings indicate that scales and subscales of both instruments are 
internally consistent and, therefore, their items measure the same 
construct. 
However, all scales and most subscales of the FIM and FIM+FAM have 
item-intercorrelations greater than .70 and alpha coefficients which exceed 
.90. These results suggest item redundancy in the scales and subscales of 
both instruments. 
4a.3 Can unweighted item scores be summed to generate scale 
and subscale scores? 
4a.3.1 Method 
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Likert proposed that items can be summed without weighting to generate 
scores when they: are substantially linearly related to the total score 
computed from all other items in that group; measure at similar points on 
the scale; contribute equally to the total score variance; and contribute 
equal proportions of information to the total score. These four criteria are 
satisfied when items are internally consistent and have similar mean scores, 
variances, and item-total correlations (296,300,301). However, when 
item-total correlations exceed .30, the criteria of equivalent item means, 
variances, and item-total correlations can be considered satisfied, even if 
they vary (302). 
4a.3.2 Results 
The first column of results in Tables 4.3 and 4.4 shows item-total 
correlations for scales and subscales of the FIM and FIM+FAM. All values 
are high (minimum values: FIM = .60; FIM+FAM = .55), indicating that 
Likert's criteria of internal consistency and equivalence of item means, 
variances, and item-total correlations can be considered satisfied. These 
findings indicate that it is legitimate to sum unweighted item scores to 
generate scale and subscale scores. 
4a.4 Do scales and subscales measure distinct constructs ? 
4a.4.1 Method 
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To evaluate the extent to which FIM and FIM+FAM scales and subscales 
measure distinct dimensions of disability, product-moment correlations 
among scales and subscales are compared with reliability coefficients. The 
extent to which intercorrelations between scales are lower than their 
reliability estimates indicates the degree of unique reliable variance 
measured by each scale relative to the other (302). This is because the 
internal consistency reliability coefficient of a scale, its alpha coefficient, 
can be thought of as the correlation between a scale and itself (88). 
Therefore, when intercorrelations between scales are similar to their 
reliability, there is no evidence of unique reliable variance. 
Three groups of correlations address the question of the distinctiveness of 
constructs measured by scales and subscales. Intercorrelations among 
scales indicate the extent to which scales are measuring distinct disability 
constructs; correlations between scales and subscales indicate the extent 
to which subscales are measuring constructs distinct from scales; and 
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intercorrelations among subscales indicate the extent to which independent 
item groups are measuring distinct aspects of disability. When there is item 
overlap, for example between the motor and total scales, correlations are 
predicted to be substantial. Although Nunnally and Bernstein (271) suggest 
that correlations among subscales exceeding .60 indicate measurement 
overlap, it is perhaps more correct that the magnitude of these correlations 
is consistent with a priori predictions of the relationships between the scales. 
4a.4.2 Results 
Tables 4.3 and 4.4 present correlations between scales and subscales for 
the FIM and FIM+FAM. Alpha coefficients are shown in parentheses. 
First, consider in Tables 4.3 and 4.4 the triangles of correlations among 
scales (coloured red). For the FIM and FIM+FAM, correlations between the 
motor and cognitive scales are below their respective alpha coefficients thus 
demonstrating unique reliable variance between these scales. This finding 
provides evidence that the motor and cognitive scales of both instruments 
are measuring distinct constructs. As predicted, correlations between the 
motor and total scales and between the cognitive and total scales are 
substantial due to item overlap. However, correlations between the motor 
and total scales of the FIM (.97) and FIM+FAM (.93) and between the 
cognitive and total scales of the FIM+FAM (.91) are very similar to their 
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respective alphas, indicating that these scales fail the test for unique 
reliable variance. These findings indicate the lack of an empirical basis for a 
separate motor scale of the FIM, and separate motor and cognitive scales 
of the FIM+FAM. 
Second, consider the rectangles of correlations between subscales and 
scales (coloured blue). As predicted, correlations are highest when there is 
item overlap. Most correlations between subscales and scales are below 
the alpha coefficients with which they are being compared, indicating the 
presence of unique reliable variance between scale and subscale. 
However, some correlations fail the test for unique reliable variance. For 
the FIM, there is a lack of empirical support for separate self-care, transfer, 
communication, and social cognition subscales. For the FIM+FAM these 
findings indicate a lack of empirical support for separate self-care, transfer, 
psychosocial adjustment, and cognitive function subscales. 
Finally, consider the triangles of correlations among subscales (coloured 
green). All correlations are below the alpha coefficients with which they are 
being compared, indicating unique reliable variance. However, eight of the 
15 correlations among FIM subscales and 11 of the 21 correlations among 
FIM+FAM subscales exceed the recommended criterion of .60 indicating 
measurement overlap between subscales. Some of these correlations are 
particularly high: self-care and transfer for the FIM (.89) and FIM+FAM 
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(.88), and psychosocial adjustment and cognitive function for the FIM+FAM 
(.84). These findings indicate little unique reliable variance and, therefore, 
considerable measurement overlap between these subscales. 
4a.5 Are items appropriately grouped into scales and subscales ? 
4a.5.1 Method 
Two types of analysis, multitrait scaling analysis (302) and principal 
components analysis (peA), are undertaken to determine whether the items 
of the FIM and FIM+FAM are appropriately grouped into scales and 
subscales. 
4a.5.1.1 Multitrait scaling analyses 
When instruments such as the FIM and FIM+FAM measure several 
subconstructs, there should be empirical evidence to show that each item 
measures one of the subconstructs better than others. Multitrait scaling 
analyses examine evidence for this on the basis of item convergent and 
discriminant validity (302). The extent to which each item measures the 
construct it is hypothesised to measure (item convergent validity) is 
compared with the extent to which it measures other constructs (item 
discriminant validity) (246). These analyses follow the logic of the multitrait-
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multimethod approach to testing convergent and discriminant validity (303, 
304). 
Item convergent and discriminant validity for the FIM and FIM+FAM are 
examined separately for scales and subscales. For each item, correlations 
with its own scale or subscale (item-own correlation) are compared with 
correlations with all other scales and subscales (item-other correlations). 
Item-own correlations determine item convergent validity by indicating the 
extent to which an item measures the construct it is purported to measure. 
The difference in magnitude between item-own and item-other correlations 
determine item discriminant validity by indicating the extent that each item 
measures other subconstructs. 
Item-own to item-other comparisons are interpreted as either definite or 
probable scaling successes or failures. A definite scaling success, 
indicating that an item is correctly grouped, is achieved when item-own 
correlations exceed item-other correlations by more than two standard errors 
(1 I ~ n = > .14). A definite scaling failure, indicating that items are 
incorrectly grouped, occurs when item-other correlations exceed item-own 
correlations by more than two standard errors. A probable scaling success 
occurs when item-own correlations exceed item-other correlations by two 
standard errors or less. Similarly, a probable scaling failure occurs when 
item-other correlations exceed item-own correlations by two standard errors 
or less. Results are summarised for each scale and subscale as percent 
scaling success and failure rates. 
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Probable scaling successes and failures indicate limited item discriminant 
validity. They represent items measuring two or more hypothesised 
constructs to a similar extent that will confound constructs and complicate 
the interpretation of their scores. Widespread probable scaling successes 
and failures indicate that hypothesised constructs that are not empirically 
distinct and suggest that the conceptual model of an instrument needs to be 
reconsidered. However, probable scaling successes and failures must be 
interpreted with reference to the actual magnitude of difference between 
item-own and item-other correlations, sample size, and the number of items 
in the scale. As sample size determines the standard error of a correlation, 
substantial differences between item-own and item-other correlations may 
not reach statistical significance when sample sizes are small. In addition, 
scaling failures are better tolerated by scales with large numbers of items as 
there may be enough other items to anchor the construct and to distinguish 
it from other constructs (302). 
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4a.5.1.2 Principal components analysis 
Exploratory factor analysis of an item pool using the principal components 
method (PCA) indicates clusters of intercorrelated items within an instrument 
(components) that are empirically distinct. As components represent 
separate dimensions of measurement, they are candidates for scales or 
subscales (305). Empirical support for the measurement model of the FIM 
and FIM+FAM is provided when components extracted by PCA conform with 
hypothesised scales and subscales. 
Principal components analysis for the FIM and FIM+FAM is undertaken on 
admission ratings (N = 209). Analyses of FIM data are cross-validated on 
an independent sample of 367 patients from the NRU audit database. 
Analyses of FIM+FAM data are cross-validated on two samples generated 
by randomly dividing the total sample (n = 105 and n = 104). Components 
extracted by PCA are rotated (varimax) to achieve simple structure. Two 
standard criteria are used to determine the number of components to rotate: 
first, all components with eigenvalues greater than 1.0 are retained (306); 
second, the scree plot of eigenvalues is examined to identify the point at 
which the negative slope of the curve levels off and begins the scree (307). 
Although there are similarities between multitrait scaling analysis and PCA, 
there are important differences which justify the use of both methods when 
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examining the measurement models of the FIM and FIM+FAM. Multitrait 
scaling analysis is an item-level confirmatory analysis that evaluates the 
appropriateness of a priori groups of items being summed to form scales. In 
contrast, peA is an item-level exploratory analysis that identifies which 
items should be summed to from scales. As peA is not constrained by the 
conceptual models and assumptions of instrument developers, it helps to 
identify dimensions of measurement that were not originally hypothesised. 
In peA the trait is d~fined by the analysis (308). Therefore, artefacts in the 
data that have little to do with the constructs measured (e.g. sample size) 
can influence results in ways that distort the interpretation of the underlying 
constructs (302, 309). Also, if items are added to or removed from an item 
pool the definitions of the traits extracted by peA may change (269). In 
contrast, the scales in multitrait scaling analysis are defined by the 
investigator and items can be added or removed to examine their 
relationships with existing scales without altering the underlying constructs 
(302). 
Scales defined in multitrait scaling analysis differ from traits defined by the 
factors extracted in peA even if their item content is identical (302). The 
correlation between an item and a trait defined by peA (component loading) 




4a.5.2.1 Multitrait scaling analysis 
Tables 4.5 to 4.8 present the results of multitrait scaling analysis. Tables 
4.5 and 4.6 present correlations between items, scales, and subscales for 
the FIM and FIM+FAM. Tables 4.7 and 4.8 summarise item convergent and 
discriminant validity as percent definite and probable scaling successes and 
failures. 
First, consider the correlations between items and scales coloured red in 
Tables 4.5 and 4.6. These correlations determine the extent to which items 
discriminate between scales. Criteria for item convergent and discriminant 
validity are satisfied when item-own scale correlations are high and exceed 
item-other scale correlations by more than two standard errors (> .14). For 
example, the feeding item of the FIM in Table 4.5 is hypothesised to belong 
in the motor rather than the cognitive scale. The item-own scale correlation 
(feeding-motor scale = .70) exceeds the item-other scale correlation 
(feeding-cognitive scale = .48) by .22. This result is a definite scaling 
success. 
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Tables 4.5 and 4.6 indicate good item discriminant validity for FIM scales, 
but limited item discriminant validity for FIM+FAM scales. All FIM items 
satisfy criteria for definite scaling successes except grooming, which 
qualifies as a probable scaling success. In contrast, 21 FIM+FAM items 
(70%) satisfy criteria for definite scaling successes. Eight items qualify as 
probably scaling successes and one item (community mobility) qualifies as a 
probable scaling failure. 
Next, consider correlations between items and subscales coloured blue in 
Tables 4.5 and 4.6. These correlations determine the extent to which items 
discriminate between subscales. Criteria for convergent and discriminant 
validity are satisfied when item-own subscale correlations are high and 
exceed all item-other subscale correlations by more than two standard 
errors. As an example, consider the dressing lower body item of the FIM in 
Table 4.5. The item-own subscale correlation (dressing lower body I self-
care) is high (.84), supporting its inclusion in this subscale. Four item-other 
subscale correlations (sphincter care, locomotion, communication, and 
social cognition) satisfy criteria for definite scaling successes, indicating 
good discriminant validity between these subscales for the dressing lower 
body item. However, the dressing lower body-transfer correlation (.87) 
slightly exceeds the item-own subscale correlation. This result represents a 
probable scaling failure and indicates that this item measures equally two 
constructs purporting to be conceptually distinct. Either the dressing lower 
body item has poor discriminant validity for these two constructs, or, the 
constructs measured by the self-care and transfer subscales are not 
empirically distinct. 
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Table 4.5 demonstrates limited item discriminant validity for FIM subscales. 
Only two items, expression and problem solving, fully satisfy criteria for 
definite scaling successes. Three items (dressing lower body, toileting, 
and stairs) qualify as probable scaling failures and 15 items register one or 
more probable scaling successes. Furthermore, the magnitude of 
differences between item-own and item-other correlations for 62% of these 
probable scaling successes and failures is small « .07) indicating that most 
FIM items measure two or more constructs equally. The fact that 11 of the 
18 FIM items demonstrate limited discriminant validity indicates that some 
hypothesised constructs are not empirically distinct. For example, all self-
care items correlate highly with the transfer subscale suggesting that the 
self-care and transfer subscales are not measuring empirically distinct 
constructs. All sphincter care and locomotion items correlate highly with the 
self-care and transfer subscales suggesting that the sphincter care, 
locomotion, self-care, and transfer subscales are not measuring empirically 
distinct constructs. Similarly, three items (comprehension, social 
interaction, and memory) correlate similarly with the communication and 
social cognition subscales indicating that these subscales are not measuring 
empirically distinct constructs. 
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Table 4.6 indicates that the FIM+FAM has poorer item discriminant validity 
than the FIM. Only four items (expression, reading, writing, speech 
intelligibility) fully satisfy the criteria for definite scaling successes. Twenty 
six-items qualify as having probable scaling successes (bolded), and three 
of these items (dressing lower body, toileting, and employability) also 
register probable scaling failures. Eight items register two probable scaling 
successes, two items (toileting and swallowing) register three probable 
scaling successes, one item (community mobility) registers four probable 
scaling successes, and one item (employability) registers five probable 
scaling errors. A total of 23 item-other subscale correlations lie within one 
standard error of the item-own subscale correlation for those items, 
indicating items that measure equally two or more constructs. The fact that 
16 items from six of the seven subscales demonstrate limited item 
discriminant validity suggests that some subscales are not measuring 
empirically distinct constructs. These subscales are: self-care and transfer; 
self-care and locomotion; sphincter, self-care and transfer; and 
psychosocial adjustment and cognitive function. 
Tables 4.7 and 4.8 summarise the results of multitrait scaling analyses for 
the FIM and FIM+FAM as percent definite and probable scaling successes 
and failures. For the FIM, results indicate good item discriminant validity for 
scales but limited item discriminant validity for subscales. For the 
FIM+FAM, results indicate limited item discriminant validity for scales and 
subscales. These findings provide strong empirical support for grouping 
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FIM items into motor and cognitive scales, but weak support for grouping 
FIM+FAM items into scales and for grouping items of both instruments into 
subscales. 
4a.S.2.2 Principal components analysis 
Table 4.9 presents results from two principal components analyses of FIM 
admission scores. Results from the two analyses are different as the first 
analysis extracts two components and the second analysis four components. 
The first analysis (PCA-1) extracts two components with eigenvalues> 1.0 
which satisfy the scree test. These components account for 71.6% of the 
total variance. The first component accounts for 59.4% of the total variance 
with 13 items loading on this component. The second component accounts 
for 12.2% of the total variance with five items loading on this component. 
The items constituting both components are identical to the motor and 
cognitive scales of the FIM. These results support the grouping of FIM 
items into motor and cognitive scales but do not support FIM subscales as 
separate dimensions of measurement. 
The second analysis (PCA-2) extracts four components with eigenvalues> 
1.0 that satisfy the scree test. These account for 74.6% of the total 
variance. Eight items from the self-care, transfer, and locomotion 
subscales load on component 1. Four items from the self-care subscale 
load on component 2. All five items of the cognitive scale load on 
component 3. The two items from the sphincter subscale load on 
component 3. The bathing item loads onto components 1 and 2 equally 
indicating that this item has limited discriminant validity. 
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The results of PCA-2 do not provide strong support for the measurement 
model of the FIM. Although results support the cognitive scale and 
sphincter subscale as separate dimensions of measurement, they do not 
support the motor scale or five other subscales (self-care, transfer, 
locomotion, communication, or social cognition) as separate dimensions of 
measurement. Results suggest that items in the motor scale might better be 
grouped in three subscales: lower limb function; upper limb function; and 
sphincter care. As bathing involves both upper and lower limbs the finding 
that is loads equally on components 1 and 2 is intuitively sound. 
Table 4.10 presents results from three principal components analyses (total 
sample and random split-halves) of FIM+FAM admission scores. The 
results of the three analyses are very similar. All three PCAs extract four 
components with eigenvalues> 1.0 which satisfy the scree test. These four 
components account for approximately 770/0 (range 75.8% to 79.50/0) of the 
total variance. The item composition of the components extracted by the 
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three peAs is consistent for all four components. Most items from the 
hypothesised self-care, transfer, and locomotion subscales load on 
component 1. All items from the psychosocial adjustment and cognitive 
function subscales load on component 2. Items from the communication 
subscale load on component 3. Three items (bladder management, bowel 
management, and swallowing) load on component 4. Five items (feeding, 
grooming, community mobility, comprehension, employability) consistently 
load on two or more components indicating that they have poor discriminant 
validity. 
Although subscale items usually load on the same component, the items 
comprising these components are not consistent with the scale or subscale 
structure of the FIM+FAM. Results suggest that the items of the motor scale 
comprise two dimensions of measurement rather than either a single scale 
or four distinct subscales as hypothesised. Similarly, items of the cognitive 
scale appear to comprise two dimensions of measurement rather than a 
single scale or three distinct subscales as hypothesised. 
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4a.6 Summary of results 
4a.6.1 FIM 
Results from item analyses provide evidence that all FIM scales and 
subscales represent internally consistent groups of items which can be 
legitimately summed without weighting to generate scores. However, there 
is evidence of item redundancy in all three scales and in four of the six 
subscales. Empirical evidence indicates that the 13-item motor and 5-item 
cognitive scales measure distinct subconstructs and that items in these 
scales adequately discriminate between the subconstructs. However, the 
motor scale measures a similar construct to the total scale. Finally, results 
provide evidence that the FIM subscales do not represent distinct 
dimensions of measurement, that there is limited item discriminant validity, 
and that a different grouping of items into subscales might be more 
appropriate. 
4a.6.2 FIM+FAM 
Results from item analyses provide evidence that all FIM+FAM scales and 
subscales represent internally consistent groups of items which can be 
legitimately summed without weighting to generate scores. However, there 
is evidence of item redundancy in all three scales and in six of the seven 
subscales. Empirical evidence indicates that the 16-item motor and 14-item 
cognitive scales measure distinct subconstructs, but that nine items (6 
motor, 3 cognitive) do not adequately discriminate between the 
subconstructs. In addition, both the motor and cognitive scales measure a 
similar construct to the total scale. Finally, results provide evidence that the 
FIM+FAM subscales do not represent distinct dimensions of measurement , 
that there is limited item discriminant validity, and that a different grouping 
of items into subscales might be more appropriate. 
4b Development and psychometric evaluation of a short-form 
version of the FIM 
The second question addressed in this chapter is the feasibility of 
developing a short-form measure. Results of the psychometric analyses of 
the FIM and FIM+FAM and comparison with the Barthel Index presented in 
Chapter 3 raised the question of item redundancy: item analyses confirm 
this is in both measures. As the FIM and FIM+FAM have been shown to be 
highly similar instruments which can be considered alternate form measures 
of the same construct, only FIM data are used for the analyses reported in 
this section. 
Based on the results of psychometric analyses presented earlier in this 
chapter, item reduction analyses are undertaken to develop a short-form 
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version of the FIM. Items are then grouped into scales, followed by tests of 
scaling assumptions and the evaluation of psychometric properties. 
4b.1 Item reduction 
4b.1.1 Method 
Items are eliminated if they fail to satisfy previously defined criteria for 
acceptability and reliability or are redundant. Items are not acceptable if 
responses are poorly distributed among item response categories or if 
maximum endorsement frequencies, floor, or ceiling effects exceed 80%. 
Items fail to satisfy criteria for reliability if corrected item-total correlations 
are <.30 (217), or if intra- or inter-rater reproducibility is <.70. Items are 
defined as redundant if inter-item correlations exceed .70 (297). The 
decision as to which of the two items to delete depends upon a comparison 
of descriptive statistics, reliability, responsiveness, and clinical 
importance. As the FIM is an evaluative instrument, item responsiveness is 
the primary criterion for item selection. 
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4b.1.2 Results 
Table 4.11 presents descriptive statistics, reliability, and responsiveness 
for FIM items. All items satisfy the criteria discussed above. Table 4.12 
presents the 31 item-intercorrelations that exceed .70. Fifteen different 
items are involved, the remaining three items, bladder management, bowel 
management, and walking have intercorrelations with all other FIM items 
that are < .70. 
No items were deleted due to poor discrimination between subjects or poor 
reliability. Therefore, for each pair of items with intercorrelations > .70, the 
item with the best responsiveness is retained and the other deleted. Ten 
items were removed due to item redundancy, leaving eight items to form the 
short-form FIM-8: feeding, bladder management, bowel management, 
shower transfer, stairs, walking, social interaction, and memory. 
4b.2 Development of scales 
4b.2.1 Method 
Two methods were used to form scales after item reduction: conceptually 
and empirically derived scales. First, items in the FIM-8 were grouped on 
the basis of a conceptual knowledge of disability. Next, item-level 
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exploratory factor analysis was performed using the principal components 
methods. Components with eigenvalues> 1.0 that satisfied the scree test 
were varimax rotated to achieve a simple structure. Components indicate 
clusters of intercorrelated items that are empirically distinct and, therefore, 
candidates for separate scales. Principal components analysis was 
performed on the whole study sample (N = 209) and cross-validated on two 
samples generated by randomly dividing this sample (n = 105, n = 104). 
4b.2.2 Results 
4b.2.2.1 Conceptually derived scales 
The conceptual model of disability generated three methods of grouping 
FIM-8 items into scales. First, an overall scale comprising all eight items 
was formed to measure global disability. Second, items were grouped into 
two scales: a 6-item motor scale (feeding, bladder management, bowel 
management, shower transfer, stairs, and walking), and a 2-item cognitive 
scale (social interaction, and memory). Third, items were grouped into 
three scales: a 4-item physical scale (feeding, shower transfer, stairs, and 
walking), a 2-item sphincter scale (bladder management, bowel 
management), and a 2-item cognitive scale (social interaction, and 
memory). This conceptual grouping is based on results from the peA 
reported in the previous section which suggested sphincter function is an 
independent dimension. 
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4b.2.2.2 Empirically derived scales 
Table 4.13 presents results from three principal components analyses of 
FIM-8 admission scores. The first analysis (PCA-1) extracts two 
components with eigenvalues> 1.0 which satisfy the scree test and which 
account for 67.9% of the total variance. The first component, which 
consists of four items measuring physical function, accounts for 52.0% of 
the variance. The second component, which consists of four items 
measuring sphincter and cognitive function, accounts for 15.9% of the 
variance. 
Cross-validation largely supports the findings of PCA-1. In PCA-2 two 
components with identical item content are extracted. In PCA-3 two 
components are also extracted but three items (feeding, bladder 
management, and bowel management), load equally and substantially onto 
both components. The other five items load on the two components in the 
same manner to PCA-1 and PCA-2. 
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4b.3 Evaluation of summated rating scales 
4b.3.1 Method 
Item groups defined on conceptual and empirical grounds were evaluated in 
terms of their appropriateness as simple summated rating scales. First, the 
internal consistency of scales was examined to determine if all items were 
indeed measuring the same construct and if items can be summed without 
weighting to generate scores. Second, intercorrelations between scales 
were examine to determine the extent to which scales measure different 
constructs. Third, multitrait scaling analyses were performed to determine 
scaling success rates. The optimal scaling method is defined as method 
which achieves the highest internal consistency, largest unique reliable 
variance between scales, and the highest scaling success rate. 
4b.3.2 Results 
4b.3.2.1 Internal consistency 
Table 4.14 presents internal consistency estimates for the four methods of 
scaling FIM-8 items. All scales have high internal consistency, with alpha 
coefficients exceeding the minimum requirement of .70 for group 
. These results indicate that items in each scale measure the comparisons. 
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same underlying construct. In addition, item-total correlations for all scales 
are high indicating that Likert's criteria of equivalent item means and 
variances can be considered satisfied. These results indicate that there is 
no clear advantage of anyone method of scaling FIM-8 items. 
4b.3.2.2 Intercorrelations between scales 
Table 4.15 presents intercorrelations between scales (with alpha coefficients 
in parentheses) for the four methods of scaling FIM-8 items. As expected all 
scales correlate highly with the FIM-8 total scale due to item overlap. Inter-
correlations between scales derived by methods 2, 3, and 4 are all well 
below the alpha coefficients for these scales indicating unique reliable 
variance for each scale. These results indicate that the scales derived by 
the four methods measure related but different constructs, and that there is 
no clear advantage of anyone method. 
4b.3.2.3 Multitrait scaling analyses 
Table 4.16 summarises multitrait scaling analysis for the three methods of 
grouping FIM-8 items with two or more scales. Method 2, the grouping of 
FIM-8 items into a 6-item motor scale and a 2-item cognitive scale, has the 
highest proportion of definite scaling success rates. These findings indicate 
that this method is superior to the others in terms of item convergent and 
discriminant validity. Methods 3 and 4 have limited item convergent and 
discriminant validity. These findings provide only limited support for the 
integrity of scales developed using methods 3 and 4. 
4b.4 Psychometric evaluation of the FIM-8 
4b.4.1 Method 
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The short-form FIM-8 (total, 6-item motor, and 2-item cognitive scales) was 
evaluated for acceptability, reliability, validity, and responsiveness. 
Acceptability was evaluated by examining scale score distributions. Three 
types of reliability were estimated: internal consistency, intra-rater, and 
inter-rater reproducibility. Two types of validity, concurrent and construct 
validity, were examined. Concurrent validity was assessed by examining 
product-moment correlations between FIM-8 scales, the original 18-item 
FIM, and the FIM+FAM. Internal construct validity was determined by 
examining internal consistency and intercorrelations between scales for the 
FIM-8. External construct validity was determined by examining product-
moment correlations between the FIM-8 and other measures. Convergent 
and discriminant validity were determined by examining the magnitude and 
pattern of correlations with measures of disability, handicap, health status, 
psychological well-being, and neuropsychological functioning. Discriminant 
validity was also evaluated by examining correlations between the FIM-8, 
age, and sex. Responsiveness was determined by calculating an effect 
size and comparing this to the original1S-item FIM and the FIM+FAM to 




Table 4.17 presents score distributions for FIM-S scales. These results 
indicate that FIM-S scales adequately represent the range of severity of 
disabilities in patients in this sample and demonstrate good variability. 
However, the cognitive scale has a notable ceiling effect of 27.So/0 which is 
above the recommended maximum of 15%. These findings indicate that the 
total and motor scales of the FIM-S are more acceptable than the cognitive 
scale. 
4b.4.2.2 Reliability 
Table 4.14 and 4.1S present reliability estimates for the FIM-S scales. 
Table 4.14 indicates that minimum criteria for internal consistency are 
satisfied. Table 4.1S indicates that criteria for reproducibility are satisfied. 
These findings provide evidence for the reliability of FIM-S scales. 
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4b.4.2.3 Validity 
Concurrent validity. Table 4.19 presents correlations between the FIM-8, 
FIM, and FIM+FAM. Correlations between the total, motor, and cognitive 
scales of the FIM-8 and corresponding FIM and FIM+FAM scales are high. 
These findings indicate that the FIM-8 can be considered an alternate form 
measure for the FIM and FIM+FAM. 
Internal construct validity. Internal consistency estimates presented in 
Table 4.14 provide evidence for internal construct validity of the FIM-8. 
Table 4.20 presents intercorrelations (with alpha coefficients in 
parentheses) for the three FIM-8. As discussed previously, the correlation 
between the motor and cognitive scale is substantially lower than the alphas 
for these scales, demonstrating the presence of unique reliable variance. 
These results provide evidence for internal construct validity by indicating 
that the motor and cognitive scales measure different but related constructs. 
External construct validity. Table 4.19 presents correlations between the 
FIM-8, FIM, and FIM+FAM. All correlations are high, thus providing 
evidence of convergent validity for FIM-8 scales. In addition, the pattern of 
correlations in Table 4.19 provides evidence of discriminant construct 
validity for the FIM-8 scales. For example, of the three FIM-8 scales, the 
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highest correlation with the FIM total scale is for the FIM-8 total scale. This 
pattern is present for all FIM scales against both the FIM and FIM+FAM. 
Table 4.21 presents correlations between FIM-8 scales and other measures 
of disability, handicap, health status, psychological distress, and age. 
The magnitude and pattern of these correlations provides evidence 
supporting the convergent and discriminant validity of the total, motor, and 
cognitive scales of the FIM-8. For example, correlations are highest with 
the four disability scales (BI, MBI, EDSS, OPCS) and lowest with mental 
health and psychological distress (SF-36 MCS and GHQ). In addition, 
correlations between the FIM-8 and the disability scales are higher for the 
motor than the cognitive scale. 
Table 4.22 presents correlations between the FIM-8 and neuropsychological 
measures. For four neuropsychological measures (MMSE, WAIS-VIQ, 
WCST, VESPAR), correlations are highest with the FIM-8 cognitive scale 
and lowest with the FIM-8 motor scale. These findings provide evidence of 
convergent and discriminant validity for the FIM-8 cognitive scale. However, 
the remaining three neuropsychological measures (Halstead Booklet 
Category Test, California Verbal Learning Test, Visual Recognition 
Memory Test) do not demonstrate this pattern of correlation with FIM-8 
scales. 
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Table 4.23 presents correlations between the FIM-8, age, and sex. These 
are low indicating that FIM-8 scores are not biased by age and sex, and 
providing further evidence of discriminant validity. 
4b.4.2.4 Responsiveness 
Table 4.24 presents results for responsiveness of the FIM-8. Change 
scores for all scales are negative, indicating an improvement in disability at 
discharge. Effect sizes indicate that the motor and total scales show 
medium responsiveness whilst the cognitive scale shows poor 
responsiveness. The responsiveness of the FIM-8 is equivalent to that of 
the FIM and FIM+FAM. 
4b.5 Summary of results 
Results support the appropriateness and psychometric adequacy of a short-
form version of the FIM, the FIM-8. The most valid grouping of the 8 items 
is into three scales: a total scale, a 6-item motor scale, and a 2-item 
cognitive scale. All three scales are psychometrically equivalent to 
comparable FIM scales. 
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Chapter 5 
Comparison of Methods of Evaluating Responsiveness: 
Method and Results 
Analyses reported in Chapters 3 and 4 examined the responsiveness of FIM 
and FIM+FAM scales. However, there is no consensus as to which of the 
available statistical methods for reporting responsiveness should be used. 
Consequently, different studies use different statistical methods for 
evaluating responsiveness, thus making comparisons difficult. 
Furthermore, there is little information about the clinical implications of 
using different methods for reporting responsiveness. 
The objective of the analyses presented in this chapter is to compare five 
different methods of evaluating responsiveness. The methods are 
compared in two ways: first, how each method rank-orders the six scales of 
the FIM and FIM+FAM, and second, the relative responsiveness each 
scale compared with an arbitrary standard. 
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5.1 Method 
Responsiveness was evaluated using five statistical methods. Data from the 
194 patients in this study who completed the inpatient neurorehabilitation 
programme are used for these analyses. As is previous studies (312,318), 
results for each statistical method are reported as the magnitude of 
instrument responsiveness and the rank ordering of the six FIM and 
FIM+FAM scales. For all methods, higher values indicate greater 
responsiveness and rank ordering is from 1 (most responsive) to 6 (least 
responsive) . 
The five methods of evaluating responsiveness are also compared using an 
approach not previously adopted. This approach examines the relative 
responsiveness, in proportional terms, of the six instruments for each 
statistical method. It is calculated by dividing the value for each scale by the 
value of a nominated arbitrary standard, defined here as the FIM total scale. 
Relative ratios of 1.0 indicate instruments that are as responsive as the 
standard, whilst values exceeding 1.0 indicate better responsiveness 
compared with the standard and values less than 1.0 indicate poorer 
responsiveness compared with the standard. This approach to comparing 
methods of evaluating responsiveness complements rank ordering by 
indicating the extent to which instruments differ in their responsiveness. 
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Five methods are used to evaluate responsiveness: 
t -statistics generated from paired samples t -tests on admission and 
discharge scores for each subject are computed as the mean change score 
divided by the standard error of change scores (SD change + ~n) (310). 
The variation in change scores is the reference against which the magnitude 
of change is judged. There are two limitations of t -statistics as indices of 
responsiveness. First, they contain an adjustment for sample size and can 
be misleading when sample sizes vary. Second, they fail to account for 
variation in scores for clinically stable subjects (310). 
Relative efficiency is the extent to which one scale is more or less efficient 
at detecting change in disability over time relative to another scale (133). 
Squared t -statistics are computed from paired samples t -tests. One scale 
is nominated as the arbitrary standard, in this study the FIM total scale. 
The relative efficiency of each scale is then computed by dividing its 
squared t -statistic by the squared t -statistic for the FIM total scale. Values 
of 1.0 indicate scales that are as efficient at detecting change over time as 
the FIM total scale, whilst values greater (or less) than 1.0 indicate scales 
that are more (or less) responsive than the FIM total scale. By relating each 
scale to a standard, relative efficiency calculations offer the advantage of 
indicating instrument responsiveness in proportional terms. However, 
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relative efficiencies have the same limitations as t -statistics and can only be 
used when comparing instruments in the same dataset. 
Effect size, as defined by Kazis et al. (132), is computed as the mean 
change score for each scale divided by the standard deviation of admission 
scores. The variation of baseline score is the reference against which the 
magnitude of change is judged. Kazis et al. recommend that the clinical 
relevance of effect sizes can be interpreted using the arbitrary criteria 
originally proposed by Cohen (.20 = small; .50 = medium; .80 = large; 132, 
311). The limitation of effect sizes as indices of responsiveness is that they 
fail to account for variation in change scores and in scores of stable subjects 
over time. 
Standardised response mean is computed as the mean change score 
divided by the standard deviation of change scores (135). Variation of 
change is the reference against which the magnitude of change is judged. 
This has direct implications for sample size determination as the ratio of 
sizes required to detect a given clinical effect is equal to the square of the 
ratio of standardised response means (292). Liang (135) recommends that 
Cohen's criteria, defined above, can be used to interpret the clinical 
importance of standardised response means. The limitation of the 
standardised response mean as an index of responsiveness is that it does 
not account for variation in scores for clinically stable subjects. 
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Guyatt et al. 's responsiveness index is calculated as the mean change 
score for respondents who changed divided by the standard deviation of 
change scores for respondents who did not change (110). Variability in 
clinically stable subjects is the reference against which the magnitude of 
change is judged (292). Consistent with the approach taken in other studies 
(312), Guyatt et al. 's responsiveness index is calculated as the mean 
change score in all respondents (not just the subsample who changed), 
divided by the standard deviation of change scores for respondents in the 
test-retest sample. 
There are a number of limitations associated with the responsiveness index 
as a method determining responsiveness. First, basing the numerator and 
denominator on different samples is subject to bias as it assumes similar 
variance in the two samples (134). Second, this method does not take into 
account systematic change that may occur in patients whose health status is 
stable (291). Third, it does not consider variability in the change group 
(136). Finally, within-patient variability on a measure in patients whose 
health status is stable (the denominator in Guyatt et al. 's method) increases 
as the length of time between assessments increases (291). 
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Guyatt et al. suggest that the most appropriate index of responsiveness is 
computed by dividing the minimum change score considered clinically 
important (minimum clinically important difference) by the variability in 
scores of stable subjects (110). However, they acknowledge that for many 
new and established instruments the minimum clinically important difference 
is unknown. They recommend that an initial estimate of responsiveness can 
be determined by comparing the within-person standard deviation to the 
change score observed after an intervention of known efficacy (110). This is 
the standardised response mean. 
5.2 Results 
Table 5.1 presents results of responsiveness analyses using the five 
statistical methods described above. The numerical estimates generated by 
the various methods differ in magnitude. This is expected as each method 
of calculating responsiveness, except relative efficiency, relates the same 
mean change score to a different denominator. That effect sizes and 
standardised response means generate different numerical estimates is 
notable as Cohen's criteria have been proposed for the interpretation of both 
methods. Therefore, applying Cohen's criteria can lead to different 
conclusions about the responsiveness of an instrument. For example, the 
responsiveness of the FIM total score is moderate as assessed by the effect 
size and large when calculated using the standardised response mean. 
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For all scales, responsiveness assessed in terms of standardised response 
means is higher than when calculated on the basis of effect sizes. The 
finding indicates that the standard deviation of change scores is consistently 
less than the standard deviation of admission scores. Liang suggests that 
this finding indicates that the correlation between admission and discharge 
scores is high (292). When correlations between admission and discharge 
scores are low «.50) effect sizes exceed standardised response means, 
whereas effect sizes and standardised response means are equal when this 
correlation is .50. 
Table 5.2 presents a rank ordering of the responsiveness of FIM and 
FIM+FAM scales for each method (1 = most responsive). In addition, the 
relative responsiveness of each scale compared to the FIM total scale is 
also presented. Rank ordering produces similar results across all methods. 
The only difference is that three methods (t -statistic, relative efficiency, 
standardised response mean) show the FIM motor scale to be more 
responsive than the FIM+FAM motor scale. For the other two methods this 
order is reversed. As these two instruments have almost identical 
responsiveness by all five statistical methods, this is of little clinical 
relevance. Relative responsiveness produces more variability between the 
different methods of evaluating responsiveness. These results indicate that 
for the five methods of reporting responsiveness studied the choice of 
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statistic has little influence on instrument responsiveness when considered 
in terms of rank ordering. 
5.3 Summary of results 
The five methods of reporting responsiveness produce numerical estimates 
that vary in magnitude. Applying Cohen's criteria to effect sizes and 
standardised response means leads to different clinical interpretations of the 
responsiveness of instruments. The five methods produce very similar rank 





The role of the NHS is to deliver modern effective health care to people in 
the United Kingdom within a limited budget. To achieve this aim, new and 
existing therapeutic interventions must be evaluated and compared in the 
environments in which they are used (313). This requires the use of health 
outcome measures that combine scientific soundness and clinical 
usefulness. The need for rigorous outcomes measurement cannot be 
overstated: information collected using health measures influences 
decisions that affect patient welfare and guide major expenditure of public 
funds (127). 
Neurorehabilitation is a complex resource-consuming intervention with a 
high service demand and a limited scientific basis (149). Careful evaluation 
of neurorehabilitation is needed urgently to determine its effectiveness 
relative to other interventions and to underpin future research and 
development. While level of disability is the primary outcome for evaluating 
rehabilitation, disability measurement is poorly developed (84). Among 
numerous existing measures, the FIM and FIM+FAM have achieved 
particular importance and widespread use. Although the clinical usefulness 
of these measures is agreed, their scientific properties have not been fully 
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documented. The objective of this study was to evaluate comprehensively 
the psychometric properties of these two measures. Given the importance 
of evaluating the responsiveness of health outcome measures, this topic 
was given particular attention. 
This study addressed three questions. First, are the FIM and FIM+FAM 
rigorous measures of disability in neurorehabilitation? This question 
included a comparison of the measurement properties of both instruments in 
stroke and MS and with the Barthel Index. Second, is there empirical 
support for the conceptual models on which both measures are based? This 
question included an evaluation of the feasibility of developing a 
psychometrically sound short-form measure. Third, how do five methods of 
evaluating responsiveness compare? 
Results show that the FIM and FIM+FAM are acceptable, reliable, valid, 
and responsive measures of disability in neurorehabilitation. Furthermore, 
they have similar measurement properties in stroke and MS patients. 
However, neither instrument shows any psychometric advantage as an 
evaluative measure over the Barthel Index. Moreover, both the FIM and 
FIM+FAM show item redundancy, limited item discriminant validity, and 
inadequate support for the hypothesised subscales. An 8-item short-form 
FIM was developed that shows similar psychometric performance to the 18-
item FIM and 30-item FIM+FAM. The five methods of evaluating 
responsiveness rank order scales similarly, but generate numerical 
estimates of different magnitude. 
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This study makes four major contributions to health measurement. First, 
findings demonstrate that the FIM and FIM+FAM (and also the Barthel 
Index) are suitable for measuring disability in clinical practice and research, 
and indicate which scores should be reported. Second, recommendations 
are made for more rigorous standards for instrument development and 
evaluation before introduction into practice. Third, results suggest that 
conceptual models of disability need to be refined. Finally, the study 
emphasises the need for consensus in evaluating responsiveness and 
makes recommendations for reporting responsiveness. 
This chapter summarises study results and compares them with findings 
from previous studies. The limitations of the study and implications for 
clinical practice and research are examined. Finally, future research 
directions are suggested. 
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6.1 Summary of results 
6.1.1 Psychometric evaluation of the FIM and FIM+FAM 
This study provides clear evidence that the FIM and the FIM+FAM are 
acceptable, reliable, valid, and responsive measures of disability in 
patients undergoing inpatient neurological rehabilitation. However, the total 
and motor scales are more responsive than the cognitive scale for both 
instruments. These findings indicate that the FIM and FIM+FAM are 
suitable for use as disability outcome measures in audit, clinical practice, 
and research in groups similar to the patients studied. 
Results also demonstrate that the FIM and FIM+FAM are psychometrically 
sound measures of disability in stroke and MS patients. There are, 
however, some differences between the performance of the two 
instruments. The FIM cognitive scale is less acceptable in MS than in stroke 
patients due to high ceiling effects. All FIM and FIM+FAM scales are more 
responsive in stroke than in MS patients, suggesting that responsiveness 
may be disease dependent. Correlations with handicap are higher for MS 
than for stroke patients indicating better discriminant validity in stroke 
patients. 
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The FIM, FIM+FAM, and Barthel Index have similar measurement 
properties in patients undergoing inpatient neurorehabilitation. 
Corresponding scales of the FIM and FIM+FAM have equivalent 
psychometric properties, indicating that the addition of FAM items to the 
FIM does not improve disability measurement. Moreover, the Barthel Index 
has equivalent psychometric properties to the motor scales of the FIM and 
FIM+FAM, except for measurement precision, indicating that the presumed 
advantages of the newer FIM and FIM+FAM are not supported by empirical 
evidence. Furthermore, the similarity in psychometric properties between 
the Barthel Index and the total and motor scales of the FIM and FIM+FAM 
calls into question the claim that the Barthel Index is too crude, simple, and 
insensitive (unresponsive) to be used to evaluate clinical practice or in 
research (163, 165, 166). In this study, the Barthel Index demonstrates 
good acceptability, internal consistency reliability, construct validity, and 
responsiveness: there is no evidence that the FIM or FIM+FAM perform 
better from a psychometric point of view. 
This is the first study to comprehensively evaluate the full range of 
psychometric properties of the FIM and FIM+FAM in the same sample, to 
compare these properties in stroke and MS, and to compare them head-to-
head with the Barthel Index. In addition, this study is the most 
comprehensive psychometric examination of the Barthel Index to date. 
Results from this study are similar to those reported in previous studies 
examining aspects of the psychometric properties of the FIM and FIM+FAM. 
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For the FIM, high internal consistency and inter-rater reproducibility have 
been demonstrated for all three FIM scales (195, 201-203,205, 206). For 
both the FIM and FIM+FAM, high correlations between the total scales and 
the opes disability scale (216), and similar intercorrelations between the 
motor and cognitive scales (191) have been reported. 
Findings from this study are consistent with previous studies that have 
evaluated aspects of the measurement properties of the FIM in stroke and in 
MS patients. For stroke patients, the FIM total scale has been shown to be 
acceptable (205, 314, 315), and all three FIM scales have been shown to 
be internally consistent (205). For MS patients, the FIM total scale has 
been shown to be acceptable (197,201, 208), internally consistent (201), 
reproducible (201), and highly correlated with the EDSS (197, 201). There 
are no studies which have compared the performance of the FIM+FAM in 
stroke and in MS patients. 
Although this is the first study to report a comprehensive head-to-head 
comparison of the measurement properties of the FIM, FIM+FAM, and 
Barthel Index, previous studies report similarities between these three 
instruments. High correlations have been shown between the total scales of 
the FIM and FIM+FAM (216), and between the motor scales of the FIM and 
FIM+FAM (191). These convergent validity estimates are the same as those 
found in this study, confirming the similarity of these scales. 
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There are, however, some differences between results of this study and 
previous research. For example, Hall et a/. (191) report a lower correlation 
between the cognitive scales of the FIM and FIM+FAM (.84 versus .97). 
Similarly, McPherson and Pentland (216) report lower correlations between 
the Barthel Index and the FIM total score (.64 versus .95), and between the 
Barthel Index and the FIM+FAM total score (.53 versus .90). These findings 
from previous studies suggest that the FIM, FIM+FAM, and Barthel Index 
are measuring related but distinct health constructs. However, differences 
in the score distributions of the instruments, which attenuate correlations 
between instruments (316), may explain why these correlations are lower 
than those obtained in this study. In the Hall et al. study, the distribution of 
FIM+FAM cognitive scores is strongly positively skewed, whereas FIM 
cognitive scores more closely approximate a normal distribution. In the 
McPherson and Pentland study, Barthel Index scores have a ceiling effect 
of 69% and are, therefore, strongly negatively skewed. Conversely, FIM 
and FIM+FAM scores more closely approximate a normal distribution. 
6.1.2 Evaluating conceptual models using item analysis 
Item analysis of the FIM and FIM+FAM demonstrates item redundancy, 
subscale overlap, limited item discriminant validity, and dimensions of 
measurement that are inconsistent with hypothesised scales. Thus, the 
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empirical evidence does not fully support underlying conceptual models. 
Item redundancy also suggests that short-form versions of both instruments 
can be developed. On the basis of further psychometric analyses, ten 
redundant items were eliminated from the FIM to produce an 8-item short-
form version. Analyses indicate that these items are best grouped into three 
scales (an 8-item total scale, a 6-item motor scale, and a 2-item cognitive 
scale) that are psychometrically equivalent to corresponding FIM and 
FIM+FAM scales. 
No previous studies have examined the conceptual models of the FIM or 
FIM+FAM by performing comprehensive item analyses. In fact, no previous 
studies have had the specific aim of examining the conceptual models of 
these instruments. However, within the context of different objectives, 
other investigators have undertaken limited item analyses for the FIM and 
the results of all-bar-one of these studies tend to support its conceptual 
model. The internal consistency of the three FIM scales is supported by 
high alpha coefficients (195, 201, 205) and high item-total correlations 
(205). Support for the FIM motor and cognitive scales as separate 
dimensions of measurement is provided by intercorrelations between these 
two scales (191), principal components analysis specifying a two-
component solution (205), multitrait scaling tests (205), and the analysis of 
Rasch-transformed FIM scores (317). 
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The results of one study call into question the conceptual model of the FIM. 
Recently, Stineman et al. (206) performed item-level exploratory factor 
analysis on FIM scores for twenty impairment groups including seven 
neurological impairments. In contrast to their previous study based on the 
same dataset (205), Stineman et al. (206) did not specify the number of 
components to be extracted by the principal components analysis. None of 
the solutions extracted, which have between two and four components, 
support the scale and subscale structure of the FIM. Rather than question 
the conceptual model of the FIM, the authors of this study suggest that 
different combinations of items may need to be used in different impairment 
groups. 
The findings of the present study do not support the conceptual model of the 
FIM because crucial analyses have been undertaken that have not been 
reported before. For example, no previous study of the FIM has reported 
item intercorrelations, intercorrelations between subscales, or item 
convergent and discriminant validity for subscales. It is the results of these 
three analyses, as well as those of a principal components analysis when 
the number of components to extract are not specified, that cast doubt on 
the conceptual model of the FIM. 
The feasibility of developing short-form versions of the FIM or FIM+FAM has 
not been investigated previously. However, results from other studies 
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suggest item redundancy in the FIM. It has been suggested that alpha 
coefficients exceeding .90 to .95 may be indicative of item redundancy (286, 
298), particularly for scales having fewer than ten items (98). The 
consistent finding in other studies that alpha coefficients for FIM scales 
exceed .90 (195,201,205) suggests the possibility of item redundancy and 
the feasibility of developing short-form measures. 
6.1.3 Comparison of methods of evaluating responsiveness 
Five methods of reporting responsiveness used in this study produce 
different results in terms of the absolute value of their numerical estimates. 
However, all five methods produce similar rank orderings of the six scales 
of the FIM and FIM+FAM. In fact, these five methods of reporting 
responsiveness generate only two rank orderings of the scales: three 
methods (t -statistics, relative efficiency, standardised response mean) 
produce one rank ordering, and two methods (effect size, Guyatt et al.'s 
responsiveness index) the other rank ordering. The difference between 
these two rank orderings is simply a juxtaposition of two scales that have 
very similar responsiveness. That is, the FIM+FAM motor scale is 
marginally more responsive than the FIM motor scale when determined 
using three methods, but marginally less responsive than the FIM motor 
scale when responsiveness is determined using the other two methods. 
These findings suggest that the choice of method of evaluating 
responsiveness has little consequence when the aim of a head-to-head 
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comparison of instruments is simply to determine which instrument is most 
responsive. However, as the relative ratios of responsiveness produce 
more variability between methods, the choice of statistic does indeed have 
an influence over the relative responsiveness of instruments. This may be 
important for sample size calculations. 
Two previous studies (312,318) which compared different methods of 
evaluating responsiveness produced conflicting results. Three statistical 
methods used in both studies (effect size, standardised response mean, 
Guyatt et al. 's responsiveness index) are also used in the present study. 
Stucki et al. (318) demonstrated almost identical rank ordering of four health 
measures using five indices of responsiveness. They concluded that the 
choice of statistic was of little consequence. In contrast, Wright and Young 
(312) demonstrate different rank orderings for the responsiveness of 
fourteen health measures using five indices of responsiveness. They 
conclude that the choice of statistic influences the relative responsiveness of 
measures. A close examination of the results from these two studies 
provides a possible explanation for their different conclusions. In the Stucki 
et al. study, the relative responsiveness of instruments differs much more 
than in the Wright and Young study. Consequently, the rank ordering of 
instruments in the Wright and Young study is influenced by small differences 
in the relative magnitude of the numerical estimates produced by different 
methods. A similar finding to the FIM total and FIM+FAM total scales in this 
study. 
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As rank ordering does not quantify relative responsiveness, this method of 
comparing instruments can be misleading. For example, in the Wright and 
Young study the responsiveness of the SF-36 Physical Functioning scale is 
rank ordered four places above the Western Ontario and McMaster Scale. 
However, the standardised response means are 1.1 and .90, respectively, 
indicating similar responsiveness. In contrast to rank ordering, relative 
ratios quantify the relative responsiveness of instruments and provide 
valuable information for investigators choosing between instruments. 
6.2 Study limitations 
The results of this study, which are based on a heterogeneous sample of 
neurologically disabled patients from three centres in and around London, 
may not be generalisable to all patients undergoing neurological 
rehabilitation in the UK. Similarly, results may not be generalisable to all 
stroke and MS patients who are undergoing inpatient rehabilitation. 
Rehabilitation units throughout the UK differ markedly in the type of 
rehabilitation programmes offered, the casemix and level of disability of 
patients, staffing levels and expertise, and facilities. Furthermore, patients 
are usually selected on the basis of their suitability for a specific 
rehabilitation programme. Although this study was conducted at three 
independent units with different expertise, the patient sample is almost 
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entirely from the south of England. In generalising the results from this 
study to other local samples, consideration should be given to differences in 
level of disability of patients. 
The disability level of patients in this study is within the range of disability 
reported by other investigators. Table 6.1 shows that patients in this study 
are more disabled than two studies of mixed patients in Scotland (214, 216), 
and less disabled than two studies of mixed patients in the US (200,205). 
The disability level of stroke patients is similar to one other study (314), 
lower than patients in another study (205), and higher than patients in 
another study (211). The disability level of MS patients is similar to that 
reported in other stud ies (197, 201, 208). 
The method used to derive FIM scores in this study may be a potential 
limitation. As the 18 items of the FIM are contained within the 30 items of 
the FIM+FAM, it is standard practice to rate all 30 items together and derive 
FIM and FIM+FAM scores subsequently (191,214,216,319). This was the 
method used in this study. Alternatively, the FIM can be administered and 
scored independently. As different methods of administering an instrument 
should be evaluated independently (130), a preliminary investigation of the 
psychometric properties of the two methods of administering the FIM (stand 
alone versus as part of the FIM+FAM) was performed. FIM scores from the 
118 patients in this study from the NRU were compared with all patients in 
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the NRU audit database (n = 728) in terms of alpha coefficients (total, 
scale), intercorrelations among and between scales, item intercorrelations, 
and correlations with other variables (8arthellndex, EDSS, age). Results 
(Table 6.2) indicate that the psychometric properties of the FIM do not differ 
between the two methods of administration. 
Another potential limitation concerns the method of administration of the 
FIM, FIM+FAM, and 8arthellndex. As patients were rated by therapists 
who were providing treatment, staff ratings may have been biased by the 
need to demonstrate improvements in disability following rehabilitation. 
Consequently, it is possible that patients may be rated lower (more 
disabled) on admission and higher on discharge. This would have the effect 
of attenuating correlations with other measures (88), and overestimating the 
responsiveness of the FIM and FIM+FAM by increasing the magnitude of the 
change scores. However, bias due to raters is likely to be minimal for two 
reasons. First, the aim of this study was not to examine the effectiveness of 
rehabilitation. Second, the composition of the treatment teams was highly 
variable and staff turnover moderate. 
The method used to evaluate reproducibility may have overestimated FIM 
and FIM+FAM reliability. Given the short intra-rater reproducibility interval, 
reliability may have been overestimated due to therapists recalling their 
initial ratings. However, as each therapist rated many patients and both 
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instruments have a large number of items, it is unlikely that observers were 
able to recall their numerous ratings with any degree of accuracy. Similarly, 
the method used to assess inter-rater reproducibility may also have 
overestimated reliability. As both the team consensus and study co-
ordinator ratings were generated from the same observers (the latter based 
on interviews of all members of the treating team), the paired ratings were 
not entirely independent. Nevertheless, the two methods of rating the same 
patient were different. 
Agreement between raters from the three clinical sites, i.e. the inter-site 
reproducibility of FIM and FIM+FAM scores, was not examined in this study. 
As both instruments are used widely in different settings where raters are 
often trained locally, inter-site variability is a potential source of random 
error affecting FIM and FIM+FAM scores. Unfortunately, there are few 
clinical settings in which this aspect of reproducibility can be studied easily 
as it requires patients to be rated by independent teams at two or more 
sites. However, a previous study (200) has addressed this problem and 
reports results that are adequate for group comparisons. 
The external construct validity of the FIM and FIM+FAM was examined in 
subsamples of the total sample which varied in size and casemix. For 
example, tests of neuropsychological functioning were administered only at 
the NRU which consists predominantly of MS patients. Ideally, all 
instruments used to examine the validity of the FIM and FIM+FAM should 
have been administered at all sites. This was not possible for practical 
reasons. Therefore, results based on these analyses may have more 
limited generalisability. 
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The validation of the short-form FIM-8 was not undertaken in an 
independent sample from that used for item reduction and scale 
development. However, some of the psychometric properties of the FIM-8 
have been examined subsequently in an independent sample of patients 
from the NRU (unpublished data). Similar results (data not reported) were 
obtained for internal consistency, correlations between scales, convergent 
validity (correlations with the Barthel Index and EDSS), discriminant validity 
(correlations with age and sex), and responsiveness. Nevertheless, the 
psychometric results of the short-form FIM-8 are preliminary and need to be 
confirmed in an independent sample. 
6.3 Implications for clinical practice and research 
6.3.1 Implications for clinical practice 
Results from this study have several implications for clinical practice and 
service delivery. First, there is now good evidence that the FIM, FIM+FAM, 
and the Barthel Index are psychometrically sound measures of disability. 
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Second, results provide new information about which FIM and FIM+FAM 
scores should be reported. Third, results help to inform choice between the 
FIM, FIM+FAM, and Barthel Index. Finally, results call into question the 
validity of clinically derived conceptual models of disability. 
This study confirms the scientific value of the FIM, FIM+FAM, and Barthel 
Index as measures of disability in neurorehabilitation, in addition to their 
previously agreed practical utility. All three measures have been 
incorporated successfully into the routine clinical practice of three busy units 
and have been shown to be Scientifically sound. Consequently, they can be 
used for local audit, to compare outcomes between different units, and to 
evaluate the effects of policy changes. 
Evidence from this study indicates that only total, motor, and cognitive 
scores should be reported for the FIM and FIM+FAM, as these are the only 
scores that have been shown to be reliable and valid. To date, there has 
been no consensus as to which FIM or FIM+FAM scores should be reported. 
Consequently, previous studies report various combinations of the whole 
range of scores (item, subscale, scales, total) for either groups or 
individual patients. Although subscale and item scores provide useful 
qualitative clinical information, there is insufficient evidence to support them 
as quantitative estimates of disability. Subscales were not shown to be valid 
measures of distinct dimensions of disability, even though they represent 
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reliable item groups. Reporting scores for single items is not recommended 
as they are unreliable and lack measurement precision and validity (100, 
217,269,320). 
Although the question of which FIM+FAM scores should be reported has not 
been addressed, it has been suggested that total scores should not be 
reported for the FIM (317). Using Rasch measurement techniques, Linacre 
et al. (321) showed that FIM items measure two distinct aspects of disability, 
motor and cognitive function. On this basis, they argued that the FIM is a 
multidimensional instrument, and that the FIM total score should not be 
reported as it is an ambiguous quantitative summary of disability which 
combines two distinct dimensions. 
The fact that an instrument has multiple dimensions does not prectude a 
total score being reported, provided it can be justified on conceptual and 
empirical grounds (269, 271, 277). Indeed, most instruments designed to 
measure broad constructs like disability can be shown to have multiple 
subdimensions when subjected to statistical analyses of dimensionality 
(factor analysis, item-response theory, or log-linear models) (269, 271). 
This finding indicates, in a statistical sense, that the items of an instrument 
form multiple clusters based on the relative strengths of relations among 
them (269). However, it does not determine whether the instrument is 
measuring multiple constructs that are distinct or a single construct that is 
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heterogeneous (269.277). Further examination of reliability and construct 
validity is required to make this distinction. 
Although results from this study confirm Linacre et a/. 's findings that the 
motor and cognitive domains of the FIM are distinct, they also indicate that 
reporting of FIM (and FIM+FAM) total scores is justifiable on conceptual and 
empirical grounds. Conceptually, it makes sense to combine all items to 
generate a total score as the different dimensions within the FIM and 
FIM+FAM are components of the construct of disability. Empirically, it is 
legitimate to report total scores as this study demonstrates them to be 
reliable and valid. It should be noted that Linacre et a/. did not examine the 
reliability or validity of FIM scores. 
Whether investigators should report FIM and FIM+FAM total or motor and 
cognitive scores depends on the purpose of measurement. Investigators 
wishing to examine motor and cognitive disability separately, or study the 
relationships between them, are more likely to report scale scores. 
Similarly, those interested in overall disability are more likely to report total 
scores. It is important to note that, for unequivocal interpretation of results, 
the construct measured must be homogeneous (271). Investigators should 
bear this in mind when analysing and interpreting FIM and FIM+FAM total 
scores. 
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Although health outcome measures are most commonly used to evaluate the 
performance of groups (51), an interesting question for further study is the 
appropriateness of using FIM and FIM+FAM scores for individual-patient 
clinical decision-making. This would be particularly useful in rehabilitation, 
which is a goal-oriented individually-tailored therapeutic intervention (322-
324). 
McHorney and Tarlov (266) discussed the issue of instruments used to 
assess individual-patients. They proposed six measurement standards: 
brevity, breadth and depth of health measured, cross-sectional and 
longitudinal measurement precision, and validity for individual-patient 
applications. Results from this study demonstrate that the FIM and 
FIM+FAM satisfy statistical standards for cross-sectional (alpha coefficients 
> .90 - .95) and longitudinal (reproducibility > .90 - .95) measurement 
precision. However, confidence intervals around individual-patient scores 
are extremely wide indicating that measurements are not accurate enough to 
be used to make clinical decisions about individual patients. Moreover, 
there are no data examining the validity of the FIM or FIM+FAM in an 
individual decision-making context. McHorney and Tarlov (266) examined 
the extent to which the SF-36, Functional Status Questionnaire (325), 
Dartmouth COOP Poster Charts (326), Nottingham Health profile (57), and 
the Duke Health Profile (327), met their six criteria as measures for 
individual decision-making. They also demonstrated wide confidence 
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intervals and the absence of relevant evidence for validity, and reached the 
same conclusions that these instruments were not appropriate in this 
context. 
Results from this study allow clinicians to make an informed choice between 
the FIM, FIM+FAM, and Barthel Index. The fact that all three instruments 
are psychometrically comparable as evaluative measures indicates that no 
advantage is gained by selecting the longer instruments, the FIM and 
FIM+FAM, over the shorter Barthel Index. The choice of instruments, 
therefore, should be guided by other practical criteria. For example, the 
Barthel Index is cheaper and simpler than the FIM and FIM+FAM and does 
not require either trained raters or the use of team consensus to generate 
ratings. Consequently, the Barthel Index can be used easily in clinical 
settings where staffing is limited, for example outpatient clinics and 
domiciliary visits, enabling change in disability to be easily monitored over 
time following a period of hospitalisation. Furthermore, preliminary 
evidence (328,329) for the validity of a postal version of the Barthel Index 
(232) suggests the possibility of ongoing disability measurement at minimum 
inconvenience to patients. 
There are, on the other hand, four advantages of the FIM and FIM+FAM 
compared with the Barthel Index. First, they have superior measurement 
precision to the Barthel Index, indicating better ability to discriminate 
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between groups of patients. Second, the FIM and FIM+FAM provide 
specific information concerning motor and cognitive dimensions of disability, 
whereas the Barthel Index only addresses physical function. Third, as they 
have more items, the FIM and FIM+FAM provide a more extensive 
qualitative assessment of the patterns and areas of disability for individual 
patients and groups. That is, the FIM and FIM+FAM generate superior 
diagnostic information than the Barthel Index. Fourth, the process of team 
consensus rating enables dissemination of information about patients 
among the multidisciplinary team. Although no studies have examined this 
aspect of the rehabilitation process, therapists comment that these 
meetings are valuable for patient management. 
Finally, results from this study indicate limited empirical support for clinically 
derived conceptual models of disability. Whilst the rationale underlying the 
development of the FIM and FIM+FAM is intuitively sound, the 
demonstration of their psychometric equivalence with the Barthel Index and 
failure to find empirical support for conceptual models indicates that 
disability is more complex than originally conceptualised. This area will be 
discussed later in this chapter. 
This study also provides evidence for the effectiveness of inpatient 
neurorehabilitation. In the total sample and stroke patients, statistically 
significant improvements were shown for overall, motor, and cognitive 
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scores, whereas in MS patients, statistically significant improvements were 
demonstrated for overall and motor, but not cognitive scores. Although this 
is not a controlled study, these results provide evidence for the 
effectiveness of an intervention whose scientific basis is not very sound. 
6.3.2 Implications for research 
Results from this study have several implications for research. First, 
findings confirm the scientific rigour and thus usefulness of the FIM, 
FIM+FAM, and Barthel Index for research in neurorehabilitation. Second, 
results demonstrate the need for a more systematic and rigorous approach 
to the psychometric evaluation of existing instruments, and the development 
of new outcome measures before they can be recommended for use in 
clinical practice. Third, findings indicate the need for better conceptual 
models of disability. Finally, findings indicate the need for consensus 
about how responsiveness should be measured. 
Findings from this study demonstrate that the FIM, FIM+FAM, and Barthel 
Index are all suitable measures for research. All three instruments satisfy 
standard criteria for reliability and validity and demonstrate responsiveness, 
indicating that they are appropriate for research applications such as 
randomised controlled clinical trials or observational studies. Moreover, the 
fact that they can be easily incorporated into clinical practice makes them 
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ideal for health services research. These findings increase the scientific 
credibility of results from studies, such as those examining the effectiveness 
of neurorehabilitation in MS (323,330), that have used the FIM or 
FIM+FAM as disability outcomes measures in similar samples. 
The psychometric equivalence of the FIM, FIM+FAM, and Barthel Index 
demonstrated in this study indicates that there is little advantage in using the 
two longer measures rather than the shorter Barthel Index. There are two 
caveats to this statement. First, it is necessary to use the FIM and 
FIM+FAM if separate motor and cognitive scores are required. Second, the 
superior measurement precision of the longer measures indicates an 
advantage over the Barthel Index if the purpose of the study is to examine 
group differences in disability. However, as most studies use health 
outcome measures for evaluative purposes, there is no psychometric 
advantage of one instrument compared with the others. Therefore, the 
choice of instrument must be based on other criteria. The practical 
advantages of the Barthel Index, discussed above, suggest it would be 
more successfully incorporated into large multi-centre studies. In addition, 
the availability of the self-report Barthel Index makes it possible to measure 
outcomes by postal survey. This is important for neurological disorders 
which are uncommon and disabling: postal survey allows the study of large 
samples of patients in geographically disparate locations and, by avoiding 
hospital attendance, reduces patient inconvenience, staff burden, and 
cost. Alternatively, the FIM or FIM+FAM would be preferred for studies 
specifically examining motor and cognitive disability. 
6.3.2.1 Evaluating existing health outcome measures 
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Results from this study indicate that the psychometric evaluation of existing 
measures should consist of a comprehensive examination of the full 
spectrum of measurement properties, the routine examination of 
incremental validity and, for multi-item measures, a detailed item analyses. 
Many instruments used in clinical practice and research have been in 
existence for some years, and were developed before psychometric 
methods became familiar to clinicians. For example, the EDSS, the 
measure of disability in MS used to evaluate the effectiveness of interferons, 
was developed in 1954 (83). Similarly, the Rankin Scale, widely used to 
evaluate treatment effectiveness in stroke (331), was developed in 1957 
(39). Likewise, the 8arthellndex, probably the most widely used generic 
measure of disability in the UK, was developed in 1955 (65, 220). 
In the last decade, the increasing awareness of psychometric methods, 
combined with recognition that the choice of outcome measure is crucial to 
the design of a successful clinical trial (70), has resulted in a flurry of 
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studies reporting post hoc psychometric evaluations. Whilst studies of 
individual measurement properties are increasingly common, there are few 
comprehensive evaluations of the full range of psychometric properties. 
Such studies are necessary because psychometric properties are largely 
independent of each other, and dependent on the samples in which they 
are examined. For example, the evaluation only of the reliability of an 
instrument (231, 238, 332) is of limited value in choosing an outcome 
measure for use in research. Although reliability is a pre-requisite for 
validity (91), it is possible to have a highly reliable scale with limited validity 
and poor responsiveness. 
One property of instruments that receives little attention is acceptability. 
Although studies usually report mean or median scores, it is less common 
to report ranges of score, standard deviations or percentiles, and rare to 
report floor and ceiling effects or skewness statistics. As existing measures 
are often used in samples that differ widely, it is important that these data 
are reported to indicate the applicability of the instrument to the study 
sample. An example of the impact of unacceptable score distributions on 
the interpretation of results was discussed earlier in this chapter. 
Acceptability data also provide useful information about the extent to which 
an instrument may achieve the aims for which it is being used. For example, 
the EDSS was developed specifically to detect between-group differences 
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and within-group changes in disability for MS patients (82). Acceptability 
data from this study show that, even though the EDSS mean score is 
situated near the scale mid-point and there are no floor or ceiling effects, 
there is little score variability. These results suggest that the EDSS has a 
poor ability to discriminate between individuals in terms of their disability, 
and suggest that its responsiveness will be limited. Further analyses have 
confirmed these predictions: each EDSS score is associated with a wide 
range of FIM and Barthel Index scores; EDSS measurement precision is 
56% of the FIM total score; the effect size is .06. 
Results from this study indicate that the routine evaluation of existing 
measures should go beyond a comprehensive assessment of their basic 
psychometric properties. The demonstration in this study that the FIM, 
FIM+FAM, and Barthel Index are all psychometrically sound but equivalent 
points to the need for including a comprehensive examination of incremental 
validity when evaluating all instruments. Whilst studies comparing individual 
psychometric properties and the use of instruments are increasingly 
common (23, 191, 262, 333-339), comprehensive head-to-head 
comparisons of instruments are not frequently undertaken. This may be 
because none of the current standards for evaluating instruments 
recommend an examination of incremental validity. However, an informed 
decision as to which of a group of measures is best for a study is dependent 
upon empirical evidence of their relative scientific and clinical properties. 
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Results from this study also indicate that the routine psychometric 
evaluation of existing multi-item measures should include item analyses. 
These are not frequently undertaken. For example, item analyses have not 
been reported for the Barthel Index, EADL, or opes. The value of item 
analyses is demonstrated by the fact that although the FIM and FIM+FAM 
satisfy standard criteria for reliability and validity, they show item 
redundancy, subscale overlap, and limited item discriminant validity. Here, 
item analyses indicate that both measures can be improved in their clinical 
usefulness (reduction of item number) and scientific rigour (more valid item 
groups). The short-form FIM-8 demonstrates that rigorous disability 
measurement can be achieved using a smaller number of items. 
Furthermore, item analyses demonstrated a misconceptualisation of 
disability which is discussed later in this chapter. Finally, and perhaps most 
importantly, item analysis of the FIM and FIM+FAM highlights some of the 
limitations of relying solely on basic tests of reliability and validity when 
evaluating instruments that were not developed using psychometric 
methods. For these reasons, item analyses should be part of the routine 
evaluation of available measures. 
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6.3.2.2 Developing new health outcome measures 
Results from this study have implications for the development and 
evaluation of new health outcome measures before their introduction into 
clinical practice. They illustrate the limitations of clinical approaches to 
instrument development, and the importance of an iterative psychometric 
approC)ch in which conceptual and measurement models are developed, 
item analysis and item reduction techniques are applied, the full spectrum 
of psychometric properties are comprehensively evaluated, and incremental 
validity is examined. 
This study demonstrates that clinical approaches to measurement are not 
always supported by empirical results. The FIM was specifically developed 
because the Barthel Index was considered inadequate to evaluate the 
effectiveness of medical rehabilitation. Similarly, the FIM+FAM was 
developed because the FIM was considered inadequate to evaluate medical 
rehabilitation in patients with neurological disability. Although the method of 
development of both instruments was intuitively sound - items were selected 
by the consensus opinion of a panel of expert rehabilitation clinicians-
empirical data from this study indicate that this approach has not achieved 
the desired goals as all three measures are psychometrically equivalent. 
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The finding of psychometric equivalence for the Barthel Index, FIM, and 
FIM+FAM highlights a difference between clinical assessment and 
measurement. There is no doubt that the greater number of items and 
response categories in the FIM and FIM+FAM provide more comprehensive 
qualitative assessments of disability than the Barthel Index. This probably 
explains why clinicians, who manage the day-to-day problems of individual 
patients, anecdotally prefer the FIM or FIM+FAM. However, all three 
instruments generate similar quantitative estimates of disability, largely 
because these additional items are redundant. For example, the four 
transfer items of the FIM+FAM are highly correlated indicating that, despite 
their clinical relevance to the functioning of individual patients, only one of 
these items needs to be included in a measure of disability. Although the 
finding that all transfer items are highly related may be predicted on clinical 
grounds, strong relationships between other items are less predictable. For 
example, transferring into a shower or bath is highly correlated with 
dressing, bathing, and toileting, indicating that this transferring item can be 
used in a measure to represent a wide range of clinical activities. This 
unpredictability concerning the extent to which items are related indicates 
that the selection of items for measurement is dependent upon the 
knowledge of their empirical relationships as well as their clinical relevance. 
Similarly, the manner in which items are grouped into scales should not be 
determined by clinical intuition alone. Empirically derived item groups 
should also be generated. Then, the reliability and validity of both methods 
of grouping items should be examined to determine the most valid 
operational definition of the construct being measured. 
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The nature of the construct of disability confirms the necessity for a 
psychometric approach to scale development. Disability, like many health 
constructs, is complex and based on theory. Disability measures 
operationalise this theory. For a construct to be measured rigorously, there 
needs to be empirical support for its conceptual basis. However, the 
development of measures for complex constructs often has to account for 
uncertainty about the underlying conceptual basis as well as the best 
method of assessment (243,269). Psychometric methods recognise these 
uncertainties and the need to generate the most valid operational definition 
of the construct. Therefore, an iterative approach to scale development is 
advised in which conceptual and measurement models are proposed, 
evaluated, and refined on the basis of empirical data (243, 269). 
Subsequently, and in independent samples representative of those in which 
they will be used, instruments developed in this manner are 
comprehensively evaluated for their acceptability, reliability, validity, and 
responsiveness. Finally, as demonstrated above, incremental validity 
should be examined to provide empirical evidence of the advantages (or 
disadvantages) of one measure compared with alternatives. Had the 
developers of the FIM and FIM+FAM adopted a psychometric rather than a 
clinical approach to scale construction, the limitations of both instruments 
would have been identified and rectified during the development process. 
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For health care evaluation in neurology a new generation of instruments with 
superior measurement properties is required to meet the future clinical 
challenges. Advances in basic neurosciences have increased our 
understanding of the mechanisms of neurological disorders and led to the 
development and introduction of new therapeutic interventions. For 
example, approximately 30 disease modifying drugs are currently being 
evaluated for the treatment of MS (19). As their relative effects are likely to 
be marginal, accurate evaluation is dependent upon high quality 
measurement of health outcomes. 
6.3.2.3 Refining conceptual models of disability 
Results from this study have implications for the future of disability 
measurement as they raise concerns over the validity of current conceptual 
models of disability. Whilst these findings support the results of other 
studies, they do not clarify how disability should be measured and, 
therefore, further work is needed to refine conceptual models of disability. 
The process of instrument development and evaluation can advance 
understanding of the conceptual basis of complex health constructs like 
disability. The items of a scale and the way they are grouped into 
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subscales, known as its measurement model, form an operational definition 
of the construct the instrument is intended to measure. The finding that 
empirical evidence does not support the measurement models of an 
instrument indicates a misconceptualisation of the construct being measured 
and provides a stimulus for further work on conceptual models of disability. 
The measurement models of the FIM and FIM+FAM are based on clinical 
consensus. This has been the most frequently used strategy for selecting 
and grouping items of disability measures (340). As functioning involves 
purposeful activities, there has been a tendency to group items according to 
a common purpose or domain. Logically, this approach has resulted in 
domains such as basic or personal activities of daily living (ADL), 
instrumental or domestic activities of daily living (IADL), self-care, mobility, 
housework, social life, and recreation (341). Understandably, 
measurement models for disability measures, such as the FIM and 
FIM+FAM, are based on this intuitively sound conceptual model. 
When this conceptual model is used as the basis for measurement, 
however, two assumptions must be satisfied. First, it must be 
demonstrated that different activities, represented as items, can indeed be 
combined as a measure and, also, provide unique information about 
disability. Second, different domains of disability, represented as 
subscales, must be shown to represent distinct aspects of disability as 
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domains that are highly related are confounded. Logically, activities (items) 
that are shown to be independent statistically cannot be considered 
indicators of the same domain of disability (subscale). Similarly, activities 
that are highly related statistically cannot be used to measure different 
domains of disability. In addition, activities that are very highly related 
provide almost identical information and, therefore, it is not necessary to 
include both items in the measure. The results generated by an instrument 
are most interpretable when its domains are both sensitive and specific: 
that is, each domain only measures the intended concept and discriminates 
this concept from those measured by the other domains of the instrument 
(127). 
The measurement models of the FIM and FIM+FAM, although intuitively 
sound, are not supported by the findings of this study. Results demonstrate 
that activities hypothesised to be distinct (e.g. bathing, dressing, toileting, 
and the different types of transfers) are very highly related. Thus, they are 
not distinct and do not contribute to an instrument unique information about 
disability. Similarly, results demonstrate that domains of disability 
hypothesised to be distinct (e.g. self-care and transfer, communication and 
social cognition) are not. Furthermore, results demonstrate that activities 
thought to be representing distinct domains (e.g. community mobility 
representing locomotion and employability representing psychosocial 
adjustment), and therefore included in different subscales, are in fact highly 
related to multiple domains and, therefore, are neither specific nor 
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sensitive. The consequences of these misconceptualisations of disability are 
item redundancy, subscale overlap, and limited item-discriminant validity. 
Finally, the fact that a principal components analysis groups activities 
differently than that predicted by the developers (e.g. upper and lower limb 
function), provides further evidence of inadequacies in the conceptual 
models underlying the development of the FIM and FIM+FAM. 
Other evidence which leads to a questioning of the measurement model of 
the FIM is provided by Stineman et al. (206). Their objective was "to seek 
more fine-grained impairment-specific dimensions beyond the motor and 
cognitive dimensions of the FIM" (page 636). They performed an item-level 
exploratory factor analysis (principal components method, varimax rotation) 
on FIM data for 20 different impairment categories including seven 
neurological impairments. Five different factor solutions were generated: 
one 2-factor solution (motor and cognitive disability); two 3-factor solutions 
(ADL, mobility, cognitive disability; upper cord, lower cord, cognitive 
disability), and two 4-factor solutions (self-care, sphincter, mobility, 
cognitive disability; low energy, high energy, sphincter, cognitive 
disability). Whilst the authors conclude that these findings indicate that the 
FIM is a multilayered, multidimensional measure of human function and that 
the impairment-specific subscales provide improved measurement, their 
results call into question the measurement model underlying the FIM. None 
of the factor solutions they obtained support the grouping of items into the 
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six domains hypothesised by the developers (self-care, sphincter, transfer, 
mobility, communication and social cognition). 
These studies are not the first to demonstrate that empirical evidence fails to 
support clinically based conceptual models of disability. In fact, twenty 
years ago the Health Insurance Experiment (341) questioned the 
appropriateness of this method of item selection and grouping for measuring 
functional activities. Jette (340) was the first to address their question. 
Rather than examine the measurement models of specific instruments Jette 
performed a factor analysis (method not stated) of 34 widely used self-report 
ADL items. From a sample of approximately 200 elder adults with 
polyarticular disability (mean age 69), five factors were extracted that 
accounted for 58.5% of the total variance: physical mobility (1 O-items), 
kitchen chores (7-items), personal care (8-items), home chores (7-items), 
and transfer (2-items). Jette's results suggest that the concept of ADL is 
more complex than initially thought. 
Recently, two studies (176, 342) have examined whether the hypothesised 
concepts of ADL and IADL are empirically distinct. Thomas et al. (342) 
performed an item-level exploratory factor analysiS (principal axis method, 
oblique rotation) on the 14 items (7 ADL, 7 IADL) of a modified version of 
the Older Americans Research Survey (OARS). From a large data set (n = 
8900; age> 65) three factors were extracted: basic self-care (5 items), 
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intermediate self-care (6 items), and complex self-management (3 items). 
Kempen et al. (176) factor analysed (principal component method, varimax 
rotation) the 18 items (10 ADL, 8 IADL) of the Groningen Activity Restriction 
Scale (GARS). Three factors were extracted with Eigenvalues exceeding 
1.0: moderately difficult activities (9-items); simple activities (7 -items); 
activities requiring special training (2-items). The findings from these 
studies indicate that ADL and IADL are not the distinct unidimensional 
constructs of disability that has been assumed. 
While the studies of Jette, Thomas, Stineman, and Kempen indicate 
misconceptualisations about disability, they do not clarify its conceptual 
basis or how it should be measured. There are two reasons for this. First, 
none of these studies has examined the validity of the item groups 
generated. Although factor analysis is widely used to define how the items 
of an instrument might be grouped into scales, examination of the construct 
validity of these item groups is essential to determine how they should be 
interpreted. It was noted earlier that when item pools representing diverse 
constructs such as disability are subjected to examinations of their 
dimensionality, multiple item clusters are often demonstrated. Whether 
these clusters of items represent distinct dimensions of measurement, or 
simply reflect the heterogeneity of the construct, remains unresolved until 
intercorrelations between the scales and item and scale convergent and 
discriminant validity are examined. 
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The second reason that these studies do not clarify the conceptual basis of 
disability is that none of them has defined the construct being measured. All 
four studies discussed above generate different item groupings. This is not 
surprising as the solutions generated by factor analysis are dependent upon 
the initial item pools analysed (305), which were unique for each study. To 
determine the conceptual basis of a construct, it must first be defined 
clearly to ensure that all important items are considered for inclusion (271). 
If a construct is not defined carefully in advance, the extent to which the 
items analysed are representative of the domain of interest remains 
uncertain, and connection between the construct and the scale is unclear 
(269). 
Work is still required to determine empirically based conceptual models of 
disability. This should be undertaken as a collaboration between clinicians 
and measurement experts. Future disability scales need to be based on 
clear definitions of the aspectls of disability that investigators are attempting 
to measure. Large item pools should be generated from semi-structured 
patient interviews, review of the literature and existing measures, and 
expert clinical opinion. Measurement models should be developed, tested, 
and refined accordingly. 
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6.3.2.4 Evaluating responsiveness 
Results from this study highlight the need for consensus about how 
responsiveness should be reported, question the use of Cohen's criteria in 
the clinical interpretation of responsiveness data, and demonstrate the 
importance of examining relative responsiveness. Until a consensus is 
achieved, it is suggested that an hypothesis testing approach to examining 
responsiveness, akin to gathering evidence for validity, might be 
appropriate. 
There is an urgent need for consensus about how responsiveness should be 
reported. As demonstrated in this study, five commonly used methods of 
calculating responsiveness generate estimates of different magnitude. 
Although this finding is predictable (each method has a different statistical 
formula), if investigators are not aware of this fact it can lead to different 
interpretations of instrument responsiveness. If, however, there are 
consistent relationships between the magnitude of the estimates generated 
by different statistics interpretation is more straightforward. For example, if 
estimates generated by standardised response means are consistently twice 
the magnitude of estimates generated by effect sizes (as they are in this 
study) one statistic can be predicted the another. Unfortunately, empirical 
evidence demonstrates that this is not the case. For example, results from 
other responsiveness stUdies demonstrate that the magnitude of estimates 
generated by standardised response means can be greater than (343), 
equal to (236, 291, 343, 344), or less than (318, 344) the magnitude of 
responsiveness estimates generated using effect sizes. 
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Another problem that arises from the different responsiveness estimates 
generated by effect sizes and standardised response means concerns their 
clinical interpretation. Cohen's criteria (.2 = small; .5 = medium; .8 = large 
(311)), are generally used for the clinical interpretation of responsiveness 
estimates generated by these two methods (132, 135). However, findings 
from this study demonstrate that quite different conclusions can be drawn 
from the same data: the responsiveness of the FIM total score is medium in 
terms of the effect size and large in terms of the standardised response 
mean. 
A further reason for not recommending the use of Cohen's criteria is that 
responsiveness estimates are dependent on the intervention and the 
disease studied. In this study, responsiveness coefficients for the FIM and 
FIM+FAM are higher in stroke than MS patients suggesting that these 
instruments are more responsive in stroke patients. However, as 
responsiveness coefficients are standardised change scores, and as FIM 
and FIM+FAM change scores are expected on clinical grounds to be smaller 
in MS than stroke patients, it is predictable that MS patients will have 
smaller responsiveness estimates. These findings by no means indicate 
that the FIM and FIM+FAM are less able to detect change in disability for 
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MS patients, and support the findings of other studies demonstrating that 
responsiveness is dependent on the magnitude of the change induced by an 
intervention (138, 291, 345). Moreover, this study demonstrates that the 
magnitude of the change induced by rehabilitation is disease-dependent. 
The responsiveness of an instrument, therefore, reflects three variables: 
the ability of the instrument to detect change, the ability of the intervention 
to induce change, and the potential of patients in the sample to undergo 
change. Consequently, responsiveness cannot be viewed as a property of 
the instrument itself. 
Although sample dependency is a feature of all psychometric properties, it 
is notable in this study that responsiveness appears more sample 
dependent than reliability and validity. Furthermore, results from this study 
provide evidence that responsiveness, unlike reliability (13), is not related 
to the number of items in a scale (272) or the number of item-response 
categories (346, 347). These findings emphasise the importance of 
examining the relative responsiveness of different instruments in the same 
clinical setting. Using this method, the study sample and therapeutic 
intervention are held constant, and the results generated reflect the relative 
ability of the different instruments to detect change in that specific clinical 
setting. 
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The sample dependency of responsiveness coefficients calculated from pre-
and post-intervention change scores, defined as prospective methods of 
determining responsiveness (138), has prompted investigators to seek 
other methods of estimating the ability of instruments to detect change. One 
commonly used approach is to compare change scores and an external 
criterion of change, such as a transition question (260). In this method, 
patients or clinicians assess the amount of change retrospectively using a 
global scale of change (e.g. -3 = markedly worse, 0 = no change, +3 = 
marked improvement). Responsiveness can then be determined in a 
number of ways. For example, by correlating change scores with scores 
from the global measure of change (high correlations indicate greater 
responsiveness) (131). Alternatively, the minimum clinically important 
difference (mean change score for minimally improved I deteriorated 
patients minus mean change score for unchanged patients) can be 
calculated (348). Or, the coefficient proposed by Guyatt et al. (110) can be 
calculated (mean change score in patients judged to have changed divided 
by the standard deviation of change scores in patients judged to have not 
changed). These methods have been defined as retrospective methods of 
determining responsiveness (138). 
Recently, Norman et al. (138) have compared prospective and retrospective 
methods of examining instrument responsiveness. Using data from several 
studies and simulation methods, the authors investigated the relationship 
between responsiveness estimated using standardised response means 
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(prospective) and estimates calculated using Guyatt's method 
(retrospective). They demonstrate that there is no predictable relationship 
between the two indices either within or across studies. The authors 
indicate that the root of the problems is the confounding of natural variation 
among patients with experimentally induced change: an effect first 
anticipated by Cronbach forty years previously when he described two 
contrasting paradigms within psychology (349). He differentiated the 
correlational approach, concerned with the study of individual differences in 
mental capacity, from the experimental approach, concerned with 
controlling and predicting behaviour through experimental interventions. 
Norman et al. reason that the two approaches to estimating responsiveness 
correspond to these paradigms. Responsiveness estimated prospectively is 
consistent with the experimental paradigm as the magnitude of the statistic 
relates the size of the treatment effect (numerator) to the variation in 
individual treatment response. Responsiveness estimated retrospectively is 
consistent with the correlational paradigm as it is based on variations 
between subjects in response to treatment, and has no direct relationship to 
the overall treatment effect. They conclude that retrospective methods of 
computing responsiveness yield little information about the ability of an 
instrument to detect treatment effects and recommend that they are not used 
as a basis for selecting instruments for clinical trials. 
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Determining instrument responsiveness is, therefore, complex. On the one 
hand prospective methods cannot divorce the ability of the instrument to 
detect change from the magnitude of the change induced by the 
intervention. On the other hand retrospective methods appear to yield little 
information about the ability of an instrument to detect treatment effects. 
Until consensus is reached as to how responsiveness should be measured, 
an hypothesis testing approach similar to that used to gather evidence for 
the validity of an instrument might be an appropriate strategy. In this 
method, the responsiveness of an instrument is determined in multiple 
studies designed to examine the extent to which the instrument is able to 
detect change in the construct being measured. 
The sample and intervention dependency of prospective methods of 
examining responsiveness can be used advantageously. Evidence 
supporting the responsiveness of an instrument is provided if hypotheses 
concerning differential responsiveness are confirmed empirically. For 
example, patients with relapsing-remitting MS are hypothesised to make 
greater functional gains from rehabilitation than patients with the progressive 
forms of this disease because of more extensive spontaneous neurological 
recovery. Recently, this hypothesis has been confirmed for the FIM and 
Barthel Index (213). Similarly, the fact that patients with secondary 
progressive MS undergo a faster deterioration in disability over time than 
patients with primary progressive MS could be exploited to provide evidence 
of responsiveness. Furthermore, the finding in this study that effect sizes 
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are greater for the motor scales than the cognitive scales of the FIM and 
FIM+FAM are consistent with clinical predictions as rehabilitation 
predominantly effects physical function. Consequently, the demonstration 
that instruments are able to detect different degrees of change provides 
support for their ability to detect change. 
Despite Norman et al. 's (138) advice not to use retrospective methods to 
quantify instrument responsiveness, these methods can be used to provide 
evidence of responsiveness. For example in this study, the demonstration 
that increases in staff ratings of improvement in disability on discharge are 
associated with a stepwise increase in magnitude of change scores cannot 
be ignored as support for the responsiveness of the FIM and FIM+FAM. 
Other authors (318) have demonstrated similar findings. It is notable that 
using retrospective methods in this manner differs from Norman et al. who 
studied the relationship between responsiveness quantified using 
prospective and retrospective methods. 
Using the approach outlined above the extent to which empirical evidence of 
responsiveness gathered from multiple studies supports a priori predictions 
based on clinical expectation can be used to provide strong evidence for the 
responsiveness of measures despite the limitations of the inherent methods. 
Clearly, more work is required to investigate the potential of this approach 
to responsiveness testing. 
6.4 Future directions 
6.4.1 Clinical acceptability of the FIM, FIM+FAM and Barthel 
Index 
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Work is required to determine the extent to which the FIM, FIM+FAM, and 
Barthel Index are rigorous measures of disability for neurorehabilitation in 
the UK. Although results from this study provide strong support for their 
clinical usefulness and scientific soundness, and even though all three 
measures are widely used across the UK, there are few data examining 
their psychometric properties in other samples of rehabilitation patients. In 
fact, other studies using the FIM, FIM+FAM, and Barthel Index in 
rehabilitation settings report findings that question their acceptability (191, 
214, 216). A study examining the score distributions of the FIM, FIM+FAM, 
and Barthel Index in rehabilitation units that routinely collect these data 
would provide this useful information. In addition, within-scale analyses 
could be undertaken on these data (e.g. alpha coefficients, item-total 
correlations, inter-item correlations, and intercorrelations between scales) 
to examine further their psychometric properties in different samples. 
If data confirm the widespread scientific soundness of the FIM, FIM+FAM, 
and Barthel Index in UK rehabilitation centres, work is then needed to 
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generate normative data to enable the interpretation of scores, in particular 
the meaning of change scores. Although the UDS collate FIM scores from 
subscribers, these data are not freely available. Otherwise, few normative 
data exist (350) and there are none for the UK. These data are required to 
guide patient selection, to evaluate different rehabilitation practices, to 
compare the effectiveness of different interventions, and to guide sample 
size calculations for clinical trials. Defining poor outcomes would help 
identify patient groups that might benefit less from rehabilitation. For these 
groups alternative management strategies are more appropriate, such as 
maximising the home environment and improving community services. At 
present, these decisions are based on the experience of rehabilitation 
clinicians. As no two rehabilitation units have the same clinical practice, 
evaluation of outcomes will enable comparisons of the relative contributions 
of the individual components of the rehabilitation process to be defined. In 
addition, there have been few comparisons of rehabilitation with other 
therapeutic interventions. Finally, sample size calculations for clinical trials 
require a meaningful description of effect sizes (293). 
6.4.2 Interpreting scores generated by health outcome 
measures 
Despite the widespread use of health outcome measures, there is no 
systematic strategy for translating health outcomes into clinical decisions. 
Within psychology, it is commonplace to relate scale values and change 
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scores to the rest of the sample (or ideally, to the population) in terms of 
standard deviation units, percentiles, or percentages. These methods 
enable comparisons across samples, constructs, and measures. Although 
these statistical benchmarks are importance for interpreting scores, they 
are unfamiliar to clinicians and their patients and, more importantly, have 
limited clinical meaning. Moreover, statistical significance does not ensure 
clinical significance (and vice versa) (293). 
Content based referencing is required to give clinical meaning to change 
scores (127,351). That is, changes on health measures need to be 
anchored to clinical or other relevant changes (352). Whilst clinical 
interpretation of scores is relatively straightforward for single item measures 
like the EDSS - each score has a specific clinical meaning - it is less clear 
for multi-item measures as all scores (except the minimum and maximum) 
represent multiple permutations of item scores. Even determining the 
clinical significance of changes on single item measures is not simple. For 
example, the recently published randomised placebo controlled study of 
interferon beta in secondary progressive MS (59) demonstrated a 
statistically significant finding of less disability in the treatment group. The 
difference of .13 EDSS points, less than half of a level, may have 
significant health policy implications but the clinical significance has not 
been determined. 
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Several methods have been proposed to aid the clinical interpretation of 
Barthel Index and FIM scores. For the Barthel Index, scores in the 0 to 8 
range indicate complete dependence, 8 to 12 partial dependence, and 12 
to 20 full independence (228). For the FIM, Granger et al. have studied the 
relationship between FIM scores and the number of minutes help per day 
required from another person for patient with MS (208) and stroke (211). 
Results from these small studies (n = 20) demonstrate that a change of one 
FIM point is associated with a change in help required of 3.38 minutes in MS 
patients, and 2.19 minutes in stroke patients. Another method for the 
clinical interpretation of FIM scores has been to examine the score 
differences associated with different discharge destinations (e.g. 
independent at home, care at home, sheltered accommodation, residential 
care) (195). 
Whilst these studies provide support for the external construct validity of the 
FIM (as predicted low scores are associated with more help in minutes and 
discharge to residential care), they are limited. For example, the amount of 
help disabled people receive is dictated by the amount of help available 
(e.g. family and social services) and influenced by the disablement 
friendliness of the environment. Indeed, these features influence self-
reports of disability (353). Similarly, the discharge destination of patients 
may depend more on the skill and facilities of the clinicians involved in the 
placement process than the disability of the patients. 
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Several other methods have been proposed for the clinical interpretation of 
scores on health measures. These include relating scores or score changes 
to the cost of health care utilisation (354), major life events (355), 
preference weightings (356), equivalence with the impact of other diseases 
(357), or visual representations (mapping) of the relationships between 
perceptions and behaviours (358). All these methods have their limitations 
(352) (for example, major life events are uncommon and their impact is 
variable), prompting Deyo et al. (359) to recommend the use of a limited 
number of measures, and Lydick and Yawn (360) to add that the continued 
collection of data concerning clinical anchors will enable clinicians, over 
time, to become increasingly familiar with the clinical significance of 
particular levels of change. 
One method for giving clinical meaning to change scores is Jaeschke et al. 's 
(348) minimum clinically important difference (MelD) approach. In this 
method, change scores are related to direct ratings of change generated by 
patients and/or clinicians on a transition question: the MelD is calculated as 
the mean change score for those persons rated as minimally improved 
minus the mean change score for those persons rated unchanged. Results 
from two studies (137,348) suggest that, when using 7-point rating scales, 
the MelD for a measure is .5 scale units per item, a change of 1.0 units per 
item is considered moderate, and of 1.5 units per item is considered large. 
Although Juniper et al. (137) suggest that these changes are generalisable 
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to all areas of health-related quality of life, results from this study suggest 
otherwise. Table 6.3 reports, for stroke and MS patients, mean change 
scores for the FIM total scale for each level of staff-rated change in disability 
on discharge. Whilst the sample sizes are small and the calculation of an 
MCID is probably inappropriate, there is a two or three fold disease-related 
difference in the magnitude of the mean change score for each level of 
improvement. 
These results are, perhaps, to be expected. The clinical significance of 
changes in health status are dependent on raters' expectations and patients' 
needs. For example, stroke patients are expected to achieve much greater 
functional gains from rehabilitation than MS patients. Similarly, different 
degrees of change in disability will have variable clinical significance for 
individuals. Moreover, transition questions (theoretically) have limited 
reliability, validity, and precision (138) as they are single item measures 
(271). If the MCID is to be used for the clinical interpretation of changes in 
health measures, the psychometric properties of transition questions must 
be comprehensively documented and disease-specific reference values are 
required. 
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6.4.3 Evaluating the effectiveness of neurorehabilitation 
Although this study has evaluated the usefulness of two disability measures, 
the role of disability itself as an outcome of rehabilitation needs to be 
considered critically. To evaluate rigorously therapeutic effectiveness, 
investigators must decide and specify in advance what the intervention is 
trying to achieve. Based on this information, measures should be chosen or 
developed that comprehensively evaluate these domains of health. Whilst 
the WHO's International Classification of Impairments, Disabilities, and 
Handicaps (ICIDH) (155) has been the framework behind many studies of 
rehabilitation, further work is required to define a conceptual basis for 
outcome studies in rehabilitation. As shown in this study, psychometric 
methods can help to do this. 
Rehabilitation is concerned with restoring, to whatever degree may be 
possible, an individual's capacity for integrated functioning in physical, 
psychological, and social terms (157). It is a multidisciplinary, problem-
solving, goal-oriented, individually tailored intervention, the aim of which is 
to lessen the impact of the disease on daily life and to enable patients to 
realise their own potential within the limitations posed by their disease (361). 
Disability is just one of many aspects of health effected by this complex 
intervention and, therefore, comprehensive studies of rehabilitation 
effectiveness should also include an evaluation of other relevant health 
constructs. 
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The ICIDH (155) provides the framework for many studies of rehabilitation. 
This classification was developed as a response to the need for a 
conceptual and operational framework for describing and measuring the 
consequences, or disablement, of chronic conditions (157). The 
conceptual distinctions were developed specifically to correspond to the 
obligations of different components of health care: impairments were 
considered the concern of medical services, disabilities the concern of 
rehabilitation services, and handicaps the concern of social welfare 
provisions (157). It was thought that this classification would bring coherent 
thinking to an arbitrary and disjointed area, lead to better understanding 
and communication and, as a result, improved health care (362). The 
ICIDH has achieved its goal: it is considered to be the cornerstone of 
rehabilitation management as it is comprehensive, relevant and amenable to 
operationalisation, and each concept can be defined influenced and 
measured (156, 363). As a result, studies of rehabilitation have determined 
effectiveness by measuring one or more of impairment, disability, and 
handicap outcomes. 
Although the ICIDH provides a conceptual model of disablement for 
evaluating the rehabilitation process, the empirical basis of the model has 
not been tested. Whilst it is widely accepted and clearly documented that 
the rehabilitation process addresses a vast number of diverse health-related 
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problems (150), there is uncertainty as to which dimensions of health are 
influenced. The situation is complicated further as clinicians and 
commissioners of health care do not agree on the aims of rehabilitation 
services. Commissioners often are looking for simple independence in ADL, 
discharge from hospital, or return to paid employment, whereas clinicians 
often have wider interests such as maximising leisure participation and 
social interaction (364). Moreover, clinicians do not agree about which 
outcomes should be measured. Wade reports from a recent international 
meeting, held in Vienna, to discuss outcomes measurement in 
rehabilitation: "some people wanted more disease-specific measures but 
others wanted more generic measures: some wanted longer more detailed 
measures while others wanted shorter, simpler measures; the level of 
measurement (impairment, or disability, or handicap) was debated" (364, 
page 93). 
Wade's opinion is that too much emphasis is placed on outcome 
measurement instruments and not enough on study design. Using the 
analogy of workers (study design) and their tools (outcome measurement 
instruments), he argues that good workers (randomised controlled trials) 
using poor tools achieve better results (outcomes) than poor workers 
(observational studies) using good tools. This opinion is in direct contrast to 
the more accepted view expressed in the psychological measurement 
literature that training in measurement principles is an area of relative 
neglect compared to the emphasis on study design (81, page 653). 
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Moreover, whilst rigorous study designs are essential, Wade's view fails to 
account for three issues. First, there is a clear consensus that 
observational studies do indeed provide scientifically credible information 
and randomised controlled studies are subject to their own problems, such 
as limited generalisability (365-367). For example, it is notable that most 
studies of interferons in MS have excluded the majority of people with the 
disease. Furthermore, in some cases undertaking randomised controlled 
trials of inpatient rehabilitation may not be feasible as such studies would 
require control groups to be admitted to a rehabilitation unit for a sham 
intervention (323). 
The second issue that Wade's opinion fails to account for is that any study 
has a higher scientific impact when the outcome measures used are proven 
to be rigorous. Finally, Wade's opinion fails to recognise that psychometric 
methods can be used to answer the question of which outcomes should be 
measured. The process of instrument development using psychometric 
methods, as discussed earlier in this chapter, can lead to advances in our 
understanding of the conceptual basis of health. Studies using 
psychometric methods to develop measures for evaluating rehabilitation 
outcomes, would result in the development of empirically based conceptual 
models of the impact of rehabilitation. These studies are urgently needed as 
the scientific basis of rehabilitation is not firmly grounded (149, 366). 
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It is important that new measures of neurorehabilitation, and neurology in 
general, consider the self-report method of administration. There are 
conceptual and methodological reasons for this. First, from a conceptual 
point of view, the person receiving an intervention is best placed to judge its 
benefit (49). Also, the perceptions of patients and the health professionals 
who treat them differ (41), and many important domains of health (e.g. 
emotional well-being) are subjective concepts (36). From a methodological 
point of view the self-report method of administration of health measures 
reduces the burden of outcomes data collection and enables postal surveys 
to be conducted. In neurology, as many disorders are uncommon, the 
recruitment of an adequately sized sample often requires multiple centres. 
Furthermore, many patients with neurological disorders are significantly 
disabled and hospital visits are often inconvenient, troublesome, and 
problematic. Finally, self-report methods of administration allow 
measurement instruments to be used in and out of hospital, thereby 
enabling the collection of better follow-up data. 
Before the development of a wave of self-report measures for neurology and 
neurorehabilitation, work is needed to clarify the impact of motor and 
cognitive disabilities on this method of administration. Many neurological 
disorders are associated with cognitive impairment. For example, 
approximately 700/0 of people with MS have abnormal cognitive functioning 
on formal neuropsychological testing (253). The impact of cognitive 
impairment on questionnaire completion and psychometric properties is 
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poorly studied. Research is needed to quantify the levels of cognitive 
impairment associated with adequate questionnaire completion and the 
impact of individual deficits (e.g. memory, reasoning, and attention). 
Similarly, little is known about the impact of visual and upper limb 
dysfunction, either separately or together, on the completion of self-report 
questionnaires. 
An area that requires further evaluation is the use of individual patient 
measures to evaluate the outcome of neurorehabilitation. Some authors 
(324, 368) argue that standardised measurement instruments, like the FIM, 
FIM+FAM, and Barthel Index are less relevant for measuring the outcomes 
of rehabilitation than other areas of medicine. This is because rehabilitation 
treats a heterogeneous mix of patients with a broad range of diseases and 
disabilities, and has diverse individually tailored treatment goals (324). 
Furthermore, others (209) argue that functional status measures are unable 
to record the small but clinically significant changes that often accompany 
successful rehabilitation. 
Goal Attainment Scaling (368) is a widely used technique (322) which was 
developed to measure aspects of health specific to both the patient and the 
aims of the intervention. Its major advantage over other measurement 
methods in rehabilitation is that it compares a patient's actual achievement 
to what the patient could be expected to accomplish. Therefore, it is a direct 
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measure of patient change and treatment effectiveness. The major 
limitations of Goal Attainment Scaling are that highly specific training (at 
least one year of experience) is required to selected and scale the goals. 
Recently, Improvement Scaling (324) has been developed. This is based 
on Goal Attainment Scaling, but is more user friendly (briefer) and requires 
less training as the goals (usually three) are selected from a list of 65 
standardised (pre-scaled) goals. 
Preliminary data gathered using Improvement Scaling is encouraging (324). 
However, the feasibility of using individual patient assessment measures in 
routine clinical practice has been questioned because they are time 
consuming (369). More importantly, empirical evidence is required to 
determine whether this is a reliable and valid method of measurement. 
Finally, there are few guidelines as to how validity can be empirically 
determined; this is assumed on the basis of content validity and patient 
specificity. However, the role of Improvement Scaling to measure outcomes 
in rehabilitation requires further examination. 
6.4.4 Item reduction techniques 
In the development of multi-item measures, one area that requires further 
investigation is the comparison of item reduction techniques. Whilst there is 
consensus that items should be generated from multiple sources to ensure 
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that all important variables are considered for inclusion in a scale, and 
consensus that item reduction and scale formation should be empirically 
based, there is no consensus as to which item reduction method should be 
used. Recently, two studies (297, 370) have demonstrated that the two 
principal methods of item reduction and scale formation, psychometric and 
clinimetric, generate two different instruments from the same item pool. 
This finding has wide reaching implications; if measures of the same 
phenomena, developed using different methods, generate different results, 
the validity of one or both methods (and all studies using scales developed 
by that method) is questioned (370). The implications of these findings have 
yet to be fully determined. 
The two methods of item reduction have different philosophies (297). In the 
clinimetric strategy (371), items are chosen from the item pool on the basis 
of empirical evidence of their importance to patients and/or clinicians. In the 
psychometric strategy, items are chosen on the basis of their empirical 
performance as measures. 
In a retrospective study, Juniper et a/. (297) compared clinical impact 
(clinimetric) and factor analysis (psychometric) methods of reducing 152 
items in the development of an instrument to measure quality of life in adults 
with asthma. In the clinimetric method, patients indicated whether they had 
experienced each item during the last year (yes / no), and rated the 
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importance of each item on a five-point scale (1 = not important, 5 = 
extremely important). For each item, an impact score was calculated as the 
product of the proportion of patients experiencing the item and its mean 
importance score. Items with the highest impact scores were selected, and 
then grouped into scales on the basis of clinical opinion. The final 
questionnaire contained 32 items in four scales: symptoms, emotional 
function, activity limitation, and environmental exposure. 
In the psychometric method, items experienced by less than 40% of 
patients were discarded. Redundant items (item intercorrelations > .70) 
were identified, and the item with the lowest item-total correlation was 
eliminated. A principal components analysis was conducted and items were 
removed that loaded on the first factor by less than .40. Last, using varimax 
rotations, solutions were generated with three, four, five, and six principal 
components, and the most clinically sensible of these solutions was 
retained. The final questionnaire contained 36 items in five scales: 
unpleasant chest sensations, fatigue and emotional function, activity 
limitations, symptoms of nocturnal asthma, and impairments associated 
with environmental stimuli. Therefore, the clinimetric and psychometric 
methods of item reduction generated instruments with a different number of 
items and scales and different scale content. Twenty items were present in 
both instruments. Juniper et al. conclude that the two methods of item 
reduction lead to appreciably different instruments. 
238 
Marx et a/. (370) compared, prospectively, clinimetric and psychometric 
methods for selecting the best 30 items from a 70-item pool to generate a 
measure of upper extremity disability. In the clinimetric strategy, items were 
selected with the highest mean scores for aggregated importance and 
severity ratings, each measured on five-point scales (1 = not at all, 5 = 
extremely). In the psychometric strategy, items were selected with the 
highest equidiscriminatory item-total correlations (a modification of item-total 
correlations that identifies items that correlate with each other but 
discriminate between individuals throughout a range of scores (217». 
Finally, clinicians modified both 30-item scales to improve their face validity 
by exchanging items from the rejected item pool. Ten items were exchanged 
in the clinimetric scale, three items in the psychometric scale. Before 
clinician modification fifteen items were common to both 30-item 
instruments, sixteen items post-modification. 
Marx et a/. examined further the similarities of the two instruments by 
computing alpha coefficients, mean total scores, and agreement between 
scores using the method of Bland and Altman (372) and an intraclass 
correlation coefficient. Results for clinimetric and psychometric scales, 
respectively, were: (before clinician modification) alphas = .96 and .97; 
mean score = 48.2 and 39.1; limits of agreement (mean difference + SO) = 
9.1 + 17.6; ICC = .93; and (after clinician modification) mean score = 40.9 
and 39.2; limits of agreement (mean difference + SO) = 1.7 + 10.4; ICC = 
.97. Marx et 81. conclude that although the scales differ in content, 
clinimetric and psychometric strategies for item reduction are 
complementary. 
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Whilst there is no doubt that the two methods generate instruments with 
different item content, the two studies reach somewhat different 
conclusions. The implications of psychometric and clinimetric methods of 
item reduction, therefore, remain unclear. Furthermore, there are 
limitations in both studies that influence the interpretation of results. Juniper 
et 81., although concluding that the instruments are different, do not 
examine the extent to which the two instruments are different from a 
psychometric point of view. Marx et 81., although concluding that the two 
methods of item reduction are complementary, do not report a 
comprehensive comparison of all psychometric properties of the instruments 
to determine fully the extent of their similarity. For example, a high 
correlation between the two measures is expected as item overlap is high 
(530/0) and the range of scores is wide (0 to 100). It is also notable that 
whilst the clinimetric methods used in the two studies are very similar (items 
are selected with highest impact factor), they differ in terms of the 
psychometric methods used. Juniper et 81. use an item elimination strategy 
based on four criteria. In contrast, Marx et 81. select items on the basis of 
an entirely different criterion. The extent to which these differences in 
method influence the results is uncertain. 
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In practice, the distinction between psychometric and clinimetric methods 
may not be as black and white as portrayed in these two studies. Whilst 
psychometric methods are indeed more statistically based than clinimetric 
methods, it is strongly recommended that the approach is inductive rather 
than deductive (269). That is, scale development should begin with a 
clearly defined construct which guides subsequent scale development. 
Similarly, validation should be confirmatory with theoretical ideas guiding 
the validation strategy and hypotheses generated about the relationships 
between the scale and other variables. In contrast, deductive methods (e.g. 
factor analysis) allow the results to dictate the construct underlying the item 
pool. Factor analysis is just one of the many analyses used in item 
reduction and has many limitations (305,309, and 271 page 533-535). 
Ultimately, scale development involves a combination of both clinimetric 
and psychometric methods to generate the most valid operational definition 
of a construct. 
6.5 Concluding remarks 
In a recent article, McDowell and Jenkinson (127) called for the academic 
discipline of health measurement to be developed further. There is no doubt 
that this is essential. Expressions of concern about health measurement 
instruments and the ways they are applied in clinical settings are increasing 
(54). Anecdotally, clinicians comment particularly on the frustration and 
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confusion they feel when asked to administer questionnaires termed "quality 
of life" measures that differ widely in content. 
A formal discipline is required to raise awareness of clinicians and guide 
instrument choice. A UK panel of experts is required to develop consensus 
guidelines for the evaluation and development of new measures, to advise 
granting bodies and journal editors, and to co-ordinate research 
programmes. Further development of theory and conceptual models is 
required at the expense of questionnaire development (54). 
The fundamental view of this thesis is that in health outcomes measurement 
scientific rigour should not be compromised. The impetus for this view is not 
only the advancement of science, the encouragement of genuine 




1. Harris AI. Handicapped and impaired in Great Britain. Part 1. London: 
Office of Population Censuses and Surveys, 1971. 
2. Wade DT. Epidemiology of disabling neurological disease: how and why 
does disability occur? Journal of Neurology, Neurosurgery, and Psychiatry 
1996;61 :242-249. 
3. Wade DT, Langton Hewer R. Epidemiology of some neurological 
diseases. International Rehabilitation Medicine 1987;8:129-137. 
4. Langhorne P, Dennis M, editors. Stroke units: an evidence based 
approach. London: British Medical Journal Books, 1998. 
5. Hatch J. The economic impact of multiple sclerosis. MS Management 
1996;3:40. 
6. Jonsson B. The economic cost of multiple sclerosis in Sweden. 
Stockholm: Stockholm School of Economics (report number EFI-6551), 
1995. 
243 
7. Prouse P, Ross-Smith K, Brill M, Singh M, Brennan P, Frank A. 
Community support for young physically handicapped people. Health Trends 
1991 ;23:105-109. 
8. Harvey C. Economic costs of multiple sclerosis: how much and who 
pays? London: National Multiple Sclerosis Society (report number ER-6005), 
1995. 
9. Dennis M. Stroke physicians unite to improve care. Hospital Doctor 
1999: 15th April; 34-35. 
10. Campbell NR. Symposium: measurement and its importance for 
philosophy. Aristotelian Society Supplement 1938;17:277-334. 
11. Stevens SS. On the theory of scales of measurement. Science 
1946; 1 03:677-680. 
12. Torgerson WS. Theory and methods of scaling. New York: John Wiley 
and Sons, 1958. 
13. Streiner DL, Norman GR. Health measurement scales: a practical guide 
to their development and use. 2nd ed. Oxford: Oxford University Press, 1995. 
244 
14. Bohrnstedt GW. Measurement. In: Rossi PH, Wright JO, Anderson AB, 
editors. Handbook of survey research. New York: Academic Press, 1983:69-
121. 
15. Bradford Hill A. Principles of medical statistics. 9th ed. London: The 
Lancet Limited, 1971. 
16. Bunker JP, Wenneburg JE. Operation rates, mortality statistics, and the 
quality of life. New England Journal of Medicine 1973;289: 1249-1251. 
17. World Health Organisation. The constitution of the World Health 
Organisation. WHO Chronicles 1947;1:29. 
18. van der Bos GAM, Limburg LCM. Public health and chronic diseases. 
European Journal of Public Health 1995;5: 1-2. 
19. Thompson AJ, Noseworthy JH. New treatment for multiple sclerosis: a 
clinical perspective. Current Opinion in Neurology 1996;9:187-198. 
20. Frater A, Costain D. Any better? Outcome measures in medical audit. 
British Medical Journal 1992;304:519-520. 
21. Reiser SJ. The era of the patient. Journal of the American Medical 
Association 1993;269:1012-1017. 
22. Hobart JC, Freeman JA, Lamping DL. Physician and patient-oriented 
outcomes in chronic and progressive neurological disease: which to 
measure? Current Opinion in Neurology 1996;9:441-444. 
245 
23. Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N. Self-reported 
functioning and well-being in patients with Parkinson's disease: comparison 
of the Short-Form Health Survey (SF-36) and the Parkinson's Disease 
Questionnaire (PDQ-39). Age and Ageing 1995;24:505-509. 
24. Fillipi M, Paty OW, Kappos L, Barkof F, Compston DA, Thompson AJ, 
Zhao GJ, Wiles CM, McDonald WI, Miller DH. Correlations between 
changes in disability and T2-weighted brain MRI activity in multiple 
sclerosis: a follow up study. Neurology 1995;45:255-260. 
25. Smith 0, Baker GA, Jacoby A, Chadwick OW. The contribution of the 
measurement of seizure severity to quality of life research. Quality of Life 
Research 1995;4: 143-158. 
26. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and 
validation of a short measure of functioning and well-being for individuals 
with Parkinson's Disease. Quality of Life Research 1995;4:241-248. 
27. The IFNB Multiple Sclerosis Study Group. Interferon beta-1 b is effective 
in relapsing-remitting multiple sclerosis. I Clinical results of a multi-centre, 
246 
randomised, double-blind, placebo-controlled trial. Neurology 1993;43:655-
661. 
28. Jacobs LD, Cookfair DL, Rudick RA, Herndon RM. Intramuscular 
interferon beta-1 a for disease progression in relapsing multiple sclerosis. 
Annals of Neurology 1996;39:285-294. 
29. Ebers GC, Oger J, Paty D. The multiple sclerosis PRISMS study: 
prevention of relapses and disability by interferon beta-1 a subcutaneously in 
multiple sclerosis. Annals of Neurology 1997;42:986. 
30. McDonald WI. New treatments for multiple sclerosis. British Medical 
Journal 1995;310:345-346. 
31. Mumford CJ. Beta interferon and multiple sclerosis: why the fuss? 
Quarterly Journal of Medicine 1996;89:1-3. 
32. Anonymous. Interferon beta-1b in MS - hope or hype? Drug and 
Therapeutics Bulletin 1996;34:9-11. 
33. Harvey P. Why interferon beta-1b was licensed is a mystery. British 
Medical Journal 1996;313:297-298 (letter). 
34. Gill TM. Quality of life assessment. Journal of the Royal Society of 
Medicine 1995;88:680-682. 
247 
35. Ware JE Jr. The status of health assessment 1994. Annual Review of 
Public Health 1995;16:327-354. 
36. Stewart AL, Ware JE Jr, editors. Measuring functioning and well-being: 
the Medical Outcomes Study approach. Durham, North Carolina: Duke 
University Press, 1992. 
37. O'Donoghue MF, Duncan JS, Sander JWAS. The subjective handicap of 
epilepsy: a new approach to measuring treatment outcome. Brain 
1998;121 :317-343. 
38. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an 
expanded disability status scale (EDSS). Neurology 1983;33:1444-1452. 
39. Rankin J. Cerebral vascular accidents in patients over the age of 60: II. 
Prognosis. Scottish Medical Journal 1957;2:200-215. 
40. Lang AET, Fahn S. Assessment of Parkinson's disease. In: Munsat TL, 
editor. Quantification of neurological deficit. Stoneham, Massachusetts: 
Butterworths, 1989:285-309. 
41. Sprangers MAG, Aaronson NK. The role of health care providers and 
significant others in evaluating the quality of life of patients with chronic 
disease: a review. Journal of Clinical Epidemiology 1992;45:743-760. 
248 
42. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients 
don't agree: cross sectional study of patients' and doctors' perceptions and 
assessments of disability in multiple sclerosis. British Medical Journal 
1997;314:1580-1583. 
43. Gothan A, Brown R, Marsden C. Depression in Parkinson's disease: a 
quantitative and qualitative analysis. Journal of Neurology, Neurosurgery, 
and Psychiatry 1986;49:381-389. 
44. Brown R, MacCarthy B, Jahanshahi M, Marsden C. Accuracy of self-
reported disability in patients with Parkinsonism. Archives of Neurology 
1989;46:955-959. 
45. Hays R, Vickery B, Hermann B, Perrine K, Cramer J, Meador K, Spritzer 
K, Devinsky O. Agreement between proxy reports and self-reports of quality 
of life in epilepsy patients. Quality of Life Research 1995;4: 159-165. 
46. Dorman P, Waddell F, Slattery J, Dennis M, Sandercock P. Are proxy 
assessments of health status after stroke with the EuroQoL questionnaire 
feasible, accurate, and unbiased? Stroke 1997;28: 1883-1887. 
47. Vickrey BG, Hays RD, Engel J, Spritzer K, Rogers WH, Rausch R, 
Graber J, Brook RH. Outcome assessment for epilepsy surgery: the impact 
249 
of measuring health-related quality of life. Annals of Neurology 1995;37: 158-
166. 
48. Devinsky O. Outcomes research in neurology: incorporating health-
related quality of life. Annals of Neurology 1995;37:141-142. 
49. Ware JE Jr. Measuring patients' views: the optimum outcome measure. 
British Medical Journal 1993;306:1429-1430. 
50. Bayley KB, London MR, Grunkemeier GL, Lansky OJ. Measuring the 
success of treatment in patient terms. Medical Care 1995;33:AS226-AS235. 
51. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based 
outcome measures for use in clinical trials. Health Technology Assessment 
1998;2(14). 
52. Gill T, Feinstein A. A critical appraisal of the quality of qual ity-of-I ife 
measurements. Journal of the American Medical Association 1994;272:619-
626. 
53. Editorial. Quality of life and clinical trials. Lancet 1995;346: 1-2. 
54. Hunt SM. The problem of quality of life. Quality of Life Research 
1997;6:205-212. 
250 
55. Muldoon MF, Barger SD, Flory JD, Manuck SB. What are quality of life 
measurements measuring? British Medical Journal 1998;316:542-545. 
56. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey 
manual and interpretation guide. Boston, Massachusetts: Nimrod Press, 
1993. 
57. Hunt SM, McEwan J. The development of a subjective health indicator. 
Social Health and Illness 1980;2:231-246. 
58. EuroQoL Group. EuroQoL: a new facility for the measurement of health-
related quality of life. Health Policy 1990;16:199-208. 
59. European Study Group on Interferon beta-1b in Secondary Progressive 
MS. Placebo-controlled multicentre randomised trial of interferon beta-1 b in 
treatment of secondary progressive multiple sclerosis. Lancet 
1998;352:1491-1497. 
60. Bensimon G, Lacomblez L, Meininger V, Group ARS. A controlled trial of 
riluzole in amyotrophic lateral sclerosis. New England Journal of Medicine 
1994;330:585. 
61. Ringel SP, Vickrey BG. Measuring quality of care in neurology. Archives 
of Neurology 1997;54:1329-1332. 
251 
62. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save 
lives? Lancet 1993;342:395-398. 
63. International Stroke Trial Collaborative Group. The International Stroke 
Trial (1ST): a randomised trial of aspirin, subcutaneous heparin, both, or 
neither among 19435 patients with acute ischaemic stroke. Lancet 
1997;349: 1641-1649. 
64. Kurtzke JF. A new scale for evaluating disability in multiple sclerosis. 
Neurology 1955;5:580-583. 
65. Mahoney FI, Barthel OW. Functional evaluation: the Barthel Index. 
Maryland State Medical Journal 1965;14:61-65. 
66. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. 
Practitioner 1964; 192: 540-542. 
67. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. 
Neurology 1967; 17:427-442. 
68. Wade DT. Measurement in neurological rehabilitation. Oxford: Oxford 
University Press, 1992. 
69. Miller OH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, 
Lublin FO, Paty OW, Reingold SC, Simon J. Guidelines for the use of 
magnetic resonance techniques in monitoring the treatment of multiple 
sclerosis. Annals of Neurology 1996;39:6-16. 
252 
70. Whitaker IN, McFarland HF, Rudge P, Reingold SC. Outcomes 
assessment in multiple sclerosis trials: a critical analysis. Multiple Sclerosis 
1995;1 :37-47. 
71. Marsden CD. Editorial: what should neurologists do? Journal of 
Neurology, Neurosurgery, and Psychiatry 1981;44:1059-1060. 
72. Lossef NA, Webb SW, O'Riordan JI, Page R, Wang L, Barker GJ, Tofts 
PS, McDonald WI, Miller DH, Thompson AJ. Spinal cord atrophy and 
disability in MS: a new reproducible and sensitive MRI method to monitor 
disease progression. Brain 1996;119:701-708. 
73. Polman CH, Hartung HP. The treatment of multiple sclerosis: current 
and future. Current Opinion in Neurology 1995;8:200-209. 
74. Herndon RM, Murray T J. Proceedings of the international conference on 
therapeutic trials in multiple sclerosis. Archives of Neurology 1983;40:663-
710. 
75. Ellison GW, Myers LW, Leake BD, Mickey MR, Ke 0, Syndulko K, 
Tourtellotte WW. Design strategies for multiple sclerosis clinical trials. 
Annals of Neurology 1994;1994:S108-S112. 
253 
76. Nauta JJP, Thompson AJ, Barkhof F, Miller DH. Magnetic resonance 
imaging in monitoring the treatment of multiple sclerosis patients: statistical 
power of parallel-groups and crossover designs. Journal of Neurological 
Sciences 1994;122:6-14. 
77. Foa R. Ethical considerations raised by clinical trials. In: Goodkin DE, 
Rudick RA, editors. Multiple sclerosis: advances in clinical trial design, 
treatment and future perspectives. London: Springer-Verlag, 1996:335-350. 
78. Weinshenker BG. Natural history of multiple sclerosis. Annals of 
Neurology 1994;36:S6-S11. 
79. Weinshenker BG, Issa M, Baskerville J. Meta-analysis of the placebo-
treated groups in clinical trials of progressive MS. Neurology 1996;46:1613-
1619. 
80. Fleiss JL. The design and analysis of clinical experiments. New York: 
Wiley, 1986. 
81. Cone JD, Foster SL. Training in measurement: always the bridesmaid. 
American Psychologist 1991 ;46(6}:653-654 (letter). 
82. Kurtzke JF. On the evaluation of disability in multiple sclerosis. 
Neurology 1961 ;11 :686-694. 
83. Kurtzke JF, Berlin L. The effects of isoniazid on patients with multiple 
sclerosis. American Review of Tuberculosis 1954;70:577-591. 
254 
84. McDowell I, Newell C. Measuring health: a guide to rating scales and 
questionnaires. 2nd ed. Oxford: Oxford University Press, 1996. 
85. Guilford JP. Psychometric methods. 2nd ed. New York: McGraw-Hili, 
1954. 
86. Nunnally JC Jr. Tests and measurements: assessment and prediction. 
New York: McGraw-Hili, 1959. 
87. Rogers T. The psychological testing enterprise: an introduction. Pacific 
Grove, California: Brooks I Cole, 1995. 
88. Nunnally JC Jr. Introduction to psychological measurement. New York: 
McGraw-Hili, 1970. 
89. Thurstone LL. A method for scaling psychological and educational tests. 
Journal of Educational Psychology 1925;16:433-451. 
90. Thurstone LL. Attitudes can be measured. American Journal of 
Sociology 1928;33:529-554. 
255 
91. Nunnally JC. Psychometric theory. 1st ed. New York: McGraw-Hili, 1967. 
92. American Psychological Association. Technical recommendations for 
educational and psychological tests and diagnostic techniques. Washington, 
DC: American Psychological Association, 1954. 
93. American Educational Research Association, National Council on 
Measurement used in Education. Technical recommendations for 
achievement tests. Washington, DC: National Education Association, 1955. 
94. American Psychological Association, American Educational Research 
Association, and National Council on Measurement in Education. 
Standards for educational and psychological tests and manuals. 
Washington, DC: American Psychological Association, 1966. 
95. American Psychological Association, American Educational Research 
Association, and National Council on Measurement in Education. Standards 
for education and psychological tests. Washington, DC: American 
Psychological Association, 1974. 
96. American Educational Research Association, American Psychological 
Association, and National Council on Measurement in Education. Standards 
for educational and psychological testing. Washington, DC: American 
Psychological Association, 1985. 
256 
97. Ware JE Jr, Brook RH, Davies-Avery A, Williams KN, Stewart AL, 
Rogers WH, Donald CA, Johnson SA. Conceptualization and measurement 
of health for adults in the Health Insurance Study. Volume I: Model of 
health and methodology. Santa Monica, California: The RAND Corporation, 
1980 (publication no. R-1987/1-HEW). 
98. Brook RH, Ware JE Jr, Davies-Avery A, Stewart AL, Donald CA, Rogers 
WH, Williams KN, Johnston SA. Overview of adult health status measures 
fielded in RAND's Health Insurance Study. Medical Care 1979;17(Suppl):1-
131. 
99. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SO, 
McGlynn A, Ware JE Jr. Functional Status and well-being of patients with 
chronic conditions: Results from the Medical Outcomes Study. Journal of 
the American Medical Association 1989;262:907-913. 
100. McHorney CA, Ware JE Jr, Rogers W, Raczek AE, Lu JFR. The validity 
and relative precision of MOS short- and long-form health status scales and 
Dartmouth COOP charts. Medical Care 1992;30:MS253-MS265. 
101. Spitzer WOo State of science 1986: quality of life and functional status 
as target variables for research. Journal of Chronic Diseases 1987;40:465-
471. 
257 
102. Kaplan RM, Bush JW, Barry CC. Health status: types of validity and 
the index of well-being. Health Services Research 1976;11 :478-507. 
103. Sackett OL, Chambers IW, McPherson AS, Goldsmith CH, McCauley 
RG. The development and application of indices of health: general methods 
and a summary of results. American Journal of Public Health 1977;67:423-
428. 
104. Bombardier C, Tugwell P. A methodological framework to develop and 
select indices for clinical trials: statistical and judgemental approaches. 
Journal of Rheumatology 1982;9:753-757. 
105. Oeyo R. Measuring functional outcomes in therapeutic trials for chronic 
disease. Controlled Clinical Trials 1984;5:223-240. 
106. Ware JE Jr. Methodological considerations in the selection of health 
status assessment procedures. In: Wenger NK, Mattson ME, Furberg CO, 
editors. Assessment of quality of life in clinical trials of cardiovascular 
therapies. New York: Le Jacq, 1984:87-111. 
107. Kirshner B, Guyatt G. A methodological framework for assessing health 
indices. Journal of Chronic Oiseases 1985;38:27-36. 
108. Deyo RA, Centor RM. Assessing the responsiveness of functional 
scales to clinical change: an analogy to diagnostic test performance. 
Journal of Chronic Diseases 1986;39:897-906. 
258 
109. Lamping DL. Assessment in health psychology. Canadian Psychology 
1985;26:121-139. 
110. Guyatt GH, Walter S, Norman G. Measuring change over time: 
assessing the usefulness of evaluative instruments. Journal of Chronic 
Diseases 1987;40:171-178. 
111. McDowell I, Newell C. Measuring health: a guide to rating scales and 
questionnaires. 1st ed. Oxford: Oxford University Press, 1987. 
112. Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A. 
Responsiveness and validity in health status measurement: a clarification. 
Journal of Clinical Epidemiology 1989;42:403-408. 
113. Streiner DL, Norman GR. Health measurement scales: a practical 
guide to their development and use. 1st ed. Oxford: Oxford University Press, 
1989. 
114. Bowling A. Measuring health: a review of quality of life measurement 
scales. Milton Keynes: Open University Press, 1991. 
259 
115. Task Force on Standards for Measurement in Physical Therapy. 
Standards for tests and measurements in physical therapy practice. Physical 
Therapy 1991 ;71 :589-622. 
116. Oeyo RA, Oiehr P, Patrick OL. Reproducibility and responsiveness of 
health status measures: statistics and strategies for evaluation. Controlled 
Clinical Trials 1991;12:142s-158s. 
117. Guyatt GH, Krishner B, Jaeschke R. Measuring health status: what are 
the necessary measurement properties? Journal of Clinical Epidemiology 
1992;45: 1341-1345. 
118. Johnston MV, Keith RA, Hinderer SR. Measurement standards for 
interdisciplinary medical rehabilitation. Archives of Physical Medicine and 
Rehabilitation 1992;73:S3-S23. 
119. Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. 
Quality of life measures in health care. I: Applications and uses in 
assessment. British Medical Journal 1992;305:1074-1077. 
120. Fletcher A, Gore S, Jones 0, Fitzpatrick R, Spiegelhalter D, Cox D. 
Quality of life measures in health care. II: Design, analysis, and 
interpretation. British Medical Journal 1992;305:1145-1148. 
121. Spiegelhalter D, Gore S, Fitzpatrick R, Fletcher A, Jones D, Cox D. 
Quality of life measures in health care. III: Resource allocation. British 
Medical Journal 1992;305:1205-1208. 
260 
122. Wilkin D, Hallam L, Doggett M-A. Measures of need and outcome for 
primary health care. Oxford: Oxford University Press, 1992. 
123. Guyatt GH, Freeny DH, Patrick DL. Measuring health-related quality of 
life. Annals of Internal Medicine 1993; 118:622-629. 
124. Ware JE Jr. Standards for evaluating the standards. Medical Outcomes 
Trust Bulletin 1994;2(3):2-3. 
125. Bowling A. Measuring disease: a review of disease-specific quality of 
life measurement scales. Buckingham: Open University Press, 1995. 
126. Hobart Je, Lamping DL, Thompson AJ. Evaluating neurological 
outcome measures: the bare essentials. Journal of Neurology, 
Neurosurgery, and Psychiatry 1996;60:127-130. 
127. McDowell I, Jenkinson C. Development standards for health measures. 
Journal of Health Services Research and Policy 1996;1 :238-246. 
261 
128. Williams JI, Naylor CD. How should health status instruments be 
assessed? Cautionary notes on procrustean frameworks. Journal of Clinical 
Epidemiology 1992;45:1347-1351. 
129. Tarlov AR. Scientific Advisory Committee appointed. Medical Outcomes 
Trust Bulletin 1994;2(2): 1. 
130. Scientific Advisory Committee of the Medical Outcomes Trust. 
Instrument review criteria. Medical Outcomes Trust Bulletin 1995;3(4):I-IV. 
131. Mackenzie CR, Charleston ME, DiGioia 0, Kelley K. A patient-specific 
measure of change in maximal function. Archives of Internal Medicine 
1986; 146: 1325-1329. 
132. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting 
changes in health status. Medical Care 1989;27(Suppl):S178-S189. 
133. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative 
measurement efficiency and sensitivity of five health status instruments for 
arthritis research. Arthritis and Rheumatism 1985;28:542-547. 
134. Norman GR. Issues in the use of change scores in randomized trials. 
Journal of Clinical Epidemiology 1989;42: 1097 -1105. 
262 
135. Liang MH, Fossel AH, Larson MG. Comparisons of five health status 
instruments for orthopaedic evaluation. Medical Care 1990;28:632-638. 
136. Tuley MR, Mulrow CD, McMahan CA. Estimating and testing an index 
of responsiveness and the relationship of the index to power. Journal of 
Clinical Epidemiology 1991;44:417-421. 
137. Juniper E, Guyatt G, Goldstein R. Determining a minimal important 
change in a disease-specific quality of life instrument. Journal of Clinical 
Epidemiology 1994;47:81-87. 
138. Norman GR, Stratford P, Regehr G. Methodological problems in the 
retrospective computation of responsiveness to change: the lesson of 
Cronbach. Journal of Clinical Epidemiology 1997;50:869-879. 
139. Cronbach LJ, Furby L. How we should measure "change" - or should 
we? Psychological Bulletin 1970;74:68-80. 
140. Nunnally JC. The study of change in evaluation research: principles 
concerning measurement, experimental design, and analysis. In: Struening 
E, Guttentag M, editors. Handbook of evaluation research. Beverley Hills, 
California: Sage, 1975:101-137. 
263 
141. National Audit Office. Physical disability 1986 and beyond. A report by 
the controller and auditor general. London: Royal College of Physicians, 
1987. 
142. Neurological Charities. Neurological provision: key areas and targets, 
response to the "Health of the Nation" by the neurological charities. London: 
Department of Health, 1991. 
143. Association of British Neurologists, British Society for Rehabilitation 
Medicine. Neurological rehabilitation in the UK: report of a working party. 
London: Association of British Neurologists, 1992. 
144. Greenwood RJ, Barnes M, McLellan DL, editors. Neurological 
rehabilitation. Edinburgh: Churchill Livingstone, 1993. 
145. Scheinberg LC. Therapeutic strategies. Annals of Neurology 
1994; 36:8122-8129. 
146. Thompson AJ. Rehabilitation of progressive neurological disorders: a 
worthwhile challenge ? Current Opinion in Neurology 1996;9:437-440. 
147. La Rocca NG, Shapiro RT, Scheinberg LC, Kraft GH. Comprehensive 
care in multiple sclerosis: the whole versus the parts. Journal of 
Neurological Rehabilitation 1994;8:95-98. 
264 
148. McGrath JR, Davis AM. Rehabilitation: where do we go and how do we 
get there? Clinical Rehabilitation 1992;6:225-235. 
149. Wade DT. Measurement in neurological rehabilitation. Current Opinion 
in Neurology 1993;6:778-784. 
150. Freeman JA. The efficacy of inpatient rehabilitation in multiple 
sclerosis. PhD thesis, University of London, 1997. 
151. Langton-Hewer R. Neurorehabilitation in the UK. International Journal 
of Rehabilitation Medicine 1980;2:116-125. 
152. Greenwood RJ. Neurology and rehabilitation in the UK: a view. Journal 
of Neurology, Neurosurgery, and Psychiatry 1992;55:51-53. 
153. Edwards 8M. Longer-term management for patients with residual or 
progressive disability. In: Edwards 8M, editor. Neurological physiotherapy: 
a problem-solving approach. London: Churchill Livingstone, 1996: 189-206. 
154. Dobkin B, Thompson AJ. The principles of neurological rehabilitation. 
In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in 
clinical practice: principles of diagnosis and management. Boston, 
Massachusetts: Butterworth-Heinmann, in press. 
265 
155. World Health Organization. International Classification of Impairments, 
Disabilities and Handicaps (ICIDH): a manual of classification relating to the 
consequences of disease. Geneva: World Health Organization, 1980. 
156. Chamie M. The status and use of the International Classification of 
Impairments, Disabilities, and Handicaps (ICIDH). World Health Statistics 
Quarterly 1990;43:273-280. 
157. Wood PHN. Appreciating the consequences of disease: the 
International Classification of Impairments, Disabilities, and Handicaps. 
WHO Chronicle 1980;34:376-380. 
158. Robinson D. The International Classification of Impairments, 
Disabilities, and Handicaps. International Rehabilitation Medicine 
1985;7:60-67. 
159. World Health Organization. ICIDH-2: International classification of 
impairments, activities, and participation. A manual of dimensions of 
disablement and functioning. Beta-1 draft for field trials. Geneva: World 
Health Organisation, 1997. 
160. Bickenbach JE, Chatterji S, Badley EM, Ustin TB. Models of 
disablement, universalism and the International Classification of 
Impairments, Disabilities, and Handicaps. Social Science and Medicine 
1999;48:1173-1187. 
266 
161. Gresham GE, Labi MLC. Functional assessment instruments currently 
available for documenting outcomes in rehabilitation medicine. In: Granger 
CV, Gresham GE, editors. Functional assessment in rehabilitation medicine. 
Baltimore, Maryland: Williams and Wilkins, 1984:65-85. 
162. Rubenstein LZ, Schairer C, Wieland GO, Kane R. Systematic biases in 
functional status assessment of elderly adults: effects of different data 
sources. Journal of Gerontology 1984;39:686-691. 
163. Granger CV, Hamilton BB, Keith RA, Zielezny M, Sherwin FS. 
Advances in functional assessment for medical rehabilitation. Topics in 
Geriatric Rehabilitation 1986; 1 (3):59-74. 
164. Keith RA. Functional assessment measures in medical rehabilitation: 
current status. Archives of Physical Medicine and Rehabilitation 1984; 
65:74-78. 
165. Hamilton BB, Granger CV, Sherwin FS, Zielezny M, Tashman JS. A 
uniform national data system for medical rehabilitation. In: Fuhrer MJ, editor. 
Rehabilitation outcomes: analysis and measurement. Baltimore, Maryland: 
Paul H Brookes, 1987:137-147. 
166. Keith RA, Granger CV, Hamilton BB, Sherwin FS. The Functional 
Independence Measure: a new tool for rehabilitation. In: Eisenberg MG, 
267 
Grzesiak RC, editors. Advances in clinical rehabilitation. New York: 
Springer-Verlag, 1987:6-18. 
167. Feinstein AR, Josephy BR, Wells CK. Scientific and clinical problems 
in indexes of functional disability. Annals of Internal Medicine 1986; 1 05:413-
420. 
168. Herndon RM, editor. Handbook of neurological rating scales. New 
York: Demos, 1997. 
169. Frey WD. Functional assessment in the '80's: a conceptual enigma, a 
technical challenge. In: Halpern AS, Fuhrer MJ, editors. Functional 
assessment in rehabilitation. Baltimore, Maryland: Paul H Brookes, 
1984: 11-43. 
170. Deyo R, Patrick D. Barriers to the use of health status measures in 
clinical investigation, patient care and policy research. Medical Care 
1989;27(Suppl):S254-S268. 
171. Slater S8, Vukmanovic C, Macukanovic P, Prulovic T, Cutler JL. The 
definition and measurement of disability. Social Science and Medicine 
1974;8:305-308. 
172. Krauze EA. The political sociology of rehabilitation. In: Albrecht GL, 
editor. The sociology of physical disability and rehabilitation. Pittsburgh: 
University of Pittsburgh Press, 1976. 
173. Duckworth D. The classification and measurement of disablement. 
London: Department of Health and Social Security, Social Research 
Branch, Research report no. 10, 1983. 
174. Wood PHN, Badley EM. People with disabilities. New York: World 
Rehabilitation Fund, 1981. 
268 
175. Martin J, Meltzer M, Elliot D. opes surveys of disability in Great 
Britain. Report 1: the prevalence of disability among adults. London: Her 
Majesty's Stationary Office, 1988. 
176. Kempen GIJM, Meedema I, Ormel J, Molenaar W. The assessment of 
disability with the Groningen Activity Restriction Scale: conceptual 
framework and psychometriC properties. Social Science and Medicine 
1996;43: 1601-161 O. 
177. Nagi SZ. The concept and measurement of disability. In: Berkowitz ED, 
editor. Disability policies and government programs. New York: Preager 
Press, 1979:1-15. 
269 
178. Nagi SZ. Disability concepts revisited: implications for prevention. In: 
Pope AM, Tarlov AR, editors. Disability in America: toward a national 
standard for prevention. Washington, DC: National Academy Press, 
1991 :309-339. 
179. Badley EM. The ICIDH: format, application in different settings, and 
distinction between disability and handicap. International Disability Studies 
1987;9: 122-125. 
180. Bury MR. The ICIDH: a review of research and prospects. International 
Disability Studies 1987;9:118-128. 
181. American Medical Association. Guide to the evaluation of permanent 
impairment. 2nd ed. Chicago: American Medical Association, 1984. 
182. Mooney V. Impairment, disability, and handicap. Clinical Orthopaedics 
1987;221 :14-25. 
183. Luck JV, Florence DW. A brief history and comparative analysis of 
disability systems and impairment rating guides. Orthopaedic Clinics of 
North America 1988;19:839-844. 
184. Sheldon MP. A physical achievement record for use with crippled 
children. Journal of Health and Physical Education 1935;6:30-34. 
270 
185. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of 
illness in the aged. The index of ADL: a standardized measure of biological 
and psychosocial function. Journal of the American Medical Association 
1963;185:914-919. 
186. Bombardier C, Tugwell P. Methodological considerations in functional 
assessment. Journal of Rheumatology 1987;14:6-10. 
187. Alexander JL, Furher MJ. Functional assessment in individuals with 
physical impairments. In: Halpern AS, Furher MJ, editors. Functional 
assessment in rehabilitation. Baltimore, Maryland: Paul H Brookes, 
1984:45-49. 
188. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. 
Interobserver agreement for the assessment of handicap in stroke patients. 
Stroke 1988; 19:604-607. 
189. Bamford J, Sandercock P, Dennis M, Slattery J, Warlow CPo A 
prospective study of acute cerebrovascular disease in the community: the 
Oxfordshire Community Stroke Project 1981-1986. I. Methodology, 
demography and incidence of cases of first-ever stroke. Journal of 
Neurology, Neurosurgery, and Psychiatry 1988;51:1373-1380. 
190. Barnes MP. FIM and FAM - a positive workshop. European 
Rehabilitation Newsletter 1995;7(February):3 and 7. 
191. Hall KM, Hamilton BB, Gordon WA, Zasler ND. Characteristics and 
comparisons of functional assessment indices: Disability Rating Scale, 
Functional Independence Measure and Functional Assessment Measure. 
Journal of Head Trauma and Rehabilitation 1993;8:60-74. 
271 
192. Albrecht GL, Harasymiw SJ. Evaluating rehabilitation outcomes by cost 
function indicators. Journal of Chronic Diseases 1979;32:525-533. 
193. Granger CV. Outcome of comprehensive medical rehabilitation: an 
analysis based upon the impairment, disability, and handicap model. 
International Rehabilitation Medicine 1985;7:45-50. 
194. Hamilton BB, Laughlin JA, Granger CV, Kayton RM. Interrater 
agreement of the seven level Functional Independence Measure (FIM). 
Archives of Physical Medicine and Rehabilitation 1991 ;72:720 (abstract). 
195. Dodds TA, Martin DP, Stolov WC, Deyo RA. A validation of the 
Functional Independence Measurement and its performance among 
rehabilitation inpatients. Archives of Physical Medicine and Rehabilitation 
1993;74:531-536. 
196. Granger CV. Guide for the Uniform Data Set for Medical Rehabilitation 
(Adult FIM) Version 4.0. Buffalo, New York: UB Foundation Activities, Inc., 
1993. 
272 
197. Marolf MV, Vaney C, Konig N, Schenk T, Prosiegel M. Evaluation of 
disability in multiple sclerosis patients: a comparative study of the 
Functional Independence Measure, the Extended Barthel Index and the 
Expanded Disability Status Scale. Clinical Rehabilitation 1996;10:309-313. 
198. Cohen J. A coefficient of agreement for nominal scales. Educational 
and Psychological Measurement 1960;20:37-46. 
199. Landis JR, Koch GG. The measurement of observer agreement for 
categorical data. Biometrics 1977;33:159-174. 
200. Segal ME, Ditunno JF, Staas WE. Interinstitutional agreement of 
individual Functional Independence Measure (FIM) items measured at two 
sites on one sample of SCI patients. Paraplegia 1993;31 :622-631. 
201. Brosseau L. The inter-rater reliability and construct validity of the 
Functional Independence Measure for multiple sclerosis subjects. Clinical 
Rehabilitation 1994;8: 1 07-115. 
202. Hamilton BB, Laughlin JA, Fielder RC, Granger CV. Interrater reliability 
of the 7-level Functional Independence Measure (FIM). Scandinavian 
Journal of Rehabilitation Medicine 1994;26: 115-119. 
273 
203. Chau N, Daler S, Andre JM, Patris A. The inter-rater agreement of two 
functional independence scales: the Functional Independence Measure and 
a subjective uniform continuous scale. Disability and Rehabilitation 
1994;16(2):63-71. 
204. Ottenbacher KJ, Hsu Y, Granger CV, Fielder RC. The reliability of the 
Functional Independence Measure: a quantitative review. Archives of 
Physical Medicine and Rehabilitation 1996;77: 1226-1232. 
205. Stineman MG, Shea JA, Jette A, Tassoni CJ, Ottenbach KJ, Fielder R, 
Granger CV. The Functional Independence Measure: tests of scaling 
assumptions, structure, and reliability across 20 diverse impairment 
categories. Archives of Physical Medicine and Rehabilitation 1996;77:1101-
1108. 
206. Stineman MG, Jette A, Fiedler R, Granger CV. Impairment-specific 
dimensions within the Functional Independence Measure. Archives of 
Physical Medicine and Rehabilitation 1997;78:636-43. 
207. Sharrack B, Hughes RAC, Soudain S, Dunn G. The psychometric 
properties of clinical rating scales used in multiple sclerosis. Brain 
1999;122:141-159. 
274 
208. Granger CV, Cotte ACR, Hamilton BB, Fielder RC, Hens MM. 
Functional assessment scales: a study of persons with multiple sclerosis. 
Archives of Physical Medicine and Rehabilitation 1990;71 :870-875. 
209. Davidoff GN, Roth EJ, Haughton JS, Ardner MS. Cognitive dysfunction 
in spinal cord injury patients: sensitivity of the Functional Independence 
Measure subscales vs. neuropsychologic assessment. Archives of Physical 
Medicine and Rehabilitation 1990;71 :326-329. 
210. Disler PB, Roy CW, Smith BP. Predicting hours of care needed. 
Archives of Physical Medicine and Rehabilitation 1993;74:139-143. 
211. Granger CV, Cotter AC, Hamilton BB, Fielder RC. Functional 
assessment scales: a study of persons after stroke. Archives of Physical 
Medicine and Rehabilitation 1993;74: 133-138. 
212. Kaplan CP, Corrigan JD. The relationship between cognition and 
functional independence in adults with traumatic brain injury. Archives of 
Physical Medicine and Rehabilitation 1994;75:643-647. 
213. van der Putten JJMF, Hobart JC, Freeman JA, Thompson AJ. 
Measuring change in rehabilitation: comparison of the responsiveness of 
the Barthel Index and the Functional Independence Measure. Journal of 
Neurology, Neurosurgery, and Psychiatry 1999;66:480-484. 
275 
214. McPherson KM, Pentland B, Cudmore SF, Prescott RJ. An inter-rater 
reliability study of the Functional Assessment Measure (FIM+FAM). 
Disability and Rehabilitation 1996;18:341-347. 
215. Alcott D, Dixon K, Swann R. The reliability of the items of the 
Functional Assessment Measure (FAM): differences in abstractness 
between FAM items. Disability and Rehabilitation 1997;19:355-358. 
216. McPherson KM, Pentland B. Disability in patients following traumatic 
brain injury - which measure? International Journal of Rehabilitation 
Research 1997 ;20: 1-10. 
217. Nunnally JC. Psychometric theory. 2nd ed. New York: McGraw-Hili, 
1978. 
218. Patrick D, Deyo R. Generic and disease-specific measures in 
assessing health status and quality of life. Medical Care 
1989;27(Suppl):S217 -S232. 
219. Ware JE Jr. Standards for validating health measures: definition and 
content. Journal of Chronic Diseases 1987;40:473-480. 
220. Wylie CM, White BK. A measure of disability. Archives of 
Environmental Health 1964;8:834-839. 
276 
221. Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel 
Index for stroke rehabilitation. Journal of Clinical Epidemiology 1989;42:703-
709. 
222. Gresham GE, Phillips TF, Labi LC. ADL status in stroke: relative merits 
of three standard indexes. Archives of Physical Medicine and Rehabilitation 
1980;61 :355-538. 
223. Shinar D, Gross C, Bronstein K, Licata-Gehr E, Eden D, Cabrera A, 
Fishman I, Roth A, Barwick J, Kunitz S. Reliability of the Activities of Daily 
Living Scale and its use in telephone interview. Archives of Physical 
Medicine and Rehabilitation 1987;68:723-728. 
224. Loewen SC, Anderson BA. Reliability of the Modified Motor 
Assessment Scale and the Barthel Index. Physical Therapy 1988;68: 1 077-
1081. 
225. Barer DH, Murphy JJ. Scaling the Barthel: a 10-point hierarchical 
version of the activities of daily living index for use with stroke patients. 
Clinical Rehabilitation 1993;7:271-277. 
226. Wade DT, Collin C. The Barthel ADL Index: a standard measure of 
disability? International Disability Studies 1988; 10:64-67. 
277 
227. Royal College of Physicians. Standardised assessment scales for 
elderly people: report of jOint workshops of the Research Unit of the Royal 
College of Physicians and the British Geriatrics Society. London: Royal 
College of Physicians of London, 1992. 
228. Granger CV, Albrecht GL, Hamilton BB. Outcome of comprehensive 
medical rehabilitation: measurement by PULSES Profile and Barthel Index. 
Archives of Physical Medicine and Rehabilitation 1979;60: 145-154. 
229. Roy CW, Togneri J, Hay E, Pentland B. An inter-rater reliability study of 
the Barthel Index. International Journal of Rehabilitation Research 
1988;11 :67-70. 
230. Wolfe COA, Taub NA, Woodrow EJ, Burney PGJ. Assessment of 
scales of disability and handicap for stroke patients. Stroke 1991 ;22: 1242-
1244. 
231. Gompertz P, Pound P, Ebrahim S. The reliability of stroke outcome 
measures. Clinical Rehabilitation 1993;7:290-296. 
232. Gompertz P, Pound P, Ebrahim S. A postal version of the Barthel 
Index. Clinical Rehabilitation 1994;8:233-239. 
233. Wade DT, Langton Hewer R. Functional abilities after stroke: 
measurement, natural history and prognosis. Journal of Neurology, 
Neurosurgery and Psychiatry 1987;50:177-182. 
278 
234. McPherson K, Sloan RL, Hunter J, Dowell CM. Validation studies of the 
OPCS scale - more useful than the Barthel Index? Clinical Rehabilitation 
1993;7:105-112. 
235. Gompertz P, Pound P, Ebrahim S. Validity of the Extended Activities of 
Daily Living Scale. Clinical Rehabilitation 1994;8:275-280. 
236. van Bennekom CAM, Jelles F, Lankhorst GJ. Responsiveness of the 
Rehabilitation Activities Profile and the Barthel Index. Journal of Clinical 
Epidemiology 1996;49:39-44. 
237. Novak S, Johnson J, Greenwood R. Barthel revisited: making 
guidelines work. Clinical Rehabilitation 1996; 10: 128-134. 
238. Goodkin DE, Cookfair D, Wende K, Bourdette D, Pullicino P, 
Scherokman B, Whitman R. Inter- and intra-rater scoring agreement using 
grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). 
Neurology 1992;42:859-863. 
239. Willoughby EW, Paty DW. Scales for rating impairment in multiple 
sclerosis: a critique. Neurology 1988;38:1793-1798. 
279 
240. Noseworthy JH, Vander voort MK, Wong CJ, Ebers GC. Interrater 
variability with the Expanded Disability Status Scale (EDSS) and Functional 
Systems (FS) in a multiple sclerosis clinical trial. Neurology 1990;40:971-
975. 
241. Harwood RH, Ebrahim S. Manual of the London Handicap Scale. 
Nottingham: Department of Health Care of the Elderly, University of 
Nottingham, 1995. 
242. Medical Outcomes Trust. Involving physicians in health outcomes 
assessment. Medical Outcomes Trust Bulletin 1996;4(2): 1. 
243. Ware JE Jr, Kosinski MA, Keller SD. SF-36 physical and mental health 
summary scales: a user's manual. Boston, Massachusetts: The Health 
Institute, New England Medical Centre, 1994. 
244. Ware JE Jr, Sherbourne DC. The MOS 36-ltem Short-Form Health 
Survey (SF-36): I. Conceptual framework and item selection. Medical Care 
1992;30:473-483. 
245. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-ltem Short-Form 
Health Survey (SF-36): II. Psychometric and clinical tests of validity in 
measuring physical and mental health constructs. Medical Care 
1993;31 :247-263. 
£ou 
246. McHorney CA, Ware JE Jr, Lu JFR, Sherbourne CD. The MOS 36-ltem 
Short-Form Health Survey (SF-36): III. Tests of data quality, scaling 
assumptions and reliability across diverse patient groups. Medical Care 
1994;32:40-66. 
247. Stewart AL, Hays RO, Ware JE Jr. The MOS Short-Form General 
Health Survey: reliability and validity in a patient population. Medical Care 
1988;26:724-735. 
248. Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, 
Raczek A. Comparison of methods for the scoring and statistical analysis of 
SF-36 health profile and summary measures: summary of results from the 
Medical Outcomes Study. Medical Care 1995;33:AS264-AS279. 
249. Goldberg OP. Manual of the General Health Questionnaire. Windsor: 
NFER-Nelson, 1978. 
250. Goldberg OP, Hillier VF. A scaled version of the General Health 
Questionnaire. Psychological Medicine 1979;9: 139-145. 
251. Folstein MF, Folstein SE, McHugh PRo "Mini-Mental State": a practical 
method for grading the cognitive state of patients for the clinician. Journal of 
Psychiatric Research 1975; 12: 189-198. 
281 
252. Wechsler D. The Wechsler Adult Intelligence Test-Revised. New York: 
The Psychological Corporation, 1981. 
253. Langdon OW. Neuropsychological problems and solutions. In: Edwards 
SM, editor. Neurological physiotherapy. London: Churchill Livingstone, 
1996:41-61. 
254. DeFilippis NA, McCampbell E. The Halstead Booklet Category Test. 
Odessa, Florida: Psychological Assessment Resources, 1993. 
255. Grant DA, Berg EA. Wisconsin Card Sorting Test. Odessa, Florida: 
Psychological Assessment Resources, 1993. 
256. Langdon OW, Warrington EK. Verbal and Spatial Reasoning Test. 
Hillsdale, New Jersey: Lawrence Erlbaum Associates, 1995. 
257. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning 
Test. San Antonio, Texas: Psychological Corporation, 1987. 
258. Lezak MD. Neuropsychological assessment. 3rd ed. Oxford: Oxford 
University Press, 1995. 
259. Warrington EK. Recognition Memory Test. Windsor: Nelson, 1984. 
260. Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A, Mowat A. Transition 
questions to assess outcomes in rheumatoid arthritis. British Journal of 
Rheumatology 1993;32:807-811. 
261. Ware JE Jr, Davies-Avery A, Donald CA. Conceptualization and 
measurement of health for adults in the Health Insurance Study. Volume V: 
General health perceptions. Santa Monica, California: The RAND 
Corporation, 1978 (publication no. R-1987/5-HEW). 
262. Essink-Bot M-L, Krabbe PFM, Bonsel GJ, Aaronson NK. An empirical 
comparison of four generic health status measures: the Nottingham Health 
Profile, the Medical Outcomes Study 36-ltem Short-Form Health Survey, 
the COOPIWONCA charts and the EuroQol instrument. Medical Care 
1997;35:522-537. 
263. Holmes WC, Bix B, Shea JA. SF-20 score and item distributions in a 
human immunodeficiency virus-seropositive sample. Medical Care 
1996;34:562-569. 
264. Leplege A, Rude N, Ecosse E, Ceinos R, Dohin E, Pouchot J. 
Measuring quality of life from the point of view of HIV-positive subjects: the 
HIV-QL31. Quality of Life Research 1997;6:585-594. 
265. Eisen M, Ware JE Jr, Donald CA, Brook RH. Measuring components of 
children's health status. Medical Care 1979;17:902-921. 
266. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical 
practice: are available health status surveys adequate? Quality of Life 
Research 1995;4:293-307. 
267. Holmes WC, Shea JA. Performance of a new, HIV/AIDS-targeted 
quality of life (HAT-QoL) instrument in asymptomatic seropositive 
individuals. Quality of Life Research 1997;6:561-571. 
268. Anastasi A, Urbina S. Psychological testing. 7th ed. Upper Saddle 
River, New Jersey: Prentice-Hall, 1997. 
269. Spector PE. Summated rating scale construction: an introduction. 
Newbury Park, California: Sage, 1992. 
270. Zubin J. The method of internal consistency for selecting items. Journal 
of Educational Psychology 1934;25:345-356. 
271. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: 
McGraw-Hili, 1994. 
272. Cronbach LJ. Coefficient alpha and the internal structure of tests. 
Psychometrika 1951 ;16:297-334. 
273. Bravo G, Potvin L. Estimating the reliability of continuous measures 
with Cronbach's alpha or the intraclass correlation coefficient: toward the 
integration of two traditions. Journal of Clinical Epidemiology 1991 ;44:381-
390. 
274. Kristof W. The statistical theory of stepped-up reliability coefficients 
when a test has been divided into several equivalent parts. Psychometrika 
1963;28:221-238. 
275. Fiske DW. Some hypotheses concerning test adequacy. Educational 
and Psychological Measurement 1966;26:69-88. 
276. Tyler TA, Fiske DW. Homogeneity indices and test length. Educational 
and Psychological Measurement 1968;28:767-777. 
277. Cortina JM. What is coefficient alpha? An examination of theory and 
applications. Journal of Applied Psychology 1993;78:98-104. 
278. Cronbach LJ. Essentials of psychological testing. 5th ed. New York: 
Harper Collins, 1990. 
279. Bartko JJ. The intraclass correlation coefficient as a measure of 
reliability. Psychological Reports 1966;19:3-11. 
280. Bartko JJ, Carpenter WT. On the methods and theory of reliability. 
Journal of Nervous and Mental Disease 1976; 163:307-317. 
285 
281. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater 
reliability. Psychological Bulletin 1979;86:420-428. 
282. McGraw KO, Wong SP. Forming inferences about some intraclass 
correlation coefficients. Psychological Methods 1996; 1 :30-46. 
283. Cronbach LJ, Meehl PE. Construct validity in psychological tests. 
Psychological Bulletin 1955;52:281-302. 
284. Cronbach LJ. Essentials of psychological testing. New York: Harper 
and Row, 1949. 
285. Gulliksen H. Theory of mental tests. New York: Wiley, 1950. 
286. Green SB, Lissitz RW, Muliak SA. Limitations of coefficient alpha as an 
index of test unidimensionality. Educational and Psychological Measurement 
1977;37:827 -838. 
287. Kerlinger FN. Foundations of behavioural research. 2nd ed. New York: 
Holt, Rinehart, and Winston, 1973. 
288. Cohen J. The earth is round (p < .05). American Psychologist 
1994;49:997 -1003. 
289. Cortina JM, Dunlap WP. On the logic and purpose of significance 
testing. Psychological Methods 1997;2:161-172. 
286 
290. Hays R, Hadorn D. Responsiveness to change: an aspect of validity, 
not a separate dimension. Quality of Life Research 1992;1:73-73. 
291. Stratford PW, Binkley JM, Riddle DL. Health status measures: 
strategies and analytic methods for assessing change scores. Physical 
Therapy 1996;76:1109-1123. 
292. Liang MH. Evaluating instrument responsiveness. Journal of 
Rheumatology 1995;22:1191-1192. 
293. Cohen J. Statistical power analysis for the behavioural sciences. 2nd 
ed. Hillsdale, New Jersey: Lawrence Erlbaum Associates, 1988. 
294. Sechrest L. Incremental validity. In: Jackson D, Messick S, editors. 
Problems in human assessment. New York: McGraw-Hili, 1967:368-371. 
295. Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology 
in clinical practice: principles of diagnosis and management. 2nd ed. Boston, 
Massachusetts: Butterworth-Heinemann, 1997. 
296. Likert RA. A technique for the development of attitudes. Archives of 
Psychology 1932; 140:5-55. 
287 
297. Juniper EF, Guyatt GH, Streiner DL, King DR. Clinical impact versus 
factor analysis for quality of life questionnaire construction. Journal of 
Clinical Epidemiology 1997;50:233-238. 
298. Hattie J. Methodological review: assessing unidimensionality of tests 
and items. Applied Psychological Measurement 1985;9: 139-164. 
299. Brook RH, Ware JE Jr, Davies-Avery A, Stewart AL, Donald CA, 
Rogers WH, Williams KN, Johnson SA. Conceptualization and 
measurement of health for adults in the Health Insurance Study. Volume 
VIII: Overview. Santa Monica, California: The RAND Corporation, 1979 
(publication no. R-1987/8-HEW). 
300. Likert RA, Roslow S, Murphy G. A simple and reliable method of 
scoring the Thurstone attitude scales. Journal of Social Psychology 
1934;5:228-238. 
301. Edwards AL. Techniques of attitude scale construction. New York: 
Appleton-Century-Crofts, 1957. 
288 
302. Ware JE Jr, Harris WJ, Gandek B, Rogers BW, Reese PRo MAP-R for 
windows: multitrait I multi-item analysis program - revised user's guide. 
Boston, MA: Health Assessment Lab., 1997. 
303. Campbell OT, Fiske OW. Convergent and discriminant validation by the 
multitrait-multimethod matrix. Psychological Bulletin 1959;56:81-105. 
304. Hays RO, Hayashi T. Beyond internal consistency reliability: rationale 
and user's guide for Multi-Trait Analysis Program on the microcomputer. 
Behavior Research Methods, Instruments, & Computers 1990;22:167-175. 
305. Fayers PM, Machin O. Factor analysis. In: Staquet MJ, Hays RO, 
Fayers PM, editors. Quality of life assessment in clinical trials: methods and 
practice. Oxford: Oxford University Press, 1998:191-223. 
306. Guttman LA. Some necessary conditions for common-factor analysis. 
Psychometrika 1954;19:149-161. 
307. Cattell RB. The scree test for the number of factors. Multivariate 
Behavioural Research 1966; 1 :245-276. 
308. Kline P. An easy guide to factor analysis. London: Routledge, 1994. 
309. Fayers PM, Hand OJ. Factor analysis, causal indicators and quality of 
life. Quality of Life Research 1997;6:139-150. 
2H9 
310. Hays RD, Anderson R, Revicki DA. Psychometric considerations in 
evaluating health-related quality of life measures. Quality of Life Research 
1993;2:441-449. 
311. Cohen J. Statistical power analysis for the behavioural sciences. 1st ed. 
Hillside, New Jersey: Lawrence Erlbaum, 1969. 
312. Wright JG, Young NL. A comparison of different indices of 
responsiveness. Journal of Clinical Epidemiology 1997;50:239-246. 
313. Black N, Brazier J, Fitzpatrick R, Reeves B, editors. Health services 
research methods: a guide to best practice. London: British Medical Journal 
Books, 1998. 
314. Brosseau L, Phillippe P, Potvin L, Boulanger Y-L. Post-stroke inpatient 
rehabilitation: I. Predicting length of stay. American Journal of Physical 
Medicine and Rehabilitation 1996;75:422-430. 
315. Brosseau L, Potvin L, Phillippe P, Boulanger Y-L. Post-stroke inpatient 
rehabilitation: II. Predicting discharge disposition. American Journal of 
Physical Medicine and Rehabilitation 1996;75:431-436. 
316. Nunnally JC. Introduction to statistics for psychology and education. 
New York: McGraw-Hili, 1975. 
317. Linacre JM, Heinemann AW, Wright BO, Granger CV, Hamilton BB. 
The structure and stability of the Functional Independence Measure. 
Archives of Physical Medicine and Rehabilitation 1994;75: 127 -132. 
L~U 
318. Stucki G, Liang MH, Fossel AH, Katz IN. Relative responsiveness of 
condition-specific and generic health status measures in degenerative 
lumbar spinal stenosis. Journal of Clinical Epidemiology 1995;48: 1369-
1378. 
319. Nyein K, McMichael L, Turner-Stokes L. Can a Barthel Index score be 
derived from the FIM? Clinical Rehabilitation 1999; 13:56-63. 
320. Mciver JP, Carmines EG. Unidimensional scaling. Newbury Park, 
California: Sage, 1981. 
321. Rasch G. Probabilistic models for some intelligence and attainment 
tests. Chicago: University of Chicago Press, 1980. 
322. Kiresuk T J, Smith A, Cardillo JE, editors. Goal Attainment Scaling: 
applications, theory, and measurement. Hillsdale, New Jersey: Lawrence 
Erlbaum Associates, 1994. 
291 
323. Freeman JA, Langdon OW, Hobart JC, Thompson AJ. The impact of 
inpatient rehabilitation on progressive multiple sclerosis. Annals of 
Neurology 1997;42:236-244. 
324. Smith A, Cardillo JE, Smith SC, Amezaga AM. Improvement Scaling 
(rehabilitation version): a new approach to measuring progress of patients 
in achieving their individual rehabilitation goals. Medical Care 1998;36:333-
347. 
325. Jette AM, Davies AR, Cleary PD. The Functional Status Questionnaire: 
reliability and validity when used in primary care. Journal of General Internal 
Medicine 1986;1 :143-149. 
326. Nelson E, Wasson J, Kirk J. Assessment of function in routine clinical 
practice: description of the COOP chart method and preliminary findings. 
Journal of Chronic Diseases 1987;40 (Suppl):55S-63S. 
327. Parkerson GR, Ghelbach SH, Wagner EH, James SA, Clapp NE, 
Muhlbaier LH. The Duke-UNC health profile: an adult health status 
instrument for primary care. Medical Care 1981; 19:806-828. 
328. Bakheit AMO, Harries SR, Hull RG. Validity of a self-administered 
version of the Barthel Index in patients with rheumatoid arthritis. Clinical 
Rehabilitation 1995;9:234-237. 
329. Hobart JC, Lamping DL, Thompson AJ. Measuring disability in 
neurological disease: validity of the self-report Barthel Index. Journal of 
Neurology 1996;243(Suppl 2):S25 (abstract). 
330. Freeman JA, Langdon OW, Hobart JC, Thompson AJ. Inpatient 
rehabilitation in multiple sclerosis: do the benefits carry over into the 
community? Neurology 1999;52:50-56. 
292 
331. Warlow CP, Dennis MS, van Gijn J, Hankey GJ, Sandercock PAG, 
Bamford JM, Wardlaw J. Stroke: a practical guide to management. Oxford: 
Blackwell Science, 1996. 
332. Collin C, Wade DT, Davis S, Horne V. The Barthel ADL Index: a 
reliability study. International Disability Studies 1988;10:61-63. 
333. Bowers ON, Kofroth LK. Comparison of Disability Rating Scale and 
Functional Independence Measure during recovery from traumatic brain 
injury. Archives of Physical Medicine and Rehabilitation 1989;70:A-58 
(abstract) . 
334. Dawson J, Fitzpatrick R, Murray 0, Carr A. Comparison of measures to 
assess outcomes in total hip replacement surgery. Quality in Health Care 
1996;5:81-88. 
293 
335. Koziol JA, Frutos A, Sipe JC, Romine JS, Beutler E. A comparison of 
two neurologic scoring instruments for multiple sclerosis. Journal of 
Neurology 1996;243:209-213. 
336. Langfitt JT. Comparison of the psychometric characteristics of three 
quality of life measures in intractable epilepsy. Quality of Life Research 
1995;4:101-114. 
337. Pinholt EM, Kroenke K, Hanley JF, Kussman MJ, Twyman PL, 
Carpenter JL. Functional assessment of the elderly: a comparison of 
standard instruments with clinical judgement. Archives of Internal Medicine 
1987; 147:484-488. 
338. Prieto L, Alonso J, Ferrer M, Anto J. Are results of the SF-36 Health 
Survey and the Nottingham Health Profile similar? A comparison on COPO 
patients. Journal of Clinical Epidemiology 1997;50:463-473. 
339. Vickrey B, Hays R, Genovese B, Myers L, Ellison G. Comparison of a 
generic to disease-targeted health-related quality-of-life measures for 
multiple sclerosis. Journal of Clinical Epidemiology 1997;50:557-569. 
340. Jette AM. Functional capacity evaluation: an empirical approach. 
Archives of Physical Medicine and Rehabilitation 1980;61 :85-89. 
341. Stewart AL, Ware JE Jr, Brook RH, Davies-Avery A. Conceptualization 
and measurement of health for adults in the Health Insurance Study. 
Volume II: Physical health in terms of functioning. Santa Monica, California: 
The RAND Corporation, 1978 (publication no. R-1987/2-Hew). 
342. Thomas VS, Rockwood K, McDowell I. Multidimensionality in 
instrumental and basic activities of daily living. Journal of Clinical 
Epidemiology 1998;51 :315-321. 
343. Beaton D, Hogg-Johnson S, Bombardier C. Evaluating changes in 
health status: reliability and responsiveness of five generic health status 
measures in workers with musculoskeletal disorders. Journal of Clinical 
Epidemiology 1997;50:79-93. 
344. Bessette L, Sangha 0, Kuntz KM, Keller B, Lew RA, Fossel AH, Katz 
IN. Comparative responsiveness of generic versus disease-specific and 
weighted versus unweighted health status measures in carpal tunnel 
syndrome. Medical Care 1998;36:491-502. 
345. Murawski MM, Miederhoff PA. On the generalisability of statistical 
expressions of health related quality of life instrument responsiveness: a 
data synthesis. Quality of Life Research 1998;7:11-22. 
346. Komorita SS, Graham WK. Number of scale points and the reliability of 
scales. Educational and Psychological Measurement 1965;25:987-995. 
295 
347. Masters JR. The relationship between number of response categories 
and reliability of Likert-type questionnaires. Journal of Educational 
Measurement 1974; 11 :49-53. 
348. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: 
ascertaining the minimal clinically significant change. Controlled Clinical 
Trials 1989;10:407-415. 
349. Cronbach LJ. The two disciplines of scientific psychology. American 
Psychologist 1957; 12:671-684. 
350. Long WB, Sacco WJ, Coombes SS, Copes WS, Bullock A, Melville JK. 
Determining normative standards for Functional Independence Measure 
transitions in rehabilitation. Archives of Physical Medicine and Rehabilitation 
1994;75: 144-148. 
351. Ware JE Jr. Content-based interpretation of health status scores. 
Medical Outcomes Trust Bulletin 1994;2(4):3. 
352. Lydick E, Epstein RS. Interpretation of quality of life changes. Quality of 
Life Research 1993;2:221-226. 
353. Agree EM. The influence of personal care and assistive devices on the 
measurement of disability. Social Science and Medicine 1999;48:427-443. 
296 
354. Ware JE Jr, Manning WGJ, Duan N, Wells KB, Newhouse JP. Health 
status and the use of outpatient mental health services. American 
Psychologist 1984;39:1090-1100. 
355. Testa MA, Anderson RB, Nackley JF, Hollenberg NK, and the Quality 
of Life Hypertension Study Group. Quality of life and hypertensive therapy in 
men: a comparison of captopril with enalapril. New England Journal of 
Medicine 1993;328:907-913. 
356. Hadorn DC, Uerbersax J. Large scale health outcomes evaluation: 
how should quality of life be measured? Part 1 - Calibration of a brief 
questionnaire and a search for preference subgroups. Journal of Clinical 
Epidemiology 1995;48:607-618. 
357. Brook RH, Ware JE Jr, Rogers WH, Keeler EB, Davies AR, Donald CA. 
Does free care improve adult health? Results from a randomised controlled 
trial. New England Journal of Medicine 1983;309:1426-1434. 
358. Cornwall A. Body mapping in health. Rapid Rural Appraisal Series 
1991 ;12:69-76. 
359. Deyo RA, Andersson G, Bombardier C, Cherkin DC, Keller RB, Lee 
CK. Outcome measures for studying patients with low back pain. Spine 
1994; 18 (Suppl):2032S-2036S. 
297 
360. Lydick E, Yawn BP. Clinical interpretation of health-related quality of 
life data. In: Staquet MJ, Hays RD, Fayers PM, editors. Quality of life 
assessment in clinical trials: methods and practice. Oxford: Oxford 
University Press, 1998:299-314 
361. Thompson AJ, Colville PL, Ketelaer P, Paty OW. Long term 
management of multiple sclerosis. MS Management 1994; 1: 1-9. 
362. Badley EM. An introduction to the concepts and classifications of the 
International Classification of Impairments, Disabilities, and Handicaps. 
Disability and Rehabilitation. 1993;15:161-178. 
363. Pearce G, Kirshner L. Handicap: the focus of multiple sclerosis 
rehabilitation. MS Management 1995;2(1):21-25. 
364. Wade DT. Outcome measurement and rehabilitation (editorial). Clinical 
Rehabilitation 1999; 13:93-95. 
365. Eddy OM. Should we change the rules for evaluating medical 
technologies? In: Gelijns AC, editor. Modern methods of clinical 
investigation. Washington, DC: National Academic Press, 1990: 117-135 
366. Wilson BA. How do we know that rehabilitation works? 
Neuropsychological Rehabilitation 1993;3: 1-4. 
298 
367. Black N. Why we need observational studies to evaluate the 
effectiveness of health care. British Medical Journal 1996;312:1215-1218. 
368. Kiresuk T J, Sherman RE. Goal Attainment Scaling: a general method 
for evaluating comprehensive community health programs. Community 
Mental Health Journal 1968;4:443-453. 
369. Browne JP, O'Boyle CA, McGee HM, McDonald NJ, Joyce CRB. 
Development of a direct weighting procedure for quality of life domains. 
Quality of Life Research 1997;6:301-309. 
370. Marx RG, Bombardier C, Hogg-Johnson S, Wright JG. Clinimetric and 
psychometric strategies for development of a health measurement scale. 
Journal of Clinical Epidemiology 1999;52:105-111. 
371. Wright JG, Feinstein AR. A comparative contrast of clinimetric and 
psychometric methods for constructing indices and rating scales. Journal of 
Clinical Epidemiology 1992;45:1201-1218. 
372. Altman DG, Bland JM. Measurement in medicine: the analysis of 
method comparison studies. The Statistician 1983;32:307-317. 
299 
Table 1.1 
Epidemiology of some neurological diseases 1 
For a health district of N = 250,000 
Disease Incidence Prevalence 
Stroke 550 1500 
Head injury 500 Unknown 
Epilepsy 175 3900 
Parkinson's disease 45 400 
Multiple sclerosis 10 250 
Motor neurone disease 5 15 
1 From Wade and Langton He\Ner 1987 (3) 
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Table 1.2 
Classification of health outcomes in neurology 1 
1 Physician-oriented outcomes 
1.1 pathophysiological parameters of disease 
1.2 clinical end-points 
2 Patient-oriented outcomes 
2.1 aspects of health status 
2.2 health-related quality of life 
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Response options for the FIM and FIM+FAM 
Independent: Another person is not required for the activity 
7 Complete independence - all of the tasks described as making up the 
activity are typically completed safely, without modification, assistive devices, or 
aids, and within a reasonable time. 
6 Modified independence - one or more of the following may be true: 
requires an assistive device, activity takes more than a reasonable time, there are 
safety (risk) considerations. 
Dependent: Subject requires help from another person for either 
supervision or physical assistance in order for the 
activity to be performed, or it is not performed. 
Modified dependence: subject expends more than half (50%) of the effort 
required to complete the task. 
S Supervision or setup - subject requires no more help than standby, 
cueing or coaxing, without physical contact, or, helper sets up needed items or 
applies orthoses. 
4 Minimal contact assistance - subject requires no more help than touching, 
and expends 75% or more of the effort. 
3 Moderate assistance - subject requires more help than touching, or 
expends half (50%) or more (up to 750/0) of the effort. 
Complete dependence: subject expends less than half (50%) of the effort or the 
activity is not performed. 
2 Maximal assistance - subject expends less than 50% of the effort, but at 
least 25%. 
1 Total assistance - subject expends less than 25% of the effort. 
304 
Table 2.1 
Health outcomes assessment 
Method of Site of Assessment 
Measure administration administration point 
FIM MDT 1 All A+ D2 
FIM+FAM MDT All A+D 
Barthel Index MDT NRU 3 RRU 4 , A+D 
Mod ified Barthel Index MDT RNRU 5 A+D 
EDSS 6 Neurologist 7 NRU A+D 
OPCS 8 Coord i nator 9 NRU, RRU A+D 
EDSS 10 Neurologist 11 NRU A+D 
LHS 12 Self-report NRU, RRU A+D 
SF-36 13 Self-report NRU, RRU A + D 14 
GHQ 15 Self-report NRU, RRU A+D 
MMSE 16 Coordinator NRU, RRU A+D 
Neuropsychological Neuro- NRU A 
testing psychologist 
Transition question MDT All D 
1 Instrument rated by consensus opinion of treating multidisciplinary team. 
2 A = admission; D = discharge. 
3 Neurorehabilitation Unit, National Hospital for Neurology and Neurosurgery, London. 
4 Rehabilitation Research Unit, University of Southampton. 
5 Regional Neurorehabilitation Unit, Homerton Hospital, London. 
6 Expanded Disability Status Scale 
7 Rated by neurologist. 
8 Office of Population Censuses and Surveys Disability Scales 
9 Instrument rated at each site by the study coordinator. 
10 Expanded Disability Status Scale 
11 Rated by neurologist. 
12 London Handicap Scale 
13 Medical Outcomes Study 36-ltem Short-Form Health Survey 
14 Administered by postal survey 4 weeks after discharge. 
15 General Health Questionnaire 
16 Mini-Mental State Examination 
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Table 3.1 
Expected correlations between FIM and FIM+FAM scales and other measures 
Scoring FIM I FIM+FAM scales 1 
Measure direction2 Total Motor Cog. Rank order3 
Barthel Index + +++ +++ ++ M>T>C 
Modified Barthel Index + +++ +++ ++ M>T>C 
EDSS4 M>T>C 
OPCS 5 M>T>C 
LHS 6 + ++ ++ + M>T>C 
SF-36 PCS 7 + ++ ++ + M>T>C 
SF-36 MCS 8 + + + + C>T>M 
GHQ9 T=M=C 
Mini Mental State Examination + ++ + +++ C>T>M 
WAIS-R Verbal IQ + + + ++ C>T>M 
Halstead Book Category Test C>T>M 
Wisconsin Card Sorting Test + + + ++ C>T>M 
Verbal and Spatial Reasoning Test + + + ++ C>T>M 
California Verbal Learning Test + + + ++ C>T>M 
Recognition Memory Test {verbal} + + + ++ C>T>M 
1 Direction and number of + and - signs reflect the direction and magnitude of correlations; 
+ /- = weak positive / negative correlation (r < .30); ++ /- - = moderate positive / negative 
correlation (.30 < r < .70); +++ /- - - = strong positive / negative correlation (r > .70). 
2 High scores indicate favourable (+) or unfavourable (-) health status. 
3 Indicates the rank order of correlations between FIM or FIM+FAM total (T), motor (M), and 
cognitive scales and the validating measure. 
4 Expanded Disability Status Scale 
5 Office of Population Censuses and Surveys Disability Scales 
6 London Handicap Scale 
7 Medical Outcomes Study 36-ltem Short-Form Health Survey Physical Component Summary Score 
8 Medical Outcomes Study 36-ltem Short-Form Health Survey Mental Component Summary Score 
9 General Health Questionnaire 
Table 3.2 
Characteristics of patient samples compared to 1994 local populations 
Clinical site 
Total NRU RNRU 
Sample Sample Population p1 Sample Population p Sample 
Variable (N = 209) (n = 118) (n = 138) (n = 60) (n = 62) (n = 31) 
Gender n (%) 
Male 106 (50.7) 55 (46.6) 66 (47.8) NS 39 (65.0) 39 (62.9) NS 13 (41.9) 
Female 103 (49.3) 63 (53.4) 72 (52.2) 21 (35.0) 23 (37.1) 18 (58.1) 
Age (years) 
Mean (SO) 44.0 (14.4) 46 (14.8) 44 (15.3) NS 39 (12.2) 37 (11.3) NS 47 (14.7) 
Range 16 -77 17 -77 16 - 87 16 - 61 16 - 57 16 - 65 
Diagnosis n (%) 
Stroke 71 (34.0) 26 (22.0) 28 (20.3) NS 26 (43.3) 28 (45.2) NS 19 (61.3) 
Multiple Sclerosis 64 (30.6) 64 (54.2) 59 (42.8) NS a (0) a (0) NS a (0) 
Head injury 33 (15.8) 3 (2.5) a (0) < .05 24 (40.0) 24 (38.7) NS 6 (19.4) 
Other 41 (19.6) 25 (21.2) 51 (37.0) < .01 10(16.7) 10 (16.1) NS 6 (19.4) 
Length of stay (days) 
Mean (SO) 64.6 (68.8) 31 (24.5) 33 (27.2) NS 128 (86.1) 128 (89.1) NS 78 (52.2) 
Range 11 - 396 11 - 137 7 -193 30 - 396 14 - 518 15 - 244 
1 Tests of significance are based on Chi-squared tests for categorical variables and one-way ANOVA for continuous variables. 
RRU 
Population 























Characteristics of stroke and MS patients 
Diagnosis 
Variable Stroke MS 
(n = 71) (n = 64) 
Gender n (%) 
Male 40 (56.3) 23 (35.9) 
Female 31 (43.7) 41 (64.1) 
Age (years) 
Mean (SO) 49.8 (13.7) 43.0 (11.9) 
Range 18 -77 21 - 69 
Length of stay (days) 
Mean (SO) 77.7 (55.3) 20.7 (11.8) 
Range 11-312 11 - 1 00 
Clinical site n (%) 
NRU 26 (36.6) 64 (100) 
RNRU 26 (36.6) 0 (0) 





Comparison of FIM and FIM+FAM admission scores for patients in the reproducibility subsamples 
Total Sample Intra-rater Inter-rater 
(N = 209) reproducibility reproducibility 
(n = 77) (n = 89) 
Scale mean (SO) mean (SO) mean (SO) 
FIM total 80.4 (29.3) 76.4 (30.4) 80.2 (31.0) 
FIM motor 55.8 (22.6) 52.6 (23.6) 55.2 (23.6) 
FIM cognitive 24.6 (9.3) 23.8 (9.8) 25.0 (9.4) 
FIM+FAM total 135.8 (45.6) 129.8 (47.4) 136.0 (48.7) 
FIM+FAM motor 68.4 (26.6) 64.5 ( 27.9) 68.0 (27.8) 






Descriptive statistics for FIM item scores at admission (N = 209) 
Response categories and endorsement 
frequencies (%) 
Item 1 2 3 4 5 6 7 Mean % Floor % Ceiling 
(SO} effect effect 
Feeding 12.0 2.9 0.0 5.7 44.5 7.7 27.3 5.0 (1.8) 12.0 27.3 
Grooming 12.0 4.8 6.2 12.9 16.3 11.0 36.8 5.0 (2.1) 12.0 36.8 
Bathing 15.3 9.1 13.4 14.4 11.0 12.0 24.9 4.3 (2.2) 15.3 24.9 
Dressing upper 12.0 7.2 8.6 15.8 8.1 21.5 26.8 4.7 (2.1) 12.0 26.8 
body 
Dressing lower body 28.2 9.1 9.6 13.9 8.6 18.2 12.4 3.7 (2.2) 28.2 12.4 
Toileting 22.5 8.1 10.0 8.1 1.9 23.4 25.8 4.3 (2.4) 22.5 25.8 
Bladder 19.6 4.8 5.3 5.3 7.7 17.7 39.7 4.9 (2.4) 19.6 39.7 
management 
Bowel management 13.4 1.4 3.3 5.7 3.8 25.8 46.4 5.5 (2.1) 13.4 46.4 
Bed transfer 17.2 7.2 13.9 10.0 7.2 25.4 19.1 4.4 (2.2) 17.2 19.1 
Toilet transfer 17.7 6.7 12.0 10.5 4.8 38.3 10.0 4.3 (2.1) 17.7 10.0 
Shower/tub transfer 29.2 9.1 12.4 21.5 9.1 16.7 1.9 3.3 (1.9) 29.2 1.9 
Walk 34.9 5.7 4.3 7.2 16.3 23.9 7.7 3.7 (2.3) 34.9 7.7 
Stairs 56.0 4.3 3.8 6.2 11.0 16.3 2.4 2.7 (2.1) 56.0 2.4 
Comprehension 7.2 4.8 5.3 7.2 13.4 14.8 47.4 5.5 (1.9) 7.2 47.4 
Expression 11.5 5.3 5.3 8.1 15.3 13.4 41.1 5.2 (2.1) 11.5 41.1 
Social interaction 10.0 7.2 10.0 7.2 8.6 16.7 40.2 5.1 (2.1) 10.0 40.2 
Problem solving 17.7 12.9 12.9 10.0 13.4 13.9 19.1 4.1 (2.2) 17.7 19.1 
Memory 12.4 12.9 7.2 7.7 7.2 10.0 42.6 4.8 (2.3) 12.4 42.6 
Table 3.6 
Descriptive statistics for FIM scale scores at admission (N = 209) 
Range of scores 
FIM No. Scale Sample Floor 
scale items Scale Sample mid-point mean (SO) effect 
0/0 
Total 18 18 - 126 18 - 122 72 80.4 (29.3) 2.4 
Motor 13 13 - 91 13 - 91 52 55.8 (22.6) 4.8 
















Reliability estimates for FIM scales (N = 209) 
Internal consistency 
FIM Item-total Alpha 
scale correlation (LL950/oCI) 2 
range (mean) 
Total .60 - .87 (.73) 
Motor .63 - .92 (.79) 
Cognitive .77 - .85 (.80) 
1 +/_ 1.96 SEM 
2 Lower limit of 95% confidence interval 











ICC 3 ICC 
(LL95%CI) (LL95%CI) 
n = 77 n = 89 
.98 (.96) .98 (.97) 
.98 (.97) .98 (.97) 
.95 (.92) .94 (.92) 
4 Uses alpha coefficient as reliability estimate in calculation of standard error of measurement. 
S Uses intra-rater reproducibility coefficient as reliability estimate in calculation of standard error of measurement. 
95% confidence interval for 
individual scores 1 









Intercorrelations between FIM scales (N = 209) 
FIM scale 
FIM scale Total Motor 
Motor .97 





Correlations between the FIM, other outcome measures, and age 
Health outcome measures 1 
Disability Handicap Health status Psychological 
distress 
FIM scale BI2 MBI3 EDSS4 OPCS5 LHS6 SF-36 SF-36 GHQ9 
PCS7 MCS8 
Total .95 .93 - .S4 - .S2 .32 .26 .10 - .13 
Motor .97 .96 - .S6 - .S4 .35 .30 .10 - .15 
Cognitive .57 .65 - .45 - .44 .11 .04 .OS - .01 
1 Sample sizes differ as not all instruments were administered at each study site. Also, the EDSS was only administered to MS patients. 
2 Barthel Index (n = 149) 
3 Modified Barthel Index (n = 60) 
4 Kurtzke Extended Disability Status Scale (n = 64) 
5 Office of Population Censuses and Surveys Overall Weighted Disability Severity Score (n =69) 
6 London Handicap Scale (n = 121) 
7 SF-36 Physical Component Summary Score (n = 123) 
8 SF-36 Mental Component Summary Score (n = 123) 
9 General Health Questionnaire (n = 85) 









Correlations between the FIM and neuropsychological measures 
Neuropsychological measures 1 
Global decline Reasoning Memory 
FIM scale MMSE 2 WAIS-VIQ 3 HBCT 4 WCST S VESPAR 6 CVLT 7 RMT8 
Total .49 .35 -.34 .52 .53 .55 .59 
Motor .32 .27 -.27 .41 .40 .48 .56 
Cognitive .76 .51 -.42 .68 .75 .61 .50 
1 Sample sizes differ as not all instruments were administered at each study site. Also, the VESPAR was only administered to MS patients. 
2 Mini-Mental State Examination (n = 90) 
3 Wechsler Adult Intelligence Test (revised version) - Verbal IQ (n = 60) 
4 Halstead Booklet Category Test (n = 44) 
5 Wisconsin Card Sorting Test (n = 40) 
6 Verbal and Spatial Reasoning Test Total Score (n = 37) 
7 California Verbal Learning Test (n = 52) 





Mean FIM change scores for different levels of staff-rated improvement in disability 
Staff-rated improvement in disability 
FIM None Minimal Moderate Marked F P 
scale n = 17 n = 42 n = 75 n = 45 
Total - 1.6 - 6.2 - 14.2 - 31.6 31.4 < .001 
Motor - 2.2 - 5.9 -11.9 - 27.2 30.2 < .001 





Mean FIM change scores and standard deviations for stroke and MS patients 
Mean change score (SO) 
FIM scale Stroke (n = 62) MS (n = 64) P 
Total - 19.3 (17.5) - 6.4 (7.9) < .001 
Motor - 16.8 (15.2) - 6.5 (6.7) < .001 





Responsiveness of the FIM (n = 194) 
Mean score (SO) Responsiveness 
FIM scale Admission Discharge Change1 Effect size 
Total 82.2 (28.6) 97.0 (27.8) - 14.8 (17.0) - .52 
Motor 57.0 (22.1) 70.0 (21.9) - 12.8 (14.5) - .58 




1 All change scores are statistically significant (p < .001). 
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Table 3.14 
Relative responsiveness of disability measures 
Measure Effect size 
FIM total 194 - .52 
FIM motor 194 - .58 
FIM cognitive 194 - .22 
FIM+FAM total 194 - .45 
FIM+FAM motor 194 - .57 
FIM+FAM cognitive 194 - .24 
Barthel Index 136 - .56 
Modified Barthel Index 57 - .67 
EDSS2 64 .06 
OPCS 3 60 .38 
1 Sample sizes differ as not all instruments were administered at each site. Also, the EDSS was 
only administered to MS patients. 
2 Expanded Disability Status Scale 
3 Office of Population Censuses and Surveys Overall Weighted Disability Severity Score 
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Table 3.15 





Dressing upper body 



























Response categories and endorsement 
frequencies (%) 
2 3 4 5 6 7 
12.0 2.9 0.0 5.7 44.5 7.7 27.3 
12.0 4.8 6.2 12.9 16.3 11.0 36.8 
15.3 9.1 13.4 14.4 11.0 12.0 24.9 
12.0 7.2 8.6 15.8 8.1 21.5 26.8 
28.2 9.1 9.6 13.9 8.6 18.2 12.4 
22.5 8.1 10.0 8.1 1.9 23.4 25.8 
3.3 2.9 1.0 2.4 6.7 12.9 70.8 
19.6 4.8 5.3 5.3 7.7 17.7 39.7 
13.4 1.4 3.3 5.7 3.8 25.8 46.4 
17.2 7.2 13.9 10.0 7.2 25.4 19.1 
17.7 6.7 12.0 10.5 4.8 38.3 10.0 
29.2 9.1 12.4 21.5 9.1 16.7 1.9 
26.8 10.5 18.7 14.4 10.0 10.0 9.6 
34.9 5.7 4.3 7.2 16.3 23.9 7.7 
56.0 4.3 3.8 6.2 11.0 16.3 2.4 
38.8 16.7 6.2 14.4 7.2 8.6 8.1 
7.2 4.8 5.3 7.2 13.4 14.8 47.4 
11.5 5.3 5.3 8.1 15.3 13.4 41.1 
11.0 0.5 3.8 9.6 14.8 20.1 40.2 
16.3 5.3 11.0 13.4 8.6 12.9 32.5 
4.8 3.8 11.5 2.4 9.6 20.6 47.4 
10.0 7.2 10.0 7.2 8.6 16.7 40.2 
8.1 7.7 13.9 14.8 13.4 24.4 17.7 
12.0 17.7 8.6 8.1 18.7 14.4 16.7 
35.4 16.7 9.1 11.0 11.0 14.4 2.4 
17.7 12.9 12.9 10.0 13.4 13.9 19.1 
12.4 12.9 7.2 7.7 7.2 10.0 42.6 
8.1 4.3 5.3 4.3 5.3 7.2 65.6 
9.1 8.6 12.9 7.2 9.6 7.7 45.0 


































































































Descriptive statistics for FIM+FAM scale scores at admission (N = 209) 
Range of scores 
FIM+FAM No. Scale Sample Floor Ceiling 
scale items Scale Sample mid-point mean (SO) effect effect 
0/0 0/0 
Total 30 30 - 210 30 - 204 120 135.8 (45.6) .5 0 
Motor 16 16 - 112 16 - 110 64 68.4 (26.6) 1.4 0 










Reliability estimates for the FIM+FAM (N = 209) 




Total .55 - .85 (.71) 
Motor .57 - .91 (.77) 
Cognitive .63 - .86 (.77) 
1 +/_ 1.96 SEM 
2 Lower limit 95% confidence interval 






Homogeneity Intra-rater Inter-rater 
coefficient ICC 3 ICC 
(LL95%)CI) (LL95% CI) 
n = 77 n = 89 
.53 .98 (.97) .98 (.97) 
.61 .98 (.97) .98 (.97) 
.62 .97 (.95) .96 (.93) 
4 Uses alpha coefficient as reliability estimate in the calculation of standard error of measurement. 
5 Uses intra-rater reproducibility coefficient as reliability estimate in the calculation of standard error of measurement. 
95%) confidence intervals for 
individual scores 1 









Intercorrelations between FIM+FAM scales (N = 209) 
FIM+FAM scale 
FIM+FAM scale Total Motor 
Motor .93 





Correlations between the FIM+FAM, other outcome measures, and age 
Health outcome measures 1 
Disability Handicap Health status Psychological 
distress 
FIM+FAM BI2 MBI3 EDSS4 OPCS5 LHS6 SF-36 SF-36 GHQ9 
scale PCS? MCSs 
Total .90 .89 - .79 - .77 .32 .24 .12 - .13 
Motor .97 .95 - .86 - .84 .36 .29 .10 - .14 
Cognitive .63 .70 - .48 - .50 .19 .10 .13 - .07 
1 Sample sizes differ as instruments were administered at different combinations of study sites and the EDSS is MS specific. 
2 Barthel Index (n = 149) 
3 Modified Barthel Index (n = 60) 
4 Kurtzke Extended Disability Status Scale (n = 64) 
5 Office of Population Censuses and Surveys Overall Weighted Disability Severity Score (n =69) 
6 London Handicap Scale (n = 121) 
7 SF-36 Physical Component Summary Score (n = 123) 
8 SF-36 Mental Component Summary Score (n = 123) 
9 General Health Questionnaire (n = 85) 









Correlations between the FIM+FAM and neuropsychological measures 
Neuropsychological measures 1 
Global decline Reasoning Memory 
FIM+FAM MMSE 2 WAIS-VIQ 3 HBCT 4 WCST 5 VESPAR 6 CVLT 7 RMT1 
scale 
Total .58 .42 - .40 .59 .60 .58 .58 
Motor .35 .29 - .28 .45 .43 .50 .56 
Cognitive .75 .54 - .49 .69 .76 .61 .50 
1 Sample sizes differ as different instruments were administered at different combinations of study sites and the VESPAR is MS specific. 
2 Mini-Mental State Examination (n = 90) 
3 Wechsler Adult Intelligence Test - Verbal IQ (n = 60) 
4 Halstead Booklet Category Test (n = 44) 
5 Wisconsin Card Sorting Test (n = 40) 
6 Verbal and Spatial Reasoning Test Total Score (n = 37) 





Mean FIM+FAM change scores for different levels of staff-rated improvement in disability 
Staff-rated improvement in disability 
FIM+FAM None Minimal Moderate Marked F p 
scale n = 17 n = 42 n = 75 n = 45 
Total .1 - 8.5 - 20.2 - 43.4 29.9 .001 
Motor - 3.2 - 6.6 - 14.2 - 31.3 29.9 .001 





Mean FIM+FAM change scores and standard deviations for stroke and MS patients 
Mean change score (SO) 
FIM+FAM scale Stroke (n = 62) MS (n = 64) P 
Total - 25.3 (25.8) - 8.7 (11.3) .001 
Motor - 19.6 (17.6) - 7.3 (8.0) .001 





Responsiveness of the FIM+FAM (n = 194) 
Mean score (SO) 
FIM+FAM scale Admission Discharge Change2 
Total 138.7 (44.5) 158.8 (42.8) - 20.1 (24.3) 
Motor 69.8 (25.9) 84.7 (25.5) - 14.9 (16.7) 
Cognitive 68.9 (22.5) 74.2 (20.5) - 5.3 (10.7) 
1 Recognition Memory Test - Visual Version (n = 49) 










The FIM in stroke and MS patients: descriptive statistics, reliability estimates, and intercorrelations between scales 
Descriptive statistics 
Possible range (scale mid-point) 
Actual range 
Mean score (SD) 
Floor I ceiling effect % 
Reliability estimates 
Homogeneity coefficient 
Item-total correlation - range 
Alpha 
Intra-rater reproducibility3 (ICC4) 
Inter-rater reproducibility5 (ICC) 
Intercorrelations between scales 
FIM total 
FIM motor 
FIM cognitLv~ ______ 
1 n = 71 unless specified. 
2 n = 64 unless specified. 
3 n = 29 for stroke, n = 17 for MS. 
4 Intraclass Correlation Coefficient 
5 n = 29 for stroke, n = 34 for MS. 
FIM total 
Stroke 1 MS2 
18 - 126 (72) 18 - 126 (72) 
21 - 122 24 - 121 
76.4 (26.5) 91.2 (24.1) 
010 010 
.52 .47 







FIM motor FIM cognitive 
Stroke MS Stroke MS 
13-91 (52) 13 - 91 (52) 5 - 35 (20) 5 - 35 (20) 
13 - 87 13 - 88 6 - 35 11 - 35 
53.3 (20.6) 61.7 (20.4) 23.1 (8.9) 29.6 (6.0) 
2.8/0 1.6/0 017.0 0/15.6 
.62 .57 .67 .54 
.55 - .92 .32 - .89 .72 - .82 .60 - .75 
.95 .95 ,91 ,83 
.99 ,93 .94 ,92 
,97 ,98 ,95 .88 
,96 ,98 ,76 .70 
1,00 1.00 .55 .54 





The FIM in stroke and MS patients: external construct validity and responsiveness 
n 
External construct validity Stroke 
Barthel Index 45 
LHS 1 33 
SF-36 PCS 2 34 
SF-36 MCS 3 34 
Age 71 
Responsiveness 
Mean change score (SO) 62 
Effect size 62 
1 London Handicap Scale 
2 SF-36 Physical Component Summary Score 
3 SF-36 Mental Component Summary Score 
FIM total 
MS Stroke MS 
64 .95 .94 
58 .15 .42 
58 .13 .14 
58 .19 .28 
64 - .13 - .05 
64 -19.3 (17.5) -6.4 (7.9) 
64 - .75 - .27 
FIM motor FIM cognitive 
Stroke MS Stroke MS 
.97 .96 .57 .50 
.22 .43 - .10 .22 
.16 .14 - .01 .09 
.24 .30 - .03 .11 
- .15 - .04 - .02 - .09 
-16.8 (15.2) -6.5 (6.7) -2.4 (4.7) .2 (3.2) 
- .84 - .32 L--__ ~2~ ________ .03_ 





The FIM+FAM in strok, d MS patients: d 
- - - - - ---- ~ -- , - - -- --- 'J -- , - ~ 
Descriptive statistics 
Possible range (scale mid-point) 
Actual range 
Mean score (SO) 
Floor I ceiling effect 0/0 
Reliability estimates 
Homogeneity coefficient 
Item-total correlation - range 
Alpha 
Intra-rater reproducibility3 (ICC4) 
Inter-rater reproducibility5 (ICC) 
Intercorrelations between scales 
FIM+FAM total 
FIM+FAM motor 
FIM+FAM cogniljve __ 
1 n = 71 for stroke unless specified. 
2 n = 64 for MS unless specified. 
3 n = 29 for stroke, n = 17 for MS. 
4 Intraclass Correlation Coefficient 
5 n = 29 for stroke, n = 34 for MS. 
---------
FIM+FAM total 
Stroke 1 MS2 
30 - 210 (120) 30 - 210 (120) 
35 - 203 54 - 203 
129.5 (41.2) 154.6 (35.2) 
010 010 
.49 .41 










16 - 112 (64) 16 -112 (64) 
16 - 108 20 - 106 
65.1 (24.2) 76.1 (23.6) 
1.4/0 010 
.59 .54 








- ~ ~- -- - ~ 
FIM+FAM cognitive 
Stroke MS 
14-98(56) 14 - 98 (56) 
19 - 96 34 - 98 
64.4 (21.0) 78.5 (15.2) 
010 0/1.6 
.56 .44 











The FIM+FAM in stroke and MS patients: external construct validity and responsiveness 
--
n 
External construct validity Stroke 
Barthel Index 45 
LHS 1 33 
SF-36 PCS 2 34 
SF-36 MCS 3 34 
Age 71 
Responsiveness 
Mean change score (SO) 62 
Effect size 62 
1 London Handicap Scale 
2 SF-36 Physical Component Summary Score 
3 SF-36 Mental Component Summary Score 
FIM+FAM total 
MS Stroke MS 
64 .92 .88 
58 .15 .41 
58 .14 .14 
58 .17 .27 
64 - .12 - .07 
64 -25.3 (25.8) -8.7 (11.3) 
64 - .66 - .28 
FIM+FAM motor FIM+FAM cognitive 
Stroke MS Stroke MS 
.97 .96 .67 .54 
.24 .44 - 01 .26 
.16 .13 .08 .09 
.25 .29 .01 .17 
- .15 - .03 - .06 - .01 
-19.6 (17.6) - 7.3 (8.0) - 5.7 (11.3) - 1.4 (6.4) 









Sample mean (SD) 
Floor effect 0/0 




Descriptive statistics for the FIM, FIM+FAM, and Barthel Index (n = 149) 
Global disability Motor disability Cognitive disability 
FIM FIM+FAM FIM FIM+FAM Barthel FIM FIM+FAM 
total total motor motor Index cognitive cognitive 
18 30 13 16 10 5 14 
18 - 126 30 - 210 13 - 91 16 -112 0-20 5 - 35 14 - 98 
19 - 122 32 - 204 13 - 91 17 - 110 0-20 6 - 35 15 - 98 
72 120 52 64 10 20 56 
85.0 (26.7) 144.8 (40.5) 57.7 (21.4) 71.0 (25.2) 11.5 (5.9) 27.2 (7.8) 73.8 (19.0) 
0 0 2.7 0 2.7 0 0 
0 0 .7 0 5.4 16.1 2.7 





Reliability estimates for the FIM, FIM+FAM, and Barthel Index 
-
Global disability Motor disability 
Variable FIM FIM+FAM FIM FIM+FAM Barthel 
total total motor motor Index 
I nternal consistency (n = 149) 
Homogeneity coefficient .51 .46 .60 .57 .51 
Item-total correlation 1 - range .53 - .87 .40 - .82 .56 - .91 .51 - .90 .46 - .84 
Cronbach's alpha coefficient .95 .96 .95 .96 .94 
Reproducibility (ICC2) 
Intra-rater (n = 77) .98 .98 .98 .98 N/A 
Inter-rater (n = 89) .98 .98 .98 .98 N/A 
--- -- - - -- ---- ----
--_._--- -
1 Corrected for overlap. 














Intercorrelations between FIM and FIM+FAM scales and the Barthel Index (n = 149) 
Global disability Motor disability Cognitive disability 
Scale FIM FIM+FAM FIM FIM+FAM Barthel FIM FIM+FAM 
total total motor motor Index cognitive cognitive 
FIM total 1.00 .98 1 .97 .97 .95 .75 .80 
FIM motor .97 .92 1.00 .996 .97 .58 .64 
FIM cognitive .75 .83 .58 .60 .57 1.00 .97 
FIM+FAM total .98 1.00 .92 .94 .90 .83 .89 
FIM+FAM motor .97 .94 .996 1.00 .97 .60 .67 
FIM+FAM cognitive .80 .89 .64 .67 .63 .97 1.00 
Barthel Index .95 .90 .97 .97 1.00 .57 .63 
C".) 
~ 
1 Values in bold indicate correlations between scales which purport to measure the same aspect of disability. 
Table 3.31 
Correlations between the FIM, FIM+FAM, 8arthellndex and other outcome measures and age 
Other measures Global disability 
Construct Scale n1 FIM FIM+FAM FIM 
total total motor 
Disability EDSS2 64 - .84 - .79 - .87 
OPCS 3 69 - .82 - .77 - .84 
Handicap LHS 4 121 .32 .32 .35 
Health status SF-36 PCS 5 122 .26 .24 .30 
SF-36 MCS 6 122 .10 .12 .10 
Psychological GHQ7 85 - .13 - 13 - .15 
distress 
Other Age 149 - .13 - .13 - .15 
1 Sample sizes differ as not all measures were administered at each clinical site. 
2 Expanded Disability Status Scale 
3 Office of Population Censuses and Surveys Overall Weighted Disability Severity Score 
4 London Handicap Scale 
5 SF-36 Physical Component Summary Score 
6 SF-36 Physical Component Summary Score 
7 General Health Questionnaire 
Motor disability Cognitive disability 
FIM+FAM Barthel FIM FIM+FAM 
motor Index cognitive cognitive 
- .86 - .89 - .45 - .48 
- .84 - .84 - .43 - .50 
.36 .33 .11 .19 
.29 .30 .04 .10 
.10 .11 .08 .13 
- .14 - .14 .01 - .07 





Correlations between the FIM, FIM+FAM, Barthel Index and neuropsychological measures 
Neuropsychological measure Global disability Motor disability Cognitive disability 
Construct Scale n 1 FIM FIM+FAM FIM FIM+FAM Barthel FIM 
total total motor motor Index cognitive 
Global decline MMSE 2 90 .49 .58 .32 .35 .36 .76 
WAIS-VIQ 3 43 .35 .42 .27 .29 .28 .51 
Reasoning HBCT 4 44 - .34 - .40 - .27 - 28 - .27 - .42 
WCST 5 40 .52 .59 .41 .45 .35 .68 
VESPAR 6 37 .53 .60 .40 .43 .38 .75 
Memory CVLT 7 52 .55 .58 .48 .50 .45 .61 
RMT1 49 .53 .56 .43 .. 46 .36 .63 
I Sample sizes differ as not all measures were administered at each study site. Also, the VESPAR was only administered to MS patients. 
2 Mini-Mental State Examination 
3 Wechsler Adult Intelligence Test - VerballQ 
4 Halstead Booklet Category Test 
S Wisconsin Card Sorting Test 
6 Verbal and Spatial Reasoning Test Total Score 













Relative precision estimates for the FIM, FIM+FAM, and Barthel Index 
Global disability Motor disability Cognitive disability 
Staff-rated n FIM FIM+FAM FIM FIM+FAM Barthel FIM FIM+FAM 
improvement in total total motor motor Index cognitive cognitive 
disability 
Minimal 30 - 5.4 - 7.7 - 5.5 - 6.1 - 2.1 .10 - 1.6 
Moderate 50 - 11.4 - 15.8 - 9.7 - 11.4 - 2.8 - 1.7 - 4.4 
Marked 28 - 30.2 - 40.1 -26.9 - 30.9 - 7.0 -3.4 - 9.3 
F - statistic 30.12 24.50 33.19 32.42 20.40 4.84 5.25 
P .0000 .0000 .0000 .0000 .0000 .0098 .0067 
Relative precision 1 1.0 .81 1.0 .98 .61 1.0 1.08 
-
1 Defined, relative to competing FIM scale, in terms of the degree to which a scale is able to detect group differences. Calculated by dividing F - statistic 





Responsiveness of the FIM, FIM+FAM, and Barthel Index (n = 136) 
Global disability Motor disability Cognitive disability 
Mean score (SO) FIM FIM+FAM FIM FIM+FAM Barthel FIM FIM+FAM 
total total motor motor Index cognitive cognitive 
Admission 87.2 (25.4) 148.7 (38.0) 59.1 (20.6) 72.7 (24.2) 11.9 (5.7) 28.1 (7.0) 76.0 (17.1) 
Discharge 99.4 (24.9) 164.7 (37.0) 70.1 (20.6) 85.4 (23.9) 15.1 (5.4) 29.3 (6.2) 79.3 (15.8) 
Change2 - 12.2 (15.3) - 15.9 (21.9) -11.1 (13.0) - 12.6 (15.0) - 3.2 (3.7) - 1.2 (4.4) - 3.3 (9.9) 
Responsiveness 
Effect size - .48 - .42 - .54 - .52 - .56 - .17 - .19 
- --- - - ---
I Recognition Memory Test - Visual Version 







Measurement model of the FIM 
Total scale: 18 items 
Motor scale: 13 items 
Sphincter care 




subscale: 2 items 
Cognitive scale: 5 items 
Communication 
subscale: 2 items 
Social cognition 





Measurement model of the FIM+FAM 
Total scale: 30 items 

























The FIM: internal consistency and intercorrelations between scales and subscales (N = 209) 
Intercorrelations between FIM scales and subscales (alphas in 
parentheses) 
Internal consistency FIM scale FIM subscale 
FIM scale Item-total Item-inter T M C Sc Sp Tr L Com Soc 
correlation correlation 
{mean} 
Total (T) .60 - .87 .21 - .96 (.56) (.96) 
Motor (M) .63 - .92 .29 - .96 (.64) .97 (.96) 
Cognitive (C) .77 - .85 .60 - .87 (.71) .79 .61 (.92) 
FIM subscale 
Self care (Sc) .73 - .87 .58 - .86 (.73) .96 .97* .65 (.94) 
Sphincter (Sp) .67 .67 .76 .77* .51 .70 (.80) 
Transfer (Tr) .82 - .94 .81 - .96 (.86) .90 .95* .51 .89 .68 (.95) 
Locomotion (L) .68 .68 .69 .75* .34 .64 .40 .71 (.81 ) 
Communication (Com) .87 .87 .73 .57 .91* .61 .44 .48 .37 (.93) 
Social cognition (Soc) .76 - .84 .69 - .79 (.74) .75 .58 .96* .62 .51 .47 .29 .75 (.90) 
Vol 
~ 
* Subscale-own scale correlations. 
~ 
Table 4.4 
The FIM+FAM: internal consistency and intercorrelations between scales and subscales (N = 209) 
Intercorrelations between FIM+FAM scales and subscales (alphas in 
parentheses) 
Internal consistency FIM+FAM scale FIM+FAM subscale 
FIM+FAM scale Item-total Item-inter T M C Sc Sp Tr L Com Pa Cf 
correlation correlation 
{mean} 
Total (T) .55 - .85 .15 - .96 (.53) (.97) 
Motor (M) .57 - .91 .29 - .96 (.61) .93 (.96) 
Cognitive (C) .63 - .86 .38 - .87 (.62) .91 .69 (.96) 
FIM+FAM subscale 
Self care (Sc) .61 - .86 .43 - .86 (.68) .92 .96* .71 (.94) 
Sphincter (Sp) .67 .67 .72 .75* .55 .71 (.80) 
Transfer (Tr) .83 - .94 .76 - .96 (.83) .84 .95* .57 .88 .66 (.95) 
Locomotion (L) .71-.78 .64 - .74 (.69) .64 .76* .40 .63 .40 .74 (.87) 
Communication (Com) .75 - .91 .63 - .87 (.74) .82 .65 .89* .68 .48 .55 .40 (.93) 
Psychosocial adj't (Pa) .61 - .79 .41 - .71 (.61) .83 .63 .92* .64 .51 .52 .35 .71 (.86) 
Cognitive functions (Cf) .81 - .85 .71 - .80 (.76) .83 .62 .93* .63 .53 .50 .33 .70 .84 (.94) 
* Subscale-own scale correlations. ~ 
" 
Table 4.5 
Item-scale and item-subscale correlations for the FIM (N = 209) 
FIM scale FIM subscale 
FIM subscale FIM item Motor Cognitive SC S~ Tr Lo 
Self-care (SC) Feeding .70*1 .48 .73* .52 .6~ .50 
Grooming .80* .66 .85* .62 .73 .50 
Bathing .86* .65 .87* .63 .82 .62 
Dressing upper body .79* .63 .82* .56 .74 .56 
Dressing lower body .88* .51 .84* .62 .87 .68 
Toileting .89* .53 .84* .71 .88 .64 
Sphi ncter -care Bladder management .65* .46 .63 .67* .62 .40 
{S~} Bowel management .65* .49 .64 .67* .62 .38 
Transfer (Tr) Bed transfer .91* .49 .87 .65 .93* .72 
Toilet transfer .92* .50 .88 .68 .94* .70 
Shower/tub transfer .83* .47 .79 .60 .82* .66 
Locomotion Walk .63* .38 .59 .33 .63 .68* 
{Lo} Stairs .70* .30 .63 .46 .71 .68* 
Communication Comprehension .51 .85* .53 .41 .42 .35 
{Com) Ex~ression .60 .77* .63 .45 .51 .42 
Social cognition Social interaction .54 .80* .57 .49 .44 .29 
(Soc) Problem solving .54 .81* .58 .43 .45 .32 
Memory .50 .79* .54 .47 .42 .25 
1 Corrected item-own scale / subscale correlation. 






































































Dressing upper body 




















































































1 Corrected item-own scale I subscale correlation. 
FIM+FAM subscale 
Sc Sp Tr Lo Co Pa Cf 
.77* .52 .6Y .54 .57 .48 .43 
.85* .62 .73 .58 .66 .64 .65 
.86* .63 .82 .70 .64 .63 .61 
.82* .56 .74 .63 .62 .60 .62 
.83* .62 .88 .74 .53 .50 .49 
.83* .71 .87 .70 .55 .56 .53 
.61 * .53 .48 .40 .50 .44 .42 
.64 .67* .61 .43 .42 .47 .48 
.65 .67* .61 .41 .42 .48 .50 
.86 .65 .94* .76 .52 .50 .47 
.87 .68 .93* .74 .52 .51 .50 
.78 .60 .83* .71 .51 .47 .45 
.78 54 .84* .79 .49 .48 .46 
.60 .33 .65 .71* .43 .38 .36 
.62 .46 .74 .78* .36 .30 .28 
.63 .37 .62 .76* .59 .69 .65 
.54 .41 .42 .47 .85* .70 .76 
.64 .45 .51 .53 .91* .67 .66 

















.54 .47 .78* .58 .57 















.71 .77* .80 
.48 .68* .61 
.55 .79* .77 
.64 .61* .64 
.67 .85 .85* 
.64 .72 .84* 
.64 .70 .81* 
.56 .48 .44 .42 .60 .73 .83* 
.57 .43 .48 .56 .61 .77 .84* 
2 Values in bold indicate item-other subscale correlations which do not satisfy criteria for definite 
scaling success. 
Table 4.7 
Item convergent and discriminant validity for FIM scales and subscales (N = 209) 
Item-scale I subscale correlation 
Item-own1 
FIM scale No. range (mean) 
items 
Motor 13 .63 - .92 (.79) 
Cognitive 5 .77 - .85 (.80) 
FIM subscale 
Self-care 6 .73 - .87 (.83) 
Sphincter care 2 .67 
Transfer 3 .82 - .94 (.90) 
Locomotion 2 .68 
Communication 2 .87 
Social cognition 3 .76 - .84 (.80) 
1 Corrected item-total correlations for scales and subscales. 
2 Item-other correlations for scales and subscales. 
Item-othe~ 
range (mean) 
.30 - .66 (.50) 
.50 - .60 (.54) 
.43 - .88 (.61) 
.38 - .64 (.50) 
.44 - .88 (.62) 
.25 - .71 (.47) 
.35 - .77 (.52) 
.29 - .72 (.49) 
Scaling success and failure rates (%) 
Definite Probable Probable Definite 
scaling scaling scaling scaling 
success success failure failure 
92.3 7.7 0 0 
100 0 0 0 
76.6 16.7 6.7 0 
60 40 0 0 
80 20 0 0 
60 30 10 0 
90 10 0 0 




Item convergent and discriminant validity for FIM+FAM scales and subscales (N = 209) 
Item-scale Isubscale correlation 
No. Item-own 1 items FIM scale 
Motor 16 .57 - .91 
Cognitive 14 .63 - .86 
FIM subscale 
Self-care 7 .61 - .86 
Sphincter care 2 .67 
Transfer 4 .83 - .94 
Locomotion 3 .71 - .78 
Communication 5 .75 - .91 
Psychosocial adjustment 4 .61 - .79 
Cognitive functions 5 .81 - .85 
1 Corrected item-total correlations for scales and subscales. 
2 Item-other correlations for scales and subscales. 
Item-othe~ 
.34 - .71 
.41 - .69 
.43 - .88 
.41 - .65 
.45 - .87 
.28 - .74 
.37 - .76 
.31 - .80 
.41 - .85 
Scaling success and failure rates (%) 
Definite Probable Probable Definite 
scaling scaling scaling scaling 
success success failure failure 
62.5 31.3 6.2 0 
78.6 21.4 0 0 
71.4 23.8 4.8 0 
66.7 33.3 0 0 
75 25 0 0 
50 50 0 0 
96.7 3.3 0 0 
62.5 12.5 25 0 





Correlations between FIM items and rotated components extracted from principal 
components analysis (PCA) for FIM admission scores 
PCA-1 1 PCA-2 2 
Component Component 
FIM item 1 2 1 2 3 4 
Feeding .643 .36 .15 .84 .12 .10 
Grooming .66 .55 .26 .85 .14 .15 
Bathing .77 .47 .60 .58 .17 .32 
Dressing upper body .68 .49 .42 .76 .18 .14 
Dressing lower body. .87 .27 .71 .45 .13 .33 
Toileting .86 .31 .68 .48 .15 .38 
Bladder management .61 .33 .27 .08 .16 .76 
Bowel management .59 .37 .16 .25 .06 .78 
Bed transfer .91 .23 .76 .38 .17 .37 
Toilet transfer .91 .26 .73 .41 .17 .38 
Shower I tub transfer .83 .24 .67 .40 .15 .36 
Walk .67 .16 .67 .20 .13 - .19 
Stairs .80 .02 .84 - .03 .09 .14 
Comprehension .21 .86 .08 .07 .84 .01 
Expression .34 .79 .10 .32 .74 - .21 
Social interaction .23 .85 .20 .15 .69 .04 
Problem solving .24 .83 .18 .03 .80 .24 
Memory .20 .85 .02 .03 .75 .33 
1 N = 209; based on components with eigenvalues> 1.0 and satisfying scree test. 
2 N = 367 (NRU database sample); based on components with eigenvalues> 1.0 and satisfying 
scree test. 
3 Values in bold indicate highest component loading for each item. When an item equally loads Nvo 
or more components all these values are bolded. 
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Table 4.10 
Correlations between items and rotated components extracted from prinCipal components 
analysis (PCA) for FIM+FAM admission scores 
PCA-1 1 (N = 209) PCA-2 2 In = 105) PCA-3 2 (n = 104) 
Components Components Components 
FIM+FAM item 1 2 3 4 1 2 3 4 1 2 3 4 
Feeding .463 .09 .50 .50 .39 .15 .34 .66 .37 .11 .52 .54 
Grooming .51 .35 .41 .47 .47 .38 .32 .55 .47 .32 .49 .45 
Bathing .69 .35 .31 .32 .68 .36 .21 .35 .70 .33 .33 .30 
Dressing upper body .59 .35 .34 .34 .56 .37 .33 .32 .58 .31 .41 .35 
Dressing lower body .83 .22 .18 .27 .80 .32 .16 .29 .82 .22 .19 .27 
Toileting .77 .26 .17 .38 .72 .25 .19 .44 .77 .25 .22 .34 
Swallowing .22 .13 .44 .63 .14 .17 .27 .77 .23 .18 .42 .62 
Bladder management .40 .31 .03 .65 .40 .25 .03 .69 .40 .33 -.04 .63 
Bowel management .37 .31 .05 .70 .47 .35 -.02 .59 .34 .24 .03 .74 
Bed transfers .85 .18 .18 .33 .82 .22 .18 .37 .83 .14 .26 .31 
Toilet transfers .82 .20 .17 .38 .80 .25 .14 .41 .83 .18 .24 .33 
Shower transfers .79 .18 .19 .25 .80 .27 .10 .25 .79 .14 .15 .31 
Car transfers .84 .20 .16 .17 .80 .25 .19 .18 .85 .15 .19 .20 
Walking .70 .13 .26 -.02 .69 .08 .31 .02 .76 .16 .22 -.04 
Stairs 
.83 .04 .10 .06 .84 -.04 .16 .05 .85 .03 .05 .11 
Community mobility 
.60 .55 .27 -.15 .55 .55 .32 -.06 .63 .53 .24 -.18 
Comprehension .17 .61 .65 .06 .26 .51 .73 .02 .19 .55 .69 .06 
Expression .27 .44 .77 .12 .28 .42 .78 .15 .28 .37 .80 .11 
Reading 
.22 .44 .73 .14 .24 .39 .78 .18 .21 .43 .74 .14 
Writing 
.33 .32 .70 .11 .27 .35 .70 .21 .25 .30 .74 .09 
Speech intelligibility .26 .25 .77 .16 .22 .17 .79 .25 .33 .33 .71 .10 
Social interaction .16 .73 .39 .24 .16 .69 .48 .21 .14 .74 .41 .18 
Emotional status .07 .67 .15 .28 -.02 .63 .24 .28 .15 .76 .11 .25 
Adjustment to limit's .18 .84 .14 .07 .21 .78 .25 .08 .21 .83 .18 .04 
Em ployabi lity 
.56 .51 .36 -.03 .56 .49 .37 .09 .58 .47 .38 -.06 
Problem solving 
.26 .85 .26 .04 .24 .83 .33 .11 .21 .86 .27 .01 
Memory 
.18 .80 .25 .16 .28 .77 .18 .17 .12 
.76 .35 .19 
Orientation 
.17 .73 .24 .39 .19 .75 .18 .36 .14 
.72 .31 .38 
Attention 
.20 .79 .18 .22 .26 .81 .17 .25 .17 
.79 .21 .26 
Safety judgement .29 .80 .21 .10 .27 .79 .22 .16 .26 
.79 .24 .17 
~ PCA-1 = total sample; based on components with eigenvalues> 1.0 and satisfying the scree test. 
PCA-2 and PCA-3 = samples generated by random split half. 
3 Values in bold indicate the highest component loading for each item. When an item equally loads 
two or more components all these values are balded. 
Table 4.11 
Item descriptive statistics, reliability, and responsiveness for the FIM (N = 209) 
Reliability 
Descriptive statistics Reeroducibility 1 Reseonsiveness 
FIM item MEF Floor Ceiling Item-total Intra- Inter- Effect size3 
%2 effect effect correlation rater rater 
% % 
Feeding 44.5 12.0 27.3 .69 .96 .94 - .42 
Grooming 36.8 12.0 36.8 .83 .92 .92 - .39 
Bathing 24.9 15.3 24.9 .87 .90 .88 - .44 
Dressing upper body 26.8 12.0 26.8 .82 .91 .90 - .46 
Dressing lower body 28.2 28.2 12.4 .83 .95 .90 - .58 
Toileting 25.8 22.5 25.8 .85 .87 .92 - .43 
Bladder care 39.7 19.6 39.7 .65 .91 .85 - .30 
Bowel care 46.4 13.4 46.4 .66 .89 .88 -.21 
Bed transfer 25.4 17.2 19.1 .85 .95 .94 
- .52 
Toilet transfer 38.3 17.7 10.0 .86 .95 .96 
- .46 
Shower/tub transfer 29.2 29.2 1.9 .78 .91 .84 
- .63 
Walk 34.9 34.9 7.7 .60 .94 .84 
- .69 
Stairs 56.0 56.0 2.4 .62 .95 .91 
- .58 
Comprehension 47.4 7.2 47.4 .64 .95 .90 
- .17 
Expression 41.1 11.5 41.1 .70 .90 .92 
- .17 
Social interaction 40.2 10.0 40.2 .65 .92 .87 
- .22 
Problem solving 19.1 17.7 19.1 .65 .86 .89 
- .18 
Memory 42.6 12.4 42.6 .62 .88 .79 
-.22 
1 
n = 77 for intra-rater reproducibility, and n = 89 for inter-rater reproducibility. 
2 Maximum Endorsement Frequency 
3 n = 194 
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Table 4.12 
Item-intercorrelations for the FIM that are greater than or equal to .70 (N = 209) 
Items (1 Items ( 
Feeding - Grooming .78 Dressing lower body - toileting .86 
Grooming - Bathing .79 Dressing lower body - Bed transfer .85 
Grooming - Dressing upper body .77 Dressing lower body - Toilet .85 
transfer 
Grooming - Toileting .73 Dressing lower body - Shower .79 
transfer 
Grooming - Bed transfer .72 Toileting - Bed transfer .86 
Grooming - Toilet transfer .73 Toileting - Toilet transfer .88 
Bathing - Dressing upper body .74 Toileting - Shower transfer .76 
Bathing - Dressing lower body 
.82 Bed transfer - Toilet transfer .96 
Bathing - Toileting 
.79 Bed transfer - Shower transfer .81 
Bathing - Bed transfer 
.79 Bed transfer - Stairs .71 
Bathing - Toilet transfer 
.81 Toilet transfer - Shower transfer .81 
Bathing - Shower transfer 
.75 Comprehension - Expression 
.87 
Dressing upper body - Dressing 
.75 Comprehension - Memory 
.71 
lower body 
Dressing upper body - TOileting 
.72 Social interaction - Problem 
.75 
solving 
Dressing upper body - Bed transfer 
.72 Memory - Problem solving 
.79 
Dressing upper body - Toilet transfer 
.74 
1 
Pearson's Product-Moment Correlation Coefficient 
Table 4.13 
Correlations between FIM-8 items and components extracted by principal components analysis (PCA) 
PCA-1 1 (n =209) PCA-2 2 (n =105) 
FIM-8 item Component 1 Component 2 Component 1 Component 2 
Feeding 
.59 3 .45 .38 .70 
Shower/tub transfer 
.75 .39 .46 .70 
Walk 
.83 .10 .07 .85 
Stairs 
.89 .09 .17 .82 
Bladder management 
.44 .63 .71 .38 
Bowel management 
.42 .67 .77 .35 
Social interaction 
.12 .85 .82 .17 
Memory 
.07 .85 .84 .08 
Eigenvalue 4.16 1.27 4.30 1.24 
Variance (percent) 52.0 15.9 53.7 15.5 
1 PCA-1 = total sample; based on components with eigenvalues> 1.0 and satisfying the scree test. 
2 PCA-2 and PCA-3 = samples generated by random split half. 
PCA-3 2 (n =104) 

















Internal consistency of four methods of scaling FIM-8 items (N = 209) 
Internal consistency 
Methods of 
scaling FIM-8 No. of Item-total Alpha Homogeneity 
items1 
items correlation coefficient coefficient 
Method 1 
Total 8 .54 - .73 .86 .45 
Method 2 
Motor 6 .58 - .76 .85 .50 
Cognitive 2 .69 .82 .69 
Method 3 
Physical 4 .56 - .72 .83 .56 
Sphincter 2 .67 .80 .67 
Cognitive 2 .69 .82 .69 
Method 4 
Component 1 4 .56 - .72 .83 .56 
Component 2 4 .61 - .65 .81 .52 
1 Methods 1, 2, and 3 are clinically-based item groupings. Method 4 is an empirically-based item 
grouping generated by principal components analysis. 
Table 4.15 
Intercorrelations between scales for methods 1 of grouping FIM-8 items (alphas in parentheses) (N=209) 
Method 1 Method 2 Method 3 Method 4 
FIM-8 scale No. Total Motor Cognitive Physical Sphincter Cognitive Component 1 Component 2 
items 
Total 8 (.86) 
Motor 6 .96 (.85) 
Cognitive 2 .74 .51 (.82) 
Physical 4 .88 (.83) 
Sphincter 2 .82 .57 (.80) 
Cognitive 2 .74 .41 .52 (.82) 
Component 1 4 .88 (.83) 
Component 2 4 .89 .57 (.81 ) 
-






Multitrait scaling analysis of four methods of scaling FIM-8 items 
Item-scale correlation Scaling success rate 0/0 
Methods of 
scaling FIM-8 Number Item-own Item-other 




Total 8 .54 - .73 N/A N/A N/A 
Method 2 
Motor 6 .58 - .76 .23 - .49 83.3 16.7 
Cognitive 2 .69 .45 - .49 100 0 
Method 3 
Physical 4 .56 - .72 .23 - .60 75 25 
Sphincter 2 .67 .46 - .53 75 25 
Cognitive 2 .69 .36 -.49 100 0 
Method 4 
Component 1 4 .56 - .72 .36 - .59 50 50 
Component 2 4 .61 - .65 .36 - .53 50 50 
I Methods 1, 2, and 3 are clinically-based item groupings. Method 4 is an empirically-based item 
grouping generated by principal components analysis. 
Table 4.17 
Descriptive statistics for FIM-8 admission scores (N = 209) 
Range of scores 
FIM-8 No. Scale Sample Floor 
scale items Possible Actual mid-point mean (SO) effect 
0/0 
Total 8 8 - 56 8 - 53 32 35.0 (12.2) 3.8 
Motor 6 6 - 42 6 - 42 24 25.0 (9.6) 5.7 















1 Intraclass Correlation Coefficient 
Table 4.18 
Reproducibility estimates for FIM-8 scales (N = 209) 
Reproducibility (ICC 1) 
FIM-8 No. Intra-rater Inter-rater 
scale items n = 77 n = 89 
Total 8 .97 .96 
Motor 6 .98 .96 





Correlations between scales of the FIM-8, FIM, and FIM+FAM (N = 209) 
FIM FIM+FAM 
FIM-8 scale Total Motor Cognitive Total Motor 
Total .971 .95 .76 .95 .95 
Motor .92 .96 .56 .87 .96 
Cognitive .73 .56 .95 .81 .58 









Intercorrelations between FIM-8 scales (alphas in parentheses) (N = 209) 
FIM-8 scale 
FIM-B scale No. Total Motor Cognitive 
items 
Total B (.B6) 
Motor 6 .96 (.B5) 





Correlations between the FIM-8 and other outcome measures 
Health outcome measures 1 
Disability Handicap Health status Psychological 
distress 
FIM-8 BI2 MBI3 EDSS4 OPCS5 LHS6 SF-36 SF-36 GHQ9 
scale PCS7 MCSs 
Total .92 .93 - .82 - .77 .25 .30 .07 - .12 
Motor .93 .94 - .84 - .80 .28 .33 .08 - .14 
Cognitive .53 .61 - .42 - .33 .05 .06 .02 - .01 
1 Sample sizes differ as not all instruments were administered at each study site. Also, the EDSS was only administered to MS patients. 
2 Barthel Index (n = 149) 
3 Modified Barthel Index (n = 60) 
4 Kurtzke Extended Disability Status Scale (n = 64) 
5 Office of Population Censuses and Surveys Overall Weighted Disability Severity Score (n = 69) 
6 London Handicap Scale (n = 121) 
7 SF-36 Physical Component Summary Score (n = 123) 
8 SF-36 Mental Component Summary Score (n = 123) 
9 General Health Questionnaire (n = 85) C".) c.n 
co 
Table 4.22 
Correlations between FIM-8 scales and neuropsychological measures 
Neuropsychological measures 1 
Global decline Reasoning Memory 
FIM-8 scale MMSE 2 WAIS-VIQ 3 HBCT 4 WCST 5 VESPAR 6 CVLT 7 RMT8 
Total .42 .29 - .34 .51 .48 .51 .58 
Motor .29 .23 - .32 .41 .39 .47 .53 
Cognitive .59 .36 - .26 .57 .52 .47 .47 
1 Sample sizes differ as different instruments were administered at different combinations of study sites and the VESPAR is MS specific 
2 Mini-Mental State Examination (n = 90) 
3 Wechsler Adult Intelligence Test - Verbal IQ (n = 60) 
4 Halstead Booklet Category Test (n = 44) 
5 Wisconsin Card Sorting Test (n = 40) 
6 Verbal and Spatial Reasoning Test - Total Score (n = 37) 
7 California Verbal Learning Test (n = 52) 





Correlations between FIM-8 scales, age, and sex (N = 209) 
FIM-8 scale No. Age Sex 
items 
Total 8 - .06 .06 
Motor 6 - .10 .02 





Responsiveness of FIM-8 scales, and relative responsiveness compared with the FIM and FIM+FAM (n = 194) 
Mean score (SO) Responsiveness (effect size) 
FIM-8 scale No. Admission Discharge Change 1 FIM-8 FIM FIM+FAM 
items 
Total 8 35.7 (11.8) 42.5 (11.5) - 6.8 (7.6) - .57 - .52 - .45 
Motor 6 25.5 (9.3) 31.4(9.1) - 5.8 (6.5) - .63 - .58 - .57 
Cognitive 2 10.1 (4.0) 11.1 (3.5) - .94 (2.4) - .24 - .22 - .24 





Responsiveness of FIM and FIM+FAM scales using five statistical methods (n = 194) 
t -statistic Relative Effect size Standardised 
Scale efficiency response mean 
FIM total - 12.1 1.0 - .52 - .87 
FIM motor - 12.3 1.03 - .58 - .88 
FIM cognitive - 6.0 .25 - .22 - .43 
FIM+FAM total - 11.5 .90 - .45 - .83 
FIM+FAM motor - 12.4 1.05 - .57 - .89 














Comparison of rank ordering and relative responsiveness of FIM and FIM+FAM scales using five statistical methods (n = 194) 
Relative 
t -statistic efficiency 
Scale RO 1 RR2 RO RR 
FIM total 3 1.0 3 1.0 
FIM motor 2 1.02 2 1.03 
FIM cognitive 6 .50 6 .24 
FIM+FAM total 4 .95 4 .91 
FIM+FAM motor 1 1.02 1 1.05 
FIM+FAM cognitive 5 .57 5 .33 
I Rank order, 1 = most responsive instrument, 6 = least responsive instrument. 
2 Relative ratio of responsiveness compared with the FIM total scale. 
Standardised Guyatt's 
Effect size response mean Responsiveness 
Index 
RO RR RO RR RO RR 
3 1.0 3 1.0 3 1.0 
1 1.12 2 1.01 1 1.12 
6 .42 6 .49 6 .27 
4 .87 4 .95 4 .87 
2 1.10 1 1.02 2 1.11 




Comparison of disability levels in different studies 
Patients I Study 
Heterogeneous samples 
Present study 
Segal et al. 1993 (200) 
Stineman et al. 1996 (205) 
McPherson and Pentland 1996 (214) 
McPherson and Pentland 1997 (216) 
Stroke patients 
Present study 
Granger et al. 1993 (211) 
Brosseau et al. 1996 (314, 315) 
Stineman et al. 1996 (205) 
MSpatients 
Present study 
Granger et al. 1990 (208) 
Brosseau 1994 (201) 
Marolf et al. 1996 (197) 
1 Scale range 18 -126; scale midpoint 72. 
2 Scale range 30 - 210; scale midpoint = 120. 
3 FIM+FAM not used in these studies. 
Mean total score 
FIM 1 FIM+FAM 2 
80.4 135.8 


















Item-intercorrelations: range (mean) 
Intercorrelations between scales 
total - motor 
total - cognitive 
motor - cognitive 




: Method used routinely at NRU n = 728. 
Method used in study. Patients from NRU n = 118. 
3 n = 64 
Method of F I M rati ng 
Stand alone 1 Derived 2 
.93 .95 










Mean FIM total scale change scores 1 corresponding with staff-rated 
changes in disability for stroke and MS patients (n in parentheses) 
Staff rated level of change in disability 
Diagnosis None Minimal Moderate Marked 
Stroke + 2.33 (6) - 7.77 (13) - 18.38 (21) - 36.21 (19) 
MS - 4.57 (7) - 4.82 (22) - 6.50 (26) - 13.25 (4) 
1 Admission minus discharge scores. Negative change score indicates less disability on 




Guidelines for rating the grooming item of the FIM and FIM+FAM 
Part one: written guidelines 
Grooming includes oral care, hair grooming (combing and brushing hair), 
washing the hands and the face, and either shaving the face or applying 
make-up. If there is no preference for shaving or applying make-up, then 
disregard. Performs safely. 
No helper 
7 Complete independence - subject cleans teeth or dentures, combs or 
brushes hair, washes the hands and the face, and either shaves the face 
or applies make-up, including all preparations. Performs safely. 
6 Modified independence - subject requires specialised equipment including 
prosthesis or orthosis) to perform grooming activities, or takes more than a 
reasonable time, or there are safety considerations. 
Helper 
5 Supervision or set-up - subject requires supervision (e.g. standing by, 
cueing or coaxing, or set up (application of orthoses, setting out grooming 
equipment, and initial preparation such as applying toothpaste to brush, 
opening make-up containers). 
4 Minimal contact assistance - subject performs > 750/0 of grooming tasks. 
3 Moderate assistance - subject performs 50% to 74°A, of grooming tasks. 
2 Maximal assistance - subject performs 25% to 490/0 of grooming tasks. 
1 Total assistance - subject performs < 25% of grooming tasks. 
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Part two: decision tree 
Grooming includes oral care, hair grooming (combing and brushing hair), washing the 
hands and the face, and either shaving the face or applying make-up. Note: this item 
may include the assessment of four or five activities depending on whether the subject 
chooses to shave or apply make-up. At level 7 the subject cleans his/ teeth or 
dentures, combs or brushes hair, washes the hands and the face, and either shaves 
the face or applies make-up, including all preparations. Performs independently and 
safely. 
START Does subject need an 
J, assistive device for 
Does subject grooming (e.g. adapted 
need help for -No~ comb) or does s/he take -No~ Score 7 
grooming more than a reasonable 
tasks? time or is there a concern 
I for safety as the subject -Yes~ Score 6 I grooms 
I 
I t Helper 
I 
I 




Does subject Does subject need only 
provide half or supervision, cueing, 
more of the -Yes~ coaxing, or help to set out -Yes~ Score 5 
effort when grooming equipment or 
hel to a I orthoses 
No No 
4,. 4,. 
Does subject require total Does subject need only 
assistance for grooming such incidental help such as 
as the helper holding the placement of a washcloth 
grooming items and in his/her hand or help to -Yes~ Score 4 performing basically all the perform just one of the 
activities several tasks included in 
? 
I I 
Yes No No 
4,. 4,. 4,. 
Score 1 Score 2 I I Score 3 
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Appendix 2 
Ethical approval, consent form, and patient information leaflet 
for each clinical site 
PATRON: Her Royal Highness The Princess of Wales 
CHAIRMAN: Mrs. E. HO\Nlett. JP 
GENERAL MANAGER: A. Wheatley. CB 
IFM/JAS 
REF: 04/18/95 
19th June 1995 
Dr. A. Thompson, 
Consultant Neurologist, 
N.H.Q.S. 
Dear Dr. Thompson, 
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LONDON we 1 N 3BG 
TEL: 071-837 361 1 
FAX: 071-8298720 
Extension 3171 
RE: DISABILITY AS AN OUTCOME OF NEUROLOGICAL REHABILITATION: 
COMPREHENSIVE EVALLULATION OF TEH FUNCTIONAL INDEPENDENCE 
MEASURE + FUNCTIONAL ASSESSMENT MEASURE (FIM + FAM) 
DISABILITY SCALE 
I am pleased to inform you that the Joint Medical Ethics 
Committee approved your project at its meeting on 8th June 1995. 
I would be grateful if you could ensure that the appropriate 
forms enclosed are completed. 
With best Wishes. 
Yours sincerely, 
Dr. I.F. Moseley, 
Chairman, 




R NEUROLOGY AND NEUROSURGERY 
Tel: 071-837 3611 
RESEARCH ON HUMAN VOLUNTEERS 
Subject/Patient Consent Form 
Consultant(s) in charge/Director of project: _~L--.L.--\-----I---+----E....-..3...£...lI~~~---L-~--\--
The subject/patient (Name): ____________ Hosp. No. ____ _ 
has given his/her consent participate in the above named study. 
The nature, purpose and possible consequences of the procedures involved have 







and Witnessed by: 







Signature Subject/Patient/Guardian: Date 
Address: 
Please return this form to: 
----------------------- ------------
PATIENT SERVICES MANAGER 
National Hospital for 
Neurology and Neurosurgery 
Queen Square 
LONDON 'VCiN 3BG 
IT IS :\ REQUIREl\IENT OF THE JOINT MEDICAL COMMITTEE THAT ,\NY ADVERSE EFFECTS 
WIIICII MAY OCCUR DURING A CLINICAL TRIAL ARE REPORTED TO THE PATIENT SERVICES 
I\IA:--.JAGER IMl\IEDIATELY. 
PATRON: Her Royal Highness The Princess of Wales 
373 
THE NATIONAL HOSPITAL FOR NEUROLOGY 
AND NEUROSURGERY 
QUEf!N SQUARE 
LONDON we1 N 3BG 
TEL: 071-837 3611 
FAX: 071-8298720 
CHAIRMAN: Mrs. E. Hovvlett. JP INFORMATION FOR PATIENTS 
GENERAL MANAGER: A. Wheatley. CB 
A STUDY TO DETERMINE THE USEFULNESS OF A DISABILI'FY SCALE 
We invite you to participate in a research project which we believe to be of potential importance. 
In order to help you to understand what the research is about, we are providing you ~th the 
following information which we want to be sure you understand before you agree to participate. 
Be sure to ask any questions you have about the information which follows and we will do our 
best to provide any further information you require 
WHY HAVE YOU BEEN ASKED TO PARTICIPATE? 
We are asking patients who are admitted to the Neuro-Rehabilitation Unit for in-patient. 
rehabilitation on Mondays to participate. 
WHAT ARE THE AIMS OF THE STUDY? 
It is generally believed that rehabilitation is important for people with neurological disease, but 
this has yet to be proven. To do this staff at rehabilitation units must be able to measure the effect 
of rehabilitation accurately. This study will evaluate a measure to determine if it is accurate 
enough to be used to assess the effect of in-patient rehabilitation. 1bis is achieved by collecting 
information from you and the staff who look after and treat you during your stay at the 
Rehabilitation Unit. 
HOW DOES THIS INVOLVE YOU? 
If you agree to paticipate we would ask you to answer some questions and fill in 2 questionnaires' 
\Nithin a few days of admission to the Neuro-Rehabilitation Unit and again before discharge. This 
takes approximately 20 minutes. We will also ask you to undertake some tests to assess your 
memory. This will take about 2 hours. None of these tests will interfere with your rehabilitation 
in any way. The study will result in NO discomforts or hazards NOR extra visits to hospital than 
would ordinarily be the case. It will not interfere or affect any other medical problems you may 
have. The research will not be of special benefit to you during your rehabilitation. All answers 
are in confidence and \vill be coded so that they are not identifiable by name. 
IOU are completely free not to participate and may withdraw from the study at any time. This 
will not jeopardise the ordinary course of medical treatment (or course of study, if you are a 
student volunteer). This \vill not affect your rights at all. You understand that in the event of 
injury caused by your participation in research, you \·vill be compensated irrespective of the 
negligence of the researchers. 
If ~'ou have any questions please do not hesitate to ask. lVlore information can be obtained from 
Dr. Jeremy Hobart (Research Doctor), Jenny Freenlan (Research Therapist) or Dr. Thompson, 
Consultant Neurologist at the Rehabilitation Unit 
Cont,1l't tl'iephone nuo1ber: 0171 837 3611 ext. 3341 
'1'1 L\\:K 'r(JL' FOR YOUR CO-lJPER.\ 110:\ 
ALL CORRESPONDE~CE TO BE ADDRESSED TO: 
MR MARK KENDALL 
ELCHA RESEARCH ETHICS COMMIITEE 
61 PHILPOT STREET 
WHITECHAPEL 
LONDON, E 1 2JH 
TEL: 071-377-7325 
Dr R Greenwood 
Regional Neuro-Rehabilitation Unit 
Homerton Hospital 
Homerton V./ ay 
London 
E96SR 
Our ref: MSIMK/cat 
Dear Dr Greenwood 
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EAST LONDON 
~ THE CITY 
HE,H TH ~ L THG"!I T'( 
Chairman 
Professor Frances Heidensohn 
25 April 1995 
Re: P/9S/61 - Disability as an outcome of neurological rehabilitation: comprehensive 
evaluation of the functional independence measure + functional assessment 
measure (FIM + F AM) disability scale 
Further to your letter of 7 April addressing the concerns of the Research Ethics Committee, I 
now have pleasure in taking Chainnan's Action in accepting the above study as ethically 
satisfactory and will report this to the next full meeting of the Ethics Committee. 
Please note the following conditions to the approval: 




If you expect your project to take longer to complete (ie collection of data), a 
letter from the principal investigator to the Chainnan will be required to further 
extend the research. This will help the Committee to maintain comprehensive 
records. 
Any changes to the protocol must be notified to the Committee. Such changes 
may not be implemented without the Committee or Chainnan's approval. 
The Committee should be notified immediately of any serious adverse events or 
if the studv is tenninated prematurely. 
You are responsible for consulting with colleagues and/or other groups who may 
be involved or affected by the research. such as extra work for laboratories. 
IContinued 
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5. You must ensure that, where appropriate, nursing and other staff are made aware 
that research in progress on patients with whom they are concerned has been 
approved by the Committee. 
6. The Committee should be sent one copy of any publication arising from your 
study, or a summary if there is to be no publication. 
Please quote the above study number in any future related correspondence. 
Yours sincerely 
M SWASH MD FRCP FRCPath 
Chainnan 
ELCHA Research Ethics Committee 
RE610NnL NEURO-REHnB I L ITnTI ON UN IT, 
HOMERTON HOSP ITnL 
WR ITTEN CONSENT FORM 
Title of research proposal: 
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Disability as an outcome of Neurological Rehabilitation: Comprehensiue Eualuation of the 
Functional Independence Measure + Functional Assessment Measure (FIM + FRM) Disability 
Scale 
E.c. No. 
Name of Patient: 
Address: 
I haue read the attached information on the research in which I haue been asked to 
~articipate and haue been giuen a copy to keep. I haue had the opportunity to discuss the 
details and ask questions about this information. The I nuestigator has explained the nature 
and purpose of the research and I belieue that I understand what is being proposed. For 
~Hample, I understand that this trial is part of a research project designed to promote 
nedicalknowledge, and that it has been approued by the East London (} City Health Authority 
lesearch Ethics Committee. I haue been informed that the proposed study inuolues 
nonitoring and special examinations which haue been explained to me, together with possible 
'isle inuolued. I understand that my personal inuoluement and my particular data from this 
:rial will remain strictly confidential. Only researchers inuolued in the trial will haue access, 
lr where applicable, the industrial sponsor which funded the research. I also understand 
:hat, where appropriate, my General Practitioner will be informed that I haue taken part in 
:his study. I hereby fully and freely consent to participate in the study which has been fully 
~Hplained to me. 
n circumstances where a patient is deemed unable to giue informed consent, a relatiue may 
Jiue their permission for their inuoluement in the study. 
'RTIENT'SNRME:(BLOCK CAPITRLS) ..••..•..•...........•..•...••.......•...•.•.... 
'nTI [NT'S NRME:S 16NRTURE •••.••••••.•••.•.••.•••.••••••••••..•••••••••.••.•••••.••••••••••••..•. 
UITNESS' NRME: ••••••....••••.•••.••.••••••••••••.•••••.••••••••••••••••••••••..••.••••••••••••••••••••• 
~ITN[SSf SIGNRTURE: ••.••.•.•••••••••••••••.•.•••••..••••••••••••••.•.•.•.•..•...•.••••••••••....••••• 
is A RELRII UE OF THE ABOUE, I GlUE MY PERM I SS I ON FOR THE I R I NUOLUEMENT IN 
HIS STUDY RS THEY ARE UNRBLE TO GlUE INFORMED CONSENT THEMSELUES 
lAME OF RELRTI UE: ..•...•................•....•........................................ 
ATlENT'S RELRTlUE NAME:SIGNATURE ..................................................... .. 
NUESTIGRTOR'S NAME: ............................................................................. .. 
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INUESTI6RTOR 'S SIGNRTURE: ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
D ATE ' ....•••.•••••••••••••.•..•••••.•••••••••••••••••••••••••••••••••••••••••••••••.••••••••.••••••••••••• . ... .... 
rhe following should be signed by the Clinician/ I nuestigator responsible for 
[)btaining consent. 
As the Clinician/ I nuestigator responsible for this research or a designated deputy, I confirm 
that I haue eMplained to the patient/uolunteer named aboue the nature and purpose of the 
research to be undertaken. 
:LINICIRN1S NOME: •..••.•••.•••••...••..••••.•...•...•.••.••••••.•.....•.......•...........•.•.••..•.• 
:LINICIAN'S SIGNATURE: •..•••••.•.•.•...•.•..•.•..•.••••.••••.••.•••••••.•••••....•.••.•.•••••••••• 
1HTE: .•••....••.•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
• ublects are warned not to take part in more than one study at any time. 
f you are at all concerned about this trial or note any untoward 
~ffect of any drug uou are receiuinQ, please contact: 
Jr. RICHARD GREENWOOD 
"el. No. 881 919 7918 ........................................ . 
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REGIONAL NEURO-REHABILITATION UNIT, HOMERTON HOSPITRL 
"INUITATION TO PARTICIPATE IN R RESEnRCH PROJECT" 
I NFORMnTI ON FOR PATI ENTS 
We inuite you to participate in a research project which we belieue to be of potential 
importance. I n order to help you to understand what the research is about, we are prouiding 
you with the following information which we want to be sure you understand before you 
formally agree to participate. Be sure to ask: any questions you haue about the information 
which follows and we will do our best to explain and to prouide any further information you 
require. 
rillE OF RESERRCH PROJECT 
Jisability as an Outcome of Neurological Rehabilitation: Comprehensiue Eualuation of the 
~unctional Independence Measure + Functional Assessment Measure (FIM + FAM) Disability 
icale 
JJHY HRUE YOU BEEN RSKED TO PRRTI C I PRTE? 
lle are ask:ing patients who are admitted to the Regional Neuro-Rehabilitation Unit at the 
iomerton Hospital for in-patient rehabilitation on a Monday to participate in the study. 
llHAT RRE THE RIMS OF THE STUDY? 
t is generally belieued that rehabilitation is important for people with neurological disease, 
Jut this has yet to be prouen. I n order to answer this question it is necessary to haue an 
)ccurate way of measuring the effects. This study will eualuate a measure to determine if it 
s dependable enough to be used to assess the effect of in-patient rehabilitation. 
iOW ODES TH I S I NUOlUE YOU 
JJe would lik:e you to answer some questions and fill in 2 questionnaires within a few days of 
Idmission to the Neuro-Rehabilitation Unit and again before discharge. This takes 
IpproHimately 39 minutes, and will not interfere with your rehabilitation in any way. RII 
mswers are in confidence and will be coded so that they are not identifiable by name. You 
I.re completely free not to agree to participation and may withdraw from the study at any 
Ime. 
I~U understand that in the euent of injury caused by your participation in the research, you 
UIII be compensated irrespectiue of the negligence of the researchers. 
ien~ral information on patients' rights, particularly as regards participation in research 
tUdles may also be obtained from my local Community Health Council. 
1
10hre .i~formation can be obtained from Dr. Greenwood, Consultant Neurologist at the 
e ablhtation Unit 
'4 hour contact number: 981 919 7969 
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REGIONAL NEURO-REHABILITATION UNIT, HOMERTON HOSPITRL 
"INUITATION TO PARTICIPATE IN R RESEARCH PROJECT" 
I NFORMATI ON FOR RELATI UES 
JJe inuite your relatiue to participate in a research project which we belieue to be of 
)otential importance. I n order to help you to understand what the research is about, we are 
Jrouiding you with the following information which we want to be sure you understand 
Jefore you formally giue permission for your to relatiue participate. Be sure to ask any 
luestions you haue about the information which follows and we will do our best to eHplain 
lnd to prouide any further information you require. We feel that your relatiue is currently 
mabie to giue informed consent and therefore we are asking for your permission (relatiues 
:annot giue consent in the place of patients). 
'ITLE OF RESEARCH PROJECT 
Iisability as an Outcome of Neurological Rehabilitation: Comprehensiue Eualuation of the 
'unctional Independence Measure + Functional Assessment Measure (FIM + rRM) Disability 
icale 
UHY HRS YOUR RELRTI UE BEEN RSKED TO PRRTI C I PRTE? 
Ue are asking patients who are admitted to the Regional Neuro-Rehabilitation Unit at the 
lomerton Hospital for in-patient rehabilitation on a Monday to participate. 
UHRT RRE THE RIMS OF THE STUDY? 
t is generally belieued that rehabilitation is important for people with neurological disease, 
lut this has yet to be prouen. It is generally belieued that rehabilitation is important for 
leople with neurological disease, but this has yet to be prouen. I n order to answer this 
luestion it is necessary to haue an accurate way of measuring the effects. This study will 
~ualuate a measure to determine if it is dependable enough to be used to assess the effect of 
n-patient rehabilitation. 
IOUJ DOES THIS INUOLUE YOU 
~ y.ou giue permission to their paticipation we would ask you to answer some questions and 
III !n 2 Questionnaires within a few days of admission to the Neuro-Rehabilitation Unit and 
Igam ~efore discharge. This takes approHimately 30 minutes. All answers are in confidence 
nd Will be coded so that they are not identifiable by name. You are completely free not to 
Igree to the participation of your relatiue. 
en~ral information on patients' rights, particularly as regards particiipation in research 
tUdles may also be obtained from my local Community Health Council. 
10re infonnation can be obtained from Or. Greenwood Consultant Neurologist at the 
ehabilitation Unit ' 
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TEW 13IWGP/JS 
14 March 1995 
Professor D L Mclellan 
Europe Professor of Rehabilitation 
Research Unit 
University Faculty of Medicine 
Southampton General Hospital 
Dear Professor Mclellan 
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SOl'TII.\.\lPTO~ .\~() SOl'TIi WEST IL\~IPSlllnE 
II EA LT II CO~UII SS I O~ 
Oakley Road. Southampton S016 4GX 
Telephone: (01703) 725400. Fax: (01703) 725457 
Submission No. 65/95 - Disability as an Outcome of Neuroloeical Rehabilitation: 
Comprehensive Evaluation of the Functional Independence Measure + Functional 
Assessment measure (FIM + FAMl Disability Scale 
The Joint Ethics Committee considered the above application at its recent meeting. I am 
pleased to inform you that ethical approval was given to this study. 
Would you please ensure that a record is made in the Medical Records of patients who 
agree to participate in a research project, to the effect that they have given their consent 
to involvement in this research study. The title of the research project should be clearly 
indicated. Please note that this applies only to patients who do wish to be involved in a 
study and not for patients who do not wish to participate. 
Should any unforeseen problem of either an ethical or procedural nature arise during the 
course of this research where you feel that the Joint Ethics Committee may be of 
assistance, please do not hesitate to contact me. 
I would be grateful if you could complete the enclosed questionnaire, and forward it to 
Ms Frances Marsden, Deputy Director of Administration Services, University of 
Southampton. This is necessary to adhere to University procedures on insurance cover. 
Yours sincerely 
Dr. T. E. Woodcock 
Honorary Secretary 
Joint Ethics Committee 
Ene. 
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REHABILITATION RESEARCH UNIT SOUTHAMPTON GENERAL HOSPITAL 
RESEARCH ON HUMAN VOLUNTEERS 
Subject / Patient Consent Form 
,rief description of project: 
Study to investigate the usefulness of the FIM+FAM disability scale 
:onsultant in charge of project: Professor DL McLellan 
,ubject / Patient Name: ________________ Hospital number: ___ _ 
las given her /his consent to participate in the above study. The nature, purpose and possible 





;ignature: ___________________________________________ Date: __ _ 
llld witnessed by: _____________________________________ _ 




;ignature: _________________________________ Date: __ _ 




INFORMATION FOR PATIENTS 
A STUDY TO DETERMINE THE USEFULNESS OF A DISABILITY SCALE 
Ie invite you to participate in a research project which we believe to be of potential importance. 
1 order to help you to understand what the research is about, we are providing you with the 
)llowing infonnation which we want to be sure you understand before you formally agree to 
articipate. Be sure to ask any questions you have about the information which follows artd we 
,ill do our best to explain and to provide any further information you require. 
my HAVE YOU BEEN ASKED TO PARTICIPATE? 
Ie are asking all patients with neurological problems who are admitted to the Research 
ehabilitation Unit at Southampton General Hospital for in-patient rehabilitation to participate. 
rnA T ARE THE AIMS OF THE STUDY? 
• is generally believed that rehabilitation is important for people with neurological disease, but 
tis has yet to be proven. To do this staff at rehabilitation units must be able to measure the effect 
f rehabilitation accurately. This study will evaluate a measure to determine if it is accurate 
nough to be used to assess the effect of in-patient rehabilitation. This is achieved by collecting 
lformation from you and the staff who look after and treat you during your stay at the 
.ehabilitation Unit. 
lOW DOES THIS INVOLVE YOU 
you agree to participate we would ask you to answer some questions and fill in 2 questionnaires 
'lthin a few days of admission to the Rehabilitation Unit and again before discharge. This takes 
pproximatelv 20 minutes. None of these tests will interfere with vour rehabilitation in anv wav. 
he study will result in NO discomforts or hazards NOR extra"' visits to hospital than ~ouid 
rdinarily be the case. It will not interfere or affect any other medical problems you may have. 
he ,research will not be of special benefit to you during your rehabilitation. All answers are in 
~nfidence and will be coded so that they are not identifiable by name. 
PTO 
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ou are completely free not to participate and may withdraw from the study at any time. This 
ill not jeopardise the ordinary course of medical treatment (or course of study, if you are a 
udent volunteer). This will not affect your rights at all. You understand that in the event of 
IjUry caused by your participation in the research, you will be compensated irrespective of the 
~gligence of the researchers. 
you have any questions please do not hesitate to ask. More information can be obtained from 
rofessor McLellan, Consultant Neurologist at the Rehabilitation lJnit 
THANK YOU FOR YOUR CO-OPERATION 
ontact telephone number: 0703 796466 
Appendix 3 
Barthel Index (BI) 1 
1 Feeding 
0= unable; 
1 = needs help cutting, spreading butter, etc.; 
2 = independent 
2 Transfer 
0= unable, no sitting balance; 
1 = major help (one or two people, physical), can sit; 
2 = minor help (verbal or physical); 
3 = independent 
3 Grooming 
0= needs help with personal care; 
1 = independent face I hair I teeth I shaving (implements provided) 
4 Toilet use 
o = dependent; 
1 = needs some help but can do something alone; 
2 = independent (on and off, dressing, wiping) 
5 Bathing 
o = dependent; 
1 = independent (or in shower) 
1 Wade and Collin 1988 (226) 
• 
6 Mobility 
o = immobile; 
1 = wheelchair independent. including corners; 
2 = walks with the help of one person (verbal or physical); 
3 = independent (but may use aid: for example, stick) 
7 Stairs 
0= unable; 
1 = needs help (verbal, physical, carrying aid); 
2 = independent 
8 Dressing 
o = dependent; 
1 = needs help but can do about half unaided; 
2 = independent (including buttons, zips, laces, etc.) 
9 Bowel 
0= incontinent (or needs to be given enemata); 
1 = occasional accident (once a week); 
2 = continent 
10 Bladder 
o = incontinent, or catheterised and unable to manage alone; 
1 = occasional accident (once a week); 





Modified Barthel Index (MBI) 1 
A score of zero is given in all of the below activities when the patient cannot 
meet the criteria as defi ned 
1 Feeding 
2 = independent. The patient can feed him/herself a meal from a tray or 
table when someone puts the food within reach. He/she must put on an 
assistive device if this is needed, cut up the food, use salt and pepper, 
spread butter etc. He/she must accomplish this in a reasonable time. Food 
should not be pureed, soft or cut up, the patient should require no 
supervision and must be aware of the need to eat and appropriateness of 
time and place. 
1 = some help is necessary (with cutting up food etc., as listed above) or 
encouragement to commence eating but the patient is then able to feed 
him/herself without further assistance or supervision. 
2 Moving from wheelchair to bed and return 
3 = independent in all phases of this activity. Patient can safely approach 
the bed in his/her wheel chair, lock brakes, lift footrests, move safely to 
bed, lie down, come to a sitting position on the side of the bed, change the 
1 Novick et al. 1996 (237) 
• 
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position of the wheel chair, if necessary, to transfer back into it safely and 
return to the wheelchair. Patient must recognise the need to transfer and do 
so in appropriate circumstances without supervision. 
2 = either some minimal help is needed in some step of this activity or the 
patient needs to be reminded or supervised for safety of one or more parts 
of this activity. 
1 = patient can come to a sitting position without the help of a second 
person but needs to be lifted out of bed, or if s/he transfers with a great deal 
of help, e.g. one strong / skilled or two normal persons. 
3 Doing personal toilet (grooming) 
1 = patient can wash hands and face, comb hair, clean teeth, and shave. 
He may use any kind of razor but must put in blade or plug without help as 
well as get it from draw or cabinet. Female patients must put on own make-
up if use, but need not braid or style hair. The patient must recognise the 
need to groom and be able to request toiletries as required. A patient who 
requires telling to wash/shave is dependent. 
0= patient requires any degree of assistance, physical or verbal. 
4 Getting on and off toilet 
2 = patient must be able to get on and toilet, fasten and unfasten clothes, 
prevent soiling of clothes and use toilet paper without help. S/he may use a 
wall bar or other stable object for support if required. if it is necessary to use 
I 
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the bedpan instead of a toilet, he/she must be able to place it on a chair, 
empty it and clean it. Patient must both recognise the need to use the toilet 
and be able to get there independently. 
1 = patient needs help because of imbalance or in handling clothes or in 
using toilet paper or requires directing or moving to the toilet. 
5 Bathing self 
1 = patient may use a bath tub, shower, or take a complete sponge bath. 
S/he must be able to do all the steps involved in whatever method is 
employed without another person being present. The patient recognised 
that he/she needs a bath/shower. 
6a Walking on a level surface 
3 = patient can walk at least 50 yards on the level without help or 
supervision. S/he may wear braces or prostheses and use crutches, canes 
or a walkerette but not a rolling walker. S/he must be able to lock and 
unlock brakes if used, assume the standing position and sit down, get the 
necessary mechanical aids into position for use, and dispose of them when 
sitting. (Putting on and taking off braces is scored under dressing.) S/he 
must be able to negotiate obstacles in home or ward environment. Walking 
must be purposeful and constructive. 
2 = patient needs help or supervision with any of the above but can walk at 
least 50 yards with a little help. 
I 
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6b Propelling a wheelchair 
1 = if patient cannot ambulate but can propel a wheelchair independently. 
S/he must be able to go round corner, turn round, manoeuvre the chair to a 
table, bed, toilet etc. S/he must be able to push a chair 50 yards. Do not 
score this item if patients gets scored for walking. Movement must be 
purposeful and constructive and not demand constant supervision or 
restraint. 
7 Ascending or descending stairs 
2 = patient is able to go up and down a flight of stairs without supervision or 
help. S/he may use handrails, crutches, or canes when needed. S/he 
must be able to carry canes or crutches as s/he ascends or descends stairs. 
Climbing of stairs must be purposeful, e.g. a person who needs to told to go 
upstairs to bed I toilet etc. needs supervision 
1 = patient needs help or supervision with any of the above items. 
0= patient unable to climb stairs or mobility on stairs, because of cognitive 
impairment, demands constant supervision. 
8 Dressing and undressing 
2 = patient is able to put and remove and fasten all clothing and tie 
shoelaces (unless it is necessary to use adaptations for this). The activity 
includes putting on and removing and fastening corset, braces or artificial 
limbs etc. when these are prescribed, but not bras. Such special clothing 
as suspenders, loafer shoes, dresses that open down the front may be 
used when necessary. Patient must recognise the need to dress and 
undress and do so at appropriate times. 
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1 = patients needs help in putting on and removing or fastening any clothing. 
S/he must be able to do at least half the work her/himself. S/hr must 
accomplish this in a reasonable time. S/he requires to be instructed to dress 
or undress, or requires help with selecting clothes. 
9 Controlling bowels 
2 = patient is able to control bowels and have no accidents. S/he can use a 
suppository or take an enema when necessary (as for spinal cord patients 
who have had bowel training). Patient requires no staff supervision 
whatsoever to avoid accidents and does not defecate in inappropriate 
places 
1 = patient requires help in using a suppository or enema, or has occasional 
accidents (occasional = one a week), or requires supervision of staff to 
avoid accidents. 
o = incontinent or frequently defecates in inappropriate places. 
10 Controlling bladder 
2 = patient is able to control bladder day and night. Spinal cord injury 
patients (or other) who use an external device (or catheter) must put them 
on independently, clean and empty leg bag, and stay dry day and night. 
1 = patient has occasional accidents, cannot wait for the bedpan, get to the 
toilet in time, needs help with an external device. requires staff supervision 
to avoid accidents (e.g. to be woken during the night) or occasionally 
micturates in inappropriate places. 




Kurtzke Expanded Disability Status Scale (EDSS) 1 
o Normal neurological exam (all grade 0 in Functional Systems [FS]; 
Cerebral grade 1 acceptable.) 
1.0 No disability, minimal signs in one FS (i.e. grade 1 excluding 
Cerebral grade 1.) 
1.5 No disability, minimal signs in one or more FS (more than one grade 
1 excluding cerebral grade 1.) 
2.0 Minimal disability in one FS (one FS grade 2, others 0 or 1.) 
2.5 Minimal disability in two FS (two FS grade 2, others 0 or 1.) 
3.0 Moderate disability in one FS (one FS grade 3, others 0 or 1), or 
mild disability in three or four FS (three/four FS grade 2, other 0 or 1) 
though fully ambulatory. 
3.5 Fully ambulatory but with moderate disability in one FS (one grade 3) 
and one or two FS grade 2; or two FS grade 3; or five FS grade 2 
(other 0 or 1.) 
4.0 Fully ambulatory without aid, self-sufficient, up and about some 12 
hours a day despite relatively severe disability consisting of one FS 
grade 4 (others 0 or 1), or combinations of lesser grades exceeding 
limits of previous steps. Able to walk without aid or rest some 500 
meters. 
1 Kurtzke 1983 (38) 
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4.5 Fully ambulatory without aid, up and about much of the day, may 
otherwise have some limitations of full activity or require minimal 
assistance; characterised by relatively severe disability, usually 
consisting of one FS grade 4 (others 0 or 1) or combinations of lesser 
grades exceeding limits of previous steps. Able to walk without aid or 
rest for some 300 meters. 
5.0 Ambulatory without aid or rest for about 200 meters; disability severe 
enough to impair full daily activities (e.g. to work full day without 
special provisions). (Usual FS equivalents are one grade 5 alone, 
other 0 or 1; or combinations of lesser grades usually exceeding 
specifications for step 4.0.) 
5.5 Ambulatory without aid or rest for about 100 meters; disability severe 
enough to preclude full daily activities. (Usual FS equivalents are 
one grade 5 alone, other 0 or 1; or combinations of lesser grades 
usually exceeding specifications for step 4.0.) 
6.0 Intermittent or unilateral constant assistance (cane, crutch, or brace) 
required to walk about 100 meters without resting. (Usual FS 
equivalents are combinations with more than two FS grade 3+.) 
6.5 Constant bilateral assistance required to walk about 20 meters 
without resting. (Usual FS equivalents are combinations with more 
than two FS grade 3+.) 
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7.0 Unable to walk beyond five meters even with aid, essentially 
restricted to wheelchair; wheels self in standard wheelchair and 
transfers alone; up and about in wheelchair some 12 hours a day. 
(Usual FS equivalents are combinations with more than two FS grade 
4+; very rarely, pyramidal grade 5 alone.) 
7.5 Unable to take more than a few steps; restricted to wheelchair; may 
need aid in transfer; wheels self but cannot carry on in standard 
wheel chair a full day; may require motorized wheelchair. (Usual FS 
equivalents are combinations with more than two FS grade 4+.) 
8.0 Essentially restricted to bed or chair or perambulated in wheelchair; 
but may be out of bed itself much of the day; retains many self-care 
functions; generally has effective use of arms. (Usual FS 
equivalents are combinations, generally grade 4+ in several 
systems.) 
8.5 Essentially restricted to bed much of the day; has some effective use 
of arm(s); retains some setf-care functions. (Usual FS equivalents 
are combinations, generally grade 4+ in several systems.) 
9.0 Helpless bed patient; can communicate and eat. (Usual FS 
equivalents are combinations, most grade 4+.) 
9.5 Totally helpless bed patient; unable to communicate effectively or 
eat/swallow. (Usual FS equivalents are combinations, almost all 
grade 4+.) 
10 Death due to MS 
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Appendix 6 
Office of Population Censuses and Surveys Disability Scales (OPCS) 1 
1 Dimensions of disability 
1.1 Locomotion 
Code Description 
L1 Cannot walk at all 
L2 Can only walk a few steps without stopping or severe 
discomfort; cannot walk up and down one step 
L3 Has fallen 12 or more times in the last year 
L4 Always needs to hold on to something to keep balance 
L5 Cannot walk up and down a flight of 12 stairs 
L6 Cannot walk 50 yards (metres) without stopping or 
severe discomfort 
L7 Cannot bend down far enough to touch knees and 
straighten up again 
La Cannot bend down and pick something up from the floor 
and straighten up again 
L9 Cannot walk 200 yards (metres) without stopping or 
severe discomfort; or can only walk up and down a flight 
of 12 stairs if holds on and takes a rest; or often needs 
to hold on to something to keep balance; or has fallen 
three or more times in the last year 
L10 Can only walk up and down a flight of 12 stairs if 
holding on (doesn't need a rest). 
L11 Cannot bend down to sweep up something from the 
floor and straighten up again 
L12 Can only walk up and down a flight of stairs if going 
side- ways or one step at a time 
L13 Cannot walk 400 yards (metres) without stopping or 
severe discomfort 
1.2 Eating, drinking, and digestion 
Code Description 
EDD1 Suffers from problems with eating, drinking, or digestion 
which severely affects the ability to lead a normal life 



















1.3 Disfigurement (scars, blemishes, and deformities) 
Code Description 
DF1 Suffers from a scar, blemish, or deformity which 
severely affects the ability to lead a normal life 
1.4 Reaching and stretching 
Code Description 
RS1 Cannot hold out either arm in front to shake hands 
RS2 Cannot put either arm up to the head to put a hat on 
RS3 Cannot put either hand behind the back to put a jacket 
on or to tuck his shirt in 
RS4 Cannot raise either arm above the head to reach for 
some-thing 
RS5 Has difficulty holding either arm in front to shake hands 
with someone 
RS6 Has difficulty putting either arm to his or her head to put 
a hat on 
RS7 Has difficulty putting either hand behind the back to put 
a jacket on or to tuck his shirt in 
RSB Has difficulty raising either arm above the head to reach 
for something 
RS9 Cannot hold one arm out in front or up to the head (but 
can with the other arm) 
RS10 Cannot put one arm behind the back to put on a jacket 
or to tuck his shirt in (but can with the other arm); or has 
difficulty putting one arm behind the back to put a jacket 
on, or to tuck his shirt in; or putting one arm out in front, 


















1.5 Personal care 
Code Description Severity 
score 
PC1 Cannot feed self without help; or cannot go to and use 11.0 
the toilet without help 
PC2 Cannot get into and out of bed without help; or cannot 9.5 
get into and out of a chair without help 
PC3 Cannot wash hands and face without help; or cannot 7.0 
dress and undress without help 
PC4 Cannot wash all over without help 4.5 
PC5 Has difficulty feeding self; or has difficulty getting to and 2.5 
using the toilet 
PC6 Has difficulty getting in and out of bed; or has difficulty 1.0 
getting in and out of a chair 
1.6 Dexterity 
Code Description Severity 
score 
01 Cannot pick up and hold a mug of coffee with either 10.5 
hand 
02 Cannot turn a tap (faucet) or control knobs on a cooker 9.5 
with either hand 
03 Cannot pick up and carry a pint of milk or squeeze the 8.0 
water from a sponge with either hand 
04 Cannot pick up a small object such as a safety pin with 7.0 
either hand 
05 Has difficulty picking up and pouring from a full kettle, or 6.5 
serving food from a pan using a spoon or ladle 
06 Has difficulty unscrewing the lid of a coffee jar or using 5.5 
a pen or pencil 
07 Cannot pick up and carry a 5 lb. (2 kg) bag of potatoes 4.0 
with either hand 
08 Has difficulty in wringing out light washing or using a 3.0 
pair of scissors 
09 Can pick up and hold a mug of tea or coffee with one 2.0 
hand but not with the other 
010 Can turn a tap or control a knob with one hand but not 1.5 
with the other; or can squeeze the water from a sponge 
with one hand but not with the other 
011 Can pick up a small object such as a safety pin with one 0.5 
hand but not with the other, or can pick up and carry a 
pint of milk with one hand but not with the other; or has 






















No voluntary control over bowels 
No voluntary control over bladder 
Loses control of bowels at least once every 24 hou rs 
Loses control of bladder at least once every 24 hours 
Loses control of bowels at least once a week 
Loses control of bowels at least twice a month 
Loses control of bladder at least once a week 
Loses control of bowels at least once a month 
Loses control of bladder at least twice a month; or loses 
control of bowels occasionally 
Loses control of bladder at least once a month 
Loses control of bladder occasionally; or uses a device 
to control bowels or bladder 
Communication 
Description 
Is impossible for people who knew him/her well to 
under- stand; or finds it impossible to understand 
people who know him/ her well 
Is impossible for strangers to understand; or is very 
difficult for people who know him/her well to understand; 
or finds it impossible to understand strangers; or finds it 
very difficult to understand people who know him/her 
well 
is very difficult for strangers to understand; or is quite 
difficult for people who know him/her well to understand; 
or finds it difficult to understand strangers; or finds it 
quite difficult to understand people who know him/her 
well 
Is quite difficult for strangers to understand; or finds it 
quite difficult to understand strangers 
Other people have some difficulty in understanding 
himlher; or has some difficulty understanding what other 
























Code Description Severity 
score 
B1 Gets so upset that he or she hits other people, or injures 10.5 
him/herself. 
B2 Gets so upset that he or she breaks or rips up things 7.5 
B3 Feels the need to have someone present all the time 7.0 
B4 Finds relationships with members of the family very 6.0 
difficult 
B5 Often has outbursts of temper at other people with very 4.0 
little cause 
B6 Finds relationships with people outside the family very 2.5 
difficult 
B7 Sometimes sits for hours doing nothing 1.5 
B8 Finds it difficult to stir him/herself to do things; or often 0.5 
feels aggressive or hostile towards other ~eo~le 
1.10 Intellectual functioning 
Code No. of Severity Number of problems from the following list: 
~roblems score 
11 11 13.0 Often forgets what he or she was 
supposed to be doing in the middle of 
something 
12 10 12.0 Often loses track of what is being said in 
the middle of a conversation 
13 9 10.5 Thoughts tend to be muddled and slow 
14 8 9.5 Often gets confused about what time of 
day it is 
15 7 8.0 Cannot watch a half-hour TV programme 
all the way through and tell someone what 
it was about 
16 6 7.0 Cannot remember and pass on a message 
correctly 
17 5 6.0 Often forgets to turn off things such as 
fires, cookers, or taps (faucets) 
18 4 4.5 Often forgets names of people in the family 
or friends seen regularly 
19 3 3.5 Cannot read a short article in newspaper 
110 2 2.0 Cannot write a short letter to someone 
without help 




Code Description Severity 
score 
S1 Cannot tell by the light where the windows are 12.0 
S2 Cannot see the shapes of furniture in a room 11.0 
53 Cannot see well enough to recognise a friend if close to 10.0 
his face 
54 Cannot see well enough to recognise a friend who is an 8.0 
arm's length away 
55 Cannot see well enough to read a newspaper headline 5.5 
56 Cannot see well enough to read a large print book 5.0 
57 Cannot see well enough to recognise a friend across a 4.5 
room 
58 Cannot see well enough to recognise a friend across a 1.5 
road 
59 Has difficulty seeing to read ordinary newsQaQer Qrint 0.5 
1.12 Consciousness 
Code 'Fit'score Severity Add scores for the following items relating to 
score eQileQtic fits: 
C51 13.8 12.5 Frequency of fits: 
o = less than once a year 
C52 12.8 - 13.0 11.5 1 = once a year but fewer than four times a 
year 
C53 11.8 10.5 2 = four times/year but less than once a month 
C54 10.8 10.0 3 = once a month but less than once a week 
C55 9.8 - 10.0 9.0 4 = once a week but less than every day 
C56 8.8 - 9.0 8.0 5 = every day 
C57 7.8 - 8.0 7.0 Timing of fits: 
C58 6.8 - 7.0 6.0 1 = only has fits during the night 
C59 5.8 - 6.0 5.0 3.8 = only has fits at night or on awakening 
C510 4.8 - 5.0 4.0 5.8 = only has fits at night, on awakening or in 
the evening 
C511 4.0 3.0 6.8 = has fits during the daytime 
C512 3.0 2.0 Warning of fit: 
C513 2.0 1.0 o = always has a warning before a fit 
1 = has fits without warning 
C514 1.0 0.5 Consciousness in fit: 
o = does not lose consciousness 
1 = loses consciousness during fit 
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1.13 Hearing 
Code Description Severity 
score 
H1 Cannot hear at all 11.0 
H2 Cannot follow a TV programme with the volume turned 8.5 
up 
H3 Has difficulty hearing someone talking in a loud voice in 6.0 
a quiet room 
H4 Cannot hear a doorbell, alarm clock, or telephone bell 5.5 
H5 Cannot use the telephone 4.0 
H6 Cannot follow a TV programme at a volume others find 2.0 
acceptable 
H7 Difficulty hearing someone talking in a normal voice in a 1.5 
quiet room 
H8 Difficulty in following a conversation against background 0.5 
nOise 
2 Overall weighted disability severity score (WSS) 
This is computed from ten of the 13 OPCS disability scales (eating, 
drinking, digestion, disfigurement, and consciousness are excluded) using 
the following formula: 
WSS = worst score + (0.4 x second worst score) + (0.3 x third worst score) 
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3 Disability severity category 
OPCS weighted OPCS severity 
severity score category 
0.5 - 2.95 1 
3 - 4.95 2 
5 - 6.95 3 
7 - 8.95 4 
9 - 10.95 5 
11 - 12.95 6 
13 - 14.95 7 
15-16.95 8 
17 - 18.95 9 
19 - 21.40 10 
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Appendix 7 
London Handicap Scale (LHS) 1 
This questionnaire is about the way your health affects your everyday life. 
Please read the instructions for each question and then answer by ticking 
the box next to the sentence which describes you best. When answering 
the questions, it may help to think about the things you have done over the 
last week and compare yourself with someone like you who is in good 
health. 
1 Getting around 
Think about how you get from one place to another, using any help, aids, 
or means of transport that you normally have available. Does your health 
stop you from getting around? 
Not at all - You go everywhere you want to, no matter how far away. 
Very slightly - You go most places you want, but not all. 
Quite a lot - You get out of the house, but not far away from it. 
Very much - You don't go outside, but you can move around from room to 
room indoors. 
Almost completely - You are confined to a single room, but can move 
around in it 
1 Harwood and Ebrahim 1995 (241) 
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Completely - You are confined to a bed or a chair. You cannot move around 
at all. There is no-one to move you. 
2 Looking after yourself 
Think about things like housework, shopping, looking after money, cooking, 
laundry, getting dressed, washing, shaving and using the toilet. Does your 
health stop you looking after yourself? 
Not at all - You can do everything yourself. 
Very slightly - Now and again you need a little help. 
Quite a lot - You need help with some tasks (such as heavy housework or 
shopping), but no more than once a day. 
Very much - You can do some things but you need help more than once a 
day. You can be left alone safely for a few hours. 
Almost completely - You need help to be available all the time. You 
cannot be left alone safely. 
Completely - You need help with everything. You need constant 
attention, day and night. 
3 Work and leisure 
Think about things like work (paid or not), housework, gardening sports, 
hobbies, going out with friends, travelling, reading, looking after children, 
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watching television and going on holiday. Does your health limit your work 
or leisure activities? 
Not at all - You can do everything you want to do. 
Very slightly - You can do almost all the things you want to do. 
Quite a lot - You find something. to do almost ail the time, but cannot do 
some things for as long as you would like. 
Very much - You are unable to do a lot of things, but can find something to 
do most of the time. 
Almost completely - You are unable to do most things, but can find 
something to do some of the time. 
Completely - You sit all day doing nothing. You cannot keep yourself busy 
or take part in activities. 
4 Getting on with people 
Think about family, friends and the people you might meet during a normal 
day. Does your health stop you getting on with people? 
Not at all - You get on well with people, see everyone you want to see, and 
meet new people. 
Very slightly - You get on well with people, but your social life is slightly 
limited. 
Quite a lot - You are fine with people you know well, but you feel 
uncomfortable with strangers. 
Very much - You are fine with. people you know well but you have few 
friends and little contact with neighbours. Dealing with strangers is very 
hard. 
Almost completely - Apart from the person who looks after you, you 
see no-one. You have no friends and no visitors. 
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Completely - You don't get on with anyone, not even people who look after 
you 
5 Awareness of your surroundings 
Think about taking in and understanding the world about you, and finding 
your way around in it. Does your health stop you understanding the world 
around you? 
Not at all - You fully understand the world around you. You see, hear, speak 
and think clearly, and your memory is good. 
Very slightly - You have problems with hearing, speaking, seeing or 
Your memory, but these do not stop you doing most things. 
Quite a lot - You have problems with hearing, speaking, seeing pr our 
memory which make life difficult a lot of the time. But, you understand what 
is going on. 
Very much - You have great difficulty understanding what is going on. 
Almost completely - You are unable to tell where you are or what day it is. 
You cannot look after yourself at all. 
Completely - You are unconscious, completely unaware of anything 
going on around you. 
6 Affording the things you need 
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Think about whether health problems have led to any extra expenses, or 
have caused you to earn less than you mould if you mere healthy. Are you 
able to afford the things you need? 
Yes, easily - You can afford everything you need. You have easily enough 
money to buy modern labour-saving devices, and anything you may need 
because of ill-health. 
Fairly easily - You have just about enough money. It is fairly easy to cope 
with expenses caused by ill-health. 
Just about - You are less well off than other people like you; however, with 
sacrifices you can get by without help. 
Not really - You only have enough money to meet your basic needs. You 
are dependent on state benefits for any extra expenses you have because 
of ill-health. 
No - You are dependent on state benefits, or money from other people or 
charities. You cannot afford things you need. 
Absolutely not - You have no money at all and no state benefits. You are 




Medical Outcomes Study 36-ltem Short-Form Health Survey (SF-36) 1 
This survey asks for your views about your health. This information will help 
keep track of how you feel and how well you are able to do your usual activities. 
Answer every question by marking the answer as indicated. If you are unsure 
about how to answer a question, please give the best answer you can. 
1. In general, would you say your health is (circle one): 
Excellent - 1 
Very good - 2 
Good - 3 
Fair - 4 
Poor - 5 
2. Compared to one year ago, how would you rate your health in general now? 
Ware et a/. 1993 (56) 
(ci rcle one) 
Much better now than one year ago - 1 
Somewhat better now than one year ago - 2 
About the same as one year ago - 3 
Somewhat worse now than one year ago - 4 
Much worse now than one year ago - 5 
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3. The following questions are about activities you might do during a typical 
day. Does your health now limit you in these activities? If so, how much? 
(circle one number on each line) 
Yes, Yes, No, not 
ACTIVITIES limited limited limited 
a lot a little at all 
~. Vigorous activities, such as 1 2 3 
running, lifting heavy objects, 
IparticipatinQ in strenuous sports 
b. Moderate activities, such as 1 2 3 
moving a table, pushing a vacuum 
~Ieaner, bowling, or playing golf 
~. Lifting or carrying groceries 1 2 3 
/d. Climbing several flights of stairs 1 2 3 
Ie. Climbing one flight of stairs 1 2 3 
~. Bending, kneeling, or stooping 1 2 3 
[g. Walking more than a mile 1 2 3 
h. Walking hall a mile 1 2 3 
i. Walking one hundred yards 1 2 3 
'. Bathing or dressing yourself 1 2 3 
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luring the past 4 weeks, have you had any of the following problems with 
yUUI ¥York or other regular daily activities as a result of your physical health? 
(circle one number on each line) 
YES NO 
a. Cut down on the amount of time you spent on work 1 2 
or other activities 
b. Accomplished less than you would like 1 2 
c. Were limited in the kind of work or other activities 1 2 
d. Had difficulty performing the work or other activities 1 2 
I(for example, it took extra effort) 
5. During the past 4 weeks, have you had any of the following problems with 
your work or other regular daily activities as a result of any emotional Problems 
(such as feeling depressed or anxious)? 
(circle one number on each line) 
YES NO 
a. Cut down on the amount of time you spent on 1 2 
work or other activities 
b. Accomplished less than you would like 1 2 
c. Didn't do work or other activities as carefully as 1 2 
usual 
luring the past 4 weeks, to what extent has your physical health or 
~motional 1 problems interfered with your normal social activities with 
family, friends, neighbours, or groups (circle one)? 
Not at all - 1 
Slightly - 2 
Moderately - 3 
Quite a bit - 4 
Extremely - 5 
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7. How much bodily pain have you had during the past 4 weeks (circle one)? 
None - 1 
Very mild - 2 
Mild - 3 
Moderate - 4 
Severe - 5 
Very severe - 6 
8. During the past 4 weeks, how much did pain interfere with your normal 
work (including both work outside the home and housework) (circle one)? 
Not at all - 1 
A little bit - 2 
Moderately - 3 
Quite a bit - 4 
Extremely - 5 
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rhese questions are about how you feel and how things have been with 
you during the past 4 weeks. For each question, please give the one answer 
that comes closest to the way you have been feeling. How much of the time 
during the past 4 weeks -
(circle one number on each line) 
A good A 
All Most bit of Some little None 
of the of the the of the otthe otthe 
time time time time time time 
a. Did you feel full of life? 1 2 3 4 5 6 
b. Have you been a very nervous 1 2 3 4 5 6 
person? 
c. Have you felt so down in the dumps 
that nothing could cheer you up? 1 2 3 4 5 6 
d. Have you felt calm and peaceful? 1 2 3 4 5 6 
e. Did you have a lot of energy? 1 2 3 4 5 6 
f. Have you felt downhearted and low? 1 2 3 4 5 6 
Ig. Did you feel worn out 1 2 3 4 5 6 
h. Have you been a happy person? 1 2 3 4 5 6 
i. Did you feel tired? 1 2 3 4 5 6 
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Juring the past 4 weeks. how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with 
friends, relatives, etc.) ? 
(circle one) 
All of the time - 1 
Most of the time - 2 
Some of the time - 3 
A little of the time - 4 
None of the time - 5 
11. How TRUE or FALSE is each of the following statements for you? 
(circle one number on each line) 
Definitely Mostly Don't Mostly Definitely 
true true know false false 
a. I seem to get ill a 
little easier than other 1 2 3 4 5 
ipeople 
b. I am as healthy as 1 2 3 4 5 
anybody I know 
c. I expect my health to 1 2 3 4 5 
Iget worse 
d. My health is 1 2 3 4 5 
!excellent 
Copyright © 1992 New England Medical Center Hospitals, Inc. All rights reserved. (MOS SF-36 English (UK) Version 1.1 
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Appendix 9 
General Health Questionnaire (GHQ) 1 
We should like to know if you have had any medical complaints and how your health has been, over the past few weeks. Please answer all 
the questions on the following pages simply by marking the answer which you think most nearly applies to you. Remember that we want to 
know about present and recent complaints, not about those you have had in the past. Have you recently: 
Item score 0 score 1 
Been feeling perfectly well and in good health? better than usual same as usual worse than usual much worse than 
usual 
Been feeling in need of a good tonic? not at all no more than usual rather more than much more than 
usual usual 
Been feeling run down and out of sorts? not at all no more than usual rather more than much more than 
usual usual 
Felt that you are ill? not at all no more than usual rather more than much more than 
usual usual 
Been getting any pains in your head? not at all no more than usual rather more than much more than 
usual usual 
Been getting a feeling of tightness or pressure in your not at all no more than usual rather more than much more than 
head? usual usual 
Been having hot or cold spells? not at all no more than usual rather more than much more than 
usual usual 




Item score 0 score 1 
Lost much sleep over worry? not at all no more than usual rather more than much more than 
usual usual 
Had difficulty staying asleep once you were off? not at all no more than usual rather more than much more than 
usual usual 
Felt constantly under strain? not at all no more than usual rather more than much more than 
usual usual 
Been getting edgy and bad-tempered? not at all no more than usual rather more than much more than 
usual usual 
Been getting scared or panicky for no good reason? not at all no more than usual rather more than much more than 
usual usual 
Found everything getting on top of you? not at all no more than usual rather more than much more than 
usual usual 
Been feeling nervous and strung-up all the time? not at all no more than usual rather more than much more than 
usual usual 
Been managing to keep yourself busy and occupied? more so than usual same as usual rather less than much less than 
usual usual 
Been taking longer over things you do? quicker than usual same as usual longer than usual much longer than 
usual 
Felt on the whole you were doing things well ? better than usual about the same as less well than usual much less well 
usual 








Felt that you are playing a useful part in things? 
Felt capable of making decisions about things? 
Been able to enjoy your normal day to day activities 
Been thinking of yourself as a worthless person? 
Felt that life is entirely hopeless? 
Felt that life isn't worth living? 
Though of the possibility that you might make away 
with yourself? 
Found at times you coutdn't do anything because you 
nerves were too bad? 
Found yourself wishing you were dead and away from 
it all ? 
Found that the idea of taking your own life kept coming 
into your mind? 
score 0 
more so than usual same as usual 
more so than usual same as usual 
more so than usual same as usual 
not at all no more than usual 
not at all no more than usual 
not at all no more than usual 
definitely not I don't think so 
not at all no more than usual 
not at all no more than usual 
definitely not I don't think so 
score 1 
less useful than much less useful 
usual 
less so than usual much less capable 
less so than usual much less than 
usual 
rather more than much more than 
usual usual 
rather more than much more than 
usual usual 
rather more than much more than 
usual usual 
has crossed my definitely has 
mind 
rather more than much more than 
usual usual 
rather more than much more than 
usual usual 







Mini-Mental State Examination (MMSE) 
Record response to each question 
Domain tested and test 
Orientation 
Year, month, day, date, time 
Country, town, district, hospital, ward 
Registration 
Examiner names three objects (for example, apple, 
table, penny) 
Patient asked to repeat three names-score one for 
each correct answer 
Then patient to learn three names (i.e. repeat until 
correct) 





Subtract 7 from 100, then repeat from result, etc. 15 
Stop after 5. 
100,93,86,79,72,65. 
(Alternative: spell 'world' backwards. 0 L ROW) 
Recall 
Ask for three objects learnt earlier 13 
1 Foistein at al. 1975 (251) 
417 
Domain tested and test Score 
Language 
Name a pencil and watch 1 2 
Repeat 'No ifs, ands, or buts' 1 1 
Give a three-stage command. Score one for each 13 
stage 
(e.g. 'Place index ringer of right hand on your 
nose, and then on your left ear. ') 
Ask patient to read and obey a written command 
on a piece of paper stating: 'Close your eyes' 11 
Ask patient to write a sentence. Score if it is 
sensible and has a subject and a verb 1 1 
Copymg 11 





Staff-report transition question of change in disability 
Name: Study No. 
In the opinion of the treating multidisciplinary team, this person has undergone 












Effect of the FIM and FIM+FAM training programme 
on rating proficiency 
Objectives 
1 To determine FIM and FIM+FAM rating accuracy for individuals and 
multidisciplinary teams (MDT). 
2 To quantify the effect of the formal training programme on the 
accuracy of individual person rating. 
Method 
Vignettes (simple, short, written scenarios of patient performance) with 
model answers were provided by the developers of the FIM+FAM. At the 
formal FIM and FIM+FAM training day individuals from the three 
rehabilitation units rated 30 standard vignettes, one for each item of the FIM 
and FIM+FAM, before and after training. In addition, after training only, 
clinicians formed MDT's (minimum of three disciplines) and rated by 
consensus opinion a set of 30 different vignettes. Manuals were provided. 
Results are reported as percent exact agreement with the model answers 
and standard deviations (SO). 
Results 
Sixty one clinicians attended the training days (NRU n = 18, RNRU n = 23, 
RRU n = 20). Seven clinical disciplines were represented: physiotherapy 
(n = 16), occupational therapy (n = 11), nursing (n = 18), speech and 
language therapy (n = 8), neuropsychology (n = 2), social work (n = 3), 
medicine (n = 3). 
Mean percent exact agreement with model answers were: 




Mean percent (SD) exact agreement 







Results indicate that a comprehensive one day training programme did not 
improve individual rating accuracy for vignettes. However, team consensus 
rating is far superior to individual rating. 
